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ABSTRACT 
 
 
Tryptophan and unnatural tryptophan derivatives are important building blocks 
for the total synthesis of natural products, as well as the development of new drugs, 
biological probes, and chiral small molecule catalysts. This thesis describes various 
catalytic methods for the preparation of tryptophan derivatives as well as their 
functionalization and use in natural product total synthesis.  
Herein, the tandem Friedel–Crafts conjugate addition/asymmetric protonation 
reaction between 2-substituted indoles and methyl 2-acetamidoacrylate to provide 
enantioenriched trytophans is reported. This method inspired further work in the area of 
transition metal catalyzed arylation reactions.	  We report the development of the copper-
catalyzed arylation of tryptamine and tryptophan derivatives. The utility of these 
transformations is highlighted in the five-step syntheses of the natural products (+)-
naseseazine A and B. Further work on the development of a mild and general Larock 
indolization protocol to access unnatural tryptophans is also discussed.  
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Chapter 1 
An Introduction to Tryptophan 
 
1.1 INTRODUCTION 
Tryptophan and unnatural tryptophan derivatives are important building blocks in 
the total synthesis of natural products, as well as for the development of new drugs,1 
biological probes,2 and chiral small molecule catalysts.3 The central tryptophan motif can 
be found within numerous biologically active natural products, either explicitly or 
implicitly, some of which are shown in Figure 1.1. Furthermore, the utilization of 
functionalized tryptophans for the study of complex biological systems has served as an 
important strategy for studying protein conformational dynamics as well as elucidating 
key protein interactions, such as the identification of a critical cation–π interaction of the 
nicotinic acetylcholine receptor.2c 
Biosynthetically, these key amino acids serve as the basis for another fascinating 
class of natural products, the pyrroloindoline alkaloids.4 This family comprises a large 
class of compounds characterized by their unique indoline fused pyrrolidine core (Figure 
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1.1).  These compounds have been shown to exhibit a broad array of biological activity 
across a range of cell lines that is intricately related to their broad structural diversity. 
Given their promising medicinal relevance, these products have inspired innovative work 
on new synthetic methodologies to access the central pyrroloindoline framework that 
have culminated in the total synthesis of a number of these challenging natural products.5  
Figure 1.1. Trytophan and cyclotryptophan natural products 
 
 Together, these molecules have served as topics of intense interest from synthetic 
chemists and chemical biologists alike. The following introductory chapter serves to 
briefly summarize and highlight modern synthetic strategies and tactics to access 
unnatural tryptophan derivatives as well as pyrroloindoline alkaloids with selected 
examples in total synthesis. 
 
1.2 SYNTHESIS OF TRYPTOPHAN DERIVATIVES 
 
 Due to their pervasiveness across many fields, the development of new methods 
to access enantioenriched tryptophan derivatives represents an important endeavor in 
synthetic chemistry.1,2,3 This is particularly true due the inherent challenges associated 
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3 
with selective backbone functionalization of the indole nucleus, making simple 
derivatization of natural (L)-tryptophan largely untenable. As a result, a range of methods 
for the preparation of enantioenriched unnatural tryptophans, including auxiliary 
controlled, enantiospecific, and enantioselective methods, have been reported.6  
 Surprisingly, to date, there exist relatively few convergent and enantioselective 
syntheses of tryptophan derivatives lacking β-substitution. Perhaps the most common 
method to access unnatural amino acids is through the asymmetric hydrogenation of 
dehydroamino acids.  In 1980, Townsend and co-workers demonstrated that subjection of 
6-methyl dehydrotryptophan to [Rh(COD)Cl]2, copper-phosphine complex 10, and 45 psi 
of hydrogen gas gave 6-methyl tryptophan (9) in high enantiomeric excess (Scheme 1.1, 
a).7 Subsequent work on asymmetric hydrogenation has further streamlined this process 
to provide excellent ee’s at low Rh-catalyst loadings, making it an efficient choice in 
many instances. Still, the preparation of the dehydroamino acids, often from the 
corresponding carboxyaldehyde, can sometimes require a laborious synthetic 
undertaking. 
An alternative enantioselective method was described by Leckta and co-workers 
in 1998.  By employing 5 mol % of copper-BINAP catalyst 13, tosylindoline 11 can 
undergo an enantioselective imino-ene reaction to furnish tosyl tryptophan derivative 12 
in 90% yield and 85% ee (Scheme 1.1, b).8  While this method offers access to 
enantioenriched products, strict substrate requirements limit the generality of this 
approach and thus this method has largely not been broadly adopted for tryptophan 
synthesis. 
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Scheme 1.1. Enantioselective methods for the synthesis of unnatural tryptophans 
 
Given the dearth of catalytic, enantioselective methods reported to date, 
alternative strategies are also commonly employed, including enantiospecific and 
auxiliary-controlled methods. One such enantiospecific approach utilizes ortho-
iodoanlines (14) in conjunction with an amino-acid derived coupling partner (Scheme 
1.2, a).9 In 1999, Cook and co-workers reported the Pd(0)-catalyzed heteroannulation 
(Larock indole synthesis) of o-iodoaniline with Schöllkpf-auxiliary derived triethylsilyl 
alkyne 15. Utilizing Larock’s originally reported conditions, functionalized indoles 
containing the amino acid moiety masked as a bis-imidate are efficiently synthesized 
(16). These products can be readily advanced to the parent amino acid through sequential 
acid-mediated hydrolysis followed by saponification. A complementary approach to the 
Larock indole synthesis was reported by Jia and Zhu in 2005, utilizing an aldehyde 
coupling partner (17) in place of a disubstituted alkyne (Scheme 1.2, b).10 Operating 
through the intermediacy of the aldimine, Pd-mediated heteroannulation affords 2-
unsubstituted tryptophans in moderate to good yield. Importantly, this method requires 
the formation of reactive aliphatic aldehyde intermediates and therefore necessitates 
protection of the amine as an imide. 
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Scheme 1.2. Enantiospecific methods for the synthesis of unnatural tryptophans 
 
 Lewis-acid mediated coupling strategies have also been employed for tryptophan 
synthesis from enantiopure starting materials. In 1989, Sato and Kozikowski reported a 
Zn(OTf)2-mediated stereospecific opening of enantiopure aziridines to directly provide 
functionalized tryptophans, albeit in modest yields (Scheme 1.3, a). Subsequent work by 
Bennani11 and Isobe12 have illustrated that improved yields of this process may be 
achieved by utilizing scandium-based Lewis acids. An alternative, auxiliary-based 
approach has also been developed by Gentilucci and coworkers, employing 
oxazolidinone-based acetamidoacrylates with a variety of Lewis-acids to effect 1,4-
addition of an indole nucleophile (Scheme 1.3, b).13 Using this approach, moderate 
diastereoselectivities are achieved depending on the indole nucleophile and Lewis acid 
employed. 
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Scheme 1.3. Enantiospecific and auxiliary based approaches for the synthesis of 
unnatural tryptophans 
 
 
1.3 TRYPTOPHAN DERIVATIVES IN TOTAL SYNTHESIS 
As highlighted above, the tryptophan motif is prevalent in many natural product 
scaffolds and it is therefore unsurprising that the methods outlined previously have been 
widely adopted in total synthesis. In most instances, the assembly of a requisite 
tryptophan moiety occurs at an early stage of the synthesis, and is subsequently 
functionalized or appended to more complex fragments in order to complete the total 
synthesis. Far fewer examples exist in the literature of late-stage tryptophan synthesis, a 
likely consequence of limitations in the existing methodology in functional group 
tolerance. 
For example, Scheme 1.4 illustrates the preparation of three unnatural 
tryptophans. In their synthesis of the (+)-naseseazines, Movassaghi and Kim utilize a 
highly selective Rh-EtDUPHOS catalyzed asymmetric hydrogenation in order to prepare 
6-bromotryptophan 25 for elaboration to the northern diketopiperazine of (+)-naseseazine 
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aryl bromide. Cook and co-workers have also utilized their methodology in their total 
synthesis of the complex polycyclic alkaloid alstophylline (Scheme 1.4, b). Employing a 
Larock indole synthesis on 300-gram scale with only 1 mol % Pd(OAc)2, aniline 27 is 
readily advanced to 6-methoxytryptophan en route to the natural product.15 Similarly, Jia 
and co-workers have utilized their Pd-catalyzed aldehyde-aniline coupling to synthesize 
4-nitrotrytophan derivative 32, which is then advanced to the natural product 
aurantioclavine (33).16 
Scheme 1.4. Tryptophan in total synthesis 
 
  
 Although early-stage tryptophan synthesis is the most common, several 
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8 
iodoaniline 35 underwent a Larock indole synthesis with a serine-derived derived alkyne 
in a moderate 49% yield. Debenzylation and concomitant Cbz deprotection furnished 
pyrroloindoline 37, which existed in equilibrium with α-carboline 38. Addition of EDC 
and HOAt resulted in facile and selective macrocycle formation from α-carboline 38, 
providing the product in 64% yield. The synthesis of kapakahine B was completed in a 
further two-steps. This elegant synthesis, which assembles the key tryptophan moiety in 
an exceptionally complex setting, illustrates both the power of the Larock indole 
synthesis, but also its limitations – the key step requires upwards of 20 mol % catalyst for 
prolonged reaction times (24 h) in order to achieve two productive turnovers.  
Scheme 1.5. Baran’s synthesis of kapakahine B 
 
 An equally impressive Larock indole synthesis was used as the key step in 
Boger’s fabulous synthesis of the chloropeptins (Scheme 1.6). 18  Utilizing an 
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Scheme 1.6. Boger’s late stage tryptophan synthesis  
 
 
1.4 STRATEGIES FOR THE SYNTHESIS OF PYRROLOINDOLINES 
The abundance of pyrroloindoline natural products and the breadth of structural 
diversity, coupled intricately with their biological activities, has sparked a tremendous 
interest from the synthetic community, both in methodology develop and in total 
synthesis.5 Due to intense interest in this area of research, the structure, activity, and 
synthesis of pyrroloindolines has been reviewed in detail.19  
From a strategic standpoint, there are numerous disconnections to arrive at the 
pyrroloindoline motif. Instrumental in enabling the enantioselective synthesis of 
pyrroloindolines, however, has been the adoption of chiral transition metal complexes. 
One such approach is exemplified in work by Overman and co-workers on the 
enantioselective, intramolecular Heck cyclization (Scheme 1.7).20 Treatment of aryl 
triflate 44 in the presence Pd(OAc)2, (S)-tBuPHOX, and pentamethylpiperidine as base 
resulted in clean Heck cyclization to provide 1,3-cyclohexadiene intermediate 45. 
Immediate quenching with TFA then effected cyclization of the pendant amine, thereby 
providing the pyrroloindoline framework (46) in 75% overall yield and 99% ee. 
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Scheme 1.7. Overman’s Heck strategy to access pyrroloindolines  
 
A mechanistically distinct approach using a Pd-catalyst was reported by Trost in 
2006, utilizing allyl alcohols in conjunction with trialkylborates to effect C3-allylation in 
high yields and good enantioselectivities (Scheme 1.8).21 The reaction is presumed to 
occur via an electrophilic, chiral Pd-π-allyl complex, thus providing high enantiofacial 
bias of the prochiral electrophile. This reaction, which provides the pyrroloindoline 
directly from a corresponding tryptamine, follows up previous work from the Trost lab on 
the asymmetric allylic alkylation of oxindole nucleophiles, the products of which can also 
be elaborated to the pyrroloindoline motif via reductive functionalization.22 
Scheme 1.8. Trost’s transition metal strategy to access pyrroloindolines  
 
 
The application of a chiral Pd-π-allyl complex constitutes a chiral electrophile 
strategy to access pyrroloindolines. Alternatively, a chiral nucleophile strategy can be 
employed as reported by Stoltz in 2009.23 Utilizing a CuPhBOX complex in the presence 
of excess base, dimethylmalonate 52 can be efficiently alkylated in excellent yields and 
enantioselectivities to afford functionalized oxindole products (Scheme 1.9). Reductive 
elaboration of these oxindole products affords the pyrroloindoline scaffolds in high ee.  
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Scheme 1.9. Stoltz’s asymmetric alkylation of oxindoles  
 
Perhaps one of the most widely adopted strategies to date is that of C3-oxidative 
functionalization via an electrophilic heteroatom. This versatile approach has been 
utilized extensively on tryptamine and tryptophan scaffolds, and occurs through direct 
C3-functionalization followed by cyclization of a pendant nucleophile onto the resulting 
iminium ion. The C3-substituent can often act as a leaving group, enabling subsequent 
functionalization in a highly selective manner. Two such examples are illustrated in 
Scheme 1.10. An early report by Danishefsky and co-workers illustrated the ability of 
electrophilic selenation to enable the highly diastereoselective selenocyclization of Boc-
tryptophan derivative 54 in 78% yield.24 Subsequent activation with MeOTf in the 
presence of a prenylstannane reagent provides reverse prenylated pyrroloindoline 57 in 
60% yield.  
Scheme 1.10. C3-functionalization/cyclization to access pyrroloindolines  
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This strategy is applicable with a range of electrophiles. As shown in scheme 
1.10, addition of N-bromosuccinimide and pyridinium p-toluensulfonate to tryptophan 54 
results in clean formation of bromopyrroloindoline 58. Subsequent treatment with excess 
base and catalytic AgNO3 results in stereoretentive substitution by an indole nucleophile. 
Extension of this strategy to other electrophilic atom sources as well as a range of 
enantioselective variants have been reported.25  
In contrast to heteroatom based electrophiles, carbon-based electrophiles can also 
be utilized with great success. In 2004, MacMillan and coworkers illustrated the success 
of this strategy via iminium activation. Utilizing imidazolinone catalyst 61 with acrolein 
as an electrophile, a highly enantioselective preparation of C3-alkylated pyrroloindolines 
was achieved (Scheme 1.11).26  
Scheme 1.11. MacMillan’s organocatalyzed pyrroloindoline synthesis  
 
Activation of Michael acceptors can also be realized utilizing chiral Brønsted 
acids, such as (R)-TRIP (Scheme 1.12). As demonstrated by Antilla and co-workers, 
addition of catalytic (R)-TRIP phosphoric acid 65 to an excess of methyl vinyl ketone 
resulted in a highly enantioselective, double conjugate addition to provide 
pyrroloindoline 66, which was readily advanced to the natural product (–)-
debromoflustramine B in an additional three steps.27 
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Scheme 1.12. Antilla’s organocatalyzed pyrroloindoline synthesis  
 
 
Distinct from the two reactions shown above, Reisman and co-workers reported a 
highly enantioselective, formal (3 + 2) cycloaddition reaction between 3-substituted 
indoles and acetamidoacrylates (Scheme 1.13).28 Employing stoichiometric SnCl4 and 
catalytic (R)-BINOL, which together presumably generate a Lewis-acid assisted Brønsted 
acid, pyrroloindolines 70 are convergently synthesized in a single step from simple 
starting materials. It is proposed that this reaction proceeds via a highly face-selective 
protonation reaction, which resolves two diastereomeric conjugate addition complexes 
(71–72). From a synthetic standpoint, a key distinction of this method compared to others 
is that the pendant amine nucleophile resides on the electrophilic coupling partner, rather 
than on the nucleophile. 
Scheme 1.13. Reisman’s formal (3+2) cycloaddition to access pyrroloindlines  
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1.5 PYRROLOINDOLINES IN TOTAL SYNTHESIS 
Given the enormous body of research dedicated to the total synthesis of 
pyrroloindolines, only a small sampling of total syntheses will be presented in the section 
below. One of the first successful examples employing a diastereoselective 
pyrroloindoline synthesis comes from the Danishefsky lab (Scheme 1.14).24 Beginning 
with Boc protected tryptophan 54, they were able to effect a selenation/cyclization 
sequence to furnish exo-pyrroloindoline 55 as a 9:1 diastereomeric mixture. Activation of 
the phenyl selenide with MeOTf and exposure to prenyl stannane 56, provided the 
reverse prenyl adduct in 60% yield. Saponification of the methyl ester, peptide coupling 
with the free amine, and successive diketopiperazine formation provided amauromine in 
only four-steps from tryptophan 54. 
Scheme 1.14. Danishefsky’s synthesis of amauromine  
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alkyne 77 in excellent yield. C–N bond formation, followed by treatment with Red-Al 
provided the natural product psychotrimine (79) in excellent overall yield. 
Scheme 1.15. Baran’s synthesis of psychotrimine  
 
In 2011, Movassaghi and Kim reported a general strategy for the synthesis of 3-
arylpyrroloindolines via a two-step bromocyclization/Friedel-Crafts sequence of 
tryptophan-derived diketopiperazines (Scheme 1.16).14 Treatment of protected 
diketopiperazine 80 with PyHBr3 in 2,2,2-trifluoroethanol effected an oxidative 
cyclization to form C3-bromopyrrolodinoline 81 in moderate yield and as a single 
diastereomer. In a subsequent step, addition of superstoichiometric silver salts resulted in 
halide abstraction to form a benzylic cation, which is then readily trapped in a 
stereoretentive fashion with excess nucleophile (82). Using this strategy, a variety of C3-
substituted pyrroloindolines are readily prepared, accomodating C3-allyl, aryl, and 
hetereoaryl substitution. Although a number of arenes react to form a mixture of 
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potassium trifluoroborate salts can be used to adequately restore regioselectivity. Using 
this method, the authors advanced bromotetracycle 81 to 3-arylpyrroloindolines 84 and 
86 in 50 and 56% yield, respectively, utilizing an excess of functionalized potassium 
trifluoroborate salt 83, derived from 6-bromotryptophan. Subsequent global deprotection 
provided (+)-naseseazines A and B in 80% yield and 9-steps longest linear sequence. 
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Scheme 1.16. Movassaghi’s synthesis of (+)-naseseazines A and B 
 
 A similar approach was adopted by Stephenson and co-workers in their synthesis 
of gliocladin C using photoredox catalysis.30 Following an oxidative cyclization of 
protected tryptophan 87, the bromopyrroloindoline underwent amidation to furnish 
carboximide 89.  Subsequent exposure to [Ru(bpy)3Cl2] and visible light generated a 
tertiary benzylic radical, which was trapped with five equivalents of indole 90 to form the 
desired C3–C3’ aryl linkage. Notably, C2 substitution of the indole nucleophile is 
imperative to achieve the desired regioselectivity in the transformation.  Additional 
elaboration to the natural product was accomplished in six-steps.   
Scheme 1.17. Stephenson’s synthesis of gliocladin C 
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 An intermediate bromopyrroloindoline 94, formed via the oxidative 
bromocyclization of tryptophan, was also utilized in Li’s synthesis of drimentine G.31 
Employing a photoredox strategy similar to Stephenson’s, generation of a tertiary 
benzylic radical followed by conjugate addition into enone 95 provided complex 
pyrroloindoine 96 in excellent yield. An additional five-steps is subsequently required to 
construct the diketopiperazine moiety and effect deoxygenation to provide the natural 
product.  
Scheme 1.18. Li’s synthesis of drimentine G 
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complex macrocyclic bispyrroloindoline (+)-nocardioazine A (102) utilizing their 
previously reported SnCl4•BINOL catalyzed formal (3 + 2) cycloaddition.32 Importantly, 
this complex natural product contains two pyrroloindoline units, each of opposite 
stereochemical configuration at the 5/5-ring junction, making an excellent case for 
convergent asymmetric synthesis. To this end, 3-allyl-N-methylindole (98) was subjected 
to the previously optimized reaction conditions to afford pyrroloindoline 99 in 52% yield, 
19:1 dr, and 90% ee. Simultaneously, treatment of 3-methyl-N-allylindole (100) under 
newly optimized conditions provided pyrroloindoline 101 in 57% yield, 5.8 : 1 dr, and 
98% ee. Subsequent functionalization of each fragment followed by coupling and 
N
Boc
NHBoc
CO2Me
NBS
PPTS
NN
BocBoc
CO2Me
Br
H
94
(96% yield)
93
NN
BocBoc
CO2Me
H
Me
Me
Me
H
O
MeMe
Me H
O
[Ir(ppy)2(dtbbpy)]PF6 (cat)
blue LED
Et3N, DMF
95
96
(91% yield)
5-steps
NN
H H
Me
Me
Me
H
NH
O
O iPr
drimentine G (97)
Chapter 1 – An Introduction to Tryptophan  
 
18 
cyclocondensation to prepare the diketopiperazine assembles the natural product in short 
order. 
Scheme 1.19. Reisman’s synthesis of nocardioazine A 
 
1.6 CONCLUSIONS 
These interesting scaffolds still serve as fascinating motivations for new synthetic 
methodologies and the basis for novel chemistry in total synthesis. Although much work 
has been done, the implementation and actualization of new synthetic strategies to meet 
unmet challenges will clearly be of interest in the coming times. 
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Chapter 2 
 
Enantioselective Synthesis of Tryptophan Derivatives by a Tandem 
Friedel–Crafts Conjugate Addition/Asymmetric Protonation Reaction† 
 
2.1 INTRODUCTION 
The biological importance of tryptophan as discussed in Chapter 1 has inspired a 
variety of racemic, enzymatic, auxiliary-controlled, and enantiospecific methodologies.1 
There are, however, very few reported catalytic asymmetric methods for the preparation 
of tryptophan derivatives containing no β-stereocenter.2,3,4  
In 2010, our laboratory reported a highly enantioselective formal (3 + 2) 
cycloaddition reaction utilizing catalytic (R)-BINOL and superstoichiometric SnCl4 
(Table 2.1).5,6,7 By exploiting the intrinsic nucleophilicity of 3-substituted indoles and the 
electrophilicity of 2-amidoacrylates, functionalized pyrroloindoline scaffolds can be 
convergently synthesized in a single step. Both the enantio- and diastereoselectivity of !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
† Portions of this chapter have been reproduced from published studies (Kieffer, M. E.; Repka, L. M.; 
Reisman, S. E. J. Am. Chem. Soc. 2012, 134, 5131) and the supporting information found therein. Work 
was conducted in collaboration with Dr. Lindsay M. Repka. 
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this transformation were found to be highly dependent on the protecting groups of the 
acrylate, with benzyl 2-trifluoroacetamidoacrylate providing the best results for a variety 
of indole nucleophiles (Table 2.1).   
Table 2.1. Substrate scope of formal (3+2) cycloaddition reaction 
 
 Interestingly, a series of epimerization studies revealed that the reaction produced 
endo/exo-diastereomers of opposite enantiomeric series.  In accord with preliminary 
mechanistic data, one limiting scenario that could explain this finding is if the initial 
conjugate addition proceeds reversibly to provide an enantiomeric mixture of enolate 
intermediates 105 and ent-105. A face-selective, catalyst controlled protonation would 
serve to irreversibly resolve the enantiomers, providing diastereomers endo- and exo-
108. Subsequent cyclization of the amide onto the iminium ion provides the product in 
moderate diastereoselectivity and high enantioselectivity. Importantly, under this 
mechanistic scenario, the diastereomeric ratio is dependent upon the relative rates of 
protonation of 105 and ent-105. Following the precedence of Yamamoto and co-workers, 
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a 1.6 equiv. SnCl4 was employed.
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it is anticipated that (R)-BINOL•SnCl4 serves as the asymmetric proton source in this 
reaction via a Lewis acid-assisted Brønsted acid (LBA).  
Scheme 2.1. Proposed mechanism of formal (3+2) cycloaddition reaction 
 
Given this mechanistic insight, we reasoned that the related Friedel–Crafts 
alkylation of 3-unsubstituted indoles would further probe the role of such an 
enantioselective protonation, instead providing functionalized tryptophan products rather 
than pyrroloindolines. Mechanistically, this reaction would occur through initial 
conjugate addition of an indole into a Lewis-acid activated acrylate (Scheme 2.2). 
Rearomatization, followed by catalyst-controlled protonation of the resultant enolate was 
expected to provide alkylation product 116. Successful implementation of this strategy 
would not only be mechanistically useful, but would also allow direct access to 
enantioenriched tryptophan derivatives from simple indole starting materials. This 
chapter describes our efforts towards the synthesis of enantioenriched tryptophan 
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derivatives through a tandem Friedel–Crafts conjugate addition/asymmetric protonation 
reaction. 
Scheme 2.2. Proposed mechanism for the formation of enantioenriched tryptophan 
 
2.1.1 Precedence for Asymmetric Protonation 
 Our hypothesis that the Friedel–Crafts conjugate addition might undergo a 
selective protonation is consistent with work published by Yamamoto and co-workers, in 
which they report that SnCl4•(R)-BINOL acts as an asymmetric proton source.8 Upon 
subjection to stoichiometric SnCl4 and (R)-BINOL, silyl enol ethers were cleanly 
converted to α-arylated ketones and esters in good yields and in excellent 
enantioselectivities (Scheme 2.3). Yamamoto proposes complex 117 acts as a Lewis 
acid-assisted Brønsted acid (LBA), in which complexation of (R)-BINOL to SnCl4 
greatly acidifies the alcohols, providing a selective proton source. Although subsequent 
reports were able to render this reaction catalytic through the addition of stoichiometric 
phenol derivatives, these complexes have never previously been applied to tandem 
conjugate addition/asymmetric protonation reactions. 
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Scheme 2.3. Yamamoto’s enantioselective protonation 
 
2.1.2 Previous Conjugate Addition/Asymmetric Protonation 
Reactions 
 The synthesis of enantioenriched compounds employing conjugate 
addition/asymmetric protonation reactions has gained considerable momentum within the 
last decade, and a variety of nucleophiles and electrophiles have been found to be 
competent coupling partners.9 One particularly relevant example comes from the labs of 
Genet and Darses, where they were able to construct enantioenriched phenylalanine 
derivatives using this approach (Scheme 2.4).10 
Scheme 2.4. Tandem conjugate addition/asymmetric protonation 
 
 Despite the prevalence of conjugate addition/asymmetric protonation reactions in 
the literature, the first report of a Friedel–Crafts conjugate addition/asymmetric 
protonation reaction was not disclosed until 2008. In their publication, Sibi and co-
workers reveal the use of a novel isoxazolidinone auxiliary, which provides high levels of 
rotamer control of the enolate (Scheme 2.5).11 When used in conjunction with Zn(NTf2)2 
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and chiral ligand 118, they observe enantioenriched pyrrole products (Scheme 2.5, a). 
Concomitant to our work in this field, the Luo lab developed a chiral diamine catalyzed 
Friedel–Crafts conjugate addition/asymmetric protonation reaction that proceeds through 
an enamine intermediate.12 They found this reaction was general for a range of α-
substituted acroleins and indoles, providing products in good yield and moderate to high 
enantioselectivity (Scheme 2.5, b). Notably, there are no examples of Friedel–Crafts 
conjugate addition/asymmetric protonation reactions using indole-based nucleophiles to 
give tryptophan derivatives. 
Scheme 2.5. Tandem Friedel–Crafts conjugate addition/asymmetric protonation 
 
2.2 SCREENING AND OPTIMIZATION 
2.2.1 Initial Screening of Acrylate and Additives 
 Our efforts to effect a tandem Friedel–Crafts conjugate addition/asymmetric 
protonation reaction began with model substrate 2-phenyl indole (119), which we 
subjected to the conditions optimized for pyrroloindoline formation. After two hours, we 
were disappointed to see only 12% yield of the desired product in low enantiomeric 
excess (Table 2.2, entry 1). As tuning of the acrylate was found to greatly affect the 
enantioselectivity in the pyrroloindoline methodology, a screen of 2-amido acrylates was 
O
NO
O O
Me
N
H
O
O N N O
PhPh
(33 mol%)
Zn(NTf2)2 (30 mol %)
4Å MS, –30 °C O
NO
O O
R
N
H
N
H
CHOR
Ph
NH2Ph
N
Me
Me
(10 mol%)
TfOH (12 mol%)
PhCl/brine, RT NH
CHO
R
(40 – 80% yield)
(75 – 93% ee)
(68 – 98% yield)
(93 – 98% ee)
a)
b)
118
Chapter 2 – Enantioselective Synthesis of Tryptophan Derivatives by a Tandem Friedel–
Crafts Conjugate Addition/Asymmetric Protonation Reaction 
28 
conducted. Gratifyingly, the use of commercially available methyl-2-acetamido acrylate 
provided the product in 73% yield and 78% ee (entry 3). Control experiments confirmed 
that while SnCl4 alone catalyzes a background reaction, a substantial rate increase is 
observed upon addition of (R)-BINOL. No reaction was observed in the absence of SnCl4 
(entry 7). 
Table 2.2. Optimization of acrylate 
 
entry R1 R2 time (h) yield (%)b ee (%)c pdt 
1 TFA Bn 2 12 35 121a 
2 TFA Me 2 12 42 121b 
3 Ac Me 5 73 78 121c 
4 CO2Me Me 13 nd 39 121d 
5 Ts Me 13 0 – 121e 
6d Ac Me 2 13 – 121c 
7e Ac Me 2 0 – 121c 
a Reaction conducted under inert atmosphere on 0.2 mmol scale. b Isolated yield. c Determined by chiral 
stationary phase SFC. d No (R)-BINOL was employed. e No SnCl4 was employed. 
 
 As the screening process progressed, we began to observe inconsistencies in the 
selectivity of the reaction. For example, a freshly opened bottle of SnCl4 provided 
acetamido ester 121c in 80% ee (Table 2.3, entry 1). However, switching to older 
sources of SnCl4 decreased enantioenrichment to 76% (entry 2). Similarly, we noted a 
marked decrease in ee as the reaction progressed (entries 3–7) and suspected that HCl 
formed by the reaction of adventitious water with SnCl4 was serving as a non-selective 
proton source. To this end, we investigated additives known to scavenge water or 
neutralize HCl. While insoluble bases such as K2CO3 appeared to have no effect on the 
reaction (entry 9), coordinating bases such as 2,6-lutidine completely shut down 
reactivity (entry 10). Instead, the use of activated 4Å molecular sieves increased both the 
yield and selectivity of the reaction, furnishing tryptophan 121c in 86% yield and 81% ee 
N
H
+
SnCl4 (1.2 equiv)
CH2Cl2, 23 °C
(R)-BINOL (0.2 equiv)
Ph N
H
Ph
CO2R2
NHR1O
OR2
H
N
R1
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(entry 11). A small solvent screen confirmed that dichloromethane was indeed the 
optimal solvent for this transformation (entries 11–13). 
Table 2.3. Tandem Friedel–Crafts conjugate addition/asymmetric protonation 
 
 
entry 
solvent time (h) additive yield (%)b ee (%)c 
1 CH2Cl2 2 – nd 80d 
2 CH2Cl2 2 – nd 76e 
3 CH2Cl2 0.25 – nd 84 
4 CH2Cl2 0.5 – nd 84 
5 CH2Cl2 1 – nd 82 
6 CH2Cl2 2 – nd 80 
7 CH2Cl2 7 – nd 80 
8 CH2Cl2 2 – 73 78 
9 CH2Cl2 2 K2CO3 73 78 
10 CH2Cl2 2 2,6-lutidine 0 – 
11 CH2Cl2 2 4Å MS 86 81 
12 DCE 2 4Å MS 87 79 
13 CHCl3 2 4Å MS 80 72 
a Reactions conducted under inert atmosphere on 0.2 mmol scale. b Isolated yield. c Determined by chiral 
stationary phase SFC. d Reaction conducted using freshly opened SnCl4. e Reaction conducted using 
previously opened SnCl4. 
 
2.2.2 Screening of Chiral Ligands 
 With an optimal acrylate, solvent, and additive in hand, we next turned to the 
optimization of the catalyst structure (Table 2.4). Although there appeared to be no 
profound effect on selectivity when altering the electronics of the BINOL backbone 
(entries 1–3), we were pleased to find that modifications to the steric profile of the ligand 
exhibited a clearer trend. Dimethyl catalyst 122e provided tryptophan 121c in improved 
selectivities and comparable yields. Further augmentation of the steric bulk of the catalyst 
by substitution with phenyl groups lowered reactivity and selectivity (entry 6). 
Interestingly, dimethoxy catalyst 122g delivered acetamido ester 121c in low yield and as 
a racemate. This is likely due to its ability to participate in alternate binding modes, 
N
H
SnCl4 (1.0 equiv)
solvent, additive, 20 °C
(R)-BINOL (0.2 equiv)
Ph N
H
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CO2Me
NHAc
120c (1.2 equiv)
OMe
O
H
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resulting in a less reactive and selective catalyst. Gratifyingly, 3,3’-disubstitution with 
halides furnished the highest selectivities, with (R)-3,3’-dibromo-BINOL providing the 
best results (entries 8–10).13 Although we found that catalyst loading could be decreased 
to 5 mol % while still observing 88% ee, we chose to employ 20 mol % loading as it gave 
reliably higher enantioselectivites for more functionalized substrates. 
Table 2.4. Optimization of a chiral ligand 
 
entry catalyst loading (mol %) yield (%) ee (%) entry catalyst loading (mol %) yield (%) ee (%) 
1 122a 20 86 54 8 122h 20 85 90 
2 122b 20 88 78 9 122i 20 76 93 
3 122c 20 82 78 10 122j 20 76 84 
4 122d 20 86 81 11 122i 5 72 88 
5 122e 20 83 87 12 122i 10 75 92 
6 122f 20 17 37 13 122i 15 77 93 
7 122g 20 7 1 14 122i 40 76 93 
a Reactions conducted under inert atmosphere on 0.2 mmol scale for 2 h. b Isolated yield. c Determined by 
chiral stationary phase SFC. 
 
2.3 SUBSTRATE SCOPE 
2.3.1 Friedel–Crafts/asymmetric protonation of substituted indoles 
 With optimal conditions in hand, an exploration of substrate scope was conducted 
(Table 2.5). In contrast to the findings from the formal (3+2) cycloaddition, we observed 
optimal results using N-protio indoles; however, methylated and allylated substrates were 
accommodated in slightly reduced selectivities. Substitution of the 4–7 positions of the 
indole backbone provided acetamido ester 121f–121i in uniformly high yield and ee. 
Although both electron-rich and electron-poor indoles furnished tryptophans in high ee, 
122d: R1 = R2 = H
122e: R1 = R2 = Me
122f: R1 = R2 = Ph
122g: R1 = R2 = OMe
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electron-deficient substrates display markedly decreased reaction rates, a finding 
consistent with a Friedel–Crafts type mechanism. 
Table 2.5. Substrate Scope 
 
a Reactions conducted under inert atmosphere on 0.1 or 0.2 mmol scale for 2 h. Isolated yields are reported. 
Enantiomeric excess was determined by chiral stationary phase SFC. b 1.6 equiv SnCl4 were employed. 
 
 We found that the reaction was amenable to substrates with both alkyl and aryl 
substitution at the 2-position of the indole. 2-Aryl indoles bearing both electron donating 
and electron withdrawing substituents at the para and meta positions were tolerated 
(121o–121s). Unfortunately, even small functionality at the ortho position, such as 
fluoro, resulted in diminished reactivity (121r); a slightly larger methyl group further 
attenuated both yield and ee (121n). For 2-alkyl indoles, the ee improved when moving 
from a methyl group to bulkier n-butyl and i-propyl; however, a drastic decrease in yield 
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and ee is observed with the introduction of a t-butyl substituent (121t–121w). 
Remarkably, a phthalimide-containing indole proceeds in 80% yield and 90% ee (121x). 
 
2.3.2 Scale-up and derivatization 
 Although optimization and substrate exploration were run in the glove box to 
streamline the screening protocol, this reaction has been reproduced on the bench top 
using standard Schlenk technique. Using 2-phenyl indole on 5 mmol scale, acetamido 
ester 121c was isolated in 77% yield and 93% ee. Furthermore, we have shown that the 
methyl ester of 121c can be selectively hydrolyzed upon subjection to aqueous LiOH in 
THF at 0°C (Scheme 2.6). Alternatively, orthogonal acetamide deprotection proceeds in 
methanolic HCl at 75 °C to afford free amine 124 in 76% yield with no erosion of ee. 
 Further functionalization of tryptophan 121c was explored by subjection to NBS 
and TFA, common conditions for the oxidative cyclization of tryptophan derivatives to 
pyrroloindolines. Surprisingly, uncyclized imine 125 is remarkably stable, and was 
isolated in 79% yield as a 1:1 mixture of diasteromers. Instead, successful cyclization 
was achieved through exposure to NCS and TFA to initially form the 2-phenyl-3-chloro 
pyrroloindoline (detected by HRMS). Subsequent silica gel promoted hydrolysis delivers 
2-phenyl-3-hydroxy pyrroloindoline 126 in 52% yield as a 6:1 mixture of diastereomers, 
constituting a new class of pyrroloindolines. 
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Scheme 2.6. Derivatization of tryptophan products 
 
2.4 MECHANISTIC STUDIES 
2.4.1 1H NMR Studies 
 As was seen in the pyrroloindoline methodology, the Friedel–Crafts conjugate 
addition/asymmetric protonation reaction exhibits excellent enantioselectivity, even in 
the presence of stoichiometric SnCl4. Therefore, to better understand the mechanism of 
this reaction, a variety of 1H NMR and deuterium labeling experiments were carried out. 
 We first set out to understand the relative rate of the background reaction 
compared to that of the SnCl4•(R)-BINOL catalyzed reaction. A 1H NMR experiment was 
designed in which the consumption of acrylate was monitored over time. As can be seen 
in Figure 2.1, the background reaction employing only SnCl4 proceeded quickly (blue 
line); within thirty minutes (2000 seconds), the reaction reached 50% conversion. 
However, addition of catalytic (R)-BINOL (red line) pushed the reaction to greater than 
80% conversion in the same time period. Closer examination of the first 3000 seconds of 
the reaction revealed that the rate of acrylate consumption is actually quite comparable 
for both the background and SnCl4•(R)-BINOL catalyzed reactions. This suggests that the 
(R)-BINOL promoted rate acceleration might occur in the first two minutes of the 
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reaction, before 1H NMR data is available. Attempts to slow the reaction through dilution 
and decreased catalyst loading in order to facilitate enhanced monitoring by 1H NMR 
proved unfruitful. 
Figure 2.1. 1H NMR studies 
 
 
2.4.2 Deuterium labeling studies 
 To better understand the asymmetric protonation, we sought to find the 
stoichiometric proton source, which likely serves to turn over the chiral diol. Excluding 
adventitious water, there are three exchangeable protons: (i) the N-H of the acrylate, (ii) 
the N-H of the indole, or (iii) the C3 proton of the indole (which is lost in 
rearomatization). Therefore, N-deutero acrylate 127 and perdeutero indole 128 were 
prepared. Control reactions were carried out on each to determine if exchange occurred 
under the reaction conditions. Molecular sieves were omitted to prevent undesired 
deuterium/proton exchange between the substrates and sieves. Additionally, solutions of 
each substrate in dry CD2Cl2 were prepared in the glovebox in order to minimize 
exposure to moisture. Upon addition of SnCl4 and (R)-Br2-BINOL, each substrate was 
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monitored by 1H NMR analysis. Although deutero acrylate 127 exhibited no deuterium-
proton scrambling, perdeutero indole 128 underwent rapid exchange. In only a few 
minutes the substrate exhibited less than 10% deuterium incorporation. Unfortunately, the 
facile exchange of deuterium under the reaction conditions renders these labeling studies 
inconclusive. Furthermore, despite efforts to rigorously exclude moisture from these 
experiments, adventitious water cannot be ruled out as the stoichiometric proton source. 
Scheme 2.7. Deuterium labeling studies 
 
2.4.3 Comparison studies 
 Due to the apparent mechanistic similarities of the formal (3+2) cycloaddition and 
the Friedel–Crafts, we wondered if our newly optimized conditions for the Friedel–Crafts 
could be applied to the synthesis of pyrroloindolines to enhance selectivity. Using 
methyl-2-acetamido acrylate, indole 130 was subjected to optimal Friedel–Crafts 
conditions (entry 2). While there was a discernible increase in the selectivity of the 
product mixture compared to the originally reported conditions for acrylate 131 (entry 
1), better results were still achieved using benzyl-2-trifluoroacetamido acrylate (entry 3). 
Interestingly, use of acrylate 131, with optimal Friedel–Crafts conditions delivered the 
product in good dr and excellent enantioselectivity (entry 4). Unfortunately, use of (R)-
3,3’-Br2-BINOL and 4Å molecular sieves also mitigates the reactivity of the 
transformation, returning an inadmissibly low yield of product. Thus, appropriate 
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matching of catalyst and acrylate is necessary to synthesize either tryptophan derivatives 
(121) or pyrroloindolines (132) in both high yield and ee. 
Table 2.6. Comparison studies 
 
entry conditions R1, R2 yield (%)a drb ee (%)c 
1 (R)-BINOL Me, Me 70 5:1 65/80 
2 (R)-Br2-BINOL, 4Å MS Me, Me 58 8:1 87/85 
3 (R)-BINOL CF3, Bn 86 4:1 94/91 
4 (R)-Br2-BINOL, 4Å MS CF3, Bn 39 7:1 98/95 
a Isolated yield. b Determined by 1H NMR analysis of crude reaction mixture. c Determined by chiral 
stationary phase SFC. d Reaction run with 1.0 equiv acrylate, 1.2 equiv SnCl4. e Reaction run with 1.2 equiv 
acrylate, 1.0 equiv SnCl4. 
 
2.5 CONCLUSION 
In summary, this report describes the development of a SnCl4•(R)-Br2-BINOL 
catalyzed tandem Friedel–Crafts conjugate addition/asymmetric protonation reaction. 
Utilizing a wide range of 2-substituted indoles and methyl-2-acetamido acrylate, we are 
able to access non-canonical tryptophan derivatives in a convergent manner. We have 
demonstrated that the acetamide and methylester functionality can be orthogonally 
deprotected and that acetamido ester 121c can be advanced to more functionalized 
compounds. Moreover, experiments directed towards elucidation of the mechanism have 
been carried out. While the rapid rate of this reaction as well as deuterium scrambling 
under the reaction conditions has complicated analysis, data suggest that catalytically 
generated 122i•SnCl4 is serving as a chiral Lewis-acid assisted Brønsted acid to protonate 
an intermediate Sn-enolate. Future work is directed towards further expansion of 
substrate scope to include C2 unsubstituted indoles. 
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2.6 EXPERIMENTAL SECTION 
 
2.6.1 Materials and Methods 
 
Unless otherwise stated, reactions were performed under a nitrogen atmosphere 
using freshly dried solvents. Methylene chloride, deuterated methylene chloride, dioxane, 
ether, tetrahydrofuran, and toluene were dried by passing through activated alumina. 
Dichloroethane and chloroform were distilled over calcium hydride. Powdered 4Å 
molecular sieves were flame-dried under vacuum immediately prior to use. Potassium 
carbonate was dried for 12 h at 130 °C under vacuum and 2,6-lutidine was distilled over 
AlCl3. All other commercially obtained reagents were used as received unless 
specifically indicated. (R)–BINOL, 2-phenylindole and 2-methylindole were purchased 
from Alfa Aesar, N-methyl-2-phenylindole was obtained from Sigma-Aldrich, and 1 M 
SnCl4 in CH2Cl2 was purchased from Acros Organics. (R)- 3,3’-diphenyl-BINOL,
 (R)-
3,3’-dimethyl-BINOL, (R)-3,3’-dichloro- BINOL, (R)-3,3’-dibromo-BINOL, (R)-3,3’-
dimethoxy-BINOL, (R)-6,6’-dimethyl-BINOL, (R)-6,6’-dibromo-BINOL, (R)-2'- 
methoxy-[1,1'-binaphthalen]-2-ol, (R)-2'-isopropoxy-[1,1'-binaphthalen]-2-ol, (R)-3,3’-
difluoro-BINOL, (R)-3-phenyl-BINOL, (R)- 5,5’,6,6’,7,7’,8,8’-octahydro-BINOL, (R)-2'-
benzoyl-[1,1'-binaphthalen]-2-ol, (R)-3-bromo-BINOL  and (R)-3-iodo-BINOL, 
TADDOL, Napthyl-TADDOL, and 2-(trimethylsilyl)indole, were prepared according to 
literature procedures. All reactions were monitored by thin-layer chromatography using 
EMD/Merck silica gel 60 F254 pre-coated plates (0.25 mm). Silica gel column 
chromatography was performed either as described by Still et al. (W.C. Still, M. Kahn, A. 
Mitra, J. Org. Chem. 1978, 43, 2923.) using silica gel (particle size 0.032-0.063) 
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purchased from Silicycle or using pre-packaged RediSep®Rf columns on a CombiSilica 
gel Rf system (Teledyne ISCO Inc.). 1H and 13C NMR were recorded on a Varian Inova 
500 (at 500 MHz and 125 MHz respectively) or a Varian Inova 600 (at 600 MHz and 150 
MHz respectively, and are reported relative to internal chloroform (1H, δ = 7.26, 13C, δ = 
77.0) or internal acetonitrile (1H, δ = 1.94, 13C, δ = 1.32). Data for 1H NMR spectra are 
reported as follows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), 
integration). Multiplicity and qualifier abbreviations are as follows: s = singlet, d = 
doublet, t = triplet, q = quartet, m = multiplet, br = broad. IR spectra were recorded on a 
Perkin Elmer Paragon 1000 spectrometer and are reported in frequency of absorption 
(cm-1). Analytical SFC was performed with a Mettler SFC supercritical CO2 analytical 
chromatography system with Chiralcel AD-H, OD-H, AS-H, and OB-H columns (4.6 
mm x 25 cm). Optical rotations were measured on a Jasco P-2000 polarimeter using a 
100 mm path-length cell at 589 nm. HRMS were acquired using either an Agilent 6200 
Series TOF with an Agilent G1978A Multimode source in electrospray ionization (ESI), 
atmospheric pressure chemical ionization (APCI) or mixed (MM) ionization mode. 
2.6.2 Catalyst and substrate preparation 
 
Preparation of (R)-3-chloro-BINOL (122h) 
 
 
To a flame-dried 100 mL flask containing MOM–protected (R)-BINOL S1 (748 mg, 
2.00 mmol, 1.00 equiv) was added Et2O (45 mL), followed by dropwise addition of n-
BuLi as a solution in hexanes (2.5 M, 960 µL, 2.40 mmol, 1.20 equiv) at room 
OMOM
OMOM
OMOM
OMOM
Cl
n-BuLi, Et2O, 23 ºC;
then C2Cl6, –78 ºC  23 ºC
(40% yield)
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temperature.  The mixture was then stirred at room temperature for 3 h and subsequently 
cooled to –78 ºC, followed by addition of C2Cl6 (569 mg, 2.40 mmol, 1.20 equiv) in one 
portion.  The reaction mixture was allowed to warm to room temperature over 3 h, then 
diluted with EtOAc (15 mL) and washed with saturated aqueous NH4Cl (50 mL). The 
aqueous layer was extracted with EtOAc (45 mL) and the combined organic layers were 
dried (Na2SO4), filtered and concentrated.  The crude yellow oil was purified by silica gel 
chromatography (0:100 to 12:88 EtOAc:hexanes) to yield 328 mg (40% yield) of SI-1 as 
a white solid.  1H NMR (500 MHz, CDCl3) δ 8.05 (s, 1H), 7.97 (d, J = 9.0 Hz, 1H), 7.87 
(d, J = 8.1 Hz, 1H), 7.81 (d, J = 8.2 Hz, 1H), 7.59 (d, J = 9.1 Hz, 1H), 7.42 (ddd, J = 8.1, 
6.7, 1.3 Hz, 1H), 7.37 (ddd, J = 8.1, 6.8, 1.2 Hz, 1H), 7.28 (ddd, J = 8.2, 6.8, 1.3 Hz, 1H), 
7.24 (ddd, J = 8.5, 6.7, 1.3 Hz, 1H), 7.18 (dddd, J = 8.6, 1.3, 0.7, 0.7 Hz, 1H), 7.16 (ddd, 
J = 8.5, 1.8, 0.8 Hz, 1H), 5.15 (d, J = 7.0 Hz, 1H), 5.04 (d, J = 7.0 Hz, 1H), 4.80 (d, J = 
5.6 Hz, 1H), 4.75 (d, J = 5.6 Hz, 1H), 3.19 (s, 3H), 2.71 (s, 3H); 13C NMR (125 MHz, 
CDCl3) δ 152.9, 148.9, 133.8, 132.6, 131.1, 130.0, 129.5, 128.8, 128.0, 127.9, 127.8, 
127.0, 126.7, 126.4, 126.1, 125.8, 125.5, 124.2, 119.9, 116.3, 98.8, 94.9, 56.5, 55.9; IR 
(NaCl/thin film): 2955, 2902, 1594, 1508, 1354, 1241, 1159, 1149, 1034, 1014, 961, 922 
cm-1; [α]D25 = +69.1 (c = 0.90, CHCl3). HRMS (FAB+) calc’d for M+ 408.1128, found 
408.1128. 
 
A 10 mL flask was charged with SI-1 (305 mg, 0.75 mmol, 1.00 equiv), dioxane (3.7 
mL) and aqueous HCl (12 M, 130 µL, 1.58 mmol, 2.10 equiv), then heated to 50 ºC for 2 
h.  The mixture was cooled to room temperature, then diluted with H2O (30 mL) and 
Cl
OMOM
OMOM
OH
OH
Cl
conc. HCl, dioxane, 50 ºC
(87% yield)
Chapter 2 – Enantioselective Synthesis of Tryptophan Derivatives by a Tandem Friedel–
Crafts Conjugate Addition/Asymmetric Protonation Reaction 
40 
extracted with EtOAc (6 x 20 mL).  The combined organic layers were dried (Na2SO4), 
filtered and concentrated.  The crude residue was purified by silica gel chromatography  
(0:100 to 20:80 EtOAc:hexanes) to yield 210 mg (87% yield) of (R)-3-chloro-BINOL 
(122j) as a white foam, which was dried over P2O5 under vacuum. 1H NMR (500 MHz, 
CDCl3) δ 8.09 (s, 1H), 7.97 (d, J = 8.9 Hz, 1H), 7.90 (d, J = 8.1 Hz, 1H), 7.83 (d, J = 8.2 
Hz, 1H), 7.45 – 7.35 (m, 3H), 7.34 – 7.28 (m, 2H), 7.16 (d, J = 8.5 Hz, 1H), 7.11 (d, J = 
8.4 Hz, 1H), 5.60 (s, 1H), 4.94 (s, 1H); 13C NMR (125 MHz, CDCl3) δ 152.1, 148.3, 
133.1, 132.4, 131.3, 129.7, 129.32, 129.26, 128.4, 127.7, 127.5, 127.3, 125.1, 124.6, 
124.1, 123.9, 122.4, 117.7, 113.6, 111.7; IR (NaCl/thin film): 3503, 3057, 1620, 1596, 
1502, 1451, 1379, 1265, 1212, 1184, 1146, 828 cm-1; [α]D25 = +55.4 (c = 1.01, CHCl3). 
HRMS (MM) calc’d for [M-H]- 319.0531, found 319.0549. 
Preparation of (R)-6,6’-dimethoxy-BINOL  
 
(R)-6,6’-dimethoxy-BINOL was prepared following a procedure adapted from a 
reported synthesis of (R)-3,3’-dimethoxy-BINOL. To a 25 mL flask containing MOM–
protected (R)-6,6’-dibromo-BINOL (1.10 g, 2.07 mmol, 1.00 equiv) was added THF (6.3 
mL).  The flask was cooled to –78 ºC, followed by dropwise addition of n-BuLi as a 
solution in hexanes (2.5 M, 2.50 mL, 6.20 mmol, 3.00 equiv).  After stirring 1 hour at –
78 ºC, B(OMe)3 (645 mg, 6.20 mmol, 3.00 equiv) was added and the reaction was 
allowed to warm to room temperature.  After 14 hours, the reaction mixture was 
concentrated to give the crude borate intermediate, which was suspended in benzene (7.2 
mL) and cooled to 0 ºC, followed by dropwise addition of aqueous hydrogen peroxide 
OMOM
OMOM
OMOM
OMOM
(i)  n-BuLi, THF, –78 ºC;
 B(OMe)3, –78  23 ºC
Br
Br
(ii) H2O2, PhH, 0 80 ºC
HO
HO(61% yield)
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(30 wt %, 0.61 mL, 5.98 mmol, 2.89 equiv).   The suspension was heated to reflux for 4 
hours, then cooled to room temperature, poured into ice-cold saturated aqueous NaSO3 
(20 mL), and extracted with EtOAc (3 x 15 mL).  The combined organics were washed 
with brine (30 mL), dried (Na2SO4), filtered, and concentrated.  The crude residue was 
purified by silica gel chromatography (0:100 to 50:50 EtOAc:hexanes) to yield 512 mg 
(61% yield) of the product as a light yellow foam.  1H NMR (500 MHz, CD3CN) δ 7.80 
(ddd, J = 9.1, 0.8, 0.4 Hz, 2H), 7.51 (d, J = 9.1 Hz, 2H), 7.20 (ddd, J = 2.5, 0.5, 0.5 Hz, 
2H), 7.09 (br s, 2H), 6.93 (ddd, J = 9.1, 0.7, 0.7 Hz, 2H), 6.87 (dd, J = 9.1, 2.5 Hz, 2H), 
5.02 (d, J = 6.7 Hz, 2H), 4.94 (d, J = 6.7 Hz, 2H), 3.11 (s, 6H) ; 13C NMR (125 MHz, 
CD3CN) δ 154.4, 151.6, 132.1, 129.6, 128.4, 127.8, 122.1, 119.6, 118.7, 110.1, 96.0, 
56.1; IR (NaCl/thin film): 3368, 2914, 1624, 1599, 1511, 1240, 1196, 1148, 1023 cm-1; 
[α]D25 = +87.1 (c = 1.00, MeCN). HRMS (MM) calc’d for [M-H]- 405.1344, found 
405.1350. 
 
A 15 mL flask was charged with (R)-MOM-hydroxy-BINOL (200 mg, 0.493 mmol, 
1.00 equiv) and K2CO3 (177 mg, 1.28 mmol, 2.60 equiv). DMF (2 mL) was added, 
followed by MeI (123 µL, 1.97 mmol, 4.00 equiv) dropwise.  The reaction was then 
heated to 55 ºC for 22 hours, then cooled to room temperature and quenched with 
saturated aqueous NH4Cl (2 mL) and Et3N (3 drops).  The mixture was stirred at room 
temperature for 6 hours, then diluted with H2O (15 mL) and extracted with EtOAc (3 x 10 
mL).  The combined organics were washed with brine (15 mL), dried (Na2SO4), and 
concentrated. THF (28 mL) and IPA (9.5 mL) were added to the crude residue, followed 
OMOM
OMOM
OH
OH
(i)  K2CO3, MeI, DMF, 55 ºC
HO
HO
(ii) 3:1:1 THF:IPA:6N HCl,
     23 ºC
MeO
MeO(36% yield)
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by dropwise addition of aqueous HCl (6.0 M, 9.4 mL).  The reaction was stirred at room 
temperature for 3 hours, then diluted with H2O (70 mL) and extracted with EtOAc (3 x 30 
mL).  The combined organics were washed with saturated aqueous NaHCO3 (2 x 45 mL) 
and brine (45 mL), then dried (Na2SO4), filtered, and concentrated.  The crude oil was 
purified by silica gel chromatography (0:100 to 30:70 EtOAc:hexanes) to yield 62 mg 
(36% yield) of (R)-6,6’-dimethoxy-BINOL as a light brown solid, which was dried over 
P2O5 under hi-vacuum. Spectral data are in agreement with the literature. 
Preparation of 1-allyl-2-phenylindole  
 
To a 50 mL flask was added NaH (620 mg, 15.5 mmol, 3.00 equiv) and DMF (8 mL) 
and the suspension was cooled to 0 ºC in an ice bath.  A solution of 2-phenylindole (1.00 
g, 5.18 mmol, 1.00 equiv) in DMF (3 mL) was added slowly to the suspension over 15 
minutes and the reaction mixture was further stirred at 0 ºC for 20 minutes, followed by 
dropwise addition of allyl bromide (670 µL, 7.77 mmol, 1.50 equiv).  The ice bath was 
then removed and the mixture was stirred for 15 minutes, then quenched by addition of 
saturated aqueous NH4Cl (5 mL) and Et3N (5 drops). After 2 hours, the reaction was 
diluted with H2O (40 mL) and extracted with EtOAc (3 x 30 mL).  The combined 
organics were washed with brine (120 mL), dried (Na2SO4), filtered, and concentrated.  
The crude was then purified by reverse phase preparatory HPLC (55:45 to 95:5 
MeCN:H2O) using an Agilent 1200 Series HPLC with an Agilent XDB-C18 5 µM 
column (9.4 x 250 mm and 21.2 x 150 mm) to yield 687 mg (57% yield) of 1-allyl-2-
NaH, allylBr, DMF, 0 ºC
N
H
Ph
N Ph N Ph(80% combined yield)
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phenylindole as a yellow solid and 331 mg (23% yield) of 1,3-diallyl-2-phenylindole as a 
yellow oil. 
1-allyl-2-phenylindole : 
1H NMR (500 MHz, CDCl3) δ 7.65 (ddd, J = 7.8, 1.2, 0.8 Hz, 1H), 7.55 – 
7.51 (m, 2H), 7.48 – 7.43 (m, 2H), 7.42 – 7.38 (m, 1H), 7.33 (br d, J = 8.2 Hz, 
1H), 7.22 (ddd, J = 7.0, 7.0, 1.3 Hz, 1H), 7.15 (ddd, J = 7.0, 7.0, 1.0 Hz, 1H), 6.60 (br s, 
1H), 6.02 (ddt, J = 17.2, 10.5, 4.4 Hz, 1H), 5.22 (dtd, J = 10.5, 1.8, 1.1 Hz, 1H), 5.00 
(dtd, J = 17.1, 2.0, 1.2 Hz, 1H), 4.74 (dt, J = 4.2, 1.9 Hz, 2H); 13C NMR (125 MHz, 
CDCl3) δ 141.5, 137.8, 133.8, 132.7, 129.1, 128.5, 128.1, 128.0, 121.7, 120.5, 120.0, 
116.5, 110.3, 102.0, 46.5; IR (NaCl/thin film): 3055, 2917, 1602, 1462, 1443, 1392, 
1345, 1317, 1162 cm-1; HRMS (APCI) calc’d for [M+H]+ = 234.1277, found 234.1284. 
1,3-diallyl-2-phenylindole:  
1H NMR (500 MHz, CDCl3) δ 7.65 (ddd, J = 7.8, 1.2, 0.7 Hz, 1H), 7.50 – 
7.40 (m, 5H), 7.33 (ddd, J = 8.1, 0.9, 0.9 Hz, 1H), 7.24 (ddd, J = 7.0, 7.0, 1.2 
Hz, 1H), 7.16 (ddd, J = 7.0, 7.0, 1.1 Hz, 1H), 6.05 (ddt, J = 17.0, 10.1, 5.9 Hz, 1H), 5.91 
(ddt, J = 17.1, 10.4, 4.7 Hz, 1H), 5.14 (dtd, J = 10.4, 1.8, 1.2 Hz, 1H), 5.08 – 5.02 (m, 
2H), 4.92 (dtd, J = 17.1, 1.9, 1.3 Hz, 1H), 4.62 (dt, J = 4.6, 1.9 Hz, 2H), 3.46 (dt, J = 6.0, 
1.7 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 138.0, 137.9, 136.7, 133.9, 131.8, 130.4, 
128.3, 128.2, 128.1, 128.0, 121.7, 119.34, 119.30, 116.2, 114.6, 110.9, 110.1, 46.4, 29.2; 
IR (NaCl/thin film): 3056, 2915, 1637, 1463, 1443, 1408, 1360, 1340, 1191 cm-1; HRMS 
(MM) calc’d for [M+H]+ = 274.1590, found 274.1591. 
Preparation of 2-(2-fluorophenyl)indole: 
 
I
NH2
i.  Pd(PPh3)2Cl2, CuI, Et3N, 23 ºC
ii.  InBr3, PhMe, 110 ºC
(77% yield)
N
HF
F
N Ph
N Ph
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2-(2-fluorophenyl)indole was prepared by an analogous procedure to that reported by 
Sakai et. al. A flame-dried flask was charged with 2-iodoaniline (200 mg, 0.90 mmol, 
1.00 equiv), ethynyl-2-fluorobenzene (133 mg, 1.10 mmol, 1.20 equiv), Pd(PPh3)2Cl2 (13 
mg, 0.02 mmol, 0.02 equiv), copper (I) iodide (2.0 mg, 0.025 mmol, 0.01 equiv) and Et3N 
(4 mL).  The mixture was stirred overnight at room temperature, then filtered through a 
plug of silica, concentrated and redissolved in PhMe (5 mL).  InBr3 (16 mg, 0.05 mmol, 
0.05 equiv) was added in one portion and the mixture was heated to 110 ºC for 5 h, then 
cooled to room temperature, filtered through celite, and concentrated.  The crude residue 
was purified by silica gel chromatography (10:90 EtOAc:hexanes) to yield 148 mg (77% 
yield) of  2-(2-fluorophenyl)indole as a white solid. 1H NMR (500 MHz, CDCl3) δ 8.89 
(br s, 1H), 7.80 (ddd, J = 7.8, 7.8, 1.8 Hz, 1H), 7.66 (dddd, J = 2.5, 1.3, 0.8, 0.8 Hz, 1H), 
7.43 (ddd, J = 8.1, 1.5, 0.8 Hz, 1H), 7.32 – 7.26 (m, 1H), 7.26 – 7.16 (m, 3H), 7.14 (ddd, 
J = 8.0, 7.0, 1.0 Hz, 1H), 6.97 (d, J = 1.9 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 159.3 
(d, JC-F= 246.4 Hz), 134.6 (d, JC-F = 501.8 Hz), 128.8 (d, JC-F = 8.8 Hz), 128.1, 128.0 (d, 
JC-F = 4.1 Hz), 124.8 (d, JC-F = 3.2 Hz), 122.7, 120.6, 120.2, 119.9 (d, JC-F = 11.0 Hz), 
116.6, 116.4, 111.0, 101.6 (d, JC-F = 3.0 Hz); IR (NaCl/thin film): 3469, 3042, 2918, 
2848, 1577, 1472, 1460, 1212, 1178, 1109, 928 cm-1; HRMS (MM) calc’d for [M+H]+ 
212.0870, found 212.0869. 
Preparation of 2-(ethylphthalimide)indole: 
 
2-(ethylphthalimide)indole was prepared by an analogous procedure to that reported 
by Sakai et. al.  A flame-dried flask was charged with 2-iodoaniline (500 mg, 2.30 mmol, 
I
NH2
NPhth
i.  Pd(PPh3)2Cl2, CuI, Et3N, 23 ºC
ii.  InBr3, PhMe, 110 ºC N
H
N
O
O(45% yield)
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1.00 equiv), 2-(but-3-yn-1-yl)isoindoline-1,3-dione (550  mg, 2.75 mmol, 1.20 equiv), 
Pd(PPh3)2Cl2 (32 mg, 0.05 mmol, 0.02 equiv), copper (I) iodide (4.5 mg, 0.025 mmol, 
0.01 equiv) and Et3N (8 mL).  The mixture was stirred overnight at room temperature, 
then filtered through a plug of silica, concentrated and redissolved in PhMe (10 mL).  
InBr3 (40 mg, 0.1 mmol, 0.05 equiv) was added in one portion and the mixture was 
heated to 110 ºC for 5 h, then cooled to room temperature, filtered through celite and 
concentrated.  The crude residue was purified by silica gel chromatography (60:40 
EtOAc:hexanes) to yield 302 mg (45% yield) of  2-(ethylphthalimide)indole as a light 
yellow solid. 1H NMR (500 MHz, CDCl3) δ 8.26 (br s, 1H), 7.83 (dd, J = 5.5, 3.1 Hz, 
2H), 7.71 (dd, J = 5.5, 3.1 Hz, 2H), 7.51 (d, J = 7.8 Hz, 1H), 7.33 (d, J = 8.1 Hz, 1H), 
7.13 (ddd, J = 8.2, 7.1, 1.2 Hz, 1H), 7.06 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 6.33 (d, J = 1.2 
Hz, 1H), 4.06 (t, J = 7.5 Hz, 2H), 3.21 (t, J = 7.4 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 
168.3, 136.1, 134.9, 134.1, 131.9, 128.6, 123.4, 121.4, 120.0, 119.7, 110.6, 101.1, 37.1, 
27.4.; IR (NaCl/thin film): 3366, 1772, 1707, 1653, 1617, 1466, 1395, 1363, 1293 cm-1; 
HRMS (MM) calc’d for [M+H]+ 291.1128, found 291.1138. 
2.6.3 Optimization of Reaction Parameters 
 
2.6.3.1 General Procedure 1 
 
An oven-dried vial was charged with 2-phenylindole (0.20 mmol, 1.00 equiv), the 
acrylate (0.24 mmol, 1.20 equiv) and an (R)-BINOL derivative and pumped into a glove 
box. The vial was charged with solvent to an indole concentration of 0.12 M, and SnCl4 
(1.00 equiv, as a 1.0 M solution in CH2Cl2) was added. The reaction was stirred at 20 °C 
for 2 hours, after which time it was removed from the glove box and quenched by 
Chapter 2 – Enantioselective Synthesis of Tryptophan Derivatives by a Tandem Friedel–
Crafts Conjugate Addition/Asymmetric Protonation Reaction 
46 
dilution with 1 M HCl (5 mL) and MeCN (1 mL). The aqueous layer was extracted with 
EtOAc (2 x 5 mL) and the combined organic layers were washed with saturated aqueous 
NaHCO3 (5 mL), dried (Na2SO4), filtered, and concentrated. The crude residue was 
purified by silica gel chromatography. 
Additive screens.  Reactions were performed following General Procedure 1 using 0.20 
equiv (R)-BINOL. After the vial was pumped into the glove box, one of the following 
additives was added:  
• flame-dried powdered 4Å molecular sieves (200 wt % relative to indole)  
• K2CO3 (1.00 equiv)  
• 2,6-lutidine (1.00 equiv) 
Upon addition of the additive, DCM was added to an indole concentration of 0.12 M and 
the reaction was further conducted as described above. 
 
Catalyst screens. Reactions were performed following General Procedure 1 using flame-
dried powdered 4Å molecular sieves (200 wt % relative to indole) as an additive and 
DCM as a solvent. 
2.6.3.2 Characterization Data 
 
(S)-Nα-Trifluoroacetyl-2-phenyltryptophan benzyl ester (121a) 
Prepared from benzyl 2-trifluoroacetamidoacrylate (65.5 mg, 0.24 mmol) 
following General Procedure 1. The crude residue was purified by silica 
gel chromatography (30:70 to 70:30 DCM:hexanes) to yield 11.1 mg (12% yield) of 121a 
as a yellow solid.  The enantiomeric excess was determined to be 35% by chiral SFC 
analysis (OB-H, 2.5 mL/min, 15% IPA in CO2, λ = 254 nm): tR(major) = 11.0 min, 
N
H
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tR(minor) = 12.9 min.  1H NMR (500 MHz, CDCl3) δ 8.14 (br s, 1H), 7.57 (ddd, J = 7.9, 
1.8, 0.7 Hz, 1H), 7.54 – 7.50 (m, 2H), 7.50 – 7.45 (m, 2H), 7.42 – 7.36 (m, 2H), 7.34 – 
7.29 (m, 3H), 7.24 (ddd, J = 8.1, 7.1, 1.1 Hz, 1H), 7.16 (ddd, J = 8.0, 7.1, 1.0 Hz, 1H), 
7.11 – 7.07 (m, 2H), 6.67 (br d, J = 7.6 Hz, 1H), 4.95 (d, J = 12.2 Hz, 1H), 4.88 (dt, J = 
7.8, 6.0 Hz, 1H), 4.53 (d, J = 12.2 Hz, 1H), 3.65 – 3.56 (m, 2H); 13C NMR (125 MHz, 
CDCl3) δ 13C NMR (125 MHz, CDCl3) δ 170.1, 156.6 (q, JC-F = 37.8 Hz), 136.3, 135.6, 
134.6, 132.4, 129.2, 128.9, 128.5, 128.44, 128.38, 128.2, 128.1, 122.8, 120.3, 118.6, 
115.3 (q, JC-F = 287.9 Hz), 111.0, 105.6, 67.5, 53.3, 26.7; IR (NaCl/thin film): 3391, 
3061, 2924, 1714, 1542, 1457, 1210, 1173 cm-1; [α]D25 = +3.5 (c = 0.44, CHCl3). HRMS 
(MM) calc’d for [M+H]+ 467.1577, found 467.1580. 
(S)-Nα-Trifluoroacetyl-2-phenyltryptophan methyl ester (121b) 
Prepared from methyl 2-trifluoroacetamidoacrylate (47.3 mg, 0.24 mmol) 
following General Procedure 1. The crude residue was purified by silica 
gel chromatography (0:100 to 5:95 EtOAc:toluene, then 0:100 to 20:80 EtOAc:hexanes) 
to yield 9.0 mg (12% yield) of 121b as a yellow solid.  The enantiomeric excess was 
determined to be 42% by chiral SFC analysis (AS-H, 2.5 mL/min, 10% IPA in CO2, λ = 
254 nm): tR(major) = 8.7 min, tR(minor) = 7.7 min. 1H NMR (500 MHz, CDCl3) δ  8.17 
(br s, 1H), 7.58 – 7.52 (m, 3H), 7.52 – 7.47 (m, 2H), 7.43 – 7.39 (m, 1H), 7.38 (ddd, J = 
8.1, 0.9, 0.9 Hz, 1H), 7.23 (ddd, J = 8.2, 7.0, 1.2 Hz, 1H), 7.16 (ddd, J = 8.0, 7.0, 1.0 Hz, 
1H), 6.65 (br d, J = 7.3 Hz, 1H), 4.83 (dt, J = 7.8, 5.6 Hz, 1H), 3.66 – 3.56 (m, 2H), 3.34 
(s, 3H); 13C NMR (125 MHz, CDCl3) δ 170.5, 156.6 (q, JC-F = 37.7 Hz), 136.3, 135.6, 
132.5, 129.2, 129.0, 128.4, 128.2, 122.8, 120.3, 118.5, 115.3 (q, J C-F= 287.7 Hz), 111.0, 
105.5, 53.2, 52.5, 26.4; IR (NaCl/thin film): 3391, 3057, 2917, 2849, 1718, 1542, 1458, 
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1449, 1211, 1170 cm-1 ; [α]D25 = +22.3 (c = 0.39, CHCl3). HRMS (MM) calc’d for 
[M+H]+ 391.1264, found 391.1267. 
2.6.4 Optimized Conjugate Addition/Asymmetric Protonation 
 
2.6.4.1 General Procedure 2 
 
An oven-dried vial was charged with the indole (1.00 equiv), methyl 2-
acetamidoacrylate (1.20 equiv) and (R)-3,3’-dibromo-BINOL (0.20 equiv) and pumped 
into a glove box. To the vial was added flame-dried powdered 4Å molecular sieves (200 
wt % relative to indole). The vial was charged with DCM to an indole concentration of 
0.12 M, and SnCl4 (1.00 equiv unless specifically indicated, as a 1 M solution in DCM) 
was added. The reaction was stirred at 20 °C for 2 hours, after which time it was removed 
from the glove box and quenched by dilution with 1 M HCl (5 mL) and MeCN (1 mL). 
The aqueous layer was extracted with EtOAc (2 x 5 mL) and the combined organic layers 
were washed with saturated aqueous NaHCO3 (5 mL), dried (Na2SO4), filtered, and 
concentrated. The crude residue was purified by silica gel chromatography. 
2.6.4.2 Characterization Data 
 
(S)-Nα-Acetyl-2-phenyltryptophan methyl ester (121c) 
Prepared from 2-phenylindole (19.0 mg, 0.10 mmol) following General 
Procedure 2.  The crude residue was purified by silica gel chromatography 
(40:60 to 100:0 EtOAc:hexanes) to yield 25.6 mg (76% yield) of 121c as a white foam.  
The enantiomeric excess was determined to be 93% by chiral SFC analysis (AD-H, 2.5 
mL/min, 30% IPA in CO2, λ = 254 nm).  tR(major) = 5.7 min, tR(minor) = 6.9 min. [α]D25 
= +37.7 (c = 0.94, CHCl3).  Spectral data matches that reported in the literature. 
N
H
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(S)-Nα-Acetyl-1-methyl-2-phenyltryptophan methyl ester (121d)  
Prepared from 1-methyl-2-phenylindole (41.4 mg, 0.20 mmol) following 
General Procedure 2.  The crude residue was purified by silica gel 
chromatography (0:100 to 55:45 EtOAc:hexanes) to yield 43.4 mg (63% yield) of 121d 
as a yellow solid.  The enantiomeric excess was determined to be 85% by chiral SFC 
analysis (AD-H, 2.5 mL/min, 20% IPA in CO2, λ = 254 nm): tR(major) = 4.6 min, 
tR(minor) = 3.9 min.  1H NMR (500 MHz, CDCl3) δ 7.60 (ddd, J = 7.9, 1.2, 0.7 Hz, 1H), 
7.56 – 7.49 (m, 2H), 7.48 – 7.44 (m, 1H), 7.42 – 7.38 (m, 2H), 7.34 (ddd, J = 8.2, 0.9, 0.9 
Hz, 1H), 7.26 (ddd, J = 8.2, 7.0, 1.2 Hz, 1H), 7.17 (ddd, J = 8.0, 7.0, 1.1 Hz, 1H), 5.72 
(br d, J = 7.8 Hz, 1H), 4.74 (dt, J = 8.0, 5.6 Hz, 1H), 3.57 (s, 3H), 3.39 (s, 3H), 3.41 (dd, 
J = 14.7, 5.7 Hz, 1H), 3.34 (dd, J=14.8, 5.6 Hz, 1H), 1.73 (s, 3H); 13C NMR (125 MHz, 
CDCl3) δ 172.2, 169.5, 139.2, 136.9, 131.6, 130.7, 128.7, 128.4, 127.9, 122.0, 119.7, 
118.7, 109.5, 106.7, 52.8, 52.0, 30.8, 26.6, 23.0.;  IR (NaCl/thin film): 3288, 3055, 2950, 
1743, 1657, 1539, 1469, 1441, 1368, 1238, 1212 cm-1; [α]D25 = +21.3 (c = 0.91, CHCl3). 
HRMS (MM) calc’d for [M+H]+ 351.1703, found 351.1708. 
(S)-Nα-Acetyl-1-allyl-2-phenyltryptophan methyl ester (121e) 
Prepared from 1-allyl-2-phenylindole (46.6 mg, 0.20 mmol) following 
General Procedure 2. The crude residue was purified by silica gel 
chromatography (0:100 to 55:45 EtOAc:hexanes) to yield 51.3 mg (68% 
yield) of 121e as a yellow foam. The enantiomeric excess was determined to be 85% by 
chiral SFC analysis (AS-H, 2.5 mL/min, 30% IPA in CO2, λ = 254 nm): tR(major) = 2.9 
min, tR(minor) = 2.4 min. 1H NMR (500 MHz, CDCl3) δ 7.62 (ddd, J = 7.8, 1.0, 1.0 Hz, 
1H), 7.53 – 7.47 (m, 2H), 7.47 – 7.42 (m, 1H), 7.42 – 7.37 (m, 2H), 7.30 (ddd, J = 8.1, 
N
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0.9, 0.9 Hz, 1H), 7.23 (ddd, J = 8.2, 7.0, 1.2 Hz, 1H), 7.17 (ddd, J = 8.0, 7.0, 1.1 Hz, 1H), 
5.85 (ddt, J = 17.1, 10.3, 4.7 Hz, 1H), 5.76 (br d, J = 7.9 Hz, 1H), 5.11 (dtd, J = 10.4, 1.7, 
1.2 Hz, 1H), 4.82 (dtd, J = 17.1, 1.9, 1.3 Hz, 1H), 4.76 (dt, J = 8.0, 5.8 Hz, 1H), 4.56 (dt, 
J = 4.7, 1.8 Hz, 2H), 3.39 (s, 3H), 3.36 (dd, J = 14.7, 5.7 Hz, 1H), 3.29 (dd, J = 14.7, 5.9 
Hz, 1H), 1.75 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 172.2, 169.5, 139.0, 136.3, 133.5, 
131.5, 130.5, 128.7, 128.5, 128.1, 122.0, 119.8, 118.8, 116.3, 110.2, 107.2, 52.8, 52.0, 
46.3, 26.8, 23.0; IR (NaCl/thin film): 3435, 3287, 3056, 2950, 2926, 2851, 1744, 1658, 
1538, 1500, 1408, 1367, 1219, 1196, 1134; [α]D25 = +13.8 (c = 2.96, CHCl3). HRMS 
(MM) calc’d for [M+H]+ 377.1860, found 377.1865. 
(S)-Nα-Acetyl-4-methyl-2-phenyltryptophan methyl ester (121f) 
 
Prepared from 4-methyl-2-phenylindole (21.0 mg, 0.10 mmol) 
following General Procedure 2. The crude residue was purified by 
silica gel chromatography (40:60 to 100:0 EtOAc:hexanes) to yield 30.8 mg (88% yield) 
of 121f as a white foam. The enantiomeric excess was determined to be 96% by chiral 
SFC analysis (AD-H, 2.5 mL/min, 25% IPA in CO2, λ = 254 nm): tR(major) = 9.9 min, 
tR(minor) = 8.9 min. 1H NMR (500 MHz, CDCl3) δ 8.32 (br s, 1H), 7.55 – 7.45 (m, 4H), 
7.44 – 7.37 (m, 1H), 7.19 (d, J = 8.0 Hz, 1H), 7.08 (m, 1H), 6.91 (m, 1H), 5.44 (br d, J = 
7.6 Hz, 1H), 4.63 (td, J = 8.2, 5.0 Hz, 1H), 3.69 – 3.45 (m, 2H), 3.44 (s, 3H), 2.78 (s, 
3H), 1.64 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 172.3, 169.7, 136.3, 136.1, 133.1, 
130.5, 129.2, 128.9, 128.3, 126.9, 122.5, 122.3, 109.0, 107.6, 54.2, 52.1, 27.6, 22.8, 20.5; 
IR (NaCl/thin film): 3295, 3052, 2952, 1741, 1659, 1602, 1547, 1514, 1492, 1449, 1372, 
1218; [α]D25 = -29.0 (c = 0.63, CHCl3). HRMS (MM) calc’d for [M+H]+ 351.1703, found 
351.1698. 
N
H
Ph
CO2Me
NHAc
Me
Chapter 2 – Enantioselective Synthesis of Tryptophan Derivatives by a Tandem Friedel–
Crafts Conjugate Addition/Asymmetric Protonation Reaction 
51 
(S)-Nα-Acetyl-6-methyl-2-phenyltryptophan methyl ester (121g) 
Prepared from 6-methyl-2-phenylindole (21.0 mg, 0.10 mmol) 
following General Procedure 2. The crude residue was purified by 
silica gel chromatography (40:60 to 100:0 EtOAc:hexanes) to yield  27.9 mg (80% yield) 
of 121g as a colorless oil. The enantiomeric excesses was determined to be 89% by chiral 
SFC analysis (AD-H, 2.5 mL/min, 30% IPA in CO2, λ = 254 nm): tR(major) = 9.1 min, 
tR(minor) = 10.1 min. 1H NMR (500 MHz, CDCl3) δ 8.01 (br s, 1H), 7.55 (ddd, J = 5.8, 
4.0, 2.1 Hz, 2H), 7.48 – 7.44 (m, 3H), 7.39 – 7.33 (m, 1H), 7.14 (s, 1H), 6.97 (dd, J = 8.3, 
1.5 Hz, 1H), 5.78 (br d, J = 7.8 Hz, 1H), 4.83 (dt, J = 8.0, 5.4 Hz, 1H), 3.55 – 3.49 (m, 
2H), 3.30 (s, 3H), 2.47 (s, 3H), 1.67 (s, 3H); 13C NMR (125 MHz, CDCl3) 172.1, 169.6, 
136.1, 135.2, 133.3, 132.4, 129.1, 128.2, 127.9, 127.3, 121.8, 118.5, 110.9, 106.5, 52.7, 
52.0, 26.6, 22.9, 21.7; IR (NaCl/thin film): 3292, 3052, 2958, 2908, 1741, 1658, 1545, 
1530, 1511, 1446, 1375, 1216; [α]D25 = +39.3 (c = 0.38, CHCl3). HRMS (MM) calc’d for 
[M+H]+ 351.1703, found 351.1698. 
(S)-Nα-Acetyl-7-methyl-2-phenyltryptophan methyl ester (121h) 
Prepared from 7-methyl-2-phenylindole (21.0 mg, 0.10 mmol) following 
General Procedure 2. The crude residue was purified by silica gel 
chromatography (30:70 to 100:0 EtOAc:hexanes) to yield 33.0 mg (94% yield) of 121h 
as a white foam. The enantiomeric excess was determined to be 94% by chiral SFC 
analysis (AD-H, 2.5 mL/min, 25% IPA in CO2, λ = 254 nm): tR(major) = 5.6 min, 
tR(minor) = 5.0 min. 1H NMR (500 MHz, CDCl3) δ 8.23 (br s, 1H), 7.61 – 7.54 (m, 2H), 
7.51 – 7.45 (m, 2H), 7.42 (d, J = 8.1 Hz, 1H), 7.40 – 7.35 (m, 1H), 7.11 – 7.04 (m, 1H), 
7.03 – 6.97 (m, 1H), 5.79 (br d, J = 8.1 Hz, 1H),  4.82 (dt, J  = 8.1, 5.7 Hz, 1H), 2.55 (dd, 
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J = 12.5, 3.1 Hz, 1H), 3.51 (dd, J = 12.5, 3.1 Hz, 1H), 3.30 (s, 3H), 2.50 (s, 3H), 1.65 (s, 
3H); 13C NMR (125 MHz, CDCl3) δ 172.1, 169.6, 135.8, 135.3, 133.3, 129.1, 128.9, 
128.4, 128.0, 123.1, 120.20, 120.18, 116.5, 107.1, 52.7, 51.9, 26.6, 22.8, 16.6; IR 
(NaCl/thin film): 3283, 3053, 2950, 1736, 1659, 1518, 1438, 1372, 1306, 1266, 1219, 
1137, 1043; [α]D25 = +26.5 (c = 0.20, CHCl3). HRMS (MM) calc’d for [M+H]+ 
351.1703, found 351.1708. 
 
 (S)-Nα-Acetyl-5-methoxy-2-phenyltryptophan methyl ester (121i) 
Prepared from 5-methoxy-2-phenylindole (45.0 mg, 0.20 mmol) 
following General Procedure 2. The crude residue was purified by 
silica gel chromatography (40:60 to 100:0 EtOAc:hexanes) to yield 62.0 mg (85% yield) 
of 121i as a colorless oil. The enantiomeric excess was determined to be 91% by chiral 
SFC analysis (AD-H, 2.5 mL/min, 30% IPA in CO2, λ = 254 nm): tR(major) = 4.7 min, 
tR(minor) = 6.5 min. 1H NMR (500 MHz, CDCl3) δ 8.24 (br s, 1H), 7.58 – 7.49 (m, 2H), 
7.50 – 7.41 (m, 2H), 7.36 (dd, J = 7.4, 7.4 Hz, 1H), 7.24 (d, J = 8.7 Hz, 1H), 7.05 (d, J = 
2.3 Hz, 1H), 6.90 – 6.80 (m, 1H), 5.82 (br d, J = 7.9 Hz, 1H), 4.82 (td, J = 7.9, 5.4 Hz, 
1H), 3.87 (s, 3H), 3.49 (m, 2H), 3.29 (s, 3H), 1.67 (s, 3H); 13C NMR (125 MHz, CDCl3) 
δ 172.2, 169.6, 154.4, 136.7, 133.2, 130.8, 129.8, 129.1, 128.2, 128.0, 112.7, 111.7, 
106.5, 100.5, 55.9, 52.7, 52.0, 26.6, 22.9; IR (NaCl/thin film): 3291, 3057, 2926, 1739, 
1652, 1558, 1539, 1520, 1483, 1455, 1374, 1218, 1178; [α]D25 = +32.6 (c = 0.93, CHCl3). 
HRMS (MM) calc’d for [M+H]+ 367.1652, found 367.1658. 
(S)-Nα-Acetyl-5-bromo-2-phenyltryptophan methyl ester (121j) 
Prepared from 5-bromo-2-phenylindole (54.0 mg, 0.20 mmol) with 1.6 
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equiv SnCl4 following General Procedure 2. The crude residue was purified by silica gel 
chromatography (30:70 to 100:0 EtOAc:hexanes) to yield 49.5 mg (60% yield) of 121j as 
a white foam. The enantiomeric excess was determined to be 93% by chiral SFC analysis 
(AD-H, 2.5 mL/min, 30% IPA in CO2, λ = 254 nm): tR(major) = 5.3 min, tR(minor) = 7.9 
min. 1H NMR (500 MHz, CDCl3) δ 8.42 (br s, 1H), 7.66 (d, J = 2.0 Hz, 1H), 7.56 – 7.50 
(m, 2H), 7.49 – 7.43 (m, 2H), 7.42 – 7.34 (m, 1H), 7.28 – 7.24 (m, 1H), 7.22 – 7.18 (m, 
1H), 5.75 (br d, J = 8.1 Hz, 1H), 4.82 (dt, J = 8.1, 5.7 Hz, 1H), 3.53 (dd, J = 14.9, 5.5 Hz, 
1H), 3.46 (dd, J = 14.9, 4.8 Hz, 1H), 3.36 (s, 3H), 1.63 (s, 3H); 13C NMR (125 MHz, 
CDCl3) δ 171.9, 169.6, 137.2, 134.2, 132.6, 131.1, 129.2, 128.3, 128.2, 125.2, 121.6, 
113.1, 112.4, 106.4, 52.6, 52.1, 26.5, 22.8; IR (NaCl/thin film): 3417, 3369, 3282, 1734, 
1654, 1521, 1466, 1437, 1374, 1215; [α]D25 = +47.2 (c = 1.04, CHCl3). HRMS (MM) 
calc’d for [M+H]+ 415.0652, found 415.0653. 
 
(S)-Nα-Acetyl-5-fluoro-2-phenyltryptophan methyl ester (121k) 
Prepared from 5-fluoro-2-phenylindole (42.0 mg, 0.20 mmol) with 1.6 
equiv SnCl4 following General Procedure 2. The crude residue was 
purified by silica gel chromatography (40:60 to 100:0 EtOAc:hexanes) to yield 44.7 mg 
(63% yield) of 121k as a colorless oil. The enantiomeric excess was determined to be 
92% by chiral SFC analysis (AD-H, 2.5 mL/min, 30% IPA in CO2, λ = 254 nm): 
tR(major) = 3.8 min, tR(minor) = 5.2 min. 1H NMR (500 MHz, CDCl3) δ 8.30 (br s, 1H), 
7.60 – 7.52 (m, 2H), 7.50 – 7.43 (m, 2H), 7.42 – 7.34 (m, 1H), 7.27 – 7.24 (m, 1H), 7.21 
(dd, J = 9.8, 2.6 Hz, 1H), 6.94 (ddd, J = 9.0, 9.0, 2.6 Hz, 1H), 5.77 (br d, J = 7.8 Hz, 1H), 
4.82 (dt, J = 8.1, 5.4 Hz, 1H), 3.53 (dd, J = 14.9, 5.6 Hz, 1H), 3.47 (dd, J = 14.9, 5.0 Hz, 
1H), 3.35 (s, 3H), 1.64 (s, 2H); 13C NMR (125 MHz, CDCl3) δ 172.7, 169.8, 168.3, 
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135.6, 134.2, 132.5, 131.9, 128.6, 123.5, 121.8, 119.7, 118.2, 110.8, 107.4, 52.9, 52.4, 
37.0, 27.0, 25.3, 23.1; IR (NaCl/thin film): 3275, 3062, 2952, 1733, 1652, 1584, 1558, 
1539, 1520, 1486, 1456, 1436, 1374, 1266, 1217, 1180; [α]D25 = +49.9 (c = 1.25, CHCl3). 
HRMS (MM) calc’d for [M+H]+ 355.1452, found 355.1455. 
(S)-Nα-Acetyl-2-(4-methylphenyl)tryptophan methyl ester (121l) 
Prepared from 2-(4-methylphenyl)indole (41.0 mg, 0.20 mmol) 
following General Procedure 2. The crude residue was purified by silica 
gel chromatography (40:60 to 100:0 EtOAc:hexanes) to yield 60.1 mg (86% yield) of 
121l as a white foam. The enantiomeric excess was determined to be 94% by chiral SFC 
analysis (AD-H, 2.5 mL/min, 30% IPA in CO2, λ = 254 nm).  tR(major) = 6.6 min, 
tR(minor) = 8.8 min. 1H NMR (500 MHz, CDCl3) δ 8.20 (br s, 1H), 7.56 (d, J = 8.1 Hz, 
1H), 7.45 (d, J = 8.1, 2H), 7.34 (d, J = 8.1, 1H), 7.28 (d, J = 8.1, 2H), 7.19 (ddd, J = 7.8, 
7.1, 1.2 Hz, 1H), 7.15 – 7.09 (m, 1H), 5.77 (br d, J = 8.1, 1H), 4.82 (dt, J = 7.8, 5.5 Hz, 
1H), 3.54 (dd, J = 13.1, 4.0 Hz, 1H), 3.50 (dd, J = 13.1, 3.7 Hz, 1H), 3.33 (s, 3H), 2.40 (s, 
3H), 1.66 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 172.2, 169.6, 138.0, 136.1, 135.6, 
130.2, 129.8, 129.4, 128.1, 122.3, 119.9, 118.7, 110.9, 106.4, 52.8, 52.0, 26.6, 22.8, 21.2; 
IR (NaCl/thin film): 3365, 3271, 3052, 2951, 1737, 1657, 1519, 1460, 1439, 1375, 1305, 
1217 cm-1; [α]D25 =  43.2 (c = 0.74, CHCl3). HRMS (MM) calc’d for [M+H]+ 351.1703, 
found 351.1700. 
 
(S)-Nα-Acetyl-2-(2-methylphenyl)tryptophan methyl ester (121m) 
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Prepared from 2-(2-methylphenyl)indole (21.0 mg, 0.1 mmol) following 
General Procedure 2.  The crude residue was purified by flash 
chromatography (40:60 to 100:0 EtOAc:hexanes) to yield 9.2 mg (26% 
yield) of 121m. The enantiomeric excess was determined to be 87% by chiral SFC 
analysis (AD-H, 2.5 mL/min, 25% IPA in CO2, λ = 254 nm): tR(major) = 4.3 min, 
tR(minor) = 4.9 min. 1H NMR (500 MHz, CDCl3) δ 8.03 (br s, 1H), 7.62 – 7.55 (dd, J = 
7.6, 0.9 Hz, 1H), 7.38 – 7.32 (m, 4H), 7.31 – 7.27 (m, 1H), 7.22 (ddd, J = 8.1, 5.6, 2.1 
Hz, 1H), 7.16 (ddd, J = 7.1, 5.6, 1.1 Hz, 1H), 5.71 (br d, J = 7.9 Hz, 1H), 4.82 – 4.68 (dt, 
J = 7.9, 5.4 Hz, 1H), 3.38 – 3.29 (m, 4H), 3.28 – 3.16 (m, 1H), 2.28 (s, 3H), 1.73 (s, 3H); 
13C NMR (125 MHz, CDCl3) δ 172.1, 169.6, 137.3, 135.8, 135.5, 132.1, 130.9, 130.8, 
128.9, 128.7, 126.0, 122.3, 119.9, 118.8, 110.8, 107.6, 52.8, 52.0, 26.6, 23.0, 20.0; IR 
(NaCl/thin film): 3385, 3271, 3062, 2924, 2853, 1734, 1653, 1559, 1539, 1521, 1457, 
1437, 1374; [α]D25 = +21.5 (c = 0.29, CHCl3). HRMS (MM) calc’d for [M+H]+ 
351.1703, found 351.1709. 
(S)-Nα-Acetyl-2-(4-chlorophenyl)tryptophan methyl ester (121n) 
Prepared from 2-(4-chlorophenyl)indole (45.0 mg, 0.20 mmol) following 
General Procedure 2. The crude residue was purified by silica gel 
chromatography (40:60 to 100:0 EtOAc:hexanes) to yield 55.2 mg (75% yield) of 121n 
as a colorless oil. The enantiomeric excess was determined to be 93% by chiral SFC 
analysis (AD-H, 2.5 mL/min, 30% IPA in CO2, λ = 254 nm): tR(major) = 6.1 min, 
tR(minor) = 7.0 min. 1H NMR (500 MHz, CDCl3) δ 8.45 (br s, 1H), 7.56 (d, J = 8.1 Hz, 
1H), 7.49 – 7.43 (m, 2H), 7.43 – 7.37 (m, 2H), 7.33 (ddd, J  = 8.1, 8.1, 1.0 Hz, 1H), 7.23 
– 7.18 (m, 1H), 7.14 (ddd, J = 8.0, 7.1, 1.1 Hz, 1H), 5.85 (br d, J = 8.1 Hz, 1H), 4.83 (dt, 
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J = 8.1, 5.5 Hz, 1H), 3.55 – 3.38 (m, 2H), 3.34 (s, 3H), 1.69 (s, 3H); 13C NMR (125 MHz, 
CDCl3) δ 172.1, 169.6, 135.8, 134.6, 133.9, 131.5, 129.4, 129.3, 122.7, 120.1, 118.9, 
111.1, 107.1, 52.8, 52.1, 29.6, 26.7, 22.9; IR (NaCl/thin film): 3280, 3058, 2948, 1737, 
1657, 1519, 1487, 1458, 1439, 1373, 1310, 1216, 1093 cm-1; [α]D25 = +40.8 (c = 0.96, 
CHCl3). HRMS (MM) calc’d for [M+H]+ 371.1157, found 371.1158. 
(S)-Nα-Acetyl-2-(3-methoxyphenyl)tryptophan methyl ester (121o) 
Prepared from 2-(3-methoxyphenyl)indole (45.0 mg, 0.20 mmol) 
following General Procedure 2. The crude residue was purified by silica 
gel chromatography (30:70 to 100:0 EtOAc:hexanes) to yield 65.0 mg 
(88% yield) of 121o as a colorless oil. The enantiomeric excess was determined to be 
92% by chiral SFC analysis (AD-H, 2.5 mL/min, 30% IPA in CO2, λ = 254 nm): 
tR(major) = 5.9 min, tR(minor) = 7.6 min. 1H NMR (500 MHz, CDCl3) δ 8.40 (br s, 1H), 
7.55 (d, J = 8.1 Hz, 1H), 7.40 – 7.31 (m, 2H), 7.19 (ddd, J = 8.1, 7.1, 1.2 Hz, 1H), 7.16 – 
7.10 (m, 2H), 7.08 (dd, J = 2.6, 1.6 Hz, 1H), 6.91 (ddd, J = 8.3, 2.6, 0.8 Hz, 1H), 5.82 (br  
d, J = 7.8 Hz, 1H), 4.83 (dt, J = 7.8, 5.5 Hz, 1H), 3.85 (s, 3H), 3.57 – 3.49 (m, 2H), 3.35 
(s, 3H), 1.65 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 172.2, 169.6, 160.0, 135.8, 135.6, 
134.4, 130.2, 129.3, 122.5, 120.6, 119.9, 118.8, 113.8, 113.5, 111.0, 106.7, 55.4, 52.8, 
52.0, 26.6, 22.8; IR (NaCl/thin film): 3282, 3058, 2951, 1738, 1658, 1603, 1520, 1462, 
1439, 1373, 1218, 1040; [α]D25 = +40.3 (c = 1.16, CHCl3). HRMS (MM) calc’d for 
[M+H]+ 367.1652, found 367.1656. 
(S)-Nα-Acetyl-2-(4-fluorophenyl)tryptophan methyl ester (121p) 
Prepared from 2-(4-fluorophenyl)indole (42.0 mg, 0.20 mmol) 
following General Procedure 2. The crude residue was purified by silica 
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gel chromatography (40:60 to 100:0 EtOAc/hexanes) to yield 55.6 mg (78% yield) of 
121p as a colorless oil. The enantiomeric excess was determined to be 92% by chiral SFC 
analysis (AD-H, 2.5 mL/min, 25% IPA in CO2, λ = 254 nm): tR(major) = 6.1 min, 
tR(minor) = 6.9 min. 1H NMR (500 MHz, CDCl3) δ  8.19 (d, J = 47.9 Hz, 1H), 7.57 (dd, J 
= 7.9, 1.1 Hz, 1 H), 7.54 – 7.51 (m, 2H), 7.36 (ddd, J = 8.1, 8.1, 0.9 Hz, 1H), 7.23 – 7.10 
(m, 4H), 5.82 (d, J = 8.1 Hz, 1H), 4.83 (dt, J = 8.1, 5.5 Hz, 1H), 3.55 – 3.40 (m, 2H), 3.34 
(s, 3H), 1.71 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 172.2, 169.5, 135.6, 135.0, 130.1, 
130.1, 129.4, 122.7, 120.2, 118.9, 116.2, 116.1, 110.9, 106.9, 52.8, 52.0, 26.7, 22.9.; IR 
(NaCl/thin film): 3364, 3271, 3061, 2925, 2853, 1738, 1661, 1553, 1505, 1460, 1440, 
1373, 1221, 1158; [α]D25 = +38.2 (c = 0.65, CHCl3). HRMS (MM) calc’d for [M+H]+ 
355.1452, found 355.1460. 
 
(S)-Nα-Acetyl-2-(3-fluorophenyl)tryptophan methyl ester (121q) 
Prepared from 2-(3-fluorophenyl)indole (42.0 mg, 0.20 mmol) following 
General Procedure 2. The crude residue was purified by silica gel 
chromatography (40:60 to 100:0 ethyl acetate/hexanes) to yield 50.6 mg 
(76% yield) of 121q as a white foam. The enantiomeric excess was determined to be 92% 
by chiral SFC analysis (AD-H, 2.5 mL/min, 30% IPA in CO2, λ = 254 nm): tR(major) = 
3.8 min, tR(minor) = 4.6 min. 1H NMR (500 MHz, CDCl3) δ 8.65 (br s, 1H), 7.57 (d, J = 
8.1 Hz, 1H), 7.41 – 7.37 (m, 1H), 7.33-7.31 (m, 2H), 7.27-7.24 (m, 1H), 7.19 (ddd, J = 
8.2, 7.0, 1.0 Hz, 1H), 7.13 (ddd, J = 7.9, 7.0, 1.0 Hz, 1H), 7.07 – 7.03 (m, 1H), 5.89 (br d, 
J = 8.1 Hz, 1H), 4.84 (dt, J = 8.1, 5.5 Hz, 1H), 3.53 (dd, J = 13.6, 4.7 Hz, 1H), 3.49 (dd, J 
= 13.6, 4.2 Hz, 1H), 3.34 (s, 3H), 1.69 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 172.1, 
169.7, 162.9 (d, JC-F = 246.3 Hz), 135.8, 135.2 (d, JC-F = 7.5 Hz), 134.5 (d, JC-F = 2.5 Hz), 
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130.6 (d, JC-F = 8.8 Hz), 129.2, 123.9 (d, JC-F = 3.8 Hz), 122.8, 120.0, 118.9, 115.1 (d, JC-
F = 21.2 Hz), 114.7 (d, JC-F = 21.2 Hz), 111.1, 107.3, 52.8, 52.0, 26.7, 22.8; IR (NaCl/thin 
film): 3370, 3275, 3060, 2952, 1735, 1655, 1614, 1585, 1522, 1438, 1374, 1266, 1200, 
1155 cm-1; [α]D25 = +37.6 (c = 1.21, CHCl3). HRMS (MM) calc’d for [M+H]+ 355.1452, 
found 355.1450. 
(S)-Nα-Acetyl-2-(2-fluorophenyl)tryptophan methyl ester (121r) 
Prepared from 2-(2-fluorophenyl)indole (21.0 mg, 0.10 mmol) following 
General Procedure 2. The crude residue was purified by silica gel 
chromatography (40:60 to 100:0 EtOAc:hexanes) to yield 12.4 mg (35% 
yield) of 121r. The enantiomeric excesses was determined to be 92% by chiral SFC 
analysis (AD-H, 2.5 mL/min, 25% IPA in CO2, λ = 254 nm): tR(major) = 9.5 min, 
tR(minor) = 8.4 min. 1H NMR (500 MHz, CDCl3) δ 8.28 (s, 1H), 7.61 (d, J = 7.9 Hz, 1H), 
7.55 (ddd, J = 7.5, 7.5, 1.8 Hz, 1H), 7.45 – 7.35 (m, 2H), 7.29 (ddd, J = 7.5, 7.5, 1.2 Hz, 
1H), 7.25 – 7.20 (m, 1H), 7.19 – 7.10 (m, 1H), 5.83 (br d, J = 7.6 Hz, 1H), 4.85 (dt, J = 
7.9, 5.5 Hz, 1H), 3.55 – 3.39 (m, 2H), 3.36 (s, 2H), 1.73 (s, 3H).; 13C NMR (125 MHz, 
CDCl3) δ 172.2, 169.5, 159.8 (d, JC-F = 246.3 Hz), 135.9, 131.4 (d, JC-F = 3.8 Hz) 130.2 
(d, JC-F = 8.8 Hz), 129.73, 128.65, 124.8 (d, JC-F = 3.8 Hz), 122.84, 120.6 (d, JC-F = 15.0 
Hz), 120.0, 119.0, 116.4 (d, JC-F = 21.3 Hz), 111.0, 108.8, 52.5, 52.0, 26.8, 26.8, 22.9; IR 
(NaCl/thin film): 3275, 3058, 2925, 2853, 1734, 1653, 1523, 1490, 1457, 1437, 1374, 
1245, 1216, 1130, 1104; [α]D25 = +39.8 (c = 0.41, CHCl3). HRMS (MM) calc’d for 
[M+H]+ 355.1452, found 355.1463. 
 
 
(S)-Nα-Acetyl-2-methyltryptophan methyl ester (121s) 
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Prepared from 2-methylindole (26.0 mg, 0.20 mmol) following General 
Procedure 2.  The crude residue was purified by silica gel 
chromatography (50:50 to 100:0 EtOAc:hexanes) to yield 31.0 mg (61% yield) of 121s as 
a white foam.  The enantiomeric excess was determined to be 85% by chiral SFC analysis 
(AD-H, 2.5 mL/min, 25% IPA in CO2, λ = 254 nm): tR(major) = 3.9 min, tR(minor) = 2.7 
min. [α]D25 = +25.9 (c = 0.99, CHCl3).  Spectral data matches that reported in the 
literature.  
 
(S)-Nα-Acetyl-2-butyltryptophan methyl ester (121t) 
Prepared from 2-butylindole (35.0 mg, 0.20 mmol) following General 
Procedure 2. The crude residue was purified by silica gel chromatography 
(40:60 to 100:0 EtOAc:hexanes) to yield 45.8 mg (72% yield) of 121t as a colorless oil. 
The enantiomeric excess was determined to be 91% by chiral SFC analysis (AD-H, 2.5 
mL/min, 20% IPA in CO2, λ = 254 nm): tR(major) = 5.1 min, tR(minor) = 4.2 min. 1H 
NMR (500 MHz, CDCl3) δ 8.03 (br s, 1H), 7.46 – 7.40 (m, 1H), 7.31 – 7.24 (m, 1H), 
7.15 – 6.99 (m, 2H), 6.00 (br d, J = 7.8 Hz, 1H), 4.88 (dt, J = 8.1, 5.7 Hz, 1H), 3.65 (s, 
3H), 3.26 (dd, J = 5.7, 0.9 Hz, 2H), 2.69 (td, J = 7.8 2.2 Hz, 2H), 1.93 (s, 3H), 1.66 – 1.57 
(m, 2H), 1.45 – 1.31 (m, 2H), 0.95 (t, J = 7.3 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 
172.6, 169.6, 137.4, 135.2, 128.8, 121.3, 119.5, 117.9, 110.4, 105.26, 105.29, 53.0, 52.3, 
31.8, 26.8, 25.7, 23.2, 22.6, 13.9; IR (NaCl/thin film): 3296, 3058, 2955, 2871, 1737, 
1658, 1562, 1530, 1463, 1439, 1376, 1217, 1129; [α]D25 = +16.3 (c = 0.83, CHCl3). 
HRMS (MM) calc’d for [M+H]+ 317.1860, found 317.1855. 
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(S)-Nα-Acetyl-2-isopropyltryptophan methyl ester (121u) 
Prepared from 2-isopropylindole (32.0 mg, 0.20 mmol) following General 
Procedure 2. The crude residue was purified by silica gel chromatography 
(40:60 to 100:0 EtOAc:hexanes) to yield 39.6 mg (66% yield) of 121u as a colorless oil. 
The enantiomeric excess was determined to be 92% by chiral SFC analysis (AD-H, 2.5 
mL/min, 15% IPA in CO2, λ = 254 nm). tR(major) = 6.4 min, tR(minor) = 5.6 min. 1H 
NMR (500 MHz, CDCl3) δ 8.16 (br s, 1H), 7.48 – 7.41 (m, 1H), 7.30 – 7.27 (m, 1H), 
7.15 – 7.02 (m, 2H), 6.04 (br d, J = 8.0 Hz, 1H), 4.89 (dt, J = 8.1, 5.7 Hz, 1H), 3.66 (s, 
3H), 3.29 (dd, J = 12.7, 4.0 Hz, 1H), 3.26 (dd, J = 12.7, 3.4 Hz, 1H), 3.18 (m, 1H), 1.93 
(s, 3H1.31 (d, J = 3.3 Hz, 3H), 1.30 (d, J = 3.3 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 
172.6, 169.7, 142.7, 135.2, 128.7, 121.3, 119.5, 117.9, 110.6, 103.6, 53.0, 52.3, 26.7, 
25.3, 23.2, 23.0; IR (NaCl/thin film): 3305, 2962, 1734, 1700, 1653, 1559, 1539, 1506, 
1457, 1436, 1374, 1299, 1217 cm-1; [α]D25 = +22.2 (c = 0.35, CHCl3). HRMS (MM) 
calc’d for [M+H]+ 303.1703, found 303.1709. 
 
 
 
(S)-Nα-Acetyl-2-(tert-butyl)tryptophan methyl ester (121v) 
Prepared from 2-(tert-butyl)indole (35.0 mg, 0.20 mmol) following 
General Procedure 2. The crude residue was purified by silica gel 
chromatography (40:60 to 100:0 EtOAc:hexanes) to yield 18.1 mg (29% yield) of 121v 
as a yellow oil. The enantiomeric excess was determined to be 84% by chiral SFC 
analysis (OD-H, 2.5 mL/min, 10% IPA in CO2, λ = 254 nm): tR(major) = 12.8 min, 
tR(minor) = 14.2 min. 1H NMR (500 MHz, CDCl3) δ 8.07 (br s, 1H), 7.47 (dd, J = 14.0, 
7.1 Hz, 1H), 7.27 (dd, J = 5.8, 4.8 Hz, 1H), 7.15 – 7.03 (m, 2H), 6.06 (br d, J = 7.4 Hz, 
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1H), 4.84 (m, 1H), 3.54 (s, 3H), 3.38 – 3.29 (m, 2H), 1.86 (s, 3H), 1.49 (s, 9H); 13C NMR 
(125 MHz, CDCl3) δ 173.2, 169.6, 143.4, 133.9, 129.8, 121.3, 119.4, 117.7, 110.4, 104.3, 
53.7, 52.2, 33.2, 30.7, 28.6, 23.0; IR (NaCl/thin film): 3326, 3047, 2961, 2918, 2868, 
1734, 1653, 1539, 1457, 1436, 1374, 1303, 1254, 1211, 1128; [α]D25 = +12.4 (c = 0.36, 
CHCl3). HRMS (MM) calc’d for [M+H]+ 317.1860, found 317.1856. 
(S)-Nα-Acetyl-2-(ethylphthalimide)tryptophan methyl ester (121w) 
Prepared from 2-(ethylphthalimide)indole (29.0 mg, 0.10 mmol) following 
General Procedure 2. The crude residue was purified by silica gel 
chromatography (70:30 to 100:0 EtOAc:hexanes) to yield 34.6 mg (80% yield) of 121w 
as a yellow foam. The enantiomeric excess was determined to be 90% by chiral SFC 
analysis (AD-H, 2.5 mL/min, 25% IPA in CO2, λ = 254 nm): tR(major) = 7.3 min, 
tR(minor) = 6.3 min. 1H NMR (500 MHz, CDCl3) δ 8.47 (br s, 1H), 7.83 (dd, J = 5.4, 2.9 
Hz, 2H), 7.72 (dd, J = 5.5, 3.1 Hz, 2H), 7.46 (d, J = 8.1 Hz, 1H), 7.31 (ddd, J = 8.1, 8.1, 
1.0 Hz, 1H), 7.13 (ddd, J = 8.1, 7.1, 1.2 Hz, 1H), 7.07 (ddd, J = 10.5, 5.8, 2.2 Hz, 1H), 
6.13 (br d, J = 8.1 Hz, 1H), 4.92 (dt, J = 8.2, 6.0 Hz, 1H), 4.05 – 3.89 (m, 2H), 3.66 (s, 
3H), 3.33 – 2.98 (m, 4H), 1.93 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 172.7, 169.8, 
168.3, 135.6, 134.2, 132.5, 131.9, 128.6, 123.5, 121.8, 119.7, 118.2, 110.8, 107.4, 52.9, 
52.4, 37.0, 27.0, 25.3, 23.1; IR (NaCl/thin film): 3369, 3280, 3052, 2948, 1770, 1738, 
1711, 1659, 1530, 1438, 1397, 1371; [α]D25 = +14.8 (c = 0.96, CHCl3). HRMS (MM) 
calc’d for [M+H]+ 355.1452, found 355.1455. 
 
2.6.5 Scale-up Procedure 
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To a flame-dried flask under nitrogen containing freshly activated powdered 4Å 
molecular sieves (200 wt %) was added 2-phenylindole (1.00 g, 5.20 mmol, 1.00 equiv), 
methyl 2-acetamidoacrylate (890 mg, 6.20 mmol, 1.20 equiv), and (R)-3,3’-dibromo-
BINOL (457 mg, 1.00 mmol, 0.20 equiv).  The flask was charged with DCM (40 mL) 
and SnCl4 (1 M in DCM, 5.20 mL, 5.20 mmol, 1.00 equiv) was added. The reaction was 
stirred at room temperature for 2 hours, then quenched by addition of 1 M HCl (50 mL).  
The aqueous layer was extracted with EtOAc (2 x 50 mL) and the combined organic 
layers were washed with saturated  aqueous NaHCO3 (50 mL), dried (Na2SO4), filtered 
and concentrated.  The crude residue was purified by silica gel chromatography (40:60 to 
100:0 EtOAc:hexanes) to yield 1.33 g (77% yield) of 121c  as a pale yellow foam. The 
enantiomeric excess was determined to be 93% by chiral SFC analysis (AD-H, 2.5 
mL/min, 30% IPA in CO2, λ = 254 nm):  tR(major) = 5.7 min, tR(minor) = 6.9 min. 
 
!!
2.6.6 Functionalization of Tryptophan 121c 
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!
2.6.6.1 Acetamide Hydrolysis of 121c !
!
A vial was charged with (S)-Nα-acetyl-2-phenyltryptophan methyl ester (121c, 30.0 
mg, 0.09 mmol), MeOH (1 mL), H2O (1 mL) and aqueous HCl (12 M, 1 mL).  The 
reaction was heated to 75 °C for 12 hours, then concentrated, redissolved in DCM (10 
mL) and washed with saturated aqueous NaHCO3 (3 X 5 mL).  The aqueous layers were 
combined and extracted with DCM (4 X 5 mL).  The combined organic layers were 
washed with brine, dried (Na2SO4), filtered and concentrated.  The crude residue was 
purified by silica gel chromatography (99:1 CH2Cl2:MeOH) to yield 20.0 mg (76% yield) 
of 124 as a light yellow oil. The enantiomeric excess was determined by chiral SFC 
analysis of the corresponding methylcarbamate (see below). 1H NMR (500 MHz, CDCl3) 
δ 8.18 (br s, 1H), 7.67 (dd, J = 7.6, 0.7 Hz, 1H), 7.62 – 7.60 (m, 2H), 7.50 – 7.43 (m, 2H), 
7.41 – 7.34 (m, 2H), 7.22 (ddd, J = 8.1, 7.1, 1.2 Hz, 1H), 7.15 (ddd, J = 7.9, 7.0, 1.0 Hz, 
1H), 3.89 (dd, J = 8.4, 5.0 Hz, 1H), 3.56 (s, 3H), 3.47 – 3.38 (m, 1H), 3.27 – 3.14 (m, 
1H), 1.69 (br s, 2H); 13C NMR (125 MHz, CDCl3) δ 175.5, 136.1, 135.8, 132.9, 129.1, 
129.0, 128.3, 128.0, 122.5, 119.9, 119.2, 110.9, 108.2, 55.2, 51.9, 30.2; IR (NaCl/thin 
film): 3367, 3062, 2948, 1732, 1603, 1489, 1457, 1207; [α]D25 = -12.4 (c = 0.85, CHCl3). 
HRMS (MM) calc’d for [M+H]+ 295.1441, found 295.1446. 
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A flame-dried flask was charged with free amine 124 (19.5 mg, 0.70 mmol, 1.00 
equiv), Et3N (19 µL, 0.13 mmol, 2.0 equiv) and DCM (5 mL). Methylchloroformate (6.0 
µL, 0.73 mmol, 1.10 equiv) was added and the solution was stirred at room temperature 
for 3 hours, then quenched with saturated aqueous NH4Cl (5 mL) and extracted with 
EtOAc (2 X 5 mL).  The combined organic layers were dried (Na2SO4), filtered and 
concentrated.  The crude residue was purified by silica gel chromatography (25:75 
EtOAc:hexanes) to yield 18.5 mg (80% yield) of methylcarbamate as a colorless oil.  The 
enantiomeric excess was determined to be 93% by chiral SFC analysis (OD-H, 2.5 
mL/min, 15% IPA in CO2, λ = 254 nm): tR(major) = 16.7 min, tR(minor) = 15.6 min.  1H 
NMR (500 MHz, CDCl3) δ 8.11 (br s, 1H), 7.61 (d, J = 7.9 Hz, 1H), 7.57 – 7.52 (m, 1H), 
7.48 – 7.45 (m, 2H), 7.40 – 7.35 (m, 2H), 7.25 – 7.19 (m, 1H), 7.16 (m, 1H), 5.06 (br d, J 
= 7.7 Hz, 1H), 4.63 – 4.59 (m, 1H), 3.54 (s, 3H), 3.50 (m, 2H), 3.38 (s, 3H); 13C NMR 
(125 MHz, CDCl3) δ 172.3, 156.1, 136.2, 135.7, 132.9, 129.2, 129.0, 128.3, 128.0, 122.5, 
120.0, 118.9, 110.9, 106.7, 54.5, 52.12, 52.07, 27.1; IR (NaCl/thin film) 3338, 2953, 
2923, 2852, 1718, 1701, 1507, 1457, 1363, 1213, 1072 cm-1; [α]D25 = +22.6 (c = 0.10, 
CHCl3). HRMS (MM) calc’d for [M+H]+ 353.1496, found 353.1497. 
Methylcarbamate: racemic 
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!!
Methylcarbamate: enantioenriched, 93% ee!
!
 
2.6.6.2 Methyl Ester Hydrolysis of 121c 
 
A 10 mL flask was charged with (S)-Nα-acetyl-2-phenyltryptophan methyl ester 121c 
(67.2 mg, 0.20 mmol, 1.00 equiv) and THF (0.9 mL) then cooled to 0 ºC, followed by 
dropwise addition of aqueous LiOH (1.75 M, 230 µL, 0.40 mmol, 2.00 equiv).  The 
reaction was vigorously stirred at 0 ºC for 2 hours, then diluted with H2O (15 mL) and 
extracted with EtOAc (2 x 10 mL).  The aqueous layer was acidified to pH = 1.5 and 
extracted with EtOAc (5 x 15 mL).  The combined organic layers from the acidic aqueous 
extraction were dried (Na2SO4), filtered, and concentrated.  The crude residue was 
purified by silica gel chromatography (0:99:1 to 15:84:1 MeOH:DCM:AcOH) to yield 
59.2 mg (92% yield) of carboxylic acid 123 as a pale yellow foam. The enantiomeric 
excess was determined to be 92% by chiral SFC analysis (AS-H, 2.5 mL/min, 28% IPA 
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in CO2, λ = 254 nm): tR(major) = 4.5 min, tR(minor) = 8.0 min.  1H NMR (500 MHz, 
CDCl3) δ 8.21 (br s, 1H), 7.63 (d, J = 7.8 Hz, 1H), 7.56 – 7.51 (m, 2H), 7.47 (dd, J = 7.6, 
7.6 Hz, 2H), 7.40 (m, 1H), 7.37 (ddd, J = 8.0, 0.8, 0.8 Hz, 1H), 7.21 (ddd, J = 8.1, 7.1, 
1.1 Hz, 1H), 7.14 (ddd, J = 8.0, 7.1, 1.0 Hz, 1H), 5.72 (br d, J = 7.4 Hz, 1H), 4.73 (td, J = 
7.1, 5.4 Hz, 1H), 3.56 (dd, J = 14.9, 5.2 Hz, 1H), 3.49 (dd, J=15.0, 6.9 Hz, 1H), 1.62 (s, 
3H); 13C NMR (125 MHz, CDCl3) δ 174.7, 170.9, 136.2, 135.7, 132.9, 129.13, 129.05, 
128.3, 128.2, 122.6, 120.1, 118.8, 111.0, 106.8, 53.1, 26.2, 22.6; IR (NaCl/thin film): 
3391, 3306, 3055, 3011, 2921, 2850, 1717, 1615, 1527, 1457, 1448, 1215 cm-1; [α]D25 = 
+9.2 (c = 1.05, MeCN). HRMS (MM) calc’d for [M+H]+ 323.1390, found 323.1390. 
 Racemic 
 
 
 
Enantioenriched, 92% ee 
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2.6.6.3 Preparation of bromo-dehydroindoline 125 
 
 
A solution of (S)-Nα-acetyl-2-phenyltryptophan methyl ester 121c (101 mg, 0.30 mmol, 
1.00 equiv) in DCM (8.4 mL) was cooled to –50 °C in an acetonitrile/dry ice bath. NBS 
(53.4 mg, 0.30 mmol, 1.00 equiv) was then added, followed by TFA (900 µL). The 
reaction was stirred in the dark at –50 °C for 3 hours, then poured onto ice, quenched 
with aqueous ammonia (1.5 mL) and extracted with DCM (3 x 25 mL). The combined 
organics were washed (40 mL H2O, then 40 mL brine), dried (Na2SO4), filtered, and 
concentrated. The product 125 was formed in a 1:1 ratio of diastereomers (determined by 
1H NMR analysis of the crude reaction mixture) and was purified by silica gel 
chromatography (30:70 to 70:30 EtOAc:hexanes) to yield 98 mg (79% yield) of the 
combined diastereomers as a bright yellow foam. The enantiomeric excesses of the two 
diastereomers were determined to be 92% and 90% by chiral SFC analysis (AS-H, 2.5 
N
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mL/min, 20% IPA in CO2, λ = 254 nm): tR(major) = 3.8 min, tR(minor) = 4.1 min; 
tR(major) = 4.6 min, tR(minor) = 6.0 min. Spectral data and optical rotation are reported 
for the mixture of diastereomers. 1H NMR (500 MHz, CDCl3) δ 8.42 – 8.32 (m, 4H), 
7.70 – 7.64 (m, 2H), 7.57 – 7.49 (m, 8H), 7.47 – 7.40 (m, 2H), 7.39 – 7.30 (m, 2H), 5.37 
(br d, J = 7.4 Hz, 1H), 5.05 (br d, J = 8.5 Hz, 1H), 4.33 (dt, J = 7.5, 5.5 Hz, 1H), 3.95 (td, 
J = 8.9, 4.0 Hz, 1H), 3.56 (dd, J = 14.8, 5.2 Hz, 1H), 3.47 – 3.41 (m, 4H), 3.38 – 3.32 (m, 
4H), 3.23 (dd, J = 14.6, 9.3 Hz, 1H), 1.45 (s, 3H), 1.27 (s, 3H); 13C NMR (125 MHz, 
CDCl3) δ 175.6, 174.8, 170.7, 170.0, 169.4, 169.2, 151.82, 151.76, 139.8, 139.6, 131.6, 
131.4, 131.3, 130.5, 130.4, 128.81, 128.80, 128.71, 128.70, 127.2, 126.6, 123.2, 122.5, 
121.9, 121.7, 59.16, 59.14, 52.5, 52.3, 50.3, 49.8, 41.6, 41.4, 22.3, 22.0; IR (NaCl/thin 
film): 3271, 3062, 2952, 2924, 2853, 1747, 1661, 1525, 1444, 1372, 1264, 1216 cm-1; 
[α]D25
 
= +17.1 (c = 0.50, CHCl3). HRMS (MM) calc’d for M+
 
415.0652, found 
415.0652. 
2.6.6.4 Preparation of 3-hydroxypyrroloindoline 126 
 
A 15 mL flask containing (S)-Nα-acetyl-1-methyl-2-phenyltryptophan methyl ester 121d 
(52.5 mg, 0.150 mmol, 1.00 equiv) was flushed with argon and then charged with MeCN 
(3.3 mL). TFA was added as a solution in MeCN (1.3 M, 125 µL, 0.150 mmol, 1.00 
equiv), followed by NCS as a solution in MeCN (0.2 M, 0.75 mL, 0.150 mmol, 1.00 
equiv). The flask was then sealed under argon and the solution was stirred in the dark at 
room temperature. After 3 hours, the reaction was quenched with aqueous ammonia (1.5 
N
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mL), poured onto ice, and extracted with DCM (3 x 15 mL). The combined organics were 
washed (20 mL H2O, then 20 mL brine), dried (Na2SO4), filtered, and concentrated to 
give the crude mixture of 3-chloropyrroloindoline diastereomers (detected by HRMS 
direct injection (MM) calc’d for [M+H]+
 
385.1313, found 385.1320). The crude residue 
was redissolved in MeCN (2 mL), then H2O (1.2 mL) and SiO2 (2.5 mL) were added. 
The mixture was vigorously stirred open to air at room temperature for 30 minutes, then 
filtered through a 1.5 mL silica plug with EtOAc (50 mL), dried (Na2SO4), filtered and 
concentrated. The 3-hydroxypyrroloindoline 126 existed in a 6:1 ratio of diastereomers, 
favoring the endo diastereomer (determined by 1H NMR analysis of the crude reaction 
mixture) and was purified by silica gel chromatography (0:100 to 10:90 EtOAc:hexanes) 
to yield 30.8 mg (contains 18 wt % CHCl3, 46% corrected yield) of the endo 
diastereomer as a yellow oil. The exo diastereomer, obtained post chromatography in a 
mixture with (S)-Nα-acetyl-1-methyl-2- phenyltryptophan methyl ester XX, was 
subjected to reverse phase preparatory HPLC (30:70 to 90:10 MeCN:H2O) using an 
Agilent 1200 Series HPLC with an Agilent XDB-C18 5 µM column (9.4 x 250 mm) to 
yield 3.5 mg (6% yield) of the exo diastereomer as a yellow oil. 
Endo diastereomer: 
The enantiomeric excess was determined to be 84% by chiral SFC analysis (AD-H, 2.5 
mL/min, 25% IPA in CO2, λ = 254 nm): tR(major) = 7.4 min, tR(minor) = 4.7 min. The 
relative stereochemistry was assigned by 2D NMR analysis. 1H NMR (500 MHz, 
CD3CN; compound exists as a 15:1 mixture of rotamers, the major rotamer is reported) δ 
7.40 – 7.35 (m, 2H), 7.34 – 7.26 (m, 3H), 7.20 (ddd, J = 7.9, 7.5, 1.3 Hz, 1H), 7.12 (ddd, 
J = 7.2, 1.3, 0.5 Hz, 1H), 6.66 (ddd, J = 7.3, 7.3, 1.0 Hz, 1H), 6.51 (d, J = 7.9 Hz, 1H), 
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4.79 (d, J = 8.8 Hz, 1H), 3.19 (s, 3H), 2.97 (s, 3H), 2.90 (br s, 1H), 2.82 (d, J = 12.7 Hz, 
1H), 2.59 (ddd, J = 12.7, 8.8, 1.1 Hz, 1H), 1.95 (s, 3H); 13C NMR (125 MHz, CD3CN; 
compound exists as a 15:1 mixture of rotamers, the major rotamer is reported) δ 172.0, 
171.3, 153.1, 138.0, 131.6, 128.9, 128.6, 128.3, 125.2, 118.0, 107.1, 95.3, 88.3, 61.3, 
52.7, 39.0, 32.7, 23.6; IR (NaCl/thin film): 3292, 3010, 2948, 1735, 1653, 1648, 1610, 
1491, 1448, 1388, 1313, 1220 cm-1; [α]D25
 
= +264.0 (c = 1.35, CHCl3). HRMS (MM) 
calc’d for [M+H]
+ 
367.1652, found 367.1650.  
 
Exo diastereomer: 
The enantiomeric excess was determined to be 85% by chiral SFC analysis (OD-H, 2.5 
mL/min, 20% IPA in CO2, λ = 254 nm): tR(major) = 6.2 min, tR(minor) = 4.0 min. The 
relative stereochemistry was assigned by 2D NMR analysis. 1H NMR (500 MHz, 
CD3CN; compound exists as a 1.5:1 mixture of rotamers, the major rotamer isdenoted by 
*, the minor rotamer by§) δ 7.60 – 7.22 (m, 6H*, 7H§), 7.17 (ddd, J = 7.3, 0.6, 0.6 Hz, 
1H*), 6.79 (dd, J = 7.5, 7.5 Hz, 1H§), 6.70 (dd, J = 7.5, 7.5 Hz, 1H*), 6.65 (d, J = 7.9 Hz, 
1H§), 6.54 (d, J = 7.9 Hz, 1H*), 4.49 (dd, J = 8.0, 6.7 Hz, 1H*), 4.07 (dd, J = 10.0, 6.9 
Hz, 1H§), 3.81 (s, 3H*), 3.71 (s, 3H§), 3.34 (s, 1H§), 3.01 (s, 1H*), 2.963 (s, 3H*), 2.958 
(s, 3H§), 2.71 (dd, J = 13.0, 8.1 Hz, 1H*), 2.68 (dd, J = 12.6, 7.0 Hz, 1H§), 2.34 (dd, J = 
12.9, 6.7 Hz, 1H*), 2.07 (dd, J = 12.7, 10.0 Hz, 1H§), 1.89 (s, 3H*), 1.80 (s, 3H§); 13C 
NMR (125 MHz, CD3CN) δ 174.1, 173.6, 172.3, 171.8, 151.2, 151.1, 136.3, 136.2, 
131.6, 131.3, 130.3, 129.60, 129.57, 129.4, 128.7, 128.6, 124.4, 123.9, 119.3, 118.2, 
108.0, 106.4, 98.8, 96.1, 90.1, 88.5, 61.2, 60.3, 53.3, 52.6, 40.9, 37.2, 33.4, 32.4, 24.6, 
23.8; IR (NaCl/thin film): 3305, 2924, 1747, 1646, 1610, 1491, 1448, 1381, 1311, 1207 
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cm-1; [α]D25
 
= -138.2 (c = 0.33, CHCl3). HRMS (MM) calc’d for [M+H]+
 
367.1652, 
found 367.1655. 
2.6.7 Deuterium Labeling Studies 
 
Preparation of N-deuteroacrylate (XX) 
 
 
Acrylate 120c was dissolved in MeOD (1 mL) under nitrogen.  After stirring for 1 
minute, the solution was concentrated under high vacuum.  This procedure was repeated 
three times to give >99% deuterium incorporation. 
Preparation of per-deutero-2-phenylindole  
 
To MeOD (1 mL) in a microwave vial was added acetyl chloride (100 µL), followed by 
2-phenylindole (6a, 50 mg) and D2O (1 mL).  The vial was sealed and heated in a 
microwave to 140 °C for 1 hour.  Upon cooling, the heterogenous solution was diluted 
with DCM.  The phases were separated and the aqueous was extracted with DCM (2 x 5 
mL).  The combined organic layers were dried (Na2SO4), filtered and concentrated to 
give per-deutero-2-phenylindole with 90% deuterium incorporation. 
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2.6.7 1H NMR Kinetics Studies 
 
 
An oven-dried vial was charged with 2-phenylindole (19.0 mg, 0.10 mmol, 1.00 equiv), 
methyl 2-acetamidoacrylate (14.0 mg, 0.10 mmol, 1.00 equiv), (R)-BINOL if necessary 
(6.0 mg, 0.02 mmol, 0.20 equiv) and 1,4-diethylbenzene (4.7 µL, 0.03 mmol, 0.30 equiv) 
as the internal standard.  The vial was pumped into a glove box and charged with CD2Cl2 
(0.75 mL, to an indole concentration of 0.12 M), then transferred to a screw-cap NMR 
tube. A 1H NMR spectrum (1 scan) was taken to determine the inital ratio of acrylate and 
1,4-diethylbenzene. SnCl4 (1 M in CD2Cl2, 120 µL, 0.12 mmol, 1.20 equiv) was then 
added through the septum of the screw-cap and the NMR tube was inverted once and 
quickly inserted into the spectrometer.  The concentration of acrylate was monitored by 
1H NMR over 9 hours and was determined by integration of its resonance at 3.83 ppm 
relative to 1,4-diethylbenzene’s resonance at 2.74 ppm. 
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 Sample directory:
 
 
 
L
M
R
V
I
-205-1
 
FidFile: CARBON01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Aug 23 2011
Sample #33, Operator: lrepka
 
R
elax. delay 1.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 1.042 sec
 
Width 31446.5 Hz
 10000 repetitions
OBSERVE  C13, 125.6553292 MHz
D
ECOUPLE  H1, 499.7250019 MHz
 
P
o
w
e
r
 39 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 5 hr, 41 min
ppm
20
40
60
80
100
120
140
160
180
200
Plotname: --Not assigned--
NH
Ph CO
2 M
e
NHTFA
  
115 Appendix 1 * Spectra Relevant to Chapter 2 
L
M
R
V
I
-171
 Sample Name:
 
 
 
L
M
R
V
I
-171
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/lrepka/vnmrsys/data
 Sample directory:
 
 
 
L
M
R
V
I
-171
 
FidFile: PROTON01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jul 25 2011
Sample #33, Operator: lrepka
 
R
elax. delay 25.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 2.500 sec
 
Width 8000.0 Hz
 8 repetitions
OBSERVE   H1, 499.7225125 MHz
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.2 Hz
F
T
 
size 65536
T
o
t
al time 3 min 40 sec
  1.02
  2.03
  1.05
  2.02
  1.03
  1.28
  1.03
  0.98
  1.00
  3.00
  3.97
  1.00
  3.04
ppm
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
NM
e
Ph CO
2 M
e
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116 Appendix 1 * Spectra Relevant to Chapter 2 
L
M
R
V
I
-171
 Sample Name:
 
 
 
L
M
R
V
I
-171
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/lrepka/vnmrsys/data
 Sample directory:
 
 
 
L
M
R
V
I
-171
 
FidFile: CARBON01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jul 25 2011
Sample #33, Operator: lrepka
 
R
elax. delay 1.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 1.042 sec
 
Width 31446.5 Hz
 1500 repetitions
OBSERVE  C13, 125.6553354 MHz
D
ECOUPLE  H1, 499.7250019 MHz
 
P
o
w
e
r
 39 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 51 min
ppm
20
40
60
80
100
120
140
160
180
200
Plotname: --Not assigned--
NM
e
Ph CO
2 M
e
NHAc
  
117 Appendix 1 * Spectra Relevant to Chapter 2 
 Sample Name:
 
 
 
L
M
R
-
allyl
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
L
M
R
-
allyl
 
FidFile: PROTON01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jan 14 2012
Sample #20, Operator: mkieffer
 
R
elax. delay 2.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 2.500 sec
 
Width 8000.0 Hz
 32 repetitions
OBSERVE   H1, 499.7225125 MHz
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.2 Hz
F
T
 
size 65536
T
o
t
al time 2 min 24 sec
  1.00
  1.99
  1.04
  1.97
  1.01
  1.02
  1.01
  1.02
  0.96
  1.03
  1.03
  1.00
  2.03
  2.92
  1.01
  1.00
  3.00
ppm
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
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M
E
K3186-1
 Sample Name:
 
 
 
M
E
K3186-1
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K3186-1
 
FidFile: PROTON01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jul 15 2011
Sample #15, Operator: mkieffer
 
R
elax. delay 2.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 2.500 sec
 
Width 8000.0 Hz
 32 repetitions
OBSERVE   H1, 499.7290203 MHz
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.2 Hz
F
T
 
size 65536
T
o
t
al time 2 min 24 sec
  0.93
  4.01
  1.06
  0.97
  1.00
  0.98
  0.97
  0.97
  1.99
  3.02
  3.00
  3.08
ppm
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
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M
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M
E
K3186-1
 Sample Name:
 
 
 
M
E
K3186-1
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K3186-1
 
FidFile: CARBON01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jul 15 2011
Sample #15, Operator: mkieffer
 
R
elax. delay 1.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 1.042 sec
 
Width 31446.5 Hz
 1000 repetitions
OBSERVE  C13, 125.6553310 MHz
D
ECOUPLE  H1, 499.7250019 MHz
 
P
o
w
e
r
 39 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 34 min
ppm
20
40
60
80
100
120
140
160
180
Plotname: --Not assigned--
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e
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M
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M
E
K3084-1
 Sample Name:
 
 
 
M
E
K3084-1
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K3084-1
 
FidFile: PROTON01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: May  9 2011
 
T
e
mp. 25.0 C / 298.1 K
Sample #39, Operator: mkieffer
 
R
elax. delay 5.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 2.500 sec
 
Width 8000.0 Hz
 32 repetitions
OBSERVE   H1, 499.7290203 MHz
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.2 Hz
F
T
 
size 65536
T
o
t
al time 4 min 0 sec
  0.93
  2.00
  1.99
  2.02
  1.08
  1.00
  0.94
  0.99
  2.02
  3.00
  3.02
  2.98
ppm
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
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121 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K3084-1
 Sample Name:
 
 
 
M
E
K3084-1
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K3084-1
 
FidFile: CARBON01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: May  9 2011
 
T
e
mp. 25.0 C / 298.1 K
Sample #39, Operator: mkieffer
 
R
elax. delay 1.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 1.042 sec
 
Width 31446.5 Hz
 512 repetitions
OBSERVE  C13, 125.6569642 MHz
D
ECOUPLE  H1, 499.7315163 MHz
 
P
o
w
e
r
 39 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 17 min
ppm
20
40
60
80
100
120
140
160
180
200
Plotname: --Not assigned--
 
NH
Ph CO
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e
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M
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122 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K3193-1
 Sample Name:
 
 
 
M
E
K3193-1
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K3193-1
 
FidFile: PROTON01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jul 21 2011
Sample #33, Operator: mkieffer
 
R
elax. delay 2.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 2.500 sec
 
Width 8000.0 Hz
 32 repetitions
OBSERVE   H1, 499.7225125 MHz
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.2 Hz
F
T
 
size 65536
T
o
t
al time 2 min 24 sec
  0.97
  2.03
  3.10
  1.06
  1.03
  1.05
  0.98
  1.00
  2.07
  3.00
  3.13
  2.96
ppm
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
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123 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K3193-1
 Sample Name:
 
 
 
M
E
K3193-1
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K3193-1
 
FidFile: CARBON01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jul 21 2011
Sample #33, Operator: mkieffer
 
R
elax. delay 1.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 1.042 sec
 
Width 31446.5 Hz
 1000 repetitions
OBSERVE  C13, 125.6553291 MHz
D
ECOUPLE  H1, 499.7250019 MHz
 
P
o
w
e
r
 39 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 34 min
ppm
20
40
60
80
100
120
140
160
180
200
Plotname: --Not assigned--
 
NH
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124 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K3148-1
 Sample Name:
 
 
 
M
E
K3148-1
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K3148-1
 
FidFile: PROTON01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jun 20 2011
 
T
e
mp. 25.0 C / 298.1 K
Sample #14, Operator: mkieffer
 
R
elax. delay 2.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 2.500 sec
 
Width 8000.0 Hz
 32 repetitions
OBSERVE   H1, 499.7290200 MHz
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.2 Hz
F
T
 
size 65536
T
o
t
al time 2 min 24 sec
  0.96
  1.99
  2.01
  2.04
  1.03
  1.00
  0.98
  1.00
  2.05
  3.00
  3.06
  2.99
ppm
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
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125 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K3130-1
 Sample Name:
 
 
 
M
E
K3130-1
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K3130-1
 
FidFile: CARBON01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jun  7 2011
 
T
e
mp. 25.0 C / 298.1 K
Sample #15, Operator: mkieffer
 
R
elax. delay 2.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 1.042 sec
 
Width 31446.5 Hz
 512 repetitions
OBSERVE  C13, 125.6569681 MHz
D
ECOUPLE  H1, 499.7315163 MHz
 
P
o
w
e
r
 39 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 26 min
ppm
20
40
60
80
100
120
140
160
180
200
Plotname: --Not assigned--
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M
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126 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K3185-1
 Sample Name:
 
 
 
M
E
K3185-1
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K3185-1
 
FidFile: PROTON01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jul 15 2011
Sample #14, Operator: mkieffer
 
R
elax. delay 2.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 2.500 sec
 
Width 8000.0 Hz
 32 repetitions
OBSERVE   H1, 499.7290205 MHz
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.2 Hz
F
T
 
size 65536
T
o
t
al time 2 min 24 sec
  0.97
  1.96
  1.98
  1.04
  0.99
  1.02
  0.99
  0.98
  0.97
  3.00
  1.99
  2.91
  2.94
ppm
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
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127 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K3185-1
 Sample Name:
 
 
 
M
E
K3185-1
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K3185-1
 
FidFile: CARBON01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jul 15 2011
Sample #14, Operator: mkieffer
 
R
elax. delay 1.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 1.042 sec
 
Width 31446.5 Hz
 1000 repetitions
OBSERVE  C13, 125.6553300 MHz
D
ECOUPLE  H1, 499.7250019 MHz
 
P
o
w
e
r
 39 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 34 min
ppm
20
40
60
80
100
120
140
160
180
Plotname: --Not assigned--
 
NH
Ph CO
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M
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128 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K
-5-Br
 Sample Name:
 
 
 
M
E
K
-5-Br
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K
-5-Br
 
FidFile: PROTON01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jun 25 2011
Sample #15, Operator: mkieffer
 
R
elax. delay 2.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 2.500 sec
 
Width 8000.0 Hz
 32 repetitions
OBSERVE   H1, 499.7290203 MHz
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.2 Hz
F
T
 
size 65536
T
o
t
al time 2 min 24 sec
  0.97
  0.99
  2.05
  2.07
  1.07
  0.35
  0.62
  0.61
  0.34
  0.99
  1.01
  2.13
  3.00
  3.02
ppm
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
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Ph CO
2 Me
NHAc
Br
  
129 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K
-5-Br
 Sample Name:
 
 
 
M
E
K
-5-Br
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K
-5-Br
 
FidFile: CARBON01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jun 25 2011
Sample #15, Operator: mkieffer
 
R
elax. delay 1.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 1.042 sec
 
Width 31446.5 Hz
 1000 repetitions
OBSERVE  C13, 125.6666408 MHz
D
ECOUPLE  H1, 499.7315163 MHz
 
P
o
w
e
r
 39 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 34 min
ppm
-40
-20
0
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40
60
80
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120
140
Plotname: --Not assigned--
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130 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K3150-1
 Sample Name:
 
 
 
M
E
K3150-1
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K3150-1
 
FidFile: PROTON01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jun 20 2011
 
T
e
mp. 25.0 C / 298.1 K
Sample #15, Operator: mkieffer
 
R
elax. delay 5.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 2.500 sec
 
Width 8000.0 Hz
 32 repetitions
OBSERVE   H1, 499.7290203 MHz
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.2 Hz
F
T
 
size 65536
T
o
t
al time 4 min 0 sec
  0.94
  1.99
  2.03
  1.04
  1.80
  0.99
  1.01
  0.97
  0.99
  2.04
  3.00
  3.11
ppm
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
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131 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K3150-1
 Sample Name:
 
 
 
M
E
K3150-1
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K3150-1
 
FidFile: CARBON01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jun 20 2011
 
T
e
mp. 25.0 C / 298.1 K
Sample #15, Operator: mkieffer
 
R
elax. delay 2.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 1.042 sec
 
Width 31446.5 Hz
 1000 repetitions
OBSERVE  C13, 125.6569633 MHz
D
ECOUPLE  H1, 499.7315163 MHz
 
P
o
w
e
r
 39 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 50 min
ppm
20
40
60
80
100
120
140
160
180
200
Plotname: --Not assigned--
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132 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K3080-1
 Sample Name:
 
 
 
M
E
K3080-1
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K3080-1
 
FidFile: PROTON01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: May  8 2011
 
T
e
mp. 25.0 C / 298.1 K
Sample #42, Operator: mkieffer
 
R
elax. delay 5.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 2.500 sec
 
Width 8000.0 Hz
 32 repetitions
OBSERVE   H1, 499.7290203 MHz
D
A
T
A
 
P
ROCESSING
F
T
 
size 65536
T
o
t
al time 4 min 0 sec
  0.94
  1.01
  2.01
  1.04
  1.98
  1.03
  1.02
  0.96
  1.00
  2.05
  3.00
  3.08
  3.18
ppm
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6
7
8
9
10
Plotname: --Not assigned--
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133 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K3080-1
 Sample Name:
 
 
 
M
E
K3080-1
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K3080-1
 
FidFile: current
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: May  8 2011
 
T
e
mp. 25.0 C / 298.1 K
Sample #42, Operator: mkieffer
 
R
elax. delay 1.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 1.042 sec
 
Width 31446.5 Hz
 384 repetitions
OBSERVE  C13, 125.6569642 MHz
D
ECOUPLE  H1, 499.7315163 MHz
 
P
o
w
e
r
 39 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 17 min
ppm
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120
140
160
180
200
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M
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134 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K3238-1
 Sample Name:
 
 
 
M
E
K3238-1
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K3238-1
 
FidFile: PROTON01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Aug 31 2011
Sample #20, Operator: mkieffer
 
R
elax. delay 2.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 2.500 sec
 
Width 8000.0 Hz
 32 repetitions
OBSERVE   H1, 499.7225128 MHz
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.2 Hz
F
T
 
size 65536
T
o
t
al time 2 min 24 sec
  0.87
  0.96
  3.84
  1.05
  1.04
  1.02
  0.91
  0.94
  3.90
  0.97
  2.94
  3.00
ppm
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
 
NH
CO
2 M
e
NHAc
Me
  
135 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K3238-1
 Sample Name:
 
 
 
M
E
K3238-1
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K3238-1
 
FidFile: CARBON01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Aug 31 2011
Sample #20, Operator: mkieffer
 
R
elax. delay 2.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 1.042 sec
 
Width 31446.5 Hz
 1000 repetitions
OBSERVE  C13, 125.6553271 MHz
D
ECOUPLE  H1, 499.7250019 MHz
 
P
o
w
e
r
 39 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 50 min
ppm
20
40
60
80
100
120
140
160
180
200
Plotname: --Not assigned--
 
NH
CO
2 M
e
NHAc
Me
  
136 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K3113-1
 Sample Name:
 
 
 
M
E
K3113-1
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K3113-1
 
FidFile: PROTON01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: May 24 2011
 
T
e
mp. 25.0 C / 298.1 K
Sample #35, Operator: mkieffer
 
R
elax. delay 5.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 2.500 sec
 
Width 8000.0 Hz
 32 repetitions
OBSERVE   H1, 499.7290200 MHz
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.2 Hz
F
T
 
size 65536
T
o
t
al time 4 min 0 sec
  0.94
  1.02
  2.01
  2.04
  1.05
  1.05
  1.05
  0.97
  1.00
  2.09
  3.00
  2.91
ppm
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
NH
CO
2 M
e
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137 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K3113-1
 Sample Name:
 
 
 
M
E
K3113-1
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K3113-1
 
FidFile: CARBON01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: May 24 2011
 
T
e
mp. 25.0 C / 298.1 K
Sample #35, Operator: mkieffer
 
R
elax. delay 1.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 1.042 sec
 
Width 31446.5 Hz
 2000 repetitions
OBSERVE  C13, 125.6569662 MHz
D
ECOUPLE  H1, 499.7315163 MHz
 
P
o
w
e
r
 39 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 1 hr, 8 min
ppm
20
40
60
80
100
120
140
160
180
200
Plotname: --Not assigned--
 
NH
CO
2 M
e
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138 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K
-para-F
 Sample Name:
 
 
 
M
E
K
-para-F
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K
-para-F
 
FidFile: PROTON01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jun 25 2011
Sample #14, Operator: mkieffer
 
R
elax. delay 2.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 2.500 sec
 
Width 8000.0 Hz
 32 repetitions
OBSERVE   H1, 499.7290203 MHz
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.2 Hz
F
T
 
size 65536
T
o
t
al time 2 min 24 sec
  0.94
  1.02
  2.02
  1.01
  4.06
  0.95
  0.99
  2.15
  3.00
  3.03
ppm
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
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e
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139 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K3086-1
 Sample Name:
 
 
 
M
E
K3086-1
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K3086-1
 
FidFile: CARBON01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: May 10 2011
 
T
e
mp. 25.0 C / 298.1 K
Sample #39, Operator: mkieffer
 
R
elax. delay 1.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 1.042 sec
 
Width 31446.5 Hz
 512 repetitions
OBSERVE  C13, 125.6569623 MHz
D
ECOUPLE  H1, 499.7315163 MHz
 
P
o
w
e
r
 39 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 17 min
ppm
20
40
60
80
100
120
140
160
180
200
Plotname: --Not assigned--
 
NH
CO
2 M
e
NHAc
F
  
140 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K3079-1
 Sample Name:
 
 
 
M
E
K3079-1
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K3079-1
 
FidFile: PROTON01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: May  8 2011
 
T
e
mp. 25.0 C / 298.1 K
Sample #41, Operator: mkieffer
 
R
elax. delay 5.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 2.500 sec
 
Width 8000.0 Hz
 32 repetitions
OBSERVE   H1, 499.7290200 MHz
D
A
T
A
 
P
ROCESSING
F
T
 
size 65536
T
o
t
al time 4 min 0 sec
  0.94
  1.01
  1.03
  2.01
  1.61
  1.04
  1.02
  1.00
  0.97
  1.00
  2.04
  3.00
  2.99
ppm
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
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141 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K3079-1
 Sample Name:
 
 
 
M
E
K3079-1
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K3079-1
 
FidFile: CARBON01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: May  8 2011
 
T
e
mp. 25.0 C / 298.1 K
Sample #41, Operator: mkieffer
 
R
elax. delay 1.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 1.042 sec
 
Width 31446.5 Hz
 256 repetitions
OBSERVE  C13, 125.6569690 MHz
D
ECOUPLE  H1, 499.7315163 MHz
 
P
o
w
e
r
 39 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
ROCESSING
F
T
 
size 65536
T
o
t
al time 8 min 45 sec
ppm
20
40
60
80
100
120
140
160
180
200
Plotname: --Not assigned--
 
NH
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142 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K
-
o
r
tho-fluoro-1
 Sample Name:
 
 
 
M
E
K
-
o
r
tho-fluoro-1
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K
-
o
r
tho-fluoro-1
 
FidFile: PROTON01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Aug 26 2011
Sample #33, Operator: mkieffer
 
R
elax. delay 2.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 2.500 sec
 
Width 8000.0 Hz
 32 repetitions
OBSERVE   H1, 499.7225128 MHz
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.2 Hz
F
T
 
size 65536
T
o
t
al time 2 min 24 sec
  0.91
  1.01
  1.02
  0.84
  1.15
  0.82
  0.56
  1.47
  1.01
  0.94
  0.97
  2.18
  3.00
  3.32
ppm
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
 
NH
CO
2 M
e
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143 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K3219-2
 Sample Name:
 
 
 
M
E
K3219-2
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K3219-2
 
FidFile: CARBON01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Aug 17 2011
Sample #7, Operator: mkieffer
 
R
elax. delay 2.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 1.042 sec
 
Width 31446.5 Hz
 1000 repetitions
OBSERVE  C13, 125.6553271 MHz
D
ECOUPLE  H1, 499.7250019 MHz
 
P
o
w
e
r
 39 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 50 min
ppm
20
40
60
80
100
120
140
160
180
200
Plotname: --Not assigned--
 
NH
CO
2 M
e
NHAc
F
  
144 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K
-
m
-OMe
 Sample Name:
 
 
 
M
E
K
-
m
-OMe
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K
-
m
-OMe
 
FidFile: PROTON01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jun 25 2011
Sample #16, Operator: mkieffer
 
R
elax. delay 2.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 2.500 sec
 
Width 8000.0 Hz
 32 repetitions
OBSERVE   H1, 499.7290203 MHz
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.2 Hz
F
T
 
size 65536
T
o
t
al time 2 min 24 sec
  0.98
  1.05
  2.11
  1.06
  2.02
  0.99
  0.98
  0.99
  1.00
  3.19
  2.19
  3.00
  2.89
ppm
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
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145 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K
-
m
-OMe
 Sample Name:
 
 
 
M
E
K
-
m
-OMe
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K
-
m
-OMe
 
FidFile: CARBON01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jun 25 2011
Sample #16, Operator: mkieffer
 
R
elax. delay 1.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 1.042 sec
 
Width 31446.5 Hz
 1000 repetitions
OBSERVE  C13, 125.6569681 MHz
D
ECOUPLE  H1, 499.7315163 MHz
 
P
o
w
e
r
 39 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 34 min
ppm
20
40
60
80
100
120
140
160
180
200
Plotname: --Not assigned--
 
NH
CO
2 M
e
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OM
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146 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K3083-1
 Sample Name:
 
 
 
M
E
K3083-1
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K3083-1
 
FidFile: PROTON01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: May  9 2011
 
T
e
mp. 25.0 C / 298.1 K
Sample #38, Operator: mkieffer
 
R
elax. delay 5.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 2.500 sec
 
Width 8000.0 Hz
 32 repetitions
OBSERVE   H1, 499.7290200 MHz
D
A
T
A
 
P
ROCESSING
F
T
 
size 65536
T
o
t
al time 4 min 0 sec
  2.59
  2.75
  3.83
  5.61
  2.63
  2.73
  8.17
  5.44
  5.49
  8.20
  5.66
  5.57
  8.27
ppm
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
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CO
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e
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M
e
  
147 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K3080-1
 Sample Name:
 
 
 
M
E
K3080-1
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K3080-1
 
FidFile: current
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: May  8 2011
 
T
e
mp. 25.0 C / 298.1 K
Sample #42, Operator: mkieffer
 
R
elax. delay 1.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 1.042 sec
 
Width 31446.5 Hz
 384 repetitions
OBSERVE  C13, 125.6569642 MHz
D
ECOUPLE  H1, 499.7315163 MHz
 
P
o
w
e
r
 39 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 17 min
ppm
20
40
60
80
100
120
140
160
180
200
 
NH
CO
2 M
e
NHAc
M
e
  
148 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K3129-1
 Sample Name:
 
 
 
M
E
K3129-1
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K3129-1
 
FidFile: PROTON01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jun  7 2011
 
T
e
mp. 25.0 C / 298.1 K
Sample #14, Operator: mkieffer
 
R
elax. delay 2.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 2.500 sec
 
Width 8000.0 Hz
 32 repetitions
OBSERVE   H1, 499.7290200 MHz
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.2 Hz
F
T
 
size 65536
T
o
t
al time 2 min 24 sec
  0.98
  1.01
  0.97
  2.05
  0.99
  1.00
  3.00
  2.05
  1.06
  3.00
  6.12
ppm
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
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e
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149 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K3129-1
 Sample Name:
 
 
 
M
E
K3129-1
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K3129-1
 
FidFile: CARBON01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jun  7 2011
 
T
e
mp. 25.0 C / 298.1 K
Sample #14, Operator: mkieffer
 
R
elax. delay 2.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 1.042 sec
 
Width 31446.5 Hz
 512 repetitions
OBSERVE  C13, 125.6569671 MHz
D
ECOUPLE  H1, 499.7315163 MHz
 
P
o
w
e
r
 39 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 26 min
ppm
20
40
60
80
100
120
140
160
180
200
Plotname: --Not assigned--
 
NH
CO
2 M
e
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150 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K
-
t
-butyl-rac
 Sample Name:
 
 
 
M
E
K
-
t
-butyl-rac
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K
-
t
-butyl-rac
 
FidFile: PROTON01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jun  5 2011
 
T
e
mp. 25.0 C / 298.1 K
Sample #27, Operator: mkieffer
 
R
elax. delay 2.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 2.500 sec
 
Width 8000.0 Hz
 32 repetitions
OBSERVE   H1, 499.7290200 MHz
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.2 Hz
F
T
 
size 65536
T
o
t
al time 2 min 24 sec
  1.01
  1.03
  0.99
  2.11
  0.99
  0.99
  3.00
  2.10
  3.08
  8.91
ppm
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
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2 M
e
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151 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K
-
t
-butyl-rac
 Sample Name:
 
 
 
M
E
K
-
t
-butyl-rac
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K
-
t
-butyl-rac
 
FidFile: CARBON01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jun  5 2011
 
T
e
mp. 25.0 C / 298.1 K
Sample #27, Operator: mkieffer
 
R
elax. delay 2.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 1.042 sec
 
Width 31446.5 Hz
 1000 repetitions
OBSERVE  C13, 125.6569662 MHz
D
ECOUPLE  H1, 499.7315163 MHz
 
P
o
w
e
r
 39 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 50 min
ppm
20
40
60
80
100
120
140
160
180
200
Plotname: --Not assigned--
 
NH
CO
2 M
e
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152 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K
-phthalimide
 Sample Name:
 
 
 
M
E
K
-phthalimide
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K
-phthalimide
 
FidFile: PROTON01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jun  6 2011
 
T
e
mp. 25.0 C / 298.1 K
Sample #20, Operator: mkieffer
 
R
elax. delay 2.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 2.500 sec
 
Width 8000.0 Hz
 32 repetitions
OBSERVE   H1, 499.7290203 MHz
D
A
T
A
 
P
ROCESSING
F
T
 
size 65536
T
o
t
al time 2 min 24 sec
  1.46
  2.90
  3.06
  1.55
  1.52
  1.56
  1.56
  1.47
  1.50
  3.11
  4.51
  6.26
  4.56
ppm
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
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N
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153 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K
-phthalimide
 Sample Name:
 
 
 
M
E
K
-phthalimide
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K
-phthalimide
 
FidFile: CARBON01
P
ulse Sequence: CARBON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Jun  6 2011
 
T
e
mp. 25.0 C / 298.1 K
Sample #20, Operator: mkieffer
 
R
elax. delay 2.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 1.042 sec
 
Width 31446.5 Hz
 1000 repetitions
OBSERVE  C13, 125.6569633 MHz
D
ECOUPLE  H1, 499.7315163 MHz
 
P
o
w
e
r
 39 dB
 
c
o
n
tinuously on
 
W
A
L
T
Z
-16 modulated
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.5 Hz
F
T
 
size 65536
T
o
t
al time 50 min
ppm
20
40
60
80
100
120
140
160
180
200
Plotname: --Not assigned--
NH
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2 M
e
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154 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K2306-1
 Sample Name:
 
 
 
M
E
K2306-1
 
D
a
t
a
 Collected on:
 
 
 indy.caltech.edu-inova500
 
A
r
chive directory:
 
 
 /home/mkieffer/vnmrsys/data
 Sample directory:
 
 
 
M
E
K2306-1
 
FidFile: PROTON01
P
ulse Sequence: PROTON (s2pul)
Solvent: cdcl3
D
a
t
a
 
c
ollected on: Aug  4 2011
Sample #14, Operator: mkieffer
 
R
elax. delay 2.000 sec
 
P
ulse 45.0 degrees
 
A
cq. time 2.500 sec
 
Width 8000.0 Hz
 32 repetitions
OBSERVE   H1, 499.7225125 MHz
D
A
T
A
 
P
ROCESSING
 
Line broadening 0.2 Hz
F
T
 
size 65536
T
o
t
al time 2 min 24 sec
  0.94
  1.00
  1.97
  1.99
  1.94
  1.03
  1.02
  1.00
  3.00
  1.07
  1.03
  3.02
ppm
1
2
3
4
5
6
7
8
9
10
Plotname: --Not assigned--
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155 Appendix 1 * Spectra Relevant to Chapter 2 
M
E
K3206-1
 Sample Name:
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Chapter 3 
 
Direct and Selective Copper-Catalyzed Arylation of Tryptamines and 
Tryptophans: Total Synthesis of (+)-Naseseazines A and B† 
 
 
3.1 INTRODUCTION 
3.1.1 Limitation of the Formal (3+2) Methodology 
The pyrroloindoline is a common structural motif that unites several 
biosynthetically distinct families of alkaloids.1 As discussed in Chapters 1 and 2, our lab 
has developed an enantioselective method to access this scaffold through the formal 
(3+2) cycloaddition of 3-substituted indoles and 2-amido acrylates. This strategy has 
been subsequently applied in the synthesis of several distinct natural products.2 For 
example, 3-allyl pyrroloindoline 135, prepared in 52% yield and 90% ee from 3-
allylindole, can be advanced in only seven-steps to the macrocyclic natural product, (+)-
nocardioazine A (136), a p-glycoprotein inhibitor.3 
  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
† Portions of this chapter have been reproduced from published studies (Kieffer, M. E.; Chuang, K. V.; 
Reisman, S. E. Chem. Sci. 2012, 3, 3170 – and – Kieffer, M. E.★; Chuang, K. V. ★; Reisman, S. E. J. Am. 
Chem. Soc. 2013, 135, 5557) and the supporting information found therein. Work was conducted in 
collaboration with Kangway V. Chuang. 
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Scheme 3.1. Total synthesis of (+)-nocardioazine A 
 
 
 One major limitation of this convergent methodology is the inability to utilize 
indoles bearing bulky C3 substituents. For instance, N-allyl-3-phenylindole (137) fails to 
react under the optimized conditions, even after prolonged reaction times and more 
forcing conditions. This finding proved to be particularly unfortunate due to the 
prevalence of an important subclass of pyrroloindoline natural products characterized by 
a C3-quaternary center bearing an aryl substituent (Figure 3.1). These compounds, 
including quadrigemine C (142) and gliocladine B (140), exhibit potent biological 
activity, yet methods for their efficient preparation have remained a challenge in modern 
synthetic chemistry.4,5 This chapter describes our efforts towards the development of a 
complementary and direct arylation reaction in order to gain convergent access to this 
subclass of natural products.  
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Figure 3.1. C3-Aryl pyrroloindoline natural products 
 
 
3.1.2 Previous Syntheses of C3-arylated Pyrroloindolines 
 In a seminal 2001 report, Overman and Govek reported the successful 
implementation of an intramolecular Heck strategy in the synthesis of (+)-asperazine, a 
bisindole alkaloid containing a unique C3-C7 aryl linkage.6 In 10-steps (L)-tryptophan 
methylester hyrdrochloride was advanced to iodoanilide 143 that, in a key step, was 
subjected to Pd2(dba)3, (2-furyl)3P, and PMP to effect a highly diastereoselective, 
intramolecular Heck reaction to form the C3-arylated quaternary center found in the 
natural product.  Oxindole 144 was further advanced to (+)-asperazine in another 10-
steps. The following year, Overman reported the total synthesis of the 
polypyrroloindoline alkaloid (–)-quadrigemine C, now utilizing a key, enantioselective 
Heck desymmetrization of a meso compound (Scheme 3.2, b).7 Treatment of meso-146 
with Pd(OAc)2 and (R)-tol-BINAP with pentamethylpiperidine affords bisoxindole 147, 
which is efficiently cyclized under reductive conditions to the natural product. 
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Scheme 3.2. Overman’s approach to C3-aryl pyrroloindolines 
 
 
 A decade later, Movassaghi and co-workers reported a general strategy towards 
this class of compounds using a bromocyclization/Friedel–Crafts approach (Scheme 
1.16, Chapter 1).5c A subsequent publication details the extension of this strategy 
towards the completion of indole-bearing natural products 155–157 (Scheme 3.3). Again, 
starting with tryptophan-derived bromo tetracycle 152, subjection to superstoichiometric 
AgBF4 to generate the benzylic tertiary carbocation followed by the addition of four 
equivalents of an indole nucleophile, provides C3-aryl pyrroloindoline 154. This common 
intermediate can be further functionalized to access (+)-gliocladins B and C and (+)- 
dideoxybionectin, demonstrating the power and versatility of this approach.5d 
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Scheme 3.3. Movassaghi’s approach to C3-aryl pyrroloindolines 
 
 
 At the outset of our studies, the strategies presented by Overman and Movassaghi 
represented the state-of-the-art in the preparation of C3-aryl pyrroloindolines. Despite the 
ability of these elegant approaches to provide access to the desired scaffold, we believed 
there might be room for improvement (Scheme 3.4). For example, while the Heck 
reaction is a powerful tool for the generation of quaternary centers, the preparation of the 
cyclization precursor is lengthy, and additional steps are required for advancement to 
pyrroloindolines. In contrast, Movassaghi’s approach is potentially more general and 
allows for late-stage aryl group installation, yet the reported conditions only provide 
moderate yields and require superstoichiometric amounts of silver salts and precious 
nucleophiles. Furthermore, only electron-rich and sterically unencumbered nucleophiles 
are tolerated with this approach. In considering various strategies, we recognized that 
there existed no direct method for the preparation of C3-arylpyrroloindolines, and 
therefore anticipated that the development of a direct arylation/cyclization cascade of 
tryptamines and tryptophans would significantly streamline the assembly and preparation 
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of a diverse array of C3-arylpyrroloindolines and enable the concise preparation of 
related natural products.  
Scheme 3.4. Strategies to access C3-aryl pyrroloindolines 
 
 
3.2 REACTION DESIGN 
 One possible strategy to effect this transformation is through transition metal 
catalysis. Although C3-functionalization/cyclization has been a widely employed 
approach for pyrroloindoline synthesis, and furthermore has been utilized successfully in 
the context of Pd-mediated C3-allylation and benzylation reactions, at the outset of our 
studies no equivalent arylation reaction had been reported.8,9,10 Mechanistically, we 
hypothesized such a transformation could proceed through initial nucleophilic attack of a 
tryptamine or tryptophan onto an electrophilic metal center to form C3-metallated 
intermediate 159 (Scheme 3.5). Iminium cyclization to form the pyrrolidine ring, 
followed by reductive elimination to furnish the all carbon quaternary center, would 
provide the desired product (161). Alternatively, we imagined that the pendant amine 
might stabilize C3-metallated 159. Reductive elimination from a spirocyclic intermediate 
(162) and subsequent iminium cyclization could also provide the pyrroloindoline product. 
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Scheme 3.5. Proposed transition metal mechanism 
 
 
Although a transformation proceeding via indole C3-metallation seemed 
attractive, we recognized from the outset that this design was not without inherent 
challenges in chemoselectivity. Specifically, key to the success of this transformation is 
the generation of C3-metallated species 159, which must undergo reductive elimination 
and cyclization to provide the desired product (Scheme 3.6). One major concern was the 
relative stability of such an intermediate, which is known to undergo facile migration to 
the C2 position of the indole.11 Reductive elimination and rearomatization could then 
furnish 2-aryl indoles.  Additionally, one could imagine coordination of the transition 
metal catalyst to either the indole nitrogen or the pendant amine to yield Buchwald-
Hartwig type products. 
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Scheme 3.6. Possible indole reactivity 
 
3.2.1 Initial Investigation into Palladium Catalysis 
 Our initial strategy was inspired by 2009 work from Buchwald and co-workers in 
which they utilized a Pd(0-II) cycle in the asymmetric dearomatization of naphthalenes 
(Scheme 3.7).12 Using chiral Davephos 166, a variety of substituted arenes served as 
competent substrates in the generation of sterically demanding, arylated quaternary 
centers.  
Scheme 3.7. Buchwald’s Pd-catalyzed intramolecular arylation 
 
 Drawing an analogous mechanism, we wondered if Pd(0)/(II) catalysis could be 
applied to the direct arylation of tryptamine derivatives. A systematic screen of 
substrates, palladium sources, and ligands revealed the ability to selectivity access each 
of the predicted product isomers, except for the desired pyrroloindoline (Scheme 3.8). 
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Employing slightly smaller ligands, C2-arylation was observed while the use of bulky 
ligands, perhaps unsurprisingly, resulted in the formation of C–N bonds. With these 
negative results, a change in strategy was deemed necessary. 
Scheme 3.8. Pd-catalyzed arylation 
 
 
3.2.2 Investigation into Copper Catalysis 
 In our previous palladium approach, a variety of strong bases were used 
deprotonate the indole in order to increase its reactivity and nucleophilicity. Given the 
undesired reactivity observed, we decided to employ an alternative tactic to modify the 
reactivity. We reasoned that, rather than increasing substrate nucleophilicity, increasing 
metal electrophilicity might facilitate the rate of reductive elimination over 1,2-migration, 
thereby enabling the preparation of C3-arylated products.  
 To this end, we were encouraged by several reports from the Gaunt group, in 
which mild arylation of nucleophiles with diaryliodonium salts could be effected through 
Cu-catalysis (Scheme 3.9).13 Specifically, Gaunt invokes a highly electrophilic Cu(III)-
aryl intermediate, which is generated under mild conditions due to the ease of oxidative 
addition to diaryliodonium salts. We hypothesized that it may be possible to harness the 
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reactivity of this Cu/iodonium system to effect the direct arylation of tryptamines to form 
pyrroloindolines, but recognized from the outset that the generation of a sterically-
demanding, aryl quaternary center may test the limits of this technology. Specifically, at 
the outset of our exploratory efforts, no examples of quaternary-center formation using 
Cu/ArI2X had been reported in the literature. 
Scheme 3.9. Gaunt’s Cu-catalyzed arylation 
 
 
 
3.3 SCREENING AND OPTIMIZATION 
 Excited about the application of this new catalyst system, tosyl tryptamine 167a 
was easily prepared and treated with Ph2IBF4, di-tert-butylpyridine, and 10 mol % 
Cu(OTf)2, identical conditions to those reported by Gaunt and co-workers. 
Disappointingly, these efforts were met with extremely low conversion of starting 
material; however, trace masses corresponding to arylated products were detected by 
UHPLCMS.  In considering the reaction conditions, we wondered whether di-tert-
butylpyridine was potentially acting as a ligand and coordinating the copper catalyst, 
thereby mitigating its reactivity. Closer inspection of Gaunt’s reported conditions 
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revealed that stoichiometric base was employed to suppress acid-catalyzed dimerization 
of the 2,3-unsubstituted indoles.  As 3-substituted indoles have a significantly lower 
propensity to dimerize, the reaction was repeated in the absence of base.  To our delight, 
3-aryl pyrroloindoline 168a was isolated in 60% yield along with 27% yield of migratory 
side product 169a (Table 3.1). 
 Our optimization efforts began with a screen of Cu(I) and Cu(II) sources (Table 
3.1).  Whereas copper catalysts with highly coordinating ligands such as halides and 
acetonitrile (entries 6–7) showed no reactivity, Cu(OAc)2 exhibited an incredibly clean 
reaction profile (entry 8) and moderate yields. Surprisingly, a low yield of side product 
169a did not necessarily correspond to a higher yield of product.  In fact, it appears that 
2-aryl indole 169a converts to an unknown oxidative dimer as the reaction proceeds. In 
terms of the iodonium salts, the best results were obtained using the non-coordinating 
tetrafluoroborate counterion. Interestingly, use of a TFA counterion results in 
chemoselective N-arylation of the indole nitrogen (170a). The non-symmetric iodonium 
salt [Ph-I-Mes]BF4, for which the mesityl group serves as a non-transferable ligand, is 
also a competent coupling partner, although longer reaction times are required. 
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Table 3.1. Optimization of Cu-source and protecting group 
 
 
entry R1 Cu source X additive C3 : C2 : N pdt yielda (%)  
1 Ts Cu(OTf)2 BF4 – 2.3 : 1 : 0 168a 62b 
2 Ts – BF4 – – 168a 0 
3 Boc Cu(OTf)2 BF4 – – 168b <5 
4 Ac Cu(OTf)2 BF4 – – 168c <5 
5 Ts (CuOTf)2•PhMe BF4 – 3.4 : 1 : 0 168a 64 
6 Ts CuI BF4 – – 168a 0 
7 Ts Cu(MeCN)4PF6 BF4 – – 168a 0 
8 Ts Cu(OAc)2 BF4 – 2.9 : 1 168a 64 
9 Ts Cu(OTf)2 PF6 – 2.5 : 1 168a 28 
10 Ts Cu(OTf)2 OTf – 2.9 : 1 168a 32 
11 Ts Cu(OTf)2 Cl – – 168a 0 
12 Ts Cu(OTf)2 TFA – 0 : 0 : 1 170a nd 
13 Ts Cu(OTf)2 BF4 dtbpy – 168a <5 
14 Ts Cu(OTf)2 BF4 – 2.6 : 1 168a 65b 
a Determined by HPLC versus an internal standard. b Isolated yield. c [Ph-I-Mes]BF4 was employed as the 
electrophile. 
 
Although both Cu(OTf)2 and Cu(OAc)2 furnished comparable yields of 
pyrroloindoline 168a when using [Ph2I]BF4 as the electrophile, the Cu(OAc)2-catalyzed 
reaction profile was cleaner overall, thereby simplifying purification. As a result, 
Cu(OAc)2 was the catalyst of choice for arylation reactions employing [Ph2I]BF4 or other 
symmetric iodonium salts. On the other hand, Cu(OTf)2 proved superior for arylation 
reactions that employed less reactive, mesityl-substituted iodonium salts. 
3.4 SUBSTRATE SCOPE OF RACEMIC ARYLATION 
3.4.1 Tryptamine and Iodonium Scope 
Using this method, a variety of arylated pyrroloindolines can be prepared in a 
single step from the corresponding N-tosyl tryptamines at ambient temperatures (Table 
3.2). We were pleased to find that tryptamine substrates bearing alkyl substitution at C4, 
C5, C6, and C7 are accommodated, providing the corresponding pyrroloindolines in good 
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yields (168b–168e). Additionally, a variety of electron-donating and electron-
withdrawing substituents are tolerated at C5. Although comparable yields are obtained, 
slower rates are observed in the reactions of indoles substituted with electron-
withdrawing groups. N-tosyltryptamines bearing alkyl substitution on the indole nitrogen 
are also competent reaction partners (168l–168m). 
We next investigated the scope of the aryl coupling partner. We were pleased to 
find that a range of electron-donating and withdrawing substituents were well tolerated at 
the para- and meta- positions, utilizing both symmetric and non-symmetric iodoniums. 
Unfortunately, ortho-substitution was poorly tolerated, providing the product in low yield 
(168p, 15% yield). Fortunately, reactivity could be restored by switching to the 
symmetric iodonium salt (168p, 50% yield).  
Table 3.2. Substrate Scope 
 
 
a Reactions were conducted on 0.30 mmol scale. Isolated yields are reported. b The symmetric 
iodonium was utilized. 
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3.4.2 Scale-up Procedure 
Our screening protocol was conducted using 10–20 mol% catalyst loading to 
ensure uniformly good yields over a range of substrates. However, to demonstrate the 
scalability and efficiency of this transformation, the reaction has been carried out on a 3 g 
scale using N-tosyltryptamine and [Ph2I]BF4 with only 2.5 mol % catalyst loading. 
Purification by filtration followed by trituration provides analytically pure 
pyrroloindoline in 63% yield, without the need for column chromatography. Notably, the 
reaction proceeds at ambient temperature with nearly equimolar ratios of indole and 
[Ph2I]BF4. 
Scheme 3.10. Scale-up reaction 
 
3.5 DIASTEREOSELECTIVE ARYLATION REACTION DESIGN 
3.5.1 Macmillan’s Enantioselective Method 
 As the manuscript for this methodology was being prepared, a similar 
enantioselective transformation was reported by MacMillan and co-workers.14 Utilizing 
chiral copper box complexes, they were able to effect both a chemoselective and 
enantioselective arylation of indole carboxamides. Their method proved general for a 
variety of substituted indoles and diaryliodonium salts (Scheme 3.11). 
  
N
H
NHTs
NN
H H
PhCu(OAc)2 (2.5 mol %)
[Ph2I]BF4
DCM, rt, 36 h
(63% yield)
trituration
10 mmol scale
Ts
2.3 g
Chapter 3 – Direct and Selective Copper-Catalyzed Arylation of Tryptamines and 
Tryptophans: Total Synthesis of (+)-Naseseazines A and B 
188 
Scheme 3.11. MacMillan’s Cu-catalyzed arylation 
 
 
 This report was particularly disappointing as we had already gathered preliminary 
data on an enantioselective variant of our arylation reaction. Employing catalytic copper 
and chiral copper phosphates, C3-aryl pyrroloindoline 168a was recovered in moderate 
but promising enantioselectivities (Scheme 3.12).  
Scheme 3.12. Enantioselective result. 
 
 
Regardless, we resolved to investigate the differences and similarities between 
our conditions and MacMillan’s conditions to gain a better understanding of the reactivity 
of these types of systems. Based on MacMillan’s work, it has been established that indole 
carboxamides in conjunction with copper catalysis and diaryliodonium salts provide 
pyrroloindoline products in a chemoselective and enantioselective fashion. Interestingly, 
subjection of our substrate (167a) to MacMillan’s conditions, provides low yields of 
arylated product and in racemic form. Similarly, subjection of MacMillan’s substrate 
(172) to our ligandless copper conditions, provided almost exclusive C2-arylation (173). 
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Scheme 3.13. Comparison Studies 
 
 
3.5.2 New Reaction Design 
 We rationalized that a careful matching of the directing group (Lewis-basicity) 
and catalyst stereoelectronics likely determined product ratios. Specifically, it appeared 
that MacMillan’s more Lewis-basic directing group may compensate for the diminished 
electrophilicity of the ligated copper complex, allowing for the complex to still 
coordinate strongly to the substrate. Similarly, the diminished electrophilicity of the 
ligated copperbox complex may prevent meaningful coordination of N-tosyltryptamine, 
resulting in poor reactivity, yield, and no enantioinduction.  
Acknowledging that our ultimate goal was to develop methodology useful in the 
application of natural product total synthesis, we recognized that neither our arylation 
method, nor that of MacMillan and co-workers, provides products with the functionality 
necessary for advancement to natural products. Instead, perhaps the most straightforward 
and useful approach was the direct and diastereoselective arylation of tryptophan 
derivatives. Starting with tryptophan-derived diketopiperazines 175, we hoped to use the 
inherent Lewis basicity of the amide to selectively direct a copper catalyst to a single face 
of the indole to provide pyrroloindoline products in a diastereoselective fashion (177). 
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Successful execution would represent the most convergent route to this class of 
compounds reported to date. 
Scheme 3.14. Proposed diastereoselective arylation 
 
 
3.6 OPTIMIZATION OF DIASTEREOSELECTIVE ARYLATION 
Our efforts to effect this diastereoselective transformation began with subjection 
of tryptophan-derived diketopiperazine 175a, to our previously optimized conditions of 
ligandless copper (Table 3.3, entry 1). We were encouraged to recover the desired 
isomer in 22% yield. However, pyrroloindoline 176 was also formed in a 1:1 C3:C2 
mixture (178), as well as a 3:1 diastereomeric ratio (177). In an effort to test our 
hypothesis on the necessary matching of directing group ability and the catalyst 
electronics, we conducted a screen of bidentate ligands. While more conventional bipy 
and phenanthroline based ligands provided minimal increases in yield, we were pleased 
to find that they were able to modulate the selectivities. We were delighted to find that 
use of the sterically congested bis(mesityl)-α-diimine ligand (L7) furnished the product in 
70% yield. Further investigation into the sterics of the diimine ligand revealed that the 
precise substitution around the adjacent arene exerts a significant effect on the reactivity 
and selectivity of the reaction. The yield of pyrroloindoline was further improved through 
the use of a triflate counterion, providing the product in 85% isolated yield as a single 
diastereomer (entry 14). 
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Table 3.3. Diastereoselective optimization 
 
 
entry ligand [Ph2I]X C3:C2a dra yield (%)a 
1 –b [Ph2I]PF6 – – 0 
2 – [Ph2I]PF6 1:1 3:1 22 
3 L1 [Ph2I]PF6 1:1 3:1 15 
4 L2 [Ph2I]PF6 1:2 2:1 <5 
5 L3 [Ph2I]PF6 6:1 10:1 20 
6 L4 [Ph2I]PF6 12:1 12:1 38 
7 L5 [Ph2I]PF6 2:1 5:1 26 
8 L6 [Ph2I]PF6 1:1 4:1 24 
9 L7 [Ph2I]PF6 >20:1 >20:1 70 
10 L8 [Ph2I]PF6 1:1 4:1 15 
11 L9 [Ph2I]PF6 2:1 20:1 35 
12 L7 [Ph2I]BF4 >20:1 >20:1 76 
13 L7 [Ph2I]AsF6 >20:1 >20:1 81 
14 L7 [Ph2I]OTf >20:1 >20:1 83 (85)c 
aYield of major diastereomer as determined by 1H NMR analysis of the crude reaction mixture. b No 
(CuOTf)2•PhMe was used. c Isolated yield. 
 
 
3.7 SCOPE OF DIASTEREOSELECTIVE ARYLATION 
With optimized conditions in hand, the substrate scope of this diastereoselective 
reaction was examined (Table 3.4).  A variety of arylated pyrroloindolines (176) can be 
prepared in one step from the corresponding diketopiperazines (175).  Interestingly, the 
diketopiperazines derived from either L- or D-alanine react to deliver diastereomeric 
pyrroloindolines 176b and 176c, respectively, which possess the same configuration at 
the newly formed quaternary center.  This observation indicates that the configuration at 
the tryptophan-derived stereogenic center is the dominant stereocontrolling factor.  The 
scope of the aryl coupling partner was also investigated and was found to be tolerant of 
both electron-rich and electron-poor arenes (176j–176l). 
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In contrast, diketopiperazine 175f, derived from L-Pro, proved to be a challenging 
substrate and provided 176f in low yield as a result of poor C3:C2 selectivity under our 
standard conditions. We hypothesized that the increased substitution at nitrogen may 
result in a destabilizing interaction with the bulky CuI(L7) catalyst. A screen of more 
sterically-accessible ligands revealed that the use 40 mol % L6 in conjunction with [Ph-
2I]PF6 restores the C3:C2 selectivity and delivers pyrroloindoline 176f in 71% yield. At 
this time, we believe that the need for increased ligand loading with L6 is likely due to 
the formation of bridging Cu-catalyst dimers. This hypothesis is further supported by the 
fact that reaction rates utilizing L6 are considerably accelerated at higher dilutions. 
Table 3.4. Substrate scope of diastereoselective arylation 
 
 
a Reactions conducted on 0.3 mmol scale using symmetric diaryliodonium triflate unless otherwise noted. 
Isoltaed yields are reported. b 40 mol % ligand L6 was used with diphenyliodonium hexfluorophosphate. c 
Non-symmetric aryl[p-xylyl]iodonium triflate was used. 
 
Given the success of a range of diketopiperazine-containing substrates, we next 
turned our attention to a more flexible system. Specifically, we wondered if an acyclic 
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tryptophan-derived carboxamide would behave similarly under our reaction conditions. 
Remarkably, subjection of acyclic 179 to our optimized conditions provided 
pyrroloindoline products in which arylation occurred with opposite facial selectivity at 
the quaternary center to that seen with diketopiperazine substrates (180).  From a 
synthetic standpoint, this presents the exciting opportunity to access either enantiomeric 
series of pyrroloindoline products from naturally occurring (L)-tryptophan. 
Figure 3.2. Reversal in diastereoselectivity 
 
 
 
3.8 MECHANISTIC HYPOTHESIS 
The mechanism of this reaction is still under investigation and our attempted 
studies have been complicated by the presence of paramagnetic species in 1H NMR 
experiments as well as the heterogeneous nature of this reaction. Currently, we can only 
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indoles, we currently favor a Cu(I–III) catalytic cycle (Scheme 3.15). Although Gaunt 
proposes oxidative addition prior to indole coordination, our studies suggest indole 
coordination is likely necessary for oxidation to a Cu(III) species. 
Scheme 3.15. Possible arylation mechanism 
 
 
 
3.9 TOTAL SYNTHESIS OF (+)-NASESEAZINES A AND B 
3.9.1 Retrosynthetic Analysis 
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functionalized iodoniun. Alkynyl diketopiperazine 82 was expected to be available via a 
peptide coupling followed by cyclocondensation of the corresponding propargylglycine 
derivative. 
Scheme 3.16. Retrosynthetic Analysis 
 
3.9.2 Forward Synthesis 
In the forward sense, we began by investigating the arylation reaction of cyclo-L-
Trp-L-Pro (175f) with diaryliodonium salt 182, readily prepared in 80% yield over two-
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2•PhMe and 40 mol% t-BuDABMe (L6), conditions previously optimized for (L)-proline-
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performed on large scale and provides the desired pyrroloindoline with excellent levels of 
diastereocontrol. Moreover, the same conditions could be applied to alanine-derived 175b 
to give pyrroloindoline 181b in 59% yield. 
Scheme 3.17. Arylation using a functionalized iodonium 
 
 
 To prepare the other coupling fragment for a Larock indolization, alkynyl 
diketopiperazine 185 was synthesized on gram scale via initial peptide coupling of amino 
acid 184 with (L)-proline methyl ester hydrochloride. One-pot Boc deprotection and 
base-mediated cyclocondensation provide the desired coupling partner.  
Scheme 3.18. Preparation of a propargyl diketopiperazine 
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reaction of bromoanilines has been considerably less developed.15,16 We were encouraged 
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of the complestatin natural products.16 Despite the use of superstoichiometric Pd(OAc)2 
and ditertbutylferrocenylphosphine as a ligand, this precedent demonstrated the viability 
of such a reaction in the context of advanced stage total synthesis and in the presence of 
numerous peptide bonds. 
We were therefore encouraged to find that the use of stoichiometric palladium 
with 1,1’-bis(di-tert-butylphosphino)ferrocene (dtbpf) gave traces of the natural product 
(Table 3.5, entry 2). Unfortunately, a closer analysis of the reaction mixture showed that 
the major products of this reaction consisted of hydrodebrominated starting material, epi-
naseseazine B, and iso-naseseazine B. Furthermore, subsequent attempts to optimize this 
reaction based on the conditions identified by Boger and co-workers proved completely 
unfruitful, and we therefore embarked on an extensive screen of less conventional 
ligands. Interestingly, treatment of stoichiometric amounts of the N-heterocyclic carbene-
based catalyst PEPPSI-IPr greatly reduced debromination, although 187 was recovered in 
low yield.  Subjecting the free aniline to identical conditions improved the recovery, 
providing a 39% isolated yield (entry 7).  Additional screening revealed that the bulky 
preformed catalyst Pd[P(o-tol)3]2 was highly active, reaching full conversion in only 15 
minutes and providing 27% yield of the product. Intrigued by the reactivity, we wondered 
whether catalysis might be achieved under these conditions. Gratifyingly, treatment with 
only 25 mol % Pd[P(o-tol)3]2 afforded 187 in 51% yield,  constituting the first catalytic 
Larock indolization on a bromoaniline in total synthesis. 
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Table 3.5. Optimization of the Larock indole synthesis 
 
 
entry R catalyst time product:debromo yield (%) 
1 TFA Pd(OAc)2 (1.1 equiv), LiCl 8 h – – 
2 TFA Pd(OAc)2 (1.1 equiv), dtbpf (1.2 equiv) 2 h 1 : 1 <10 
3 TFA Pd2(dba)3 (0.5 equiv), dtbpf (1.2 equiv) 2 h 1 : 1 <10 
4 TFA Pd(OAc)2 (1.1 equiv), DavePhos (1.2 equiv) 2 h 1 : 1 <10 
5 TFA Pd(OAc)2 (1.1 equiv), PCy3 (1.2 equiv) 8 h 0 : 1 – 
6 TFA PEPPSI-IPr (1.1 equiv) 8 h >20 :1 <20 
7 H PEPPSI-IPr (1.1 equiv) 8 h >20 :1 39 
8 H Pd[P(o-tol)3]2 (1.1 equiv) 15 min 10 :1 27 
9 H Pd[P(o-tol)3]2 (25 mol %) 90 min >20 : 1 51 
 
 
An analogous sequence was applied to furnish the related natural product (+)-
naseseazine A by utilizing alanine-derived diketopiperazine 181b.  Through this Cu-
catalyzed arylation chemistry, these complex polycyclic alkaloids are available in only 
five steps (longest linear sequence) from commercially available starting materials in 
19% and 25% overall yield respectively, highlighting the ability to generate structurally 
diverse pyrroloindolines in an extremely convergent manner. 
 
3.10 CONCLUSION 
In conclusion, this report describes the discovery and development of new, Cu-
catalyzed arylation reactions of tryptamine and tryptophan-derivatives to form 3-
arylpyrroloindolines. Direct and selective C3-arylation is achieved through the use of 
copper catalysts in conjunction with hypervalent iodine(III) salts as the aryl source. N-
sulfonyltryptamines were found to react uniquely using copper(I) or (II) salts and 
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diaryliodonium tetrafluoroborates to afford racemic C3-aryl pyrroloindolines in good 
yields. Furthermore, the addition of α-diimine ligands to the system has enabled the 
development of an efficient and highly diastereoselective tryptophan arylation reaction. 
Using this transformation to assemble the pyrroloindoline core enables the concise, 
stereoselective syntheses of the bisindole alkaloids (+)-naseseazines A and B in overall 
yields of 25 and 19%, respectively.  
 
3.11 EXPERIMENTAL SECTION 
3.11.1 Materials and Methods 
Unless otherwise stated, reactions were performed under a nitrogen atmosphere using 
freshly dried solvents. Tetrahydrofuran (THF), methylene chloride (CH2Cl2), acetonitrile 
(MeCN), dimethylformamide (DMF), and toluene (PhMe) were dried by passing through 
activated alumina columns. Triethylamine (Et3N) was distilled over calcium hydride prior 
to use. Unless otherwise stated, chemicals and reagents were used as received. All 
reactions were monitored by thin-layer chromatography using EMD/Merck silica gel 60 
F254 pre-coated plates (0.25 mm) and were visualized by UV, p-anisaldehyde, or 
KMnO4 staining. Reaction samples were analyzed on an Agilent 1290 Series LC/MS 
using an Eclipse Plus C18 column (RRHD 1.8 µm, 2.1 x 50 mm, 11,072 plates). Flash 
column chromatography was performed either as described by Still et al. using silica gel 
(particle size 0.032-0.063) purchased from Silicycle or using pre-packaged RediSep®Rf 
columns on a CombiFlash Rf system (Teledyne ISCO Inc.).  Alumina was purchased 
from Sigma-Aldrich (Aluminum oxide, ~150 mesh, 58Å pore size, activated, basic, 
Brockmann I) and deactivated with 3% v/w H2O (30.0 mL / 970 g).  1H and 13C NMR 
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spectra were recorded on a Varian 400 MR (at 400 MHz and 101 MHz, respectively), a 
Varian Inova 500 (at 500 MHz and 126 MHz, respectively), or a Varian Inova 600 (at 
600 MHz and 150 MHz, respectively), and are reported relative to internal CHCl3 (1H, δ 
= 7.26) or DMSO (1H, δ = 2.50), and CDCl3 (13C, δ = 77.0), or DMSO (13C, δ = 40.0). 
Data for 1H NMR spectra are reported as follows: chemical shift (δ ppm) (multiplicity, 
coupling constant (Hz), integration). Multiplicity and qualifier abbreviations are as 
follows: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad. IR 
spectra were recorded on a Perkin Elmer Paragon 1000 spectrometer and are reported in 
frequency of absorption (cm–1). HRMS were acquired using an Agilent 6200 Series TOF 
with an Agilent G1978A Multimode source in electrospray ionization (ESI), atmospheric 
pressure chemical ionization (APCI), or mixed (MM) ionization mode. 
3.11.2 Optimization of Racemic Arylation 
A. Palladium-Catalyzed Reaction Screens 
 
 
 To a flame-dried vial in the glove box was charged PCyPh2 (11 mg, 0.04 mmol), 
Pd2(dba)3 (11 mg, 0.02 mmol), N-tosyltryptamine (31 mg, 0.1 mmol), bromobenzene (51 
µL, 0.5 mmol), LiOtBu (16 mg, 0.2 mmol) and THF (1 mL).  The vial was sealed and 
heated to 80 oC for 12 hours.  The reaction mixture was filtered through a plug of silica 
and concentrated in vacuo.  The crude residue was purified by silica gel flash 
chromatography (20% EtoAc in hexanes) to afford 2-phenyl tryptamine 17 (16.9 mg, 
0.04 mmol, 44%). 1H NMR (CDCl3, 500 MHz) δ 8.11 (s, 1H), 7.58 (d, J = 8.2 Hz, 2H), 
7.52 – 7.42 (m, 5H), 7.40 (ddd, J = 4.1, 1.5, 1.5 Hz, 1H), 7.37 (d, J = 8.1 Hz, 1H), 7.20 
N
H
NHTs
N
H
NHTs
PhLiOt-Bu (2.0 equiv)
THF, 80 °C, 12 h
bromobenzene
Pd2(dba)3 (20 mol%)
PCyPh2(40 mol%)
(44% yield)
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(dd, J = 16.1, 7.8 Hz, 3H), 7.09 (dd, J = 7.8, 7.2 Hz, 1H), 4.35 (t, J = 5.8 Hz, 1H), 3.28 
(dd, J = 13.3, 6.8 Hz, 2H), 3.08 (dd, J = 7.1, 7.1 Hz, 2H), 2.40 (s, 3H); 13C NMR (CDCl3, 
126 MHz) δ 143.2, 136.7, 135.8, 132.5, 129.6, 129.0, 128.5, 128.10, 128.09, 127.0, 
122.6, 120.0, 118.8, 110.9, 108.3, 43.2, 25.0, 21.5;HRMS (MM) calc’d for [M+H]+ 
391.1475, found 391.1491. 
 
 
 
 To a flame-dried vial in the glove box was charged XPhos (19 mg, 0.04 mmol), 
Pd2(dba)3 (11 mg, 0.02 mmol), N-tosyltryptamine (31 mg, 0.1 mmol), bromobenzene (51 
µL, 0.5 mmol), LiOtBu (16 mg, 0.2 mmol) and THF (1 mL).  The vial was sealed and 
heated to 80 oC for 6 hours.  The reaction mixture was filtered through a plug of silica 
and concentrated in vacuo.  The crude residue was purified by silica gel flash 
chromatography (20% EtoAc in hexanes) to afford N-phenyl tryptamine (35.2 mg, 0.09 
mmol, 90%). 1H NMR (CDCl3, 500 MHz) δ  7.70 – 7.65 (m, 2H), 7.57 – 7.43 (m, 6H), 
7.39 – 7.32 (m, 1H), 7.23 (dd, J = 11.6, 4.5 Hz, 3H), 7.16 – 7.10 (m, 1H), 7.09 (s, 1H), 
4.54 (t, J = 6.1 Hz, 1H), 3.34 (q, J = 6.6 Hz, 2H), 2.99 (t, J = 6.7 Hz, 2H), 2.38 (s, 3H); 
13C NMR (CDCl3, 126 MHz) δ 143.3, 139.4, 136.8, 136.1, 129.6, 128.3, 127.0, 126.4, 
126.2, 124.1, 122.7, 120.1, 118.8, 112.7, 110.7, 43.1, 25.4, 21.5. HRMS (MM) calc’d for 
[M+H]+ 391.1475, found 391.1470. 
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 To a flame-dried vial in the glove box was charged BrettPhos (6.4 mg, 0.012 
mmol), Pd2(dba)3 (3.5 mg, 0.006 mmol), N-Boc-N’-methyltryptamine (8 mg, 0.1 mmol), 
bromobenzene (16 µL, 0.15 mmol), LiOtBu (4.8 mg, 0.06 mmol) and THF (1 mL).  The 
vial was sealed and heated to 80 oC for 6 hours.  The reaction mixture was filtered 
through a plug of silica and concentrated in vacuo.  The crude residue was purified by 
silica gel flash chromatography (20% EtoAc in hexanes) to afford N-phenyl tryptamine 
(28.0 mg, 0.02 mmol, 72%). 1H NMR (CDCl3, 500 MHz) δ  7.54 (d, J = 7.9 Hz, 1H), 
7.34 (dd, J = 10.7, 4.9 Hz, 2H), 7.28 (d, J = 8.2 Hz, 1H), 7.24 – 7.18 (m, 4H), 7.07 (ddd, 
J = 7.9, 7.0, 1.0 Hz, 1H), 6.85 (s, 1H), 3.97 – 3.87 (m, 2H), 3.72 (s, 3H), 3.06 – 2.95 (m, 
2H), 1.42 (s, 10H).  13C NMR (CDCl3, 126 MHz) 148.4, 143.5, 139.4, 136.4, 135.6, 
132.6, 131.9, 129.6, 128.5, 127.2, 127.1, 127.0, 125.7, 124.3, 119.2, 109.4, 84.4, 62.1, 
47.4, 37.9, 21.4, 20.8.  FTIR (NaCl, thin film): 3056, 3027, 2949, 2891, 2827, 1762, 
1605, 1491, 1347, 1160, 1092, 1022.  HRMS (MM) calc’d for [M+H]+ 409.1381, found 
409.1363. 
 
B. Copper-Catalyzed Reaction Screen 
 
General Procedure – To a flame-dried, 1-dram vial was charged the appropriate 
tryptamine (0.10 mmol), 4,4’-di-tert-butylbiphenyl, diaryl iodonium salt (0.11 mmol), 
copper catalyst (0.010 mmol), and additive (0.10 mmol, if applicable). Anhydrous 
CH2Cl2 (1.0 mL) was then added and the reaction stirred under inert atmosphere and 
monitored by UHPLC-MS for optimal yield. 
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The following response factors relative to an internal standard of 4,4’-di-tert-
butylbiphenyl were measured and calculated based on three runs of varied concentration 
at λ  = 254 nm:  
N-Tosyltryptamine 167a (Starting Material): Response Factor =  0.117 
N-Tosylpyrroloindoline 168a (Product): Response Factor =  0.253 
UHPLC samples were analyzed at λ = 254 nm and yields calculated based on the above 
factors. 
 
 
 
 
 
entry R Cu source X additive pdt yield (%)a 
1 Ts Cu(OTf)2 BF4 – 19a 62b 
2 Ts – BF4 – 19a 0 
3 Boc Cu(OTf)2 BF4 – 19b <5 
4 Ac Cu(OTf)2 BF4 – 19c <5 
5 Ts (CuOTf)2•PhMe BF4 – 19a 64 
6 Ts CuI BF4 – 19a 0 
7 Ts Cu(MeCN)PF6 BF4 – 19a 0 
8 Ts Cu(OAc)2 BF4 – 19a 64 
9 Ts Cu(OTf)2 PF6 – 19a 28 
10 Ts Cu(OTf)2 OTf – 19a 32 
11 Ts Cu(OTf)2 Cl – 19a 0 
12 Ts Cu(OTf)2 BF4 dtbpy 19a <5 
13 Ts Cu(OTf)2 BF4 NaHCO3 19a 55 
14 Ts Cu(OTf)2 BF4 AcOH 19a 62 
15 Ts Cu(OTf)2 BF4 –c 19a 65 
[a] Determined by HPLC versus an internal standard. [b] Isolated yield. [c] [Ph-I-Mes]BF4 was employed 
as the electrophile 
 
3.11.3 Preparation of N-tosyl tryptamine derivatives 
General Procedure A – To a solution of tryptamine (1.00 equiv) in CH2Cl2 (0.1 M) was 
added Et3N (1.50 equiv). The solution was cooled to 0 °C in an ice bath and p-
toluenesulfonyl chloride (1.01 equiv) added in one portion as solid against a positive 
steam of nitrogen. The solution was stirred for 15 minutes, then the ice bath removed and 
allowed to warm up to ambient temperature (20 to 25 °C) and stirred for an additional 4 
N
H
NHR1 copper catalyst
Ph2IX, CH2Cl2, 23 °C NN
H R1
Ph
H
167a-c 168a-c
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hours. The reaction was then quenched with 1 N aq. HCl (equal volume to CH2Cl2 used) 
and the organic layer separated and washed with another portion of 1N aq. HCl. The 
combined aqueous layers were then combined and back extracted with CH2Cl2 (20 mL), 
then the organic layers combined, dried over anhydrous Na2SO4, filtered, and 
concentrated in vacuo. The resulting crude residue was purified by flash chromatography 
(SiO2) to afford N-tosyltryptamine as a white or off-white solid. 
 
 N-Tosyltryptamine 167b: Prepared according to General 
Procedure A.  Reaction run on 6.40 mmol (1.30 g) scale. The crude 
material was purified by silica gel chromatography (gradient elution, 10-60% EtOAc in 
Hexane) to afford 167b as a white, amorphous solid (1.58 g, 4.81 mmol, 75 % yield). 1H 
NMR (CDCl3, 500 MHz) δ  7.98 (s, 1H), 7.67 – 7.60 (m, 2H), 7.25 – 7.19 (m, 3H), 7.17 
(dd, J = 1.5, 0.7 Hz, 1H), 7.01 (dd, J = 8.3, 1.6 Hz, 1H), 6.92 (d, J = 2.3 Hz, 1H), 4.46 (t, 
J = 6.0 Hz, 1H), 3.26 (q, J = 6.5 Hz, 2H), 2.89 (dd, J = 6.9, 6.3 Hz, 2H), 2.41 (s, 3H), 
2.40 (s, 3H); 13C NMR (CDCl3, 126 MHz) 143.2, 136.7, 134.7, 129.6, 128.7, 127.0, 
127.0, 123.8, 122.7, 118.1, 110.9, 110.9, 42.9, 25.4, 21.5, 21.4; FTIR (NaCl, thin film): 
3401, 3290, 3042, 2919, 2864, 1597, 1423, 1320, 1303, 1157, 1093.  HRMS (MM) calc’d 
for [M+H]+ 329.1318, found 329.1316. 
 
 N-Tosyltryptamine 167c: Prepared according to General 
Procedure A.  Reaction run on 3.68 mmol (641 mg) scale. The 
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crude material was purified by silica gel chromatography (gradient elution, 10-60% 
EtOAc in Hexane) to afford 167c as a white, amorphous solid (940 mg, 2.87 mmol, 78 % 
yield). 
1H NMR (CDCl3, 500 MHz) δ  7.94 (s, 1H), 7.67 – 7.59 (m, 2H), 7.29 (d, J = 8.1 Hz, 
1H), 7.21 (d, J = 8.0 Hz, 2H), 7.14 (s, 1H), 6.92 – 6.86 (m, 2H), 4.46 (t, J = 6.1 Hz, 1H), 
3.25 (q, J = 6.5 Hz, 2H), 2.90 (t, J = 6.6 Hz, 2H), 2.45 (s, 3H), 2.40 (s, 3H).  13C NMR 
(CDCl3, 126 MHz) δ 143.2, 136.8, 136.7, 132.1, 129.6, 127.0, 124.7, 121.9, 121.3, 118.1, 
111.3, 111.2,  43.0, 25.5, 21.6, 21.5.  FTIR (NaCl, thin film): 3401, 3280, 2913, 2859, 
1456, 1404, 1320, 1301, 1157, 1093.  HRMS (MM) calc’d for [M+H]+ 329.1318, found 
329.1307. 
 
 N-Tosyltryptamine 167d: Prepared according to General Procedure 
A.  Reaction run on 3.84 mmol (669 mg) scale. The crude material 
was purified by silica gel chromatography (gradient elution, 10-60% EtOAc in Hexane) 
to afford 167d as a white, amorphous solid (1.02g, 3.11 mmol, 81 % yield). 1H NMR 
(CDCl3, 500 MHz) δ  8.27 (s, 1H), 7.90 (d, J = 8.2 Hz, 2H), 7.57 – 7.50 (m, 1H), 7.48 (d, 
J = 8.5 Hz, 2H), 7.24 (dd, J = 9.7, 2.0 Hz, 3H), 4.75 (t, J = 6.1 Hz, 1H), 3.53 (q, J = 6.5 
Hz, 2H), 3.18 (t, J = 6.6 Hz, 2H), 2.73 (s, 3H), 2.66 (s, 3H);  13C NMR (126 MHz, cdcl3) 
δ 143.3, 136.7, 136.0, 129.6, 127.0, 126.3, 122.7, 122.3, 120.5, 119.7, 116.2, 112.0, 43.0, 
25.6, 21.5, 16.6l  FTIR (NaCl, thin film): 3400, 3275, 3047, 2908, 2849, 1436, 1320, 
1303, 1157, 1093, 1063.  HRMS (MM) calc’d for [M+H]+ 329.1318, found 329.1307. 
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 N-Tosyltryptamine 167e:  Prepared according to General Procedure 
A.   Reaction run on 3.43 mmol (610 mg) scale. The crude material 
was purified by silica gel chromatography (gradient elution, 10-60% EtOAc in Hexane) 
to afford 167e as an off-white, amorphous solid (940 mg, 2.83 mmol, 82 % yield). 1H 
NMR (CDCl3, 500 MHz) δ  8.12 (s, 1H), 7.64 – 7.60 (m, 2H), 7.28 – 7.24 (m, 1H), 7.22 
(dd, J = 8.5, 0.6 Hz, 2H), 7.02 (d, J = 2.4 Hz, 1H), 6.99 – 6.89 (m, 2H), 4.45 (t, J = 6.0 
Hz, 1H), 3.24 (q, J = 6.6 Hz, 2H), 2.87 (dd, J = 6.8, 6.4 Hz, 2H), 2.40 (s, 3H); 13C NMR 
(126 MHz, CDCl3) δ 157.6 (d, JC-F = 233.8 Hz), 143.5, 136.4, 132.8, 129.6, 127.1 (d, JC-F 
= 10.0 Hz), 127.0, 124.4, 111.9 (d, JC-F = 8.8 Hz), 111.6 (d, JC-F = 5.0 Hz), 110.6 (d, JC-F 
= 26.3 Hz), 103.4 (d, JC-F = 22.5 Hz), 42.71, 25.32, 21.47;  FTIR (NaCl, thin film): 3392, 
3275, 2933, 2864, 1486, 1457, 1319, 1301, 1157, 1093 cm-1.  HRMS (MM) calc’d for 
[M+H]+ 333.1068, found 333.1058. 
 
 N-Tosyltryptamine 167f:  Prepared according to General 
Procedure A.  Reaction run on 3.34 mmol (650 mg) scale. The crude 
material was purified by silica gel chromatography (gradient elution, 10-60% EtOAc in 
Hexane) to afford 167f as an off-white, amorphous solid (1.08 g, 3.10 mmol, 92 % yield). 
1H NMR (CDCl3, 500 MHz) δ  8.18 (s, 1H), 7.65 – 7.57 (m, 2H), 7.28 (d, J = 2.0 Hz, 
1H), 7.24 (d, J = 0.5 Hz, 1H), 7.21 (dd, J = 8.5, 0.6 Hz, 2H), 7.11 (dd, J = 8.7, 1.9 Hz, 
1H), 7.00 (d, J = 2.3 Hz, 1H), 4.49 (t, J = 6.0 Hz, 1H), 3.23 (q, J = 6.6 Hz, 2H), 2.86 (td, 
J = 6.7, 0.6 Hz, 2H), 2.40 (s, 3H);  13C NMR (CDCl3, 126 MHz) δ 143.5, 136.4, 134.7, 
129.7, 127.9, 126.9, 125.2, 124.1, 122.5, 117.9, 112.3, 111.2, 42.7, 25.2, 21.5;  FTIR 
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(NaCl, thin film): 3385, 3275, 2913, 2859, 1464, 1422, 1319, 1156, 1093 cm-1;  HRMS 
(MM) calc’d for [M+H]+ 349.0772, found 349.0766. 
 
5-Bromo-N-Tosyltryptamine 167g: Reaction run on 7.99 mmol 
(1.91 g) scale. The crude material was purified by silica gel 
chromatography (gradient elution, 10-60% EtOAc in Hexane) to afford 167g as a white 
amorphous solid (2.63g, 6.69 mmol, 84% yield). 1H NMR (CDCl3, 500 MHz) δ 8.17 (s, 
1H), 7.68 – 7.65 (m, 1H), 7.63 – 7.59 (m, 2H), 7.41 (dd, J = 8.5, 1.6 Hz, 1H), 7.23 (dd, J 
= 8.5, 0.6 Hz, 2H), 7.12 (dd, J = 8.5, 0.4 Hz, 1H), 6.95 (d, J = 2.3 Hz, 1H), 4.48 (t, J = 
6.0 Hz, 1H), 3.23 (q, J = 6.5 Hz, 2H), 2.85 (t, J = 6.6 Hz, 2H), 2.41 (s, 3H);  13C NMR 
(CDCl3, 126 MHz) δ 143.5, 136.4, 135.4, 130.5, 129.7, 129.4, 127.3, 126.9, 123.5, 113.3, 
110.9, 82.9, 42.8, 25.2, 21.6;  FTIR (NaCl, thin film): 3376, 3290, 2922, 2864, 1598, 
1460, 1420, 1320, 1157, 1093 cm-1; HRMS (MM) calc’d for [M+H]+ 393.0267, found 
393.0260. 
5-Iodo-N-tosyltryptamine 167h: To a 50-mL Schlenk tube was 
charged 5-bromo-N-tosyltryptamine 167g (858 mg, 2.18 mmol, 1.00 
equiv), CuI (42.0 mg, 0.220 mmol, 0.10 equiv), and NaI (654 mg, 4.36 
mmol, 2.00 equiv). The vessel was then evacuated and backfilled with N2 three times, 
and N,N’-dimethylethylene diamine (47 µL, 0.44 mmol, 0.20 equiv) and 1,4-dioxane (2.2 
mL) added. The vessel was then sealed and heated to 100 °C for 23 hours, then cooled to 
room temperature, and quenched with concentrated aqueous NH4OH (10 mL), then 
diluted with H2O (30 mL). The mixture was then extracted with CH2Cl2 (3 x 30 mL), the 
organic layers combined, dried over anhydrous Na2SO4, filtered, and concentrated in 
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vacuo. Flash chromatography (gradient elution, 10-60% EtOAc in Hexanes) afforded 5-
iodo-N-tosyltryptamine as a white solid (900 mg, 2.04 mmol, 94% yield). 1H NMR 
(CDCl3, 500 MHz) δ 8.27 (s, 1H), 7.63 – 7.57 (m, 2H), 7.44 (d, J = 1.8 Hz, 1H), 7.24 – 
7.17 (m, 4H), 6.96 (d, J = 2.4 Hz, 1H), 4.62 (t, J = 6.0 Hz, 1H), 3.22 (q, J = 6.6 Hz, 2H), 
2.83 (t, J = 6.6 Hz, 2H), 2.40 (s, 3H).  13C NMR (CDCl3, 126 MHz) δ 143.5, 136.3, 
134.9, 129.7, 128.5, 126.9, 124.9, 124.0, 120.9, 112.8, 112.6, 111.0, 42.7, 25.1, 21.5;  
FTIR (NaCl, thin film): 3391, 3290, 2928, 2854, 1598, 1456, 1417, 1319, 1288, 1157, 
1093 cm-1;  HRMS (MM) calc’d for [M+H]+ 441.0128, found 441.0130. 
 
5-Methoxy-N-Tosyltryptamine 167i: Prepared according to 
General Procedure A.   Reaction run on 5.94 mmol (1.13 g) scale. 
The crude material was purified by silica gel chromatography (gradient elution, 10-60% 
EtOAc in Hexane) to afford 167i as a white amorphous solid (1.68g, 4.88 mmol, 82 % 
yield). 1H NMR (CDCl3, 500 MHz) δ 7.98 (s, 1H), 7.64 – 7.58 (m, 2H), 7.24 (dd, J = 8.7, 
0.5 Hz, 1H), 7.20 (d, J = 7.9 Hz, 2H), 6.95 (d, J = 2.3 Hz, 1H), 6.87 – 6.81 (m, 2H), 4.45 
(t, J = 6.0 Hz, 1H), 3.80 (s, 3H), 3.25 (q, J = 6.5 Hz, 2H), 2.91 (t, J = 6.6 Hz, 2H), 2.40 (s, 
3H); 13C NMR (CDCl3, 126 MHz) δ 154.0, 143.3, 136.6, 131.6, 129.6, 127.2, 127.0, 
123.3, 112.5, 112.0, 111.2, 100.2, 55.8, 42.8, 25.4, 21.5; FTIR (NaCl, thin film): 3390, 
3285, 2928, 2824, 1486, 1459, 1437, 1319, 1215, 1156, 1092 cm-1; HRMS (MM) calc’d 
for [M+H]+ 345.1267, found 345.1266. 
 
 N-Tosyltryptamine 167j: Prepared according to General 
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Procedure A.   Reaction run on 10.90 mmol (2.61 g) scale. The crude material was 
purified by silica gel chromatography (gradient elution, 10-60% EtOAc in Hexane) to 
afford 167j as a white, amorphous solid (3.42g, 8.70 mmol, 80 % yield). 1H NMR 
(CDCl3, 500 MHz) δ 8.11 (s, 1H), 7.63 – 7.56 (m, 2H), 7.49 (dd, J = 1.7, 0.5 Hz, 1H), 
7.23 (d, J = 8.4 Hz, 1H), 7.21 – 7.18 (m, 2H), 7.13 (dd, J = 8.4, 1.7 Hz, 1H), 6.95 (d, J = 
2.4 Hz, 1H), 4.44 (t, J = 6.1 Hz, 1H), 3.24 (q, J = 6.5 Hz, 2H), 2.89 (t, J = 6.4 Hz, 2H), 
2.40 (s, 3H).  13C NMR (CDCl3, 126 MHz) δ 143.4, 137.1, 36.5, 129.6, 126.9, 125.8, 
123.2, 122.8, 119.7, 115.8, 114.2, 111.8, 42.9, 25.3, 21.5;  FTIR (NaCl, thin film): 3368, 
3270, 2933, 2864, 1457, 1399, 1319, 1156, 1092.  HRMS (MM) calc’d for [M+H]+ 
393.0267, found 393.0252. 
 
General procedure B – To a solution of N-tosyltryptamine (1.57 g, 5.00 mmol, 1.00 
equiv) in DMF (17 mL) at 20 °C was added NaH (60% dispersion in mineral oil, 0.700 g, 
17.5 mmol, 3.5 equiv) slowly, with vigorous stirring, and stirring continued at 20 °C. 
After 30 minutes, the solution was cooled to 0 °C in an ice bath, and the appropriate alkyl 
halide (5.00 mmol, 1.00 equiv) was added dropwise by syringe over three minutes. 
Stirring was continued at 0 °C for two hours, and the reaction allowed to warm to 20 °C 
and stirring continued for 13 hours. The reaction was then carefully quenched by the 
dropwise addition of saturated, aqueous ammonium chloride (10 mL), and the mixture 
diluted with EtOAc (100 mL), and washed with brine (2 x 50 mL). The organic layer was 
then dried over anhydrous Na2SO4, filtered, and concentrated in vacuo. Flash 
chromatography (SiO2) afforded N’-alkylated tryptamines as a white solid. 
 
Chapter 3 – Direct and Selective Copper-Catalyzed Arylation of Tryptamines and 
Tryptophans: Total Synthesis of (+)-Naseseazines A and B 
210 
 N-tosyl-N’-methyltryptamines 167k: Prepared according to General 
Procedure B.  Reaction run on 5.00 mmol (1.57 g) scale. The crude 
material was purified by silica gel chromatography (gradient elution, 20-40% EtOAc in 
Hexane) to afford 20k as a white, amorphous solid (1.18 g, 3.59 mmol, 72 % yield). 1H 
NMR (CDCl3, 500 MHz) δ  7.64 (d, J = 8.3 Hz, 2H), 7.40 (d, J = 7.9 Hz, 1H), 7.29 (d, J 
= 8.2 Hz, 1H), 7.25 – 7.19 (m, 3H), 7.05 (dd, J = 7.4, 7.4 Hz, 1H), 6.82 (s, 1H), 4.41 (t, J 
= 6.0 Hz, 1H), 3.73 (s, 3H), 3.26 (q, J = 6.5 Hz, 2H), 2.92 (t, J = 6.6 Hz, 2H), 2.41 (s, 
3H).  13C NMR (CDCl3, 126 MHz) δ  143.1, 143.1, 137.0, 136.8, 129.6, 129.5, 129.5, 
129.5, 129.5, 129.5, 127.3, 127.2, 126.9, 121.7, 118.9, 118.9, 118.5, 109.9, 109.9, 109.3, 
109.3, 43.2, 43.2, 32.6, 32.5, 25.3, 25.3, 21.5, 21.4, 14.1;  FTIR (NaCl, thin film):3292, 
3051, 2929, 1616, 1473, 1325, 1158, 1093 cm-1;  HRMS (MM) calc’d for [M+H]+ 
329.1318, found 329.1314. 
 
 N-tosyl-N’-benzyltryptamines: Prepared according to General 
Procedure B.   Reaction run on 5.00 mmol (1.57 g) scale. The crude 
material was purified by silica gel chromatography (gradient elution, 
20-30% EtOAc in Hexane) to afford 167l as a white, amorphous solid (1.52 g, 3.76 
mmol, 75 % yield). 1H NMR (CDCl3, 500 MHz) δ  7.62 (d, J = 8.3 Hz, 2H), 7.41 (d, J = 
7.9 Hz, 1H), 7.33 – 7.22 (m, 4H), 7.21 – 7.13 (m, 3H), 7.12 – 7.07 (m, 2H), 7.06 – 7.01 
(m, 1H), 6.85 (s, 1H), 5.23 (s, 2H), 4.44 (t, J = 6.1 Hz, 1H), 3.27 (q, J = 6.6 Hz, 2H), 2.91 
(t, J = 6.7 Hz, 2H), 2.38 (s, 3H); 13C NMR (CDCl3, 126 MHz) δ  143.2, 137.3, 136.8, 
136.8, 129.6, 128.8, 127.7, 127.5, 127.0, 126.8, 126.5, 122.0, 119.3, 118.7, 110.7, 109.8, 
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49.9, 43.1, 25.5, 21.5; FTIR (NaCl, thin film): 3284, 3057, 3029, 2922, 1597, 1466, 1326, 
1159, 1094, 1076 cm-1; HRMS (MM) calc’d for [M+H]+ 405.1557, found 405.1630. 
 
3.11.4 Preparation of Diaryliodonium Tetrafluoroborates 
General Procedure C – To a solution of aryl iodide (1.00 equiv) in Ac2O (0.5 M) was 
added mCPBA (1.50 equiv).  After stirring 1 hour at 23 °C, the mixture was cooled to 0 
°C and mesitylene (1.10 equiv) was added followed by dropwise addition of HBF4 (50% 
aq solution, 2.00 equiv).  The reaction continued stirring at 0 °C for 30 minutes, followed 
by 6 hours at 23 °C.  The mixture was diluted with water, extracted with CH2Cl2, dried 
over MgSO4, filtered and concentrated in vacuo.  Crude reaction mixtures were dissolved 
in minimal CH2Cl2 and precipated with Et2O to yield fine, white powders.  The 
precipitate was filtered and dried overnight under high vacuum at 100 °C.   
 
 (2-Methylphenyl)(2,4,6-trimethylphenyl)iodonium tetrafluoroborate: Prepared 
according to General Procedure C.  Reaction run on 10.0 mmol (2.18 
g) scale. Trituration afforded the product as a white powder (3.0 g, 
7.1 mmol, 71 % yield). 1H NMR (500 MHz, DMSO) δ 7.96 (d, J = 7.8 Hz, 1H), 7.56 – 
7.54 (m, 2H), 7.29 – 7.23 (m, 1H), 7.21 (s, 2H), 2.56 (s, 6H), 2.56 (s, 3H), 2.29 (s, 3H).  
13C NMR (DMSO, 125 MHz) δ 143.5, 142.1, 141.2, 137.2, 132.9, 132.4, 130.4, 129.8, 
122.3, 119.1, 26.6, 24.9, 21.0.  FTIR (NaCl, thin film): 1587, 1558, 1457, 1382, 1301, 
1064, 1024.  HRMS (MM) calc’d for [M]+ 337.0448, found 337.0443. 
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(3-Methylphenyl)(2,4,6-trimethylphenyl)iodonium tetrafluoroborate: Prepared 
according to General Procedure C.  Reaction run on 10.0 mmol 
(2.18 g) scale. Trituration afforded the product as a white powder 
(3.9 g, 9.2 mmol, 92 % yield). 
1H NMR (500 MHz, DMSO) δ 7.85 (s, 1H), 7.76 (d, J = 8.0 Hz, 1H), 7.45 (d, J = 7.6 Hz, 
1H), 7.38 (t, J = 7.8 Hz, 1H), 7.22 (s, 2H), 2.60 (s, 6H), 2.32 (s, 3H), 2.29 (s, 3H);  13C 
NMR (DMSO, 126 MHz) δ 143.5, 142.45, 142.1, 135.1, 133.0, 132.2, 132.0, 130.3, 
122.9, 114.8, 26.8, 21.2, 21.0.  FTIR (NaCl, thin film): 2913, 1595, 1558, 1452, 1301, 
1063, 1024 cm-1;  HRMS (MM) calc’d for [M]+ 337.0448, found 337.0443. 
 
(4-Methylphenyl)(2,4,6-trimethylphenyl)iodonium tetrafluoroborate: Prepared 
according to General Procedure C.  Reaction run on 10.0 mmol 
(2.18 g) scale. Trituration afforded the product as a white powder 
(3.4 g, 8.2 mmol, 80 % yield). 
1H NMR (500 MHz, DMSO) δ 7.90 – 7.84 (m, 2H), 7.31 (dd, J = 8.5, 0.6 Hz, 2H), 7.20 
(s, 2H), 2.60 (s, 6H), 2.33 (s, 3H), 2.29 (s, 3H).  13C NMR (DMSO, 125 MHz) δ 143.5, 
142.7, 141.9, 135.0, 133.0, 130.2, 123.2, 111.4, 26.8, 21.7, 21.0.  FTIR (NaCl, thin film): 
1586, 1451, 1381, 1064, 1024.  HRMS (MM) calc’d for [M]+ 337.0448, found 447.0446. 
 
(4-Fluorophenyl)(2,4,6-trimethylphenyl)iodonium tetrafluoroborate: Prepared 
according to General Procedure C.  Reaction run on 10.0 mmol 
(2.22 g) scale. Trituration afforded the product as a white powder 
(1.7 g, 4.1 mmol, 40 % yield). 1H NMR (500 MHz, DMSO) δ 8.08 – 8.01 (m, 2H), 7.40 – 
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7.34 (m, 2H), 7.22 (s, 2H), 2.60 (s, 6H), 2.30 (s, 3H).  13C NMR (DMSO, 125 MHz) 
δ 164.2 (d, JC-F = 250.0 Hz), 143.7, 142.00, 137.8 (d, JC-F = 8.75 Hz), 130.3, 123.4, 119.7 
(d, JC-F = 22.5 Hz), 109.1, 26.8, 21.0; FTIR (NaCl, thin film): 1576, 1482, 1301, 1237, 
1165, 1064, 1024 cm-1; HRMS (MM) calc’d for [M–BF4]+ 341.0197, found 341.0188. 
 
(4-Chlorophenyl)(2,4,6-trimethylphenyl)iodonium tetrafluoroborate: Prepared 
according to General Procedure C.  Reaction run on 10.0 mmol 
(2.39 g) scale. Trituration afforded the product as a white powder 
(1.92 g, 4.3 mmol, 44 % yield). 1H NMR (500 MHz, DMSO) δ 7.99 – 7.93 (m, 2H), 7.60 
– 7.55 (m, 2H), 7.23 (d, J = 0.5 Hz, 2H), 2.59 (s, 6H), 2.30 (s, 3H);  13C NMR (DMSO, 
125 MHz) δ 143.7, 142.1, 137.5, 136.7, 132.3, 130.3, 123.3, 112.8, 26.77, 21.02;  FTIR 
(NaCl, thin film): 1469, 1380, 1301, 1064, 1027 cm-1;  HRMS (MM) calc’d for [M–BF4]+ 
356.9901, found 356.9895. 
 
(4-Bromophenyl)(2,4,6-trimethylphenyl)iodonium tetrafluoroborate: Prepared 
according to General Procedure C.  Reaction run on 10.0 mmol 
(2.83 g) scale. Trituration afforded the producct as a white powder 
(2.67 g, 5.5 mmol, 55 % yield). 1H NMR (500 MHz, DMSO) δ 7.91 – 7.86 (m, 2H), 7.73 
– 7.68 (m, 2H), 7.23 (d, J = 0.5 Hz, 2H), 2.59 (s, 6H), 2.30 (s, 3H).  13C NMR (DMSO, 
126 MHz) δ 143.8, 142.1, 136.8, 135.2, 130.3, 126.3, 123.2, 113.5, 26.8, 21.0;  FTIR 
(NaCl, thin film): 1085, 1469, 1388, 1303, 1064 1024 cm-1;  HRMS (MM) calc’d for [M–
BF4]+ 400.9396, found 400.9392. 
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(4-iodophenyl)(2,4,6-trimethylphenyl)iodonium tetrafluoroborate: Prepared 
according to General Procedure C.  Reaction run on 5.0 mmol (1.24 
g) scale. Trituration afforded the product as a white powder (1.59 g, 
3.0 mmol, 30 % yield). 1H NMR (500 MHz, DMSO) δ 7.88 – 7.82 (m, 2H), 7.73 – 7.69 
(m, 2H), 7.22 (s, 2H), 2.58 (s, 6H), 2.30 (s, 3H); 13C NMR (DMSO, 125 MHz) δ  143.71, 
142.06, 140.93, 136.50, 130.31, 123.13, 114.38, 100.25, 26.77, 21.02;  FTIR (NaCl, thin 
film): 1464, 1380, 1303, 1064, 1024, 984 cm-1;  HRMS (MM) calc’d for [M–BF4]+ 
448.9258, found 448.9248. 
 
(4-ethoxycarbonyl)(2,4,6-trimethylphenyl)iodonium tetrafluoroborate: Prepared 
according to General Procedure C.  Reaction run on 10.0 mmol 
(2.76 g) scale. Trituration afforded the product as a white 
powder (2.20 g, 4.6 mmol, 46 % yield). 
1H NMR (500 MHz, DMSO) δ 8.11 – 8.05 (m, 2H), 8.02 – 7.96 (m, 2H), 7.24 (d, J = 0.5 
Hz, 2H), 4.32 (q, J = 7.1 Hz, 2H), 2.59 (s, 6H), 2.30 (s, 3H), 1.30 (t, J = 7.1 Hz, 3H);  13C 
NMR (DMSO, 125 MHz) δ 165.03, 143.8, 142.2, 135.2, 133.1, 132.4, 130.4, 123.2, 
119.8, 62.0, 26.8, 21.0, 14.5;  FTIR (NaCl, thin film): 2984, 1719, 1583, 1449, 1395, 
1365, 1277, 1064, 1024 cm-1;  HRMS (MM) calc’d for [M–BF4]+ 395.0502, found 
395.0493. 
3.11.5 Preparation of N-Tosylpyrroloindolines 
General Procedure D – To a flame-dried flask was charged the appropriate N-
tosyltryptamine derivative (0.300 mmol, 1.0 equiv), the appropriate iodonium (0.330 
mmol, 1.1 equiv), Cu(OAc)2 or Cu(OTf)2 (0.030 mmol or 0.060 mmol, 0.10 equiv or 0.20 
I
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I
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mmol) and CH2Cl2 (3.0 mL). The reaction was stirred for the time indicated, at which 
point the reaction was diluted with CH2Cl2 (10 mL), and quenched with saturated aq. 
NaHCO3 (15 mL). The organic layer was separated and washed with additional NaHCO3 
(2 x 15 mL) and the resulting aqueous layers were then combined and back extracted 
with CH2Cl2 (15 mL). The organic layers were combined, dried over anhydrous Na2SO4, 
filtered, and concentrated in vacuo. The crude residue was purified by flash 
chromatography (SiO2 or basic alumina) to afford the N-tosylpyrroloindoline as a white 
or off-white solid. 
 
Pyrroloindoline 168a: Prepared according to General Procedure D using 10 mol% 
Cu(OAc)2 for 4 hours. Reaction run on 0.30 mmol (94 mg) scale. The 
crude material was purified on basic alumina (gradient elution, 40% 
THF in hexanes) to afford 168a as a white, amorphous solid (72.6 mg, 
0.19 mmol, 62 % yield). 
1H NMR (CDCl3, 500 MHz) δ 7.76 – 7.71 (m, 2H), 7.30 (dd, J = 8.5, 0.6 Hz, 2H), 7.25 – 
7.15 (m, 3H), 7.14 – 7.09 (m, 3H), 7.00 (ddd, J = 7.4, 1.1, 0.5 Hz, 1H), 6.80 – 6.74 (m, 
1H), 6.70 (dd, J = 7.8, 0.6 Hz, 1H), 5.43 (s, 1H), 4.91 (s, 1H), 3.65 (ddd, J = 10.6, 7.8, 
1.4 Hz, 1H), 3.25 (td, J = 11.0, 5.6 Hz, 1H), 2.48 (ddd, J = 12.4, 5.6, 1.0 Hz, 1H), 2.44 (s, 
3H), 2.34 (ddd, J = 12.4, 11.3, 7.9 Hz, 1H).  13C NMR (CDCl3, 126 MHz) δ 148.8, 143.6, 
143.0, 136.3, 131.4, 129.8, 128.8, 128.6, 127.0, 127.0, 125.7, 123.9, 119.6, 110.1, 85.6, 
61.8, 48.1, 37.3, 21.5.  FTIR (NaCl, thin film):  3366, 2978, 2878, 1610, 1595, 1491, 
1466, 1332, 1318, 1303, 1159, 1094.  HRMS (MM) calc’d for [M+H]+ 391.1475, found 
391.1473. 
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Pyrroloindoline 168a: Prepared according to General Procedure D using 10 mol% 
Cu(OAc)2 for 6 hours. Reaction run on 0.30 mmol (98.5 mg) scale. The 
crude material was purified on basic alumina (gradient elution, 40% THF 
in Hexane) to afford 168a as a white foam (99.4 mg, 0.25 mmol, 82 % 
yield). 
1H NMR (CDCl3, 500 MHz) δ  7.78 – 7.70 (m, 2H), 7.30 (dd, J = 8.5, 0.6 Hz, 2H), 7.24 – 
7.15 (m, 3H), 7.12 – 7.08 (m, 2H), 6.95 (dd, J = 6.5, 0.8 Hz, 1H), 6.89 – 6.82 (m, 1H), 
6.72 (dd, J = 7.4, 7.4 Hz, 1H), 5.47 (s, 1H), 4.70 (s, 1H), 3.67 (ddd, J = 10.5, 7.8, 1.5 Hz, 
1H), 3.24 (ddd, J = 10.9, 10.9, 5.6 Hz, 1H), 2.47 (ddd, J = 12.4, 5.6, 1.1 Hz, 1H), 2.44 (s, 
3H), 2.35 (ddd, J = 12.4, 11.2, 7.8 Hz, 1H), 2.16 (s, 3H).  13C NMR (CDCl3, 126 MHz) 
δ147.4, 143.6, 143.1, 136.5, 130.8, 129.8, 129.7, 128.6, 126.98, 126.94, 125.7, 121.4, 
119.7, 119.5, 85.5, 62.2, 48.2, 37.6, 21.5, 16.7.  FTIR (NaCl, thin film): 3351, 3059, 
2892, 1595, 1447, 1332, 1153, 1089.  HRMS (MM) calc’d for [M+H]+ 405.1631, found 
405.1629. 
 
Pyrroloindoline 168b: Prepared according to General Procedure D using 10 mol% 
Cu(OAc)2 for 6 hours.  Reaction run on 0.30 mmol (98.5 mg) scale. 
The crude material was purified on basic alumina (gradient elution, 
40% THF in Hexane) to afford 168b as a white, amorphous solid (76.6 
mg, 0.19 mmol, 63 % yield). 
1H NMR (CDCl3, 500 MHz) δ  7.73 (d, J = 8.3 Hz, 2H), 7.29 (d, J = 8.0 Hz, 2H), 7.25 – 
7.16 (m, 3H), 7.15 – 7.10 (m, 2H), 6.91 (dd, J = 7.9, 1.0 Hz, 1H), 6.79 (d, J = 0.4 Hz, 
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1H), 6.61 (d, J = 7.9 Hz, 1H), 5.41 (s, 1H), 3.64 (ddd, J = 10.5, 7.8, 1.3 Hz, 1H), 3.25 
(ddd, J = 11.0, 11.0, 5.6 Hz, 1H), 2.50 – 2.38 (m, 1H), 2.43 (s, 3H), 2.32 (ddd, J = 12.3, 
11.3, 7.9 Hz, 1H), 2.22 (s, 3H).  13C NMR (CDCl3, 126 MHz) δ 146.4, 143.5, 143.1, 
136.3, 131.7, 129.8, 129.2, 129.0, 128.6, 126.97, 126.95, 125.7, 124.4, 110.1, 85.9, 61.8, 
48.1, 37.1, 21.5, 20.9.  FTIR (NaCl, thin film): 3385, 2922, 1617, 1597, 1496, 1448, 
1340, 1159, 1093.  HRMS (MM) calc’d for [M+H]+ 405.1631, found 405.1644. 
 
 
Pyrroloindoline 168c: Prepared according to General Procedure D using 10 mol% 
Cu(OAc)2 for 6 hours. Reaction run on 0.30 mmol (98.5 mg) scale. 
The crude material was purified on basic alumina (gradient elution, 
40% THF in Hexane) to afford 168c as a white foam (61.0 mg, 0.15 
mmol, 50 % yield). 
1H NMR (CDCl3, 500 MHz) δ  7.77 – 7.70 (m, 2H), 7.30 (dd, J = 8.5, 0.6 Hz, 2H), 7.25 – 
7.14 (m, 3H), 7.13 – 7.07 (m, 2H), 6.88 (d, J = 7.6 Hz, 1H), 6.59 (ddd, J = 7.6, 1.4, 0.7 
Hz, 1H), 6.55 – 6.51 (m, 1H), 5.41 (s, 1H), 4.83 (s, 1H), 3.64 (ddd, J = 10.6, 7.8, 1.4 Hz, 
1H), 3.27 (ddd, J = 11.0, 11.0, 5.6 Hz, 1H), 2.49 – 2.41 (m, 1H), 2.44 (s, 3H), 2.31 (ddd, 
J = 7.9, 6.9, 5.7 Hz, 1H), 2.28 (s, 3H).  13C NMR (CDCl3, 126 MHz) δ 149.0, 143.6, 
143.2, 138.8, 136.4, 129.8, 128.6, 128.6, 127.0, 126.9, 125.7, 123.6, 120.4, 111.0, 85.9, 
61.6, 48.2, 37.3, 21.5, 21.5.  FTIR (NaCl, thin film): 3353, 2889, 1595, 1490, 1448, 1331, 
1307, 1159, 1119, 1092.  HRMS (MM) calc’d for [M+H]+ 405.1631, found 405.1609. 
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Pyrroloindoline 168d: Prepared according to General Procedure D using 10 mol% 
Cu(OAc)2 for 6 hours. Reaction run on 0.30 mmol (98.5 mg) scale. The 
crude material was purified on basic alumina (gradient elution, 40% 
THF in Hexane) to afford 168d as a white, crystalline solid (69.2 mg, 
0.17 mmol, 57% yield). 1H NMR (CDCl3, 500 MHz) δ  7.81 – 7.70 (m, 2H), 7.30 (d, J = 
7.9 Hz, 2H), 7.25 – 7.15 (m, 3H), 7.13 – 7.07 (m, 2H), 6.95 (d, J = 7.4 Hz, 1H), 6.86 (d, J 
= 7.1 Hz, 1H), 6.72 (dd, J = 7.4, 7.4 Hz, 1H), 5.47 (s, 1H), 4.70 (s, 1H), 3.67 (ddd, J = 
10.5, 7.8, 1.4 Hz, 1H), 3.24 (ddd, J = 10.9, 10.9, 5.6 Hz, 1H), 2.47 (ddd, J = 12.4, 5.6, 1.1 
Hz, 1H), 2.44 (s, 3H), 2.35 (ddd, J = 12.4, 11.2, 7.8 Hz, 1H), 2.16 (s, 3H); 13C NMR 
(CDCl3, 126 MHz) δ 147.4, 143.6, 143.1, 136.5, 130.8, 129.8, 129.7, 128.6, 127.0, 126.9, 
125.7, 121.4, 119.7, 119.5, 85.5, 62.2, 48.2, 37.6, 21.5, 16.7; FTIR (NaCl, thin film): 
3350, 2892, 1594, 1490, 1465, 1448, 1331, 1319, 1305, 1243, 1151, 1109, 1089 cm-1;  
HRMS (MM) calc’d for [M+H]+ 405.1631, found 405.1590. 
 
Pyrroloindoline 168e: Prepared according to General Procedure D using 10 mol% 
Cu(OAc)2 for 24 hours. Reaction run on 0.30 mmol (99.7 mg) scale. 
The crude material was purified on basic alumina (gradient elution, 40% 
THF in Hexane) to afford 168e as a white, crystalline solid (80.1 mg, 
0.20 mmol, 65 % yield). 1H NMR (CDCl3, 500 MHz) δ  7.73 (d, J = 8.3 Hz, 2H), 7.30 (d, 
J = 8.0 Hz, 2H), 7.26 – 7.17 (m, 3H), 7.15 – 7.08 (m, 2H), 6.82 (ddd, J = 8.9, 8.9, 2.6 Hz, 
1H), 6.71 (dd, J = 8.2, 2.6 Hz, 1H), 6.63 (dd, J = 8.5, 4.2 Hz, 1H), 5.43 (s, 1H), 3.65 
(ddd, J = 10.5, 7.8, 1.4 Hz, 1H), 3.27 (ddd, J = 10.9, 10.9, 5.7 Hz, 1H), 2.48 – 2.39 (m, 
1H), 2.44 (s, 3H), 2.33 (ddd, J = 12.5, 11.2, 7.9 Hz, 1H).  13C NMR (CDCl3, 126 MHz) δ 
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157.4 (d, JC-F = 235.0 Hz), 144.7, 143.7, 142.3, 136.1, 133.3 (d, JC-F = 7.5 Hz), 129.9, 
128.7, 127.3, 127.0, 125.6, 115.2 (d, JC-F = 22.5 Hz), 111.2 (d, JC-F = 23.8 Hz), 110.8 (d, 
JC-F = 7.5 Hz), 86.2, 62.0, 48.0, 37.0, 21.5.  FTIR (NaCl, thin film): 3365, 2891, 1996, 
1593, 1488, 1448, 1329, 1306, 1154, 1091.  HRMS (MM) calc’d for [M+H]+ 409.1381, 
found 409.1375. 
 
Pyrroloindoline 168f: Prepared according to General Procedure D 
using 10 mol% Cu(OAc)2 for 24 hours. Reaction run on 0.30 mmol 
(105 mg) scale. The crude material was purified on basic alumina 
(gradient elution, 40% THF in Hexane) to afford 168f as a white, crystalline solid (81.7 
mg, 0.19 mmol, 64 % yield). 
1H NMR (CDCl3, 500 MHz) δ  7.74 – 7.69 (m, 2H), 7.29 (dd, J = 8.5, 0.6 Hz, 2H), 7.27 – 
7.19 (m, 3H), 7.13 – 7.09 (m, 2H), 7.06 (dd, J = 8.3, 2.1 Hz, 1H), 6.93 (d, J = 2.1 Hz, 
1H), 6.62 (d, J = 8.3 Hz, 1H), 5.44 (s, 1H), 4.95 (s, 1H), 3.64 (ddd, J = 10.6, 7.8, 1.5 Hz, 
1H), 3.27 (ddd, J = 11.0, 11.0, 5.6 Hz, 1H), 2.50 – 2.40 (m, 1H), 2.43 (s, 3H), 2.33 (ddd, 
J = 12.5, 11.2, 7.9 Hz, 1H).  13C NMR (CDCl3, 126 MHz) δ 147.3, 143.8, 142.3, 136.1, 
133.6, 129.9, 128.8, 128.7, 127.3, 126.9, 125.5, 124.1, 111.0, 85.8, 61.8, 48.0, 37.0, 21.5.  
FTIR (NaCl, thin film): 3386, 3059, 2971, 1598, 1481, 1447, 1336, 1258, 1158, 1090 
1037.  HRMS (MM) calc’d for [M+H]+ 425.1085, found 425.1083. 
 
Pyrroloindoline 168g: Prepared according to General Procedure D using 10 mol% 
Cu(OAc)2 for 24 hours. Reaction run on 0.30 mmol (118.0 g) scale. 
The crude material was purified on basic alumina (gradient elution, 
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40% THF in Hexane) to afford 168g as a white, crystalline solid (82.1 mg, 0.18 mmol, 58 
% yield). 1H NMR (CDCl3, 500 MHz) δ  7.75 – 7.69 (m, 2H), 7.29 (dd, J = 8.5, 0.6 Hz, 
2H), 7.27 – 7.18 (m, 4H), 7.10 (dd, J = 8.1, 1.5 Hz, 2H), 7.06 (d, J = 2.0 Hz, 1H), 6.58 (d, 
J = 8.3 Hz, 1H), 5.43 (s, 1H), 4.96 (s, 1H), 3.64 (ddd, J = 10.7, 7.8, 1.5 Hz, 1H), 3.27 
(ddd, J = 11.0, 11.0, 5.6 Hz, 1H), 2.48 – 2.44 (m, 1H), 2.43 (s, 3H), 2.33 (ddd, J = 8.2, 
6.4, 4.8 Hz, 1H).  13C NMR (CDCl3, 126 MHz) 147.8, 143.8, 142.3, 136.1, 134.1, 131.5, 
129.9, 128.7, 127.3, 126.9, 126.9, 125.5, 111.5, 111.1, 85.7, 61.8, 48.0, 37.0, 21.5.  FTIR 
(NaCl, thin film): 3386, 3059, 2971, 1598, 1477, 1336, 1258, 1093, 1037.  HRMS (MM) 
calc’d for [M+H]+ 469.0580, found 469.0578. 
 
 
Pyrroloindoline 168h: Prepared according to General Procedure D using 10 mol% 
Cu(OAc)2 for 24 hours.  Reaction run on 0.30 mmol (132.1 mg) scale. 
The crude material was purified on basic alumina (gradient elution, 40% 
THF in Hexane) to afford 168h as a white, amorphous solid (92.6 mg, 
0.19 mmol, 62 % yield). 1H NMR (CDCl3, 500 MHz) δ  7.67 (d, J = 8.3 Hz, 2H), 7.33 
(dd, J = 8.2, 1.8 Hz, 1H), 7.25 (d, J = 7.9 Hz, 2H), 7.23 – 7.15 (m, 4H), 7.08 – 7.03 (m, 
2H), 6.45 (d, J = 8.3 Hz, 1H), 5.38 (d, J = 6.8 Hz, 1H), 4.93 (s, 1H), 3.59 (ddd, J = 10.6, 
7.8, 1.5 Hz, 1H), 3.23 (ddd, J = 10.9, 10.9, 5.6 Hz, 1H), 2.45 – 2.35 (m, 1H), 2.39 (s, 3H), 
2.28 (ddd, J = 12.5, 11.2, 7.8 Hz, 1H); 13C NMR (CDCl3, 126 MHz) δ 148.4, 143.6, 
142.4, 137.4, 136.1, 134.6, 132.6, 129.9, 128.7, 127.3, 126.9, 125.5, 112.2, 85.5, 80.3, 
61.6, 48.0, 37.0, 21.5.  FTIR (NaCl, thin film): 3385, 3057, 2968, 1597, 1476, 1446, 
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1420, 1334, 1260, 1159, 1093 cm -1; HRMS (MM) calc’d for [M+H]+ 517.0441, found 
517.0436. 
 
Pyrroloindoline 168i: Prepared according to General Procedure D using 10 mol% 
Cu(OAc)2 for 6 hours. Reaction run on 0.30 mmol (103.3 mg) scale. 
The crude material was purified on basic alumina (gradient elution, 
40% THF in Hexane) to afford 168i as a white, amorphous solid (72.6 
mg, 0.19 mmol, 62 % yield). 1H NMR (CDCl3, 500 MHz) δ  7.76 – 7.70 (m, 2H), 7.30 (d, 
J = 7.9 Hz, 2H), 7.25 – 7.15 (m, 3H), 7.15 – 7.08 (m, 2H), 6.69 (dd, J = 8.5, 2.5 Hz, 1H), 
6.64 (d, J = 8.4 Hz, 1H), 6.60 (d, J = 2.5 Hz, 1H), 5.40 (s, 1H), 4.71 (s, 1H), 3.71 (s, 3H), 
3.65 (ddd, J = 10.5, 7.8, 1.3 Hz, 1H), 3.25 (ddd, J = 11.0, 11.0, 5.6 Hz, 1H), 2.49 – 2.44 
(m, 1H), 2.43 (s, 3H), 2.32 (ddd, J = 12.4, 11.3, 7.9 Hz, 1H); 13C NMR (CDCl3, 126 
MHz) 153.9, 143.6, 142.7, 142.6, 136.3, 133.0, 129.8, 128.6, 127.1, 127.0, 125.7, 113.6, 
110.8, 110.6, 86.3, 62.1, 55.8, 48.1, 37.0, 21.5; FTIR (NaCl, thin film): 3380, 3057, 3025, 
2947, 2832, 1598, 1492, 1336, 1159, 1093, 1035; HRMS (MM) calc’d for [M+H]+ 
421.1580, found 421.1577. 
 
Pyrroloindoline 168k: Prepared according to General Procedure D using 10 mol% 
Cu(OAc)2 for 24 hours. Reaction run on 0.30 mmol (98.5 mg) scale. The 
crude material was purified on basic alumina (gradient elution, 20 – 25% 
THF in Hexane) to afford 168k as a white, solid (65.1 mg, 0.16 mmol, 
54% yield). 1H NMR (CDCl3, 500 MHz) δ  7.71 – 7.65 (m, 2H), 7.23 (d, J = 8.0 Hz, 2H), 
7.20 – 7.17 (m, 3H), 7.17 – 7.13 (m, 1H), 6.96 – 6.89 (m, 2H), 6.85 (dd, J = 7.3, 1.1 Hz, 
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1H), 6.67 (ddd, J = 7.4, 7.4, 0.8 Hz, 1H), 6.50 (d, J = 7.9 Hz, 1H), 5.53 (s, 1H), 3.76 
(ddd, J = 12.1, 7.0, 1.0 Hz, 1H), 3.13 (ddd, J = 11.9, 11.9, 5.2 Hz, 1H), 3.06 (s, 3H), 2.44 
(s, 3H), 2.21 (ddd, J = 12.2, 5.0, 1.2 Hz, 1H), 2.05 (ddd, J = 12.0, 12.0, 7.1 Hz, 1H); 13C 
NMR (CDCl3, 126 MHz) 150.5, 143.6, 143.0, 136.5, 132.2, 129.7, 128.8, 128.4, 127.2, 
126.7, 125.9, 123.62, 117.8, 106.2, 91.9, 61.1, 48.8, 38.0, 31.2, 21.5; FTIR (NaCl, thin 
film): 3056, 3027, 2949, 2891, 2827, 1762, 1605, 1491, 1347, 1160, 1092, 1022 cm-1;  
HRMS (MM) calc’d for [M+H]+ 405.1631, found 405.1600. 
 
Pyrroloindoline 168l: Prepared according to General Procedure D using 
10 mol% Cu(OAc)2 for 24 hours. Reaction run on 0.30 mmol (121 mg) 
scale. The crude material was purified on basic alumina (gradient elution, 
20 – 25% THF in Hexane) to afford 168l as a white foam (83.4 mg, 0.17 mmol, 58% 
yield). 1H NMR (CDCl3, 500 MHz) δ 7.64 – 7.52 (m, 2H), 7.41 – 7.36 (m, 2H), 7.36 – 
7.30 (m, 2H), 7.29 – 7.24 (m, 1H), 7.19 – 7.12 (m, 5H), 7.09 – 7.02 (m, 1H), 6.89 – 6.81 
(m, 3H), 6.64 (ddd, J = 7.4, 7.4, 0.9 Hz, 1H), 6.42 (d, J = 7.8 Hz, 1H), 5.69 (s, 1H), 4.89 
(d, J = 16.4 Hz, 1H), 4.63 (d, J = 16.4 Hz, 1H), 3.82 (dd, J = 12.5, 6.8 Hz, 1H), 3.25 
(ddd, J = 12.2, 12.2, 5.1 Hz, 1H), 2.41 (s, 3H), 2.24 (dd, J = 11.9, 4.7 Hz, 1H), 2.06 (ddd, 
J = 12.1, 12.1, 7.2 Hz, 1H);  13C NMR (CDCl3, 126 MHz) δ 149.7, 143.6, 143.5, 138.5, 
136.4, 132.2, 129.7, 128.7, 128.4, 128.4, 127.3, 127.2, 126.9, 126.7, 125.8, 123.9, 117.9, 
106.5, 90.7, 61.3, 48.5, 48.1, 38.2, 21.5;  FTIR (NaCl, thin film): 3062, 3027, 2898, 1604, 
1493, 1346, 1158, 1089 cm-1;  HRMS (MM) calc’d for [M+H]+ 481.1944, found 
481.1947. 
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Pyrroloindoline 168a: Prepared according to General Procedure D using 20 mol% 
Cu(OTf)2 for 12 hours.  Reaction run on 0.30 mmol (94 mg) scale with 
the symmetric di-o-tolyliodonium tetrafluoroborate. The crude material 
was purified by silica gel chromatography (gradient elution, 20% EtOAc 
in Hexane) to afford 168a as a white, amorphous solid (60.6 mg, 0.15 mmol, 50 % yield). 
1H NMR (CDCl3, 500 MHz) δ 7.69 – 7.63 (m, 2H), 7.20 (d, J = 7.9 Hz, 2H), 7.14 – 7.04 
(m, 4H), 7.03 – 6.98 (m, 1H), 6.92 (dd, J = 7.4, 0.8 Hz, 1H), 6.76 (ddd, J = 7.4, 7.4, 1.0 
Hz, 1H), 6.65 (d, J = 7.8 Hz, 1H), 5.67 (s, 1H), 4.94 (s, 1H), 3.59 (ddd, J = 10.1, 7.7, 4.0 
Hz, 1H), 3.36 (ddd, J = 10.1, 8.6, 6.6 Hz, 1H), 2.69 (ddd, J = 12.9, 7.9, 7.9 Hz, 1H), 2.40 
(s, 3H), 2.39 – 2.34 (m, 1H), 2.03 (s, 3H);  13C NMR (CDCl3, 126 MHz) δ 148.4, 143.5, 
139.4, 136.4, 135.6, 132.6, 131.9, 129.6, 128.5, 127.2, 127.1, 127.0, 125.7, 124.3, 119.2, 
109.4, 84.4, 62.1, 47.4, 37.9, 21.4, 20.8;  FTIR (NaCl, thin film): 3390, 3057, 2975, 2883, 
1606, 1485, 1338, 1158 cm-1;  HRMS (MM) calc’d for [M+H]+ 405.1631, found 
405.1633. 
 
Pyrroloindoline 168b: Prepared according to General Procedure D using 20 mol % 
Cu(OTf)2 for 12 hours.  Reaction run on 0.30 mmol (94 mg) scale. The 
crude material was purified by silica gel chromatography (gradient 
elution, 20% EtOAc in Hexane) to afford 168b as a white, amorphous 
solid (90.0 mg, 0.22 mmol, 74 % yield). 1H NMR (CDCl3, 500 MHz) 
δ 7.76 – 7.71 (m, 2H), 7.30 (dd, J = 8.5, 0.6 Hz, 2H), 7.11 (ddd, J = 7.7, 7.7, 1.3 Hz, 1H), 
7.04 (dd, J = 4.7, 4.0 Hz, 2H), 6.99 (ddd, J = 3.8, 3.8, 1.6 Hz, 3H), 6.77 (ddd, J = 7.4, 1.0 
Hz, 1H), 6.70 (d, J = 7.8 Hz, 1H), 5.39 (s, 1H), 3.64 (ddd, J = 10.6, 7.8, 1.4 Hz, 1H), 3.25 
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(ddd, J = 10.9, 10.9, 5.6 Hz, 1H), 2.51 – 2.40 (m, 1H), 2.44 (s, 3H), 2.37 – 2.29 (m, 1H), 
2.28 (s, 3H); 13C NMR (CDCl3, 126 MHz) δ 148.7, 143.6, 140.0, 136.7, 136.31, 131.6, 
129.8, 129.2, 128.7, 127.0, 125.6, 123.8, 120.0, 110.1, 85.7, 61.5, 48.1, 37.3, 21.5, 20.9;  
FTIR (NaCl, thin film):  3395, 3052, 3022, 2913, 1607, 1465, 1336, 1159, 1094, 1035 
cm-1; HRMS (MM) calc’d for [M+H]+ 405.1631, found 405.1624. 
 
Pyrroloindoline 168c: Prepared according to General Procedure D using 20 mol % 
Cu(OTf)2 for 4 hours. Reaction run on 0.30 mmol (94 mg) scale. The 
crude material was purified by silica gel chromatography (gradient 
elution, 6:3:1 Hexanes:CH2Cl2:Acetone) to afford 168c as a white foam 
(88.1 mg, 0.21 mmol, 70 % yield). 1H NMR (CDCl3, 500 MHz) δ 7.75 – 
7.70 (m, 2H), 7.30 (dd, J = 8.5, 0.6 Hz, 2H), 7.11 (ddd, J = 7.9, 7.4, 1.3 Hz, 1H), 7.04 – 
6.96 (m, 3H), 6.80 – 6.72 (m, 3H), 6.71 – 6.67 (m, 1H), 5.36 (s, 1H), 4.89 (br s, 1H), 3.74 
(s, 3H), 3.63 (ddd, J = 10.6, 7.8, 1.5 Hz, 1H), 3.23 (td, J = 10.9, 5.6 Hz, 1H), 2.47 – 2.40 
(m, 1H), 3.2.44 (s, 3H) 2.32 (ddd, J = 12.4, 11.2, 7.8 Hz, 1H); 13C NMR (CDCl3, 126 
MHz) δ 158.5, 148.77, 143.6, 136.3, 135.0, 131.7, 129.8, 128.7, 127.0, 126.8, 123.8, 
119.6, 113.9, 110.1, 85.8, 61.2, 55.2, 48.2, 37.3, 21.5; FTIR (NaCl, thin film):  3390, 
3047, 2953, 2834, 1608, 1512, 1483, 1466, 1336, 1251, 1183, 1159, 1094 cm-1; HRMS 
(MM) calc’d for [M+H]+ 421.1580, found 421.1580. 
 
Pyrroloindoline 168d: Prepared according to General Procedure D using 20 mol % 
Cu(OTf)2 for 12 hours. Reaction run on 0.30 mmol (94 mg) scale. The 
crude material was purified on basic alumina (gradient elution, 40% THF 
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in Hexane) to afford 168d as a white, amorphous solid (86.5 mg, 0.20 mmol, 68 % yield). 
1H NMR (CDCl3, 500 MHz) δ  7.76 – 7.69 (m, 2H), 7.30 (dd, J = 8.5, 0.6 Hz, 2H), 7.21 – 
7.15 (m, 2H), 7.15 – 7.09 (m, 1H), 7.06 – 7.00 (m, 2H), 6.95 (ddd, J = 7.4, 1.2, 0.5 Hz, 
1H), 6.77 (ddd, J = 7.4, 7.4, 1.0 Hz, 1H), 6.70 (dd, J = 4.5, 4.0 Hz, 1H), 5.37 (s, 1H), 4.91 
(br s, 1H), 3.65 (ddd, J = 10.7, 7.8, 1.5 Hz, 1H), 3.24 (ddd, J = 11.0, 11.0, 5.6 Hz, 1H), 
2.51 – 2.40 (m, 1H), 2.44 (s, 3H), 2.28 (ddd, J = 12.4, 11.2, 7.8 Hz, 1H); 13C NMR 
(CDCl3, 126 MHz) δ 148.7, 143.7, 141.5, 136.2, 132.9, 131.0, 129.9, 129.0, 128.7, 127.1, 
126.9, 123.7, 119.7, 110.2, 85.6, 61.3, 48.1, 37.1, 21.5;  FTIR (NaCl, thin film): 3386, 
3051, 2970, 2893, 1607, 1493, 1466, 1483, 1399, 1336, 1159, 1093 cm-1;  HRMS (MM) 
calc’d for [M+H]+ 425.1085, found 425.1077. 
 
Pyrroloindoline 168e: Prepared according to General Procedure D using 20 mol % 
Cu(OTf)2 for 12 hours. Reaction run on 0.30 mmol (94 mg) scale. The 
crude material was purified by silica gel chromatography (gradient 
elution, 20% EtOAc in Hexane) to afford 168e as a white, amorphous 
solid (75.2 mg, 0.19 mmol, 63% yield). 1H NMR (CDCl3, 500 MHz) δ 7.77 – 7.72 (m, 
2H), 7.31 (d, J = 7.9 Hz, 2H), 7.14 – 7.08 (m, 2H), 7.02 – 6.97 (m, 2H), 6.92 – 6.86 (m, 
2H), 6.77 (ddd, J = 7.4, 7.4, 1.0 Hz, 1H), 6.70 (d, J = 7.8 Hz, 1H), 5.42 (s, 1H), 3.66 
(ddd, J = 10.6, 7.8, 1.4 Hz, 1H), 3.25 (ddd, J = 11.0, 11.0, 5.6 Hz, 1H), 2.49 – 2.45 (m, 
1H), 2.44 (s, 3H), 2.32 (ddd, J = 12.5, 11.4, 7.9 Hz, 1H), 2.25 (s, 3H); 13C NMR (CDCl3, 
126 MHz) δ 148.8, 143.6, 143.0, 138.2, 136.4, 131.4, 129.9, 128.7, 128.4, 127.8, 127.0, 
126.3, 124.0, 122.8, 119.6, 110.1, 85.7, 61.8, 48.2, 37.6, 21.5, 21.5;  FTIR (NaCl, thin 
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film): 3390, 2047, 2970, 1607, 1483, 1466, 1340, 1159, 1094 cm-1; HRMS (MM) calc’d 
for [M+H]+ 405.1631, found 405.1626. 
 
Pyrroloindoline 168f: Prepared according to General Procedure D using 20 mol % 
Cu(OTf)2 for 12 hours. Reaction run on 0.30 mmol (94 mg) scale. The 
crude material was purified on basic alumina (gradient elution, 40% THF 
in Hexane) to afford 168f as a white, amorphous solid (80.3 mg, 0.20 
mmol, 66 % yield). 1H NMR (CDCl3, 500 MHz) δ  7.77 – 7.70 (m, 2H), 
7.30 (dd, J = 8.5, 0.6 Hz, 2H), 7.16 – 7.09 (m, 1H), 7.09 – 7.04 (m, 2H), 6.97 (ddd, J = 
7.4, 1.2, 0.5 Hz, 1H), 6.93 – 6.86 (m, 2H), 6.78 (ddd, J = 7.4, 7.4, 1.0 Hz, 1H), 6.70 (d, J 
= 7.8 Hz, 1H), 5.38 (s, 1H), 3.66 (ddd, J = 10.6, 7.8, 1.4 Hz, 1H), 3.24 (ddd, J = 11.0, 
11.0, 5.6 Hz, 1H), 2.49 – 2.42 (m, 1H), 2.44 (s, 3H), 2.30 (ddd, J = 12.4, 11.2, 7.8 Hz, 
1H); 13C NMR (CDCl3, 126 MHz) δ 161.6 (d, JC-F = 245.0 Hz), 148.7, 143.7, 138.7, 
138.7, 136.2, 131.3, 129.8, 128.9, 127.3 (d, JC-F = 7.5 Hz), 126.9, 123.7, 119.7, 115.3 (d, 
JC-F = 20.0 Hz), 110.2, 109.9, 85.7, 61.2, 48.1, 37.3, 21.5;  FTIR (NaCl, thin film): 3391, 
3051, 2970, 2892, 1607, 1510, 1483, 1466, 1400, 1336, 1233, 1160, 1095 cm-1; HRMS 
(MM) calc’d for [M+H]+ 409.1381, found 409.1363. 
 
Pyrroloindoline 168g: Prepared according to General Procedure D using 20 mol % 
Cu(OTf)2 for 12 hours. Reaction run on 0.30 mmol (94 mg) scale. 
Reaction run on 0.30 mmol (94 mg) scale. The crude material was 
purified on basic alumina (gradient elution, 40% THF in Hexane) to 
afford 168g as a white, amorphous solid (83.4 mg, 0.19 mmol, 59 % 
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yield). 1H NMR (CDCl3, 500 MHz) δ  7.76 – 7.69 (m, 2H), 7.36 – 7.28 (m, 4H), 7.12 
(ddd, J = 7.7, 7.7, 1.2 Hz, 1H), 7.00 – 6.92 (m, 3H), 6.77 (ddd, J = 7.4, 7.4, 1.0 Hz, 1H), 
6.70 (d, J = 7.8 Hz, 1H), 5.37 (s, 1H), 4.91 (s, 1H), 3.65 (ddd, J = 10.7, 7.8, 1.4 Hz, 1H), 
3.24 (ddd, J = 10.9, 10.9, 5.6 Hz, 1H), 2.49 – 2.40 (m, 1H), 2.44 (s, 3H), 2.27 (ddd, J = 
12.4, 11.2, 7.9 Hz, 1H); 13C NMR (CDCl3, 126 MHz) δ 148.6, 143.7, 142.0, 136.1, 131.6, 
130.9, 129.9, 129.0, 127.5, 126.9, 123.71, 121.0, 119.7, 110.2, 85.5, 61.4, 48.1, 37.0, 
21.5;  FTIR (NaCl, thin film): 3391, 3051, 2970, 2892, 1608, 1597, 1484, 1466, 1396, 
1336, 1159, 1095 cm-1;  HRMS (MM) calc’d for [M+H]+ 469.0580, found 469.0553. 
 
 
 Pyrroloindoline 168h: Prepared according to General Procedure D using 20 mol % 
Cu(OTf)2 for 12 hours. Reaction run on 0.30 mmol (94 mg) scale. The 
crude material was purified on basic alumina (gradient elution, 40% THF 
in Hexanes) to afford 168h as a white, amorphous solid (95.8 mg, 0.19 
mmol, 62 % yield). 1H NMR (CDCl3, 500 MHz) δ 7.75 – 7.69 (m, 2H), 7.55 – 7.51 (m, 
2H), 7.30 (d, J = 7.9 Hz, 2H), 7.12 (ddd, J = 7.7, 7.7, 1.2 Hz, 1H), 6.96 – 6.92 (m, 1H), 
6.88 – 6.83 (m, 2H), 6.76 (ddd, J = 7.4, 7.4, 1.0 Hz, 1H), 6.70 (d, J = 7.8 Hz, 1H), 5.35 
(s, 1H), 3.64 (ddd, J = 10.7, 7.8, 1.4 Hz, 1H), 3.24 (ddd, J = 11.0, 11.0, 5.6 Hz, 1H), 2.49 
– 2.39 (m, 1H), 2.44 (s, 3H), 2.26 (ddd, J = 12.4, 11.2, 7.9 Hz, 1H); 13C NMR (CDCl3, 
126 MHz) δ 148.7, 143.8, 142.8, 137.6, 136.2, 130.9, 129.9, 129.0, 127.7, 126.9, 123.7, 
119.8, 110.3, 92.5, 85.5, 61.5, 48.1, 36.9, 21.6;  FTIR (NaCl, thin film):  3390, 3047, 
2948, 2878, 1612, 1486, 1336, 1158, 1005 cm-1;  HRMS (MM) calc’d for [M+H]+ 
517.0441, found 517.0424. 
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Pyrroloindoline 168i: Prepared according to General Procedure D using 20 mol % 
Cu(OTf)2 for 12 hours. Reaction run on 0.30 mmol (94.0 mg) scale. The 
crude material was purified by silica gel chromatography (gradient 
elution, 6:3:1 Hexanes:DCM:Acetone) to afford 168i as a colorless oil 
(78.2 mg, 0.17 mmol, 56 % yield). 1H NMR (CDCl3, 500 MHz) δ  7.91 – 
7.85 (m, 2H), 7.75 – 7.69 (m, 2H), 7.29 (dd, J = 8.5, 0.6 Hz, 2H), 7.21 – 7.15 (m, 2H), 
7.14 – 7.08 (m, 1H), 6.96 (ddd, J = 7.4, 1.2, 0.5 Hz, 1H), 6.76 (ddd, J = 7.5, 7.5, 1.0 Hz, 
1H), 6.71 (dd, J = 7.2, 0.7 Hz, 1H), 5.43 (s, 1H), 4.92 (s, 1H), 4.34 (q, J = 7.1 Hz, 2H), 
3.66 (ddd, J = 10.7, 7.8, 1.4 Hz, 1H), 3.26 (ddd, J = 11.0, 11.0, 5.6 Hz, 1H), 2.49 (ddd, J 
= 12.3, 5.5, 1.0 Hz, 1H), 2.43 (s, 3H), 2.31 (ddd, J = 12.4, 11.3, 7.9 Hz, 1H), 1.36 (t, J = 
7.1 Hz, 3H); 13C NMR (CDCl3, 126 MHz) δ 166.1, 148.7, 148.0, 143.8, 136.2, 130.9, 
129.9, 129.9, 129.7, 129.0, 126.9, 125.63, 123.8, 119.7, 110.2, 85.4, 61.8, 60.9, 48.1, 
37.1, 21.5, 14.3; FTIR (NaCl, thin film): 3387, 3052, 2979, 2895, 1713, 1610, 1483, 
1467, 1343, 1278, 1160, 1110 cm-1. HRMS (MM) calc’d for [M+H]+ 463.1686, found 
463.1666. 
3.11.6 Catalyst Efficiency and Scalability 
 
To a flame-dried, 100 mL flask was charged N-tosyltryptamine (3.15 g, 10.0 mmol, 1.0 
equiv), Ph2IBF4 (4.04 g, 11.0 mmol, 1.1 equiv) and Cu(OAc)2 (45.4 mg, 0.25 mmol, 
0.025 equiv).  The dissolved in 50 mL CH2Cl2  and allowed to stir at room temperature 
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H
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for 12 hours at which point the reaction was diluted with CH2Cl2 (100 mL), washed with 
saturated aqueous NaHCO3 (2 x 50 mL) and the resulting aqueous layers were then 
combined and back extracted with CH2Cl2 (50 mL). The organic layers were combined, 
dried over anhydrous Na2SO4, filtered, and concentrated in vacuo.  The resultant yellow 
solid was dissolved in 50 mL CH2Cl2, 100 mL Et2O and 200 mL hexanes to afford a light 
yellow powder.  The powder was filtered and dried under vacuum to give 168a (2.55g, 
6.5 mmol, 65% yield). 
3.11.7 Preparation of Diimine Ligands 
 α-Diimine ligands were prepared following literature precedent by Bercaw et al. 
MesDABMe (L7) and tBuDABMe (L6) were readily prepared on greater than 40 gram scale 
in comparable yields to those reported in the literature. Ligands were thoroughly dried 
under high-vacuum (< 1.0 mTorr) at 50 °C for 4 hours prior to use and stored in a 
glovebox under inert atmosphere. 
 
3.11.8 Preparation of Diketopiperazine Substrates 
The preparation of diketopiperazines 175a-f have been previously prepared in the 
literature. Diketopiperazine substrates 175d and 175e were prepared according to known 
literature procedures. Improved yields were obtained for substrates 175a-175c using an 
analogous procedure as reported by Movassaghi et al. 
 
General Procedure (I) for the Synthesis of Diketopiperazine Substrates: 
 To a solution of L-tryptophan methyl ester hydrochloride (1.0 equiv) in CH2Cl2 
(0.1 M) at 0 °C was added Et3N (4.5 equiv) dropwise.  HOBt•H2O (1.5 equiv) and Boc-
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amino acid (2.0 equiv) were sequentially added and stirred vigorously.  Once 
homogenous, EDC•HCl (1.5 equiv) was added in a single portion and the solution 
allowed to warm to 23 °C.  The reaction was stirred for 15 hours, at which time it was 
quenched by the addition of 1N HCl, and the aqueous layer extracted with CH2Cl2 (2 x). 
The combined organics were then washed with saturated aqueous NaHCO3, and the 
aqueous layer back extracted with CH2Cl2 (2 x). The organics were pooled, then dried 
over Na2SO4, filtered, and concentrated in vacuo. The resulting oil/foam was 
subsequently dissolved in CH2Cl2 (0.2 M), and cooled to 0 °C. TFA (1.5 mL/5 mL 
CH2Cl2) was added dropwise, then the solution was warmed to 23 °C and stirred for 2 h. 
The mixture was concentrated in vacuo and the resulting viscous residue dissolved in 
methanol (0.25 M), and cooled to 0°C. Ammonium hydroxide (28–30% in H2O, 1 mL/ 6 
mL MeOH) was then added dropwise and the reaction mixture allowed to warm to 23 °C 
and stirred for 24 h. The resulting suspension was cooled to 0 °C, and the fine white 
precipitate was filtered and rinsed with cold methanol.  The white solid is then crushed 
and dried under high vacuum (< 1 mTorr) at 50 °C for a minimum of 2 h.  
 
Cyclo-(L)-Trp-(L)-Phe (175a) 
 Prepared from L-tryptophan methyl ester hydrochloride 
following General Procedure I on 19.6 mmol scale. The crude reaction 
mixture was filtered to yield 5.8 g (89% yield) of 175a as a white solid.  Spectral data 
matches that reported in the literature. 
 
Cyclo-(L)-Trp-(L)-Ala (175b) 
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 Prepared from L-tryptophan methyl ester hydrochloride 
following General Procedure I on 9.8 mmol scale.  The crude reaction 
mixture was filtered to yield 2.3 g (92% yield) of 175b as a white solid.  Spectral data 
matches that reported in the literature. 
 
Cyclo-(L)-Trp-(D)-Ala (175c) 
 Prepared from L-tryptophan methyl ester hydrochloride 
following General Procedure I on 7.9 mmol scale.  The crude reaction 
mixture was filtered to yield 1.8 g (89% yield) of 175c as a white solid.  Spectral data 
matches that reported in the literature. 
Large Scale Preparation of Cyclo-(L)-Trp-(L)-Pro (175f): 
 
 To a solution of L-proline methyl ester hydrochloride (11.0 g, 
66.6 mmol, 1.00 equiv) in CH2Cl2 (700 mL) at 0 °C was added 
triethylamine (32.5 mL, 233 mmol, 3.50 equiv) dropwise by addition funnel. N-
hydroxybenzotriazole monohydrate (15.3, 100 mmol, 1.50 equiv) and Boc-(L)-
tryptophan (31.8 g, 100 mmol, 1.50 equiv) were then added successively. After 10 
minutes, EDC•HCl (19.2 g, 100 mmol, 1.50 equiv) was added in a single portion and the 
mixture allowed to warm to 23 °C over 2.0 hours. After 20 hours, the solution was 
quenched by the addition of 1N HCl (1.0 L), and the aqueous layer extracted with CH2Cl2 
(2 x 150 mL). The combined organics were then washed with saturated aqueous NaHCO3 
(1.0 L), and the aqueous layer back extracted with CH2Cl2 (200 mL). The combined 
organics were then dried over anhydrous sodium sulfate, filtered, and concentrated in 
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vacuo. The resulting white foam was then dissolved in CH2Cl2 (200 mL), and 
trifluoroacetic acid (60 mL) added dropwise by addition funnel. After 2 h, the solution 
was concentrated in vacuo and the viscous residue dissolved in methanol (900 mL) and 
cooled to 0 °C. Ammonium hydroxide (28 to 30% in H2O, 35.0 mL) was added dropwise 
by addition funnel. The solution was then stirred for 14 hours, concentrated in vacuo, and 
redissolved in CH2Cl2 (1.0 L). The solution was next washed with H2O (3 x 500 mL), and 
the aqueous layer back extracted with CH2Cl2 (250 mL). The organic layers were then 
dried over anhydrous Na2SO4, filtered, and concentrated in vacuo. The residue was 
dissolved in MeOH (200 mL) and the solution cooled to 0 °C. After 20 minutes, the 
resulting white precipitate was collected. The filtrate was then concentrated to 100 mL 
and recooled to 0 °C, and a second crop of precipitate collected. The process was 
repeated a third time to collect a third crop of product. The resulting precipitates were 
combined, powdered, and dried under high vacuum at 50 °C for 12 hours to afford 
analytically pure cyclo-L-Pro-L-Trp as a white solid (12.4 g, 43.8 mmol, 66% yield).  
Spectral data matches that reported in the literature. 
 
Preparation of Trifluoroacetyltryptophan methyl carboxamide (7): 
To (L)-Tryptophan methyl ester hydrochloride (5.84 g, 22.9 mmol) was 
added methylamine (33% solution in EtOH, 50 mL). The mixture was 
stirred for 48 h at 20 °C, then concentrated in vacuo, and the mixture co-evaporated with 
CH2Cl2 (50 mL), then Et2O (3 x 100 mL), sequentially to afford a white solid. The solid 
was then suspended in anhydrous CH2Cl2 (250 mL), and Et3N (9.6 mL, 68.7 mmol, 3.0 
equiv) added dropwise by syringe at 20 °C. The resulting mixture was then cooled to 0 
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°C, and TFAA (3.23 mL, 22.9 mmol, 1.00 equiv) added dropwise by syringe. After 24 
hours, the reaction was quenched with 1N HCl (200 mL), extracted with CH2Cl2 (200 
mL), dried over Na2SO4, filtered and concentrated.  The residue was then dissolved in 
EtOAc (250 mL), and filtered through a short plug of silica gel, and the filter cake 
washed with additional EtOAc (250 mL). The filtrate was then concentrated, and the 
resulting yellow solid was treated with Et2O/pentane to afford 7 as a white, amorphous 
powder (2.97 g, 42% yield). 1H NMR (500 MHz, DMSO-d6) 10.82 (d, J = 0.9 Hz, 1H), 
9.61 (d, J = 8.2 Hz, 1H), 8.21 (q, J = 4.3 Hz, 1H), 7.65 (d, J = 7.9 Hz, 1H), 7.33 (d, J = 
8.1 Hz, 1H), 7.13 (d, J = 2.3 Hz, 1H), 7.10 – 7.04 (m, 1H), 6.99 (ddd, J = 7.9, 7.1, 1.0 Hz, 
1H), 4.52 (ddd, J = 9.9, 8.5, 4.8 Hz, 1H), 3.20 (dd, J = 14.6, 4.6 Hz, 1H), 3.08 (dd, J = 
14.6, 10.0 Hz, 1H), 2.62 (d, J = 4.6 Hz, 3H); 13C NMR (126 MHz, DMSO-d6) 170.3, 
156.2 (q, JC-F = 36.4 Hz), 136.1, 127.1, 123.7, 121.0, 118.4, 118.3, 115.8 (q, JC-F = 288.2 
Hz), 111.4, 109.7, 54.3, 27.2, 25.7; FTIR (NaCl, thin film): 3277, 1700, 1696, 1653, 
1636, 1560, 1347, 1185; [α]D25 = +8.53 (c = 0.44, CHCl3); LRMS (EI+) calc’d [M+H]+ 
314.1, found 314.1. 
 
3.11.9 Preparation of Diaryliodonium Triflate Salts  
The following diaryliodonium salts were prepared following known procedures: 
diphenyliodonium tetrafluoroborate, diphenyliodonium hexafluoroarsentate, 
diphenyliodonium triflate, bis-p-tolyliodonium triflate,   and bis-p-methoxyiodonium 
triflate. Diphenyliodonium hexafluorophosphate was purchased from Alfa-Aesar. m-
CPBA (Sigma-Aldrich, <77%) was dried under high vacuum (< 1 mTorr) at 23 °C for 4 
hours as reported by Oloffson and coworkers. 
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Preparation of 2-iodo-p-xylene diacetate (SI-1): 
 
To a solution of 2-iodo-1,4-dimethylbenzene (11.6 g, 50.0 mmol, 1.00 equiv) 
in AcOH (1.0 L) at 50 °C was added NaBO3•4H2O (84.7 mmol, 0.55 mmol, 
11.0 equiv) portion wise over 30 minutes. The solution was vigorously stirred at 50 °C 
for 5 hours, then cooled to ambient temperature and diluted with H2O (500 mL) and 
extracted with CH2Cl2 (3 x 500 mL). The combined organics were then washed with 
water (3 x 500 mL), dried over anhydrous sodium sulfate, filtered, and concentrated in 
vacuo. The crude residue was suspended in a minimum of Et2O, then triturated with 
hexanes and the precipitate collected by vacuum filtration. 2-Iodo-p-xylene diacetate was 
obtained as a white, crystalline solid (14.0 g, 40.0 mmol, 80% yield). Spectral data 
obtained match that previously reported, 1H and 13C NMR data is reported for 
convenience. 1H NMR (500 MHz, CDCl3) δ 7.97 (d, J = 1.2 Hz, 1H), 7.37 (d, J = 7.8 Hz, 
1H), 7.30 (dd, J = 7.8, 1.2 Hz, 1H), 2.65 (s, 3H), 2.36 (s, 3H), 1.97 (s, 6H); 13C NMR 
(126 MHz, CDCl3): δ 176.3, 138.5, 137.3, 137.3, 133.5, 130.4, 126.8, 24.9, 20.6, 20.2. 
 
General Procedure II 
To a solution of iodoarene in CH2Cl2 (0.25 M) was added mCPBA (1.1 equiv), and BF-
3•OEt2 (2.5 equiv). The solution was stirred for 45 minutes, then the solution cooled to 0 
°C in a dry ice corresponding aryl boronic acid (1.00 equiv) added a solid in a single 
portion. The solution was stirred for 15 minutes, then warmed to room temperature and 
stirring continued for 45 minutes. The solution was then recooled to 0 °C and TfOH (2.00 
I
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equiv) added dropwise via syringe. The solution was stirred for 5 minutes at 0 °C, then 
warmed to room temperature and concentrated under reduced pressure. The resulting 
solution was then filtered through a plug of silica gel, eluting with 5% MeOH/CH2Cl2, 
the filtrate concentrated, and the residue triturated from Et2O to afford pure 
diaryliodonium triflate, typically as a white, crystalline solid. 
 
General Procedure III 
To a solution of aryl boronic acid (1.00 equiv) in CH2Cl2 (0.25 M) at 0 °C was added 
BF3•OEt2 (1.1 equiv) dropwise by syringe. The solution was stirred for 15 minutes, then a 
solution of iodoxylene diacetate (1.00 equiv) in CH2Cl2 (0.5 M) added dropwise by 
cannula transfer over 15 minutes. The solution was slowly warmed to 23 °C over 1 h, 
then recooled to 0 °C and TfOH (2.00 equiv) added dropwise via syringe. The solution 
was stirred for 5 minutes at 0 °C, then warmed to room temperature and concentrated 
under reduced pressure. The resulting solution was then filtered through a plug of silica 
gel, eluting with 5 % MeOH/CH2Cl2, the filtrate concentrated, and the residue triturated 
from Et2O to afford pure diaryliodonium triflate salt, typically as a white, crystalline 
solid. 
 
Di-(3-tolyl)iodonium triflate (SI-2) 
 Prepared by General Procedure II from 3-methylphenyl boronic acid 
and 3-methyliodobenzene on 5.00 mmol scale. Trituration from Et2O 
afforded the product as a white, crystalline solid (1.54 g, 3.36 mmol, 67% yield). 1H 
NMR (500 MHz, DMSO-d6) δ 8.10 (td, J = 1.8, 0.9 Hz, 2H), 8.04 (ddt, J = 7.9, 1.8, 0.9 
I
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Hz, 2H), 7.48 (ddt, J = 7.7, 1.8, 1.0 Hz, 2H), 7.41 (t, J = 7.8 Hz, 2H), 2.34 (d, J = 0.8 Hz, 
6H); 13C NMR (126 MHz, DMSO-d6) δ 142.3, 135.78, 133.2, 132.7, 131.9, 116.6, 21.2; 
FTIR (NaCl, thin film): 3744, 3675, 1596, 1259, 1172, 1036, 1026 cm-1; LRMS (EI+) 
calc’d [M–OTf]+ 309.1, found 309.0. 
 
Di-(3,5-dimethylphenyl)iodonium triflate (SI-3) 
Prepared by General Procedure II from 3,5-dimethyliodobenzene and 
3,5-dimethylphenylboronic acid on 10.0 mmol scale. Trituration from 
Et2O afforded the product as a white, crystalline solid (3.72 g, 7.65 mmol, 77% yield). 1H 
NMR (500 MHz, DMSO-d6) δ 7.88 (dt, J = 1.5, 0.8 Hz, 4H), 7.30 (tt, J = 1.5, 0.8 Hz, 
2H), 2.30 (d, J = 0.9 Hz, 12H); 13C NMR (500 MHz, DMSO-d6): δ 141.9, 133.9, 132.9, 
116.2, 21.1; FTIR (NaCl, thin film):  1599, 1558, 1451, 1381, 1243, 1221, 1171, 1154, 
1026 cm-1; LRMS (EI+) calc’d [M–OTf]+ 337.2, found 337.2. 
 
(2-naphthyl)(p-xylyl)iodonium triflate (SI-4) 
Prepared by General Procedure III from 2-naphthyl boronic acid on 5.00 
mmol scale. Trituration from Et2O afforded the product as a white, 
crystalline solid (2.15 g, 4.23 mmol, 85% yield). 1H NMR (500 MHz, DMSO-d6) δ 8.93 
(d, J = 1.9 Hz, 1H), 8.29 (dd, J = 1.7, 0.9 Hz, 1H), 8.18 (dd, J = 8.8, 1.9 Hz, 1H), 8.10 – 
7.99 (m, 4H), 7.73 – 7.66 (m, 2H), 7.43 (d, J = 7.8 Hz, 1H), 7.38 (ddd, J = 7.7, 1.7, 0.8 
Hz, 1H), 2.61 (s, 3H), 2.31 (s, 3H); 13C NMR (500 MHz, DMSO-d6): δ 139.6, 137.9, 
137.6, 136.5, 134.4, 133.9, 133.8, 132.00, 131.5, 130.6, 129.4, 128.6, 128.6, 128.4, 121.6, 
IMe Me
Me Me
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113.0, 25.0, 20.5; FTIR (NaCl, thin film):  3670, 3588, 1653, 1635, 1490, 1347, 1259, 
1172, 1036, 1024 cm-1; LRMS (EI+) calc’d [M–OTf]+ 359.0, found 359.0. 
 
(3-bromophenyl)(p-xylyl)iodonium triflate (SI-5) 
Prepared by General Procedure III from 3-bromophenyl boronic acid on 
5.00 mmol scale. Trituration from Et2O afforded the product as a white, 
crystalline solid (1.33 g, 2.48 mmol, 50% yield). 1H NMR (500 MHz, DMSO-d6) δ 8.53 
(dd, J = 1.8, 1.8 Hz, 1H), 8.28 (dd, J = 1.8, 0.9 Hz, 1H), 8.18 (ddd, J = 8.0, 1.8, 0.9 Hz, 
1H), 7.85 (ddd, J = 8.1, 1.9, 0.9 Hz, 1H), 7.51 - 7.42 (m, 2H), 7.44 - 7.38 (m, 1H), 2.57 
(s, 3H), 2.32 (s, 3H); 13C NMR (500 MHz, DMSO-d6): δ 139.2, 137.5, 137.1, 136.7, 
134.9, 133.9, 133.6, 133.5, 131.1, 123.3, 121.2, 116.1, 24.5, 20.0; FTIR (NaCl, thin film):  
3074, 1569, 1554, 1490, 1456, 1275, 1242, 1170, 1025 cm-1; LRMS (EI+) calc’d [M–
OTf]+ 388.1, found 388.9. 
3.11.10 Optimization of Reaction Parameters for Diastereoselective 
Arylation  
Optimization Procedure – In a glovebox, (CuOTf)2•PhMe (20.7 mg, 0.040 mmol), and 
ligand (0.088 mmol) were dissolved in anhydrous CH2Cl2 (4.0 mL). The solution was 
stirred vigorously for 1.0 hr, filtered through a plug of cotton and removed from the 
glovebox. A portion of the solution (1.00 mL, 0.020 mmol, 20 mol % in Cu) was added 
to an oven-dried, 1-dram vial containing diketopiperazine (0.100 mmol) and 
diaryliodonium salt (0.110 mmol). The solution was stirred at 23 °C (care was taken not 
to exceed 25 °C) for 24 hrs, then quenched by the addition of concentrated ammonia (28–
30% in H2O, 1.0 mL). After 5 minutes, the mixture was diluted with EtOAc (30 mL) and 
I
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washed with a mixture water (20 mL) and brine (20 mL). The aqueous layer was then 
back extracted with EtOAc (2 x 10 mL) and the combined organics dried over anhydrous 
MgSO4, filtered, and concentrated in vacuo to afford a solid residue. 
The residue was then dissolved in a standard solution of maleic acid in DMSO-d6, and the 
solution analyzed for yield, C3:C2 ratio, and dr. NMR yields were obtained via careful 
integration against the standard. 
 
Preparation of minor diastereomer 177 
To an oven dried vial was added diketopiperazine 175a (33 mgs, 0.1 
mmol), diaryliodonium hexafluorophosphate (47 mgs, 0.11 mmol) and 
(CuOTf)2•PhMe (5.2 mgs, 0.01 mmol).  The solids were dissolved in 1 
mL CH2Cl2 and the reaction was allowed to stir for 24 hours, then quenched by the 
addition of 1 mL NH4OH.  The mixture was diluted with EtOAc and extracted with 
EtOAc (2 X 10 mL).  The organic layers were combined, dried over Na2SO4, filtered and 
concentrated. The minor diastereomer was purified from the crude residue by silica gel 
chromatography (50% hexanes, 47.5% ethyl acetate, 2.5% methanol) to afford 177 as a 
white solid.  1H NMR (500 MHz, CDCl3) 7.30 – 7.27 (m, 2H), 7.26 – 7.22 (m, 3H), 7.22 
– 7.16 (m, 3H), 7.15 – 7.09 (m, 2H), 7.04 (ddd, J = 7.7, 7.7, 1.3 Hz, 1H), 6.88 – 6.83 (m, 
1H), 6.67 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 6.61 (d, J = 7.8 Hz, 1H), 5.77 (s, 1H), 5.69 (d, J 
= 9.3 Hz, 1H), 4.40 – 4.32 (m, 1H), 4.16 (ddd, J = 10.5, 3.8, 1.3 Hz, 1H), 3.51 (dd, J = 
14.5, 3.8 Hz, 1H), 3.15 (dd, J = 13.7, 7.3 Hz, 1H), 2.69 (ddd, J = 16.6, 14.1, 10.2 Hz, 
2H); 13C NMR (126 MHz, CDCl3) 168.8, 166.8, 147.2, 142.3, 135.6, 133.3, 129.2, 128.9, 
128.8, 128.6, 127.5, 127.3, 126.5, 124.1, 119.6, 109.6, 85.5, 59.2, 58.6, 56.1, 38.6, 36.2; 
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FTIR (NaCl, thin film): 3306, 3058, 2929, 1674, 1607, 1482, 1447, 1318, 1223, 1071 cm-
1; [α]D25 = –329 (c = 0.31, CHCl3); LRMS (EI+) calc’d for [M+H]+ 410.2, found 410.2. 
3.11.11 Substrate Scope for Diastereoselective Arylation – 
Characterization Data 
General Procedure IV:  Tryptophan Arylation 
Catalyst Preparation – In a glovebox, copper(I)trifluoromethanesulfonate toluene 
complex (0.10 equiv) and alpha-diimine-ligand (0.22 equiv) were dissolved in anhydrous 
CH2Cl2 (0.1 M in Cu). The solution was vigorously stirred for 1.0 hour, and then filtered 
through a plug of cotton.1 The solution was then removed from the glovebox for 
immediate use. 
 
Arylation Reaction – A flame-dried flask containing a magnetic stirbar was charged with 
tryptophan substrate (0.300 mmol, 1.00 equiv) and diaryliodonium salt (0.330 mmol, 1.1 
equiv), then equipped with a rubber septum. To the solids was added the freshly-prepared 
Cu-catalyst solution prepared above (3.00 mL, 0.030 mmol, 20 mol %) and the solution 
vigorously stirred at 20 °C. After the time indicated below, the solution was quenched 
with aqueous ammonia (3.00 mL of a 27-33% solution in H2O) and stirred for 5 minutes. 
The reaction was then diluted with EtOAc (30 mL) and washed with a mixture of H2O 
(30 mL) and brine (30 mL). The aqueous portion was back extracted with EtOAc (2 x 10 
mL) and the combined organics dried over anhydrous MgSO4, filtered, and concentrated 
in vacuo. The crude residue was purified by column chromatography on silica gel to 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 Filtering the catalyst solution was found to improve the overall selectivity, reactivity, and reproducibility of the 
reaction.  
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afford pure arylpyrroloindoline product, typically as either a white, amorphous powder or 
a white foam. 
 
Pyrroloindoline 176a 
Prepared following General Procedure IV using MesDABMe and 
diphenyliodonium triflate.  The crude residue was purified by silica gel 
chromatography (50% hexanes, 47.5% ethyl acetate, 2.5% methanol) to afford 176a as a 
white solid (104.0 mg, 0.254 mmol, 85% yield). 1H NMR (500 MHz, CDCl3) δ 7.38 – 
7.31 (m, 6H), 7.28 (ddd, J = 5.1, 2.3, 2.3 Hz, 2H), 7.20 (d, J = 7.0 Hz, 2H), 7.12 (ddd, J = 
7.7, 7.7, 1.2 Hz, 1H), 6.97 – 6.89 (m, 1H), 6.75 (dd, J = 7.5, 7.5 Hz, 1H), 6.69 (d, J = 7.9 
Hz, 1H), 5.85 (s, 1H), 5.60 (s, 1H), 4.44 (dd, J = 8.4, 8.4 Hz, 1H), 4.24 (ddd, J = 10.7, 
3.7, 1.1 Hz, 1H), 3.61 (dd, J = 14.5, 3.7 Hz, 1H), 3.23 (dd, J = 13.7, 7.4 Hz, 1H), 2.77 
(ddd, J = 13.6, 10.2, 2.2 Hz, 2H); 13C NMR (126 MHz, CDCl3) δ 168.8, 166.8, 147.1, 
142.3, 135.6, 133.3, 129.3, 128.9, 128.9, 128.7, 127.6, 127.6, 126.5, 124.2, 119.7, 109.7, 
85.5, 59.3, 58.7, 56.2, 38.6, 36.3; FTIR (NaCl, thin film): 3315, 3087, 3052, 3027, 2928, 
2849, 1676, 1605, 1498, 1407, 1348, 1306, 1261, 1221 cm-1; [α]D25 = +113 (c = 1.8, 
CHCl3); LRMS (EI+) calc’d [M+H]+ 410.2, found 410.2.  
 
Pyrroloindoline 176b 
Prepared following General Procedure IV using MesDABMe and 
diphenyliodonium triflate for 24 h. Reaction was run with additional 
CH2Cl2 (3.00 mL) for solubility. The crude residue was purified by silica 
gel chromatography (20% hexanes : 77.5% ethyl acetate: 2.5% methanol) to afford 176b 
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as a white solid (66.2 mg, 0.199 mmol, 66% yield). 1H NMR (500 MHz, CDCl3) δ 7.40 – 
7.32 (m, 4H), 7.32 – 7.26 (m, 1H), 7.09 (dd, J = 7.7, 7.7 Hz, 1H), 6.94 (d, J = 7.5 Hz, 
1H), 6.74 (d, J = 7.5, 7.5 Hz, 1H), 6.65 (d, J = 7.8 Hz, 1H), 5.82 (d, J = 8.3 Hz, 1H), 5.79 
(s, 1H), 4.48 (dd, J = 8.3, 8.3 Hz, 1H), 4.15 – 4.05 (m, 1H), 3.21 (dd, J = 13.8, 7.6 Hz, 
1H), 2.84 (dd, J = 13.8, 9.3 Hz, 1H), 1.46 (d, J = 6.8 Hz, 3H); 13C NMR (126 MHz, 
CDCl3) δ 169.3, 167.9, 147.2, 142.3, 133.2, 128.9, 128.7, 127.4, 126.5, 124.2, 119.7, 
109.8, 85.5, 59.4, 59.0, 51.3, 38.3, 15.7; FTIR (NaCl, thin film): 3255, 2928, 2849, 1669, 
1653, 1486, 1419, 1219 cm-1; [α]D25 = +158 (c = 0.85, CHCl3); LRMS (EI+) calc’d for 
[M+H]+ 334.2, found 334.1. 
 
Pyrroloindoline 176c 
Prepared following General Procedure IV using MesDABMe and 
diphenyliodonium triflate for 24 h. Reaction was run with additional 
CH2Cl2 (3.00 mL) for solubility. The crude residue was purified by silica gel 
chromatography (77.5% ethyl acetate, 20% hexanes, 2.5% methanol) to afford 5c as a 
white solid (49.5 mg, 0.149 mmol, 50% yield). 1H NMR (500 MHz, CDCl3) δ 7.40 – 7.32 
(m, 4H), 7.31 – 7.26 (m, 1H), 7.09 (ddd, J = 7.6, 7.6, 1.0 Hz, 1H), 7.01 (d, J = 3.8 Hz, 
1H), 6.88 (dd, J = 7.4, 0.5 Hz, 1H), 6.72 (dd, J = 7.4, 7.4 Hz, 1H), 6.65 (d, J = 7.9 Hz, 
1H), 5.84 (d, J = 3.0 Hz, 1H), 5.54 (d, J = 3.0 Hz, 1H), 4.43 (dd, J = 10.6, 7.0 Hz, 1H), 
4.01 (qd, J = 7.2, 4.2 Hz, 1H), 3.29 (dd, J = 13.7, 7.0 Hz, 1H), 2.65 (dd, J = 13.7, 10.7 
Hz, 1H), 1.46 (d, J = 7.2 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 168.8, 167.9, 147.1, 
142.2, 133.6, 128.9, 128.7, 127.3, 126.7, 124.0, 119.5, 109.6, 86.0, 58.8, 57.2, 53.6, 39.4, 
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19.8; FTIR (NaCl, thin film): 3275, 3042, 2913, 1684, 1652, 1437, 1308, 1266, 1221 cm-
1; [α]D25 = +119 (c = 1.1, CHCl3); LRMS (EI+) calc’d for [M+H]+ 334.2, found 334.1 
 
Pyrroloindoline 176d 
Prepared following General Procedure IV using MesDABMe and 
diphenyliodonium triflate for 24 h. Reaction was run with additional 
CH2Cl2 (3.00 mL) for solubility.  The crude residue was purified by silica 
gel chromatography (77.5% ethyl acetate, 20% hexane, 2.5% methanol) to afford 176d as 
a white solid (61.5 mg, 0.193 mmol, 64% yield). 
1H NMR (500 MHz, CDCl3) δ 7.39 – 7.30 (m, 4H), 7.29 – 7.26 (m, 1H), 7.09 (ddd, J = 
7.7, 7.7, 1.3 Hz, 1H), 6.96 – 6.90 (m, 1H), 6.86 (d, J = 4.2 Hz, 1H), 6.73 (ddd, J = 7.5, 
7.5, 1.0 Hz, 1H), 6.65 (d, J = 7.8 Hz, 1H), 5.81 (s, 1H), 4.43 (dd, J = 8.5, 8.5 Hz, 1H), 
4.02 (dd, J = 17.0, 1.6 Hz, 1H), 3.85 (dd, J = 17.0, 4.6 Hz, 1H), 3.23 (dd, J = 13.7, 7.4 
Hz, 1H), 2.77 (dd, J = 13.8, 9.8 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 169.4, 165.2, 
147.1, 142.3, 133.3, 128.9, 128.7, 127.3, 126.5, 124.2, 119.7, 109.8, 85.4, 59.2, 58.0, 
46.7, 38.7; FTIR (NaCl, thin film): 3280, 3047, 2928, 2854, 1674, 1602, 1483, 1441, 
1310, 1263, 1219, 1155 cm-1; [α]D25 = +80.2 (c = 0.59, CHCl3); LRMS (EI+) calc’d for 
[M+H]+ 320.1, found 320.1. 
 
Pyrroloindoline 176e 
Prepared following General Procedure IV using MesDABMe and diphenyliodonium triflate 
for 24 h. The crude residue was purified by silica gel chromatography (20% hexanes, 
N
H
N NH
O
O
H
H
Chapter 3 – Direct and Selective Copper-Catalyzed Arylation of Tryptamines and 
Tryptophans: Total Synthesis of (+)-Naseseazines A and B 
243 
77.5% ethyl acetate, 2.5% methanol) to afford 176e as a white solid (55.5 mg, 0b.154 
mmol, 51% yield). 
1H NMR (500 MHz, CDCl3) δ 7.39 – 7.31 (m, 4H), 7.30 – 7.26 (m, 
1H), 7.11 – 7.06 (m, 1H), 6.96 – 6.92 (m, 1H), 6.73 (ddd, J = 7.5, 7.5, 
1.0 Hz, 1H), 6.66 – 6.62 (m, 1H), 5.87 (s, 1H), 5.80 (d, J = 2.6 Hz, 1H), 
5.44 (d, J = 2.4 Hz, 1H), 4.47 – 4.39 (m, 1H), 3.91 – 3.87 (m, 1H), 3.23 (dd, J = 13.7, 7.4 
Hz, 1H), 2.79 (dd, J = 13.7, 9.7 Hz, 1H), 2.60 (heptd, J = 7.1, 2.6 Hz, 1H), 1.05 (d, J = 
7.2 Hz, 3H), 0.87 (d, J = 6.8 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 169.4, 166.7, 
147.3, 142.4, 133.3, 128.9, 128.6, 127.3, 126.5, 124.3, 119.6, 109.5, 85.5, 60.4, 59.1, 
58.2, 38.8, 28.4, 19.3, 16.0; FTIR (NaCl, thin film): 3292, 2964, 1669, 1609, 1483, 1465, 
1419, 1347, 1291, 1222 cm-1; [α]D25 = +107 (c = 0.52, CHCl3); LRMS (EI+) calc’d for 
[M+H]+ 362.2, found 362.2. 
 
Pyrroloindoline 176f 
Prepared following General Procedure IV using 40 mol % t-BuDABMe 
and diphenyliodonium hexafluorophosphate for 4 h. The crude residue 
was purified by silica gel chromatography (77.5% ethyl acetate, 20% 
hexanes, 2.5% methanol) to afford 176f as a white solid (76.6 mg, 0.213 mmol, 71% 
yield). 
1H NMR (500 MHz, CDCl3) δ 7.38 - 7.34 (m, 4H), 7.31 - 7.27 (m, 1H), 7.08 (ddd, J = 
7.9, 7.5, 1.3 Hz, 1H), 6.91 (ddd, J = 7.5, 1.3, 0.6 Hz, 1H), 6.73 (ddd, J = 7.5, 7.5, 1.0 Hz, 
1H), 6.67 - 6.61 (m, 1H), 5.83 (s, 1H), 5.36 (s, 1H), 4.55 - 4.48 (m, 1H), 4.14 (ddd, J = 
9.1, 7.3, 1.6 Hz, 1H), 3.54 - 3.46 (m, 2H), 3.21 (dd, J = 13.9, 7.4 Hz, 1H), 2.81 (dd, J = 
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13.9, 9.8 Hz, 1H), 2.31 (dddd, J = 12.8, 7.0, 7.0, 3.4 Hz, 1H), 2.17 (dddd, J = 12.9, 10.7, 
9.2, 7.2 Hz, 1H), 2.07 - 1.96 (m, 1H), 1.90 (dddd, J = 14.9, 6.8, 4.0, 1.9 Hz, 1H); 13C 
NMR (126 MHz, CDCl3) δ 167.9, 165.7, 147.0, 142.3, 133.6, 128.8, 128.8, 128.6, 127.3, 
126.7, 124.1, 119.7, 109.7, 85.3, 60.5, 60.3, 59.9, 45.2, 38.1, 27.6, 23.2; FTIR (NaCl, thin 
film): 3330, 2952, 2878, 1665, 1607, 1484, 1467, 1423, 1340, 1313, 1219, 1154, 1068 
cm-1; [α]D25 = +108 (c = 0.63, CHCl3); LRMS (EI+) calc’d for [M+H]+ 360.2, found 
360.2. 
 
Pyrroloindoline 176g 
Prepared following General Procedure IV using MesDABMe and di(p-
tolyl)iodonium triflate for 32 h. The crude residue was purified by silica 
gel chromatography (50% hexanes, 47.5% ethyl acetate, 2.5% 
methanol) to afford 176g as a white solid (98.2 mg, 0.232 mmol, 77% 
yield). 1H NMR (500 MHz, CDCl3) δ 7.37 – 7.31 (m, 2H), 7.28 (ddd, J = 4.7, 1.9, 1.9 Hz, 
1H), 7.24 – 7.18 (m, 4H), 7.16 (d, J = 8.0 Hz, 2H), 7.11 (ddd, J = 7.7, 7.7, 1.3 Hz, 1H), 
6.93 – 6.89 (m, 1H), 6.74 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 6.67 (d, J = 7.8 Hz, 1H), 5.84 
(d, J = 2.9 Hz, 1H), 5.56 (s, 1H), 5.43 (d, J = 2.8 Hz, 1H), 4.48 – 4.38 (m, 1H), 4.23 (ddd, 
J = 10.8, 3.7, 1.3 Hz, 1H), 3.61 (dd, J = 14.5, 3.7 Hz, 1H), 3.21 (dd, J = 13.7, 7.3 Hz, 
1H), 2.74 (ddd, J = 18.4, 14.1, 10.4 Hz, 2H), 2.33 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 
168.8, 166.8, 147.1, 139.3, 137.1, 135.6, 133.5, 129.5, 129.3, 128.9, 128.6, 127.6, 126.4, 
124.1, 119.7, 109.6, 85.6, 59.0, 58.7, 56.2, 38.7, 36.3, 20.9; FTIR (NaCl, thin film): 3315, 
3027, 2923, 2859, 1686, 1602, 1412, 1343, 1308, 1219 cm-1; [α]D25 = +208 (c = 0.61, 
CHCl3); LRMS (EI+) calc’d for [M+H]+ 424.2, found 424.2. 
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Pyrroloindoline 176h 
Prepared following General Procedure IV using MesDABMe and di(m-
tolyl)iodonium triflate for 4 h. The crude residue was purified by silica 
gel chromatography (50% hexanes, 47.5% ethyl acetate, 2.5% 
methanol) to afford 176h as a white solid (119.0 mg, 0.280 mmol, 94% yield). 1H NMR 
(500 MHz, CDCl3) δ 7.33 (dd, J = 7.3, 7.3 Hz, 2H), 7.28 (d, J = 7.3 Hz, 1H), 7.24 (d, J = 
7.8 Hz, 1H), 7.20 (d, J = 7.1 Hz, 2H), 7.16 – 7.07 (m, 4H), 6.93 (d, J = 7.4 Hz, 1H), 6.74 
(dd, J = 13.8, 6.3 Hz, 1H), 6.68 (d, J = 7.8 Hz, 1H), 5.87 (d, J = 2.9 Hz, 1H), 5.60 (s, 1H), 
5.46 (d, J = 2.7 Hz, 1H), 4.49 – 4.39 (m, 1H), 4.24 (dd, J = 10.8, 2.7 Hz, 1H), 3.61 (dd, J 
= 14.5, 3.7 Hz, 1H), 3.23 (dd, J = 13.7, 7.3 Hz, 1H), 2.81 – 2.68 (m, 2H), 2.34 (s, 3H); 
13C NMR (126 MHz, CDCl3) δ 168.8, 166.8, 147.1, 142.2, 138.6, 135.6, 133.4, 129.3, 
128.9, 128.7, 128.6, 128.1, 127.6, 127.2, 124.1, 123.6, 119.6, 109.6, 85.5, 59.2, 58.7, 
56.2, 38.7, 36.3, 21.6; FTIR (NaCl, thin film): 3385, 3270, 3032, 2918, 2839, 1676, 1602, 
1409, 1350, 1313, 1234, 1197 cm-1; [α]D25 = +169 (c = 0.81, CHCl3); LRMS (EI+) calc’d 
for [M+H]+ 424.2, found 424.2. 
 
Pyrroloindoline 176i 
Prepared following General Procedure IV using MesDABMe and bis(3,5-
dimethylphenyl)iodonium triflate for 4 h. The crude residue was purified 
by silica gel chromatography (50% hexanes, 47.5% ethyl acetate, 2.5% 
methanol) to afford 176i as a white solid (119.4 mg, 0.273 mmol, 91% yield). 1H NMR 
(500 MHz, CDCl3) 7.37 – 7.31 (m, 2H), 7.30 – 7.26 (m, 1H), 7.23 – 7.18 (m, 2H), 7.14 – 
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7.09 (m, 1H), 6.97 – 6.94 (m, 2H), 6.94 – 6.90 (m, 2H), 6.74 (ddd, J = 7.5, 7.5, 1.0 Hz, 
1H), 6.71 – 6.65 (m, 1H), 5.88 (d, J = 2.9 Hz, 1H), 5.61 (s, 1H), 5.44 (d, J = 2.8 Hz, 1H), 
4.43 (ddd, J = 9.8, 7.1, 1.0 Hz, 1H), 4.24 (ddd, J = 10.8, 3.7, 1.4 Hz, 1H), 3.62 (dd, J = 
14.5, 3.7 Hz, 1H), 3.23 (dd, J = 13.7, 7.1 Hz, 1H), 2.77 (dd, J = 14.5, 10.8 Hz, 1H), 2.68 
(dd, J = 13.7, 10.1 Hz, 1H), 2.30 (d, J = 0.4 Hz, 6H); 13C NMR (126 MHz, CDCl3) 168.9, 
166.7, 147.1, 142.1, 138.4, 135.7, 133.5, 129.3, 129.0, 128.9, 128.5, 127.6, 124.4, 124.1, 
119.6, 109.6, 85.5, 59.1, 58.7, 56.2, 38.8, 36.3, 21.4; FTIR (NaCl, thin film): 3288, 3051, 
2919, 2854, 1684, 1604, 1484, 1455, 1418, 1346, 1312, 1255, 1204, 1156, 1109 cm-1; 
[α]D25 = +101 (c = 2.0, CHCl3); LRMS (EI+) calc’d for [M+H]+ 438.2, found 438.2. 
 
Pyrroloindoline 176j 
Prepared following General Procedure IV using MesDABMe using di(p-
methoxyphenyl)iodonium triflate for 42 h. The crude residue was 
purified by silica gel chromatography (50% hexanes, 47.5% ethyl acetate, 
2.5% methanol) to afford 176j as a white solid (88.1 mg, 0.200 mmol, 67% yield). 1H 
NMR (500 MHz, CDCl3) 7.36 – 7.30 (m, 2H), 7.28 (d, J = 7.2 Hz, 1H), 7.27 – 7.23 (m, 
2H), 7.20 (d, J = 7.0 Hz, 2H), 7.11 (ddd, J = 7.7, 7.7, 1.2 Hz, 1H), 6.91 (dd, J = 7.4, 0.7 
Hz, 1H), 6.89 – 6.86 (m, 2H), 6.74 (ddd, J = 7.5, 7.5, 0.9 Hz, 1H), 6.67 (d, J = 7.8 Hz, 
1H), 5.81 (s, 1H), 5.57 (s, 1H), 4.48 – 4.40 (m, 1H), 4.24 (ddd, J = 10.8, 3.7, 1.2 Hz, 1H), 
3.79 (s, 3H), 3.61 (dd, J = 14.5, 3.5 Hz, 1H), 3.18 (dd, J = 13.7, 7.3 Hz, 1H), 2.74 (ddd, J 
= 20.3, 14.1, 10.4 Hz, 2H); 13C NMR (126 MHz, CDCl3) 168.9, 166.8, 158.7, 147.1, 
135.6, 134.2, 133.5, 129.3, 128.9, 128.6, 127.7, 127.6, 124.1, 119.7, 114.2, 109.7, 85.7, 
58.8, 58.7, 56.2, 55.3, 38.7, 36.3; FTIR (NaCl, thin film): 3309, 3052, 2938, 2839, 1684, 
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1653, 1609, 1513, 1457, 1419, 1312, 1251, 1183, 1032 cm-1; [α]D25 = +70 (c = 0.80, 
CHCl3); LRMS (EI+) calc’d for [M+H]+ 440.2, found 440.2. 
 
Pyrroloindoline 176k 
Prepared following General Procedure IV using MesDABMe and (2-
naphthyl)(p-xylyl)iodonium triflate for 42 h. The crude residue was 
purified by silica gel chromatography (50% hexanes, 47.5% ethyl 
acetate, 2.5% methanol) to afford 176k as a white solid (113.0 mg, 0.246 mmol, 81% 
yield). 1H NMR (500 MHz, CDCl3) 7.85 – 7.78 (m, 4H), 7.54 – 7.45 (m, 2H), 7.38 (ddd, 
J = 11.4, 3.9, 3.9 Hz, 1H), 7.36 – 7.31 (m, 2H), 7.31 – 7.26 (m, 1H), 7.23 – 7.18 (m, 2H), 
7.14 (ddd, J = 7.7, 7.7, 1.2 Hz, 1H), 6.93 (dd, J = 7.4, 0.9 Hz, 1H), 6.78 – 6.68 (m, 2H), 
5.98 (s, 1H), 5.59 (s, 1H), 5.50 (s, 1H), 4.57 – 4.49 (m, 1H), 4.25 (ddd, J = 10.8, 3.7, 1.3 
Hz, 1H), 3.62 (dd, J = 14.5, 3.7 Hz, 1H), 3.39 (ddd, J = 16.0, 8.0, 8.0 Hz, 1H), 2.80 (ddd, 
J = 14.4, 12.1, 10.5 Hz, 2H).  13C NMR (126 MHz, CDCl3) δ 168.8, 166.7, 147.2, 139.2, 
135.6, 133.3, 133.0, 132.4, 129.3, 129.0, 128.9, 128.8, 128.0, 127.6, 127.5, 126.6, 126.4, 
125.5, 124.3, 124.2, 119.7, 109.7, 85.4, 59.5, 58.8, 56.2, 38.5, 36.3; FTIR (NaCl, thin 
film): 3330, 3052, 2918, 1676, 1605, 1483, 1409, 1343, 1303 cm-1; [α]D25 = +237 (c = 
0.57, CHCl3); LRMS (EI+) calc’d for [M+H]+ 460.2, found 460.2. 
 
Pyrroloindoline 176l 
Prepared following General Procedure IV using MesDABMe and (3-
bromophenyl)(p-xylyl)iodonium triflate for 42 h. The crude residue 
was purified by silica gel chromatography (50% hexanes, 47.5% ethyl 
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acetate, 2.5% methanol) to afford 176l as a white solid (79.3 mg, 0.163 mmol, 54% 
yield). 1H NMR (500 MHz, CDCl3) 7.48 (dd, J = 1.8, 1.8 Hz, 1H), 7.44 – 7.39 (m, 1H), 
7.33 (dd, J = 7.3, 7.3 Hz, 2H), 7.30 – 7.25 (m, 2H), 7.24 – 7.18 (m, 3H), 7.13 (dd, J = 7.4, 
7.4 Hz, 1H), 6.93 (d, J = 7.5 Hz, 1H), 6.76 (dd, J = 7.5, 7.5 Hz, 1H), 6.69 (d, J = 7.8 Hz, 
1H), 5.79 (d, J = 1.3 Hz, 1H), 5.59 (s, 1H), 5.50 (s, 1H), 4.42 (dd, J = 8.4, 8.4 Hz, 1H), 
4.25 (dd, J = 10.8, 3.0 Hz, 1H), 3.60 (dd, J = 14.5, 3.7 Hz, 1H), 3.15 (dd, J = 13.8, 7.5 
Hz, 1H), 2.78 (ddd, J = 18.5, 14.2, 10.1 Hz, 2H); 13C NMR (126 MHz, CDCl3) 168.6, 
166.9, 147.1, 144.8, 135.5, 132.5, 130.6, 130.4, 129.6, 129.3, 129.0, 128.9, 127.6, 125.3, 
124.2, 123.1, 119.9, 109.9, 85.4, 59.1, 58.5, 56.2, 38.5, 36.2; FTIR (NaCl, thin film): 
3315, 3057, 2933, 2864, 1679, 1612, 1560, 1482, 1412, 1343, 1313, 1221 cm-1; [α]D25 = -
+91.4 (c = 2.8, CHCl3); LRMS (EI+) calc’d for [M+H]+ 488.1, found 488.1. 
 
Pyrroloindoline 180 
Prepared following General Procedure IV using MesDABMe and 
diphenyliodonium triflate for 3 h. The crude residue was purified by 
silica gel chromatography (60% hexanes, 37.5% ethyl acetate, 2.5% methanol) to afford 
180 as a white solid (94.6 mg, 0.243 mmol, 81% yield). 1H NMR (500 MHz, CDCl3) 
7.55 (d, J = 2.9 Hz, 1H), 7.34 – 7.30 (m, 2H), 7.30 – 7.27 (m, 1H), 7.27 – 7.23 (m, 1H), 
7.23 – 7.18 (m, 3H), 6.96 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 6.73 (d, J = 7.8 Hz, 1H), 5.17 
(d, J = 2.8 Hz, 1H), 4.63 (d, J = 2.3 Hz, 1H), 4.25 (ddd, J = 12.6, 4.2, 4.2 Hz, 1H), 3.24 
(dd, J = 12.6, 4.1 Hz, 1H), 3.07 (s, 3H), 2.48 (dd, J = 12.6, 12.6 Hz, 1H); 13C NMR (126 
MHz, CDCl3) 169.0, 156.9 (q, JC-F = 37.6 Hz), 148.0, 144.9, 130.1, 129.4, 128.9, 127.5, 
125.9, 125.3, 120.9, 115.5 (q, JC-F = 287.7 Hz), 110.3, 83.8, 53.4, 49.1, 35.9, 33.3; FTIR 
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(NaCl, thin film): 3361, 3057, 2937, 1718, 1653, 1608, 1559, 1487, 1469, 1320, 1268, 
1216, 1187, 1163, 1058, 1034 cm-1; [α]D25 = +215 (c = 1.3, CHCl3); LRMS (EI+) calc’d 
for [M+H]+ 390.1, found 390.1. 
3.11.12 Stereochemical Assignment of Tryptophan Arylation 
 
The stereochemical assignment of the pyrroloindole products was assigned by 1H, 13C, 
COSY, HSQC, HMBC, and NOESY 2D experiments on L-Trp-L-Phe derived 
pyrroloindoline and assigned by spectroscopic analogy for pyrroloindoles 176b-f. 
Acyclic tryptophan-derived carboxamide 180 was independently analyzed by 1H, 13C, 
COSY, HSQC, HMBC, and NOESY 2D experiments and found to arylate from the 
opposite face of the prochiral indole moiety. Selected NOESY 2D data is included in the 
spectral data 
3.11.13 Total Synthesis of (+)-Naseseazines A and B 
Preparation of N-(2-bromo-5-iodophenyl)-2,2,2-trifluoroacetamide  
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To a solution of 2-bromo-5-iodoaniline (14.9 g, 50.0 mmol, 1.0 equiv) in CH2Cl2 (250 
mL) was added Et3N (10.4 mL, 75.0 mmol, 1.50 equiv). The solution was cooled to 0 °C 
and trifluoroacetic anhydride (7.8 mL, 55.0 mmol, 1.10 equiv) added dropwise by 
syringe. The solution was stirred for 30 minutes and slowly warmed to 23 °C and stirring 
continued for 4 hours. The reaction was then quenched by the addition of 0.5 N HCl (150 
mL), and the reaction washed with 0.5 N HCl (2 x 100 mL). The combined organics were 
then back extracted with Et2O (100 mL), and the organics dried over Na2SO4, filtered, 
and concentrated in vacuo to afford pure 2-bromo-5-iodotrifluoroacetanilide as a white 
fluffy solid (18.8 g, 47.7 mmol, 95% yield). 1H NMR (500 MHz, CDCl3): δ 8.63 (d, J = 
2.0 Hz, 1H), 8.37 (s, 1H), 7.42 (dd, J = 8.4, 2.1 Hz, 1H), 7.29 (d, J = 8.4 Hz, 1H); 13C 
NMR (126 MHz, CDCl3): δ 154.58 (q, J = 38.0 Hz), 136.2, 134.0, 133.7, 130.5, 115.3 (q, 
J = 288.7 Hz), 113.8, 93.0; IR (NaCl, thin film):  3267, 3081, 1709, 1574, 1529, 1459, 
1395, 1260, 1186, 1165, 1034 cm-1; LRMS (EI+) calc’d for [M+H]+ 393.9, found 393.9. 
 
 Preparation of (3-trifluoroacetamido-4-bromophenyl)(mesityl)iodonium 
hexafluorophosphate  
 
To a solution of 2-bromo-5-iodotrifluoroacetanilide (11.8 g, 30.0 mmol, 1.00 equiv) in 
CH2Cl2 (120 mL) was added mCPBA (80%, 7.15 g, 33.0 mmol, 1.10 equiv). The solution 
was stirred for 5 minutes, then BF3•OEt2 (9.26 mL, 75.0 mmol, 2.50 equiv) was added 
dropwise by syringe to afford a bright orange solution. After 45 minutes, the solution was 
cooled to 0 °C and 2,4,6-trimethylphenylboronic acid (5.41 g, 33.0 mmol, 1.10 equiv) 
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added in a single portion. The mixture was stirred for an additional 15 minutes, warmed 
to 23 °C over 15 minutes, then stirred for an additional 20 minutes at room temperature.  
Saturated aqueous NaPF6 (150 mL) was added to the solution, and the heterogeneous 
mixture stirred vigorously for 1 hr. The solution was diluted with CH2Cl2 (100 mL) and 
H2O (150 mL), the layers separated, and the aqueous layer extracted with CH2Cl2 (2 x 
100 mL). The combined organics were then dried over anhydrous Na2SO4, filtered, and 
concentrated in vacuo to afford a thick oil. The oil was co-evaporated once from Et2O 
(100 mL), and diluted with Et2O (500 mL). The clear supernatant was decanted and the 
residual oil co-evaporated from Et2O (200 mL), resulting in precipitation. The resulting 
solid was suspended in Et2O (500 mL) and cooled in an ice-bath for 20 minutes, then 
collected by vacuum filtration and dried under high vacuum (<1 mTorr) for 15 h to afford 
diaryliodonium hexafluorophosphate 183 as an off-white, powdery solid (14.6 g, 22.2 
mmol, 74 % yield). 1H NMR (500 MHz, DMSO-d6) δ 11.53 (s, 1H), 8.24 (d, J = 1.8 Hz, 
1H), 7.91 (dd, J = 8.6, 1.9 Hz, 1H), 7.88 (d, J = 8.5 Hz, 1H), 7.27 – 7.21 (m, 2H), 2.62 (s, 
6H), 2.30 (s, 3H); 13C NMR (126 MHz, DMSO-d6) δ 155.9 (q, J = 37.6 Hz), 143.8, 
142.1, 136.5 (d, J = 13.8 Hz), 135.7 (d, J = 35.8 Hz), 130.4, 126.0, 123.4, 116.3 (q, J = 
288.2 Hz), 113.2 , 26.8, 21.0; FTIR (NaCl, thin film):  3365, 3092, 2926, 1735, 1582, 
1523, 1457, 1405, 1267, 1204, 1157, 1031 cm-1; LRMS (EI+) calc’d [M–PF6]+ 511.9, 
found 511.9. 
 
Preparation of Diketopiperazine 185 
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(75% yield, 2 steps)
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To a solution of freshly prepared amino acid (4.75 g, 14.5 mmol, 1.00 equiv) in THF (0.4 
M, 240 mL) at 0 °C was added EDC•HCl (3.34 g, 17.4 mmol, 1.20 equiv), anhydrous 
HOBt (2.74 g, 20.3 mmol, 1.40 equiv) and Et3N (4.5 mL, 32 mmol, 2.2 equiv). The 
mixture was then stirred for 5 minutes, and L- proline methyl ester hydrochloride (2.89 g, 
17.4 mmol, 1.20 equiv) was added. The reaction was slowly warmed to 23 °C over 2 
hours and stirring continued for 20 hours. The reaction was then quenched with 1 N HCl 
(500 mL) and extracted with EtOAc (3 x 250 mL), then the combined organics washed 
with saturated aqueous NaHCO3 (500 mL), and aqueous layer back extracted with EtOAc 
(200 mL). The combined organic layers were then dried over anhydrous Na2SO4, filtered, 
and concentrated in vacuo to afford crude dipeptide as a viscous oil. 
 The residue was then dissolved in CH2Cl2 (100 mL), and trifluoroacetic acid (30 mL) 
was added dropwise by addition funnel at room temperature over 10 minutes. Stirring 
was continued for 20 minutes, then the solution diluted with toluene (100 mL) and the 
mixture concentrated in vacuo to afford a thick oil. The residue was then redissolved in 
MeOH (75 mL) and the mixture cooled to 0 °C. Et3N (55 mL) was then added dropwise 
the stirring solution over 10 minutes by addition funnel. Upon completion of the addition, 
the cooling bath was removed and the reaction was warmed to 23 °C over 1 hr. After an 
additional 3 hrs at room temperature, the solution was concentrated, the crude residue 
dissolved in Et2O (500 mL), and the solution washed with water (2 x 500 mL). The 
organic layers were back extracted with Et2O (250 mL), and the combined organic layers 
washed with brine (200 mL), dried over anhydrous MgSO4, filtered, and concentrated in 
vacuo to afford a yellow oil. The residue was purified by silica gel flash chromatography 
(5% MeOH in EtOAc) to afford diketopiperazine 185 as a white solid (3.32 g, 10.8 
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mmol, 75% yield). 1H NMR (500 MHz, CDCl3) δ 6.15 (s, 1H), 4.17 – 4.10 (m, 2H), 3.65 
– 3.57 (m, 1H), 3.53 (ddd, J = 12.0, 8.9, 3.2 Hz, 1H), 3.10 (dd, J = 17.5, 3.6 Hz, 1H), 
2.58 (dd, J = 17.5, 10.5 Hz, 1H), 2.43 – 2.32 (m, 1H), 2.14 – 1.97 (m, 2H), 1.97 – 1.83 
(m, 1H), 0.97 (t, J = 7.9 Hz, 9H), 0.59 (q, J = 7.9 Hz, 6H); 13C NMR (126 MHz, CDCl3) 
δ 169.0, 163.9, 101.9, 86.6, 59.3, 53.9, 45.4, 28.4, 22.6, 22.5, 7.4, 4.3; FTIR (NaCl, thin 
film): 3233, 2954, 2908, 2873, 2176, 1675, 1457, 1417, 1338, 1306, 1018 cm-1; [α]D25 = -
–108 (c = 0.93, CHCl3); HRMS (MM) calc’d for [M+H]+ 307.1836, found 307.1839. 
 
Preparation of Pyrroloindoline 181f 
 
In a glovebox, Cu(OTf)2•PhMe (310 mg, 0.600 mmol) and tBuDABMe (1.10 g, 2.40 
mmol) were added to an oven-dried, 200 mL round-bottomed flask. Anhydrous CH2Cl2 
(60.0 mL) was then added by syringe, and the resulting deep-purple solution was stirred 
for 1 hr at 25 °C in the glovebox. The solution was then filtered through a tight plug of 
cotton, and the resulting solution removed from the glovebox. 
To a flame-dried, 1-liter round-bottomed flask was charged cyclo-L-Pro-L-Trp 175f (1.50 
g, 5.30 mmol, 1.00 equiv), (4-bromo-3-trifluoroacetamidophenyl)mesityliodonium 
hexafluorophosphate (4.19 g, 6.36 mmol, 1.20 equiv) in anhydrous CH2Cl2 (480 mL). 
The solution was stirred at 23 °C for 10 minutes, then cooled to 15 °C in a cold water 
bath. To the flask was then added the freshly prepared catalyst solution of CuI(tBuDABMe) 
(53.0 mL, 1.06 mmol, 0.20 equiv) dropwise over 20 minutes. The deep-purple solution 
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was allowed to warm to 23 °C over 2 hours, then stirred for 20 hours at 23 °C by which 
time the solution had turned to a deep red. The solution was then quenched by the 
addition of aqueous ammonium hydroxide (1.8 M, 500 mL). The mixture was transferred 
to a separatory funnel, vigorously shaken, and the layers partitioned. The aqueous layer 
was then back extracted with EtOAc (2 x 100 mL), and the combined organic layers dried 
over anhydrous Na2SO4, filtered, and concentrated in vacuo. Repeated silica gel 
chromatography (5% MeOH, 25% Hexanes, 70% EtOAc) afforded aryl pyrrolodine 181f 
as an amorphous white solid (1.79 g, 3.26 mmol, 62% yield). 
 
1H NMR (500 MHz, CDCl3) δ 8.47 (s, 1H), 8.42 (d, J = 2.3 Hz, 1H), 7.54 (d, J = 8.5 Hz, 
1H), 7.10 (ddd, J = 7.7, 7.7, 1.3 Hz, 1H), 7.04 (dd, J = 8.5, 2.3 Hz, 1H), 6.97 (ddd, J = 
7.6, 1.2, 0.5 Hz, 1H), 6.76 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 6.64 (ddd, J = 7.8, 0.8, 0.8 Hz, 
1H), 5.73 (s, 1H), 4.59 - 4.51 (m, 1H), 4.20 - 4.11 (m, 1H), 3.51 - 3.40 (m, 2H), 3.09 (dd, 
J = 14.0, 7.9 Hz, 1H), 2.96 (dd, J = 14.0, 8.9 Hz, 1H), 2.30 (dddd, J = 12.9, 7.0, 7.0, 3.5 
Hz, 1H), 2.15 (dddd, J = 13.0, 10.5, 9.0, 7.2 Hz, 1H), 2.02 - 1.93 (m, 1H), 1.88 (ddddd, J 
= 17.2, 10.5, 8.6, 4.3, 4.3 Hz, 1H); 13C NMR (126 MHz, CDCl3) δ 168.2, 165.4, 154.8 (q, 
JC-F = 38.0 Hz), 147.2, 144.1, 133.5, 132.8, 132.0, 129.0, 125.9, 124.2, 120.0, 119.9, 
115.46 (q, JC-F = 288.7 Hz), 112.8, 110.0, 85.0, 60.5, 60.1, 59.8, 45.2, 38.1, 27.5, 23.3; 
FTIR (NaCl, thin film): 3270, 1733, 1683, 1586, 1539, 1485, 1467, 1418, 1312, 1245, 
1198, 1162 cm-1; [α]D25 = +67.8 (c = 1.8, CHCl3); LRMS (EI+) calc’d for [M+H]+ 549.1, 
found 549.1. 
 
Preparation of Aniline 186: 
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To a solution of pyrroloindoline 181f (150 mg, 0.273 mmol, 1.00 equiv) in EtOH at 23 
°C was added NaBH4 (77.0 mg, 2.02 mmol, 7.4 equiv). The solution was stirred 
vigorously for 1 h, then cooled to 0 °C and slowly quenched with saturated aqueous 
ammonium chloride (5 mL). The mixture was then diluted with H2O (50 mL) and 
extracted with EtOAc (3 x 25 mL). The combined organics were then dried over sodium 
sulfate, filtered, and concentrated under reduced pressure. Purification of the crude 
residue by flash silica gel chromatography (75% EtOAc, 20% Hexanes, 5% MeOH) 
afforded bromoaniline 186 as a white, amorphous solid (114 mg, 0.252 mmol, 92% 
yield). 1H NMR (500 MHz, CDCl3) δ 7.37 (d, J = 8.3 Hz, 1H), 7.08 (ddd, J = 7.7, 7.7, 1.3 
Hz, 1H), 6.93 - 6.89 (m, 1H), 6.72 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 6.70 (d, J = 2.3 Hz, 
1H), 6.65 - 6.58 (m, 2H), 5.76 (d, J = 2.8 Hz, 1H), 5.35 (d, J = 3.0 Hz, 1H), 4.52 - 4.44 
(m, 1H), 4.18 - 4.07 (m, 3H), 3.48 (ddd, J = 8.6, 5.2, 5.2 Hz, 2H), 3.11 (dd, J = 13.9, 7.4 
Hz, 1H), 2.76 (dd, J = 13.9, 9.7 Hz, 1H), 2.31 (dddd, J = 12.8, 7.0, 7.0, 3.3 Hz, 1H), 2.15 
(dddd, J = 12.9, 10.6, 9.2, 7.2 Hz, 1H), 2.05 - 1.96 (m, 1H), 1.95 - 1.86 (m, 1H); 13C 
NMR (126 MHz, CDCl3) δ167.9, 165.6, 147.1, 144.3, 143.0, 133.1, 132.8, 128.7, 124.1, 
119.7, 117.4, 114.0, 109.6, 108.0, 85.1, 60.5, 60.2, 59.5, 45.2, 38.0, 27.6, 23.3; FTIR 
(NaCl, thin film): 3457, 3341, 3003, 2953, 2881, 1661, 1612, 1572, 1484, 1466, 1422, 
1341, 1293, 1252, 1214, 1152 cm-1; [α]D25 = +118 (c = 0.80, CHCl3); LRMS (EI+) calc’d 
for [M+H]+ 453.1, found 453.1. 
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Preparation of (+)-Naseseazine B (187) 
 
 In a glovebox, a 1-dram vial was charged with bromoaniline 186 (74.6 mg, 0.165 
mmol, 1.00 equiv), alkyne 10 (127 mg, 0.412 mmol, 2.50 equiv), Na2CO3 (43.7 mg, 
0.412 mmol, 2.50 equiv), and Pd[P(o-tol)3]2 (29.5 mg, 0.0412 mmol, 25 mol %). DMF 
(1.70 mL) was then added and the solution stirred vigorously for 3 minutes at 25 °C. The 
solution was then heated to 100 °C for 1.5 h, cooled, and concentrated under reduced 
pressure and dried under high vacuum to ensure complete removal of residual DMF. The 
residue was then dissolved in CH2Cl2 (3 mL) and filtered through a plug of silica gel (50 
g) to remove residual catalyst and base, then the filter cake rinsed (5% MeOH in CH2Cl2, 
200 mL). The filtrate was then concentrated, and the crude residue dissolved in 1M 
methanolic HCl (10 mL), and stirred for 2 h at 23 °C. The solution was then concentrated 
and the residue was quenched by the addition of methanolic NH3 (1 N, 5 mL) and 
reconcentrated. The residue was purified by flash chromatography on silica gel (2 to 7% 
MeOH in CH2Cl2) afforded Naseseazine B (187) as a white, powdery solid (47.3 mg, 
0.837 mmol, 51% yield). Excess TES-alkyne 185 could be recovered during 
chromatography. 
 
Spectroscopic and physical data, including 1H, 13C NMR in CD3OD, DMSO-d6, IR, MS, 
and [α]D25, obtained for Naseseazine B matched that as reported during isolation by Raju 
N
H
N N
O
O
H
H
NH2
Br
H NH
N NH
O
O
H
NHNH
N
O
O
H
H
naseseazine B
H
(51% yield)
Pd[P(o-tol)3]2 (25 mol %),
Na2CO3 (2.5 equiv), DMF, 100 °C
HN
N
O
O
SET
H
H
Chapter 3 – Direct and Selective Copper-Catalyzed Arylation of Tryptamines and 
Tryptophans: Total Synthesis of (+)-Naseseazines A and B 
257 
et. al and data obtained by Movassaghi and Kim. See below for 1H and 13C comparison 
table. The use of natural amino acids in this report to synthesize (+)-naseseazine B is in 
agreement with Movassaghi and Kim’s structural reassignment of the natural product.2 
During the course of this study, we determined that the exact chemical shifts (δ) of 
Naseseazine B observed in CD3OD had a slight concentration dependence. 
 
1H NMR (600 MHz, CD3OD) δ 7.56 (d, J = 8.5 Hz, 1H), 7.40 (d, J = 0.6 Hz, 1H), 7.12 
(s, 1H), 7.04 (td, J = 7.6, 1.1 Hz, 1H), 7.00 (dd, J = 8.5, 1.1 Hz, 1H), 6.82 (dd, J = 7.2, 
1.0 Hz, 1H), 6.69 – 6.64 (m, 2H), 5.82 (s, 1H), 4.71 – 4.61 (m, 1H), 4.38 (app t, J = 4.4 
Hz, 1H), 4.24 (app t, J = 8.1, 1H), 3.96 (dd, J = 9.6, 6.6 Hz, 1H), 3.51 – 3.36 (m, 3H), 
3.30 – 3.27 (m, 2H), 3.26 – 3.21 (m, 2H), 2.57 (dd, J = 13.7, 10.1 Hz, 1H), 2.24 (dddd, J 
= 10.0, 6.9, 6.9, 3.1 Hz, 1H), 2.13 – 2.03 (m, 1H), 2.00 – 1.93 (m, 2H), 1.93 – 1.84 (m, 
1H), 1.72 – 1.60 (m, 1H), 1.49 – 1.40 (m, 1H), 1.01 – 0.92 (m, 1H); 13C NMR (126 MHz, 
CD3OD) δ 170.8, 170.1, 168.4, 167.3, 149.1, 137.9, 137.0, 136.0, 129.4, 127.7, 126.4, 
124.9, 120.5, 119.6, 111.1, 110.4, 109.7, 86.9, 61.8, 61.7, 61.5, 60.0, 57.1, 46.2, 45.9, 
39.5, 29.2, 29.0, 28.5, 24.2, 22.6. 
 
 1H NMR (600 MHz, DMSO-d6) δ 10.80 (d, J = 2.4 Hz, 1H), 7.68 (s, 1H), 7.57 (d, J = 
8.4 Hz, 1H), 7.31 (d, J = 1.6 Hz, 1H), 7.19 (d, J = 2.4 Hz, 1H), 7.03 – 6.96 (m, 2H), 6.80 
(dd, J = 7.5, 1.2 Hz, 1H), 6.75 (s, 1H), 6.61 (d, J = 6.6, 1 H), 6.58 (dd, J = 6.6, 1H), 5.68 
(s, 1H), 4.72 (ddd, J = 9.3, 7.7, 1.3 Hz, 1H), 4.34 (ddd, J = 8.9, 7.4, 1.4 Hz, 1H), 4.29 
(app t J = 5.3 Hz, 1H), 4.06 (ddd, J = 9.9, 6.8, 1.4 Hz, 1H), 3.37 – 3.33 (m, 2H), 3.25 
(ddd, J = 12.1, 9.0, 3.9 Hz, 1H), 3.22 (dd, J = 14.9, 4.8 Hz, 1H), 3.13 (dd, J = 13.7, 7.4 
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Hz, 1H), 3.05 (dd, J = 14.9, 5.8 Hz, 1H), 2.37 (dd, J = 13.7, 10.4 Hz, 1H), 2.16 (dddd, J = 
12.4, 7.0, 7.0, 3.6 Hz, 1H), 2.03 - 1.91 (m, 2H), 1.90 - 1.78 (m, 2H), 1.69 (dddd, J = 10.7, 
8.7, 5.8, 2.5 Hz, 1H), 1.67 - 1.57 (m, 1H), 1.46 - 1.38 (m, 1H). 13C NMR (126 MHz, 
DMSO-d6) δ 169.1, 167.9, 165.9, 165.5, 148.1, 135.9, 135.6, 134.6, 127.9, 126.1, 125.1, 
123.4, 119.2, 118.0, 117.9, 109.3, 109.2, 84.9, 60.0, 59.8, 59.5, 58.4, 55.2, 44.6, 38.7, 
27.7, 27.1, 25.7, 23.0, 21.9. IR: 3270, 2943, 2859, 1653, 1559, 1419, 1340 cm-1; [α]D25 = 
+97 (c = 0.45, MeOH) LRMS (EI+) calc’d for [M+H]+ 565.3, found 565.3. 
Comparison of 1H NMR data for Natural vs. Synthetic (+)-Naseseazine B 
Raju et al. Report, 
Natural 
(+)–Naseseazine B 
1H NMR, 600 MHz, CD3OD 
This Work, 
Synthetic 
(+)–Naseseazine B 
1H NMR, 600 MHz, CD3OD 
δ 7.58 (d, J = 8.4 Hz, 1H) δ 7.56 (d, J = 8.5 Hz, 1H) 
7.41 (d, J = 1.4 Hz, 1H) 7.40 (d, J = 0.6 Hz, 1H) 
7.12 (s, 1H) 7.12 (s, 1H) 
7.06 (td, J =7.6, 1.3 Hz) 7.04 (td, J = 7.6, 1.1 Hz, 1H) 
7.03 (dd, J = 8.4, 1.8 Hz, 1H) 7.00 (dd, J = 8.5, 1.1 Hz, 1H) 
6.84 (dt, J =7.2, 0.9 Hz, 1H) 6.82 (dt, J = 7.2 Hz, 1.0 Hz, 1H), 
6.69 (t, J  = 7.6 Hz, 1H) 6.69 – 6.64 (m, 2H) 
6.68 (t, J = 7.6 Hz, 1H) – 
5.85 (s, 1H) 5.82 (s, 1H) 
4.75 (dd, J = 10.2, 8.7 Hz, 1H) 4.71 – 4.61 (m, 1H) 
4.40 (br t, J =4.7 Hz, 1H) 4.38 (app t, J = 4.4, 1H) 
4.33 (dd, J = 9.5, 7.1 Hz, 1H) 4.24 (app t, J = 8.1, 1H) 
3.99 (ddd, J = 11.4, 6.6 , 1.6 Hz, 1H) 3.96 (dd, J = 9.6, 6.6 Hz, 1H) 
3.49 (m, 1H) 3.51 – 3.36 (m, 3H) 
3.44 (m, 1H) – 
3.44 (m, 1H) – 
3.32 (m, 1H) 3.30 – 3.27 (m, 2H) 
3.28 (m, 1H) – 
3.27 (m, 1H) 3.26 – 3.21 (m, 2H) 
3.24 (m, 1H) – 
2.59 (dd, J = 13.8, 10.2 Hz, 1H) 2.57 (dd, J = 13.7, 10.1 Hz, 1H) 
2.28 (m, 1H) 2.24 (dddd, J = 10.0, 6.9, 6.9, 3.1 Hz, 1H) 
2.11 (m, 1H) 2.13 – 2.03 (m, 1H) 
2.00 (m, 1H) 2.00 – 1.93 (m, 2H) 
1.97 (m, 1H) – 
1.95 (m, 1H) 1.93 – 1.84 (m, 1H) 
1.67 (m, 1H) 1.72 – 1.60 (m, 1H) 
1.44 (m, 1H) 1.49 – 1.40 (m, 1H) 
0.92 (m, 1H) 1.01 – 0.92 (m, 1H) 
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Comparison of 13C NMR data for Natural vs. Synthetic (+)-Naseseazine B 
Raju et al. Report, 
Natural 
(+)–Naseseazine B 
13C NMR, 151 MHz, CD3OD 
This Work, 
Synthetic 
(+)–Naseseazine B 
13C NMR, 126 MHz, CD3OD 
Chemical Shift Difference, Δδ 
δ 170.7 δ 170.8 0.1 
170.2 170.1 0.1 
168.4 168.4 0.0 
167.3 167.3 0.0 
149.0 149.1 0.1 
137.9 137.9 0.0 
136.9 137.0 0.1 
136.0 136.0 0.0 
129.1 129.4 0.3 
127.6 127.7 0.1 
126.1 126.4 0.3 
124.8 124.9 0.1 
120.3 120.5 0.2 
120.3 – – 
119.4 119.6 0.2 
111.0 111.1 0.1 
110.3 110.4 0.1 
109.5 109.4 0.1 
86.8 86.9 0.1 
61.8 61.8 0.0 
61.7 61.7 0.0 
61.3 61.5 0.2 
59.9 60.0 0.1 
57 57.1 0.1 
45.9 46.2 0.3 
45.8 45.9 0.1 
39.5 39.5 0.0 
29.2 29.2 0.0 
29.1 29.0 0.1 
28.3 28.5 0.2 
24.1 24.2 0.1 
22.4 22.6 0.2 
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In a glovebox, Cu(OTf)2•PhMe  (77.6 mg 0.150 mmol) and tBuDABMe (277 mg, 0.600 
mmol, 2.40 mmol) were added to an oven-dried, 50 mL round-bottomed flask. 
Anhydrous CH2Cl2 (27.0 mL) was then added by syringe, and the resulting deep-purple 
solution was stirred for 1 hr at 25 °C in the glovebox. The solution was then filtered 
through a tight plug of cotton, and the resulting solution removed from the glovebox. 
To a flame-dried, 100-mL round-bottomed flask was charged cyclo-L-Ala-L-Trp 175b 
(334 mg, 1.30 mmol, 1.00 equiv) and (4-bromo-3-
trifluoroacetamidophenyl)mesityliodonium hexafluorophosphate (940 mg, 1.43 mmol, 
1.10 equiv)). To the flask was then added the freshly prepared catalyst solution of 
CuI(tBuDABMe) (26.0 mL, 0.260 mmol, 0.20 equiv) dropwise over 20 minutes. The deep-
purple solution was allowed to warm to 23 °C over 2 hours, then stirred for 8 hours at 23 
°C. The solution was then quenched by the addition of aqueous ammonium hydroxide 
(1.8 M, 20 mL). The mixture was then diluted with EtOAc (100 mL), transferred to a 
separatory funnel, vigorously shaken, and the layers partitioned. The aqueous layer was 
then back-extracted with EtOAc (2 x 100 mL), and the combined organic layers dried 
over anhydrous Na2SO4, filtered, and concentrated in vacuo. Repeated silica gel 
chromatography (78% EtOAc, 20% hexanes, 2 % MeOH) afford aryl pyrrolodine 181b 
as a white solid (402.0 mg, 0.767 mmol, 59% yield). 1H NMR (500 MHz, CDCl3) δ 8.51 
(s, 1H), 8.39 (d, J = 2.3 Hz, 1H), 7.53 (d, J = 8.5 Hz, 1H), 7.20 (s, 1H), 7.09 (ddd, J = 
7.7, 7.7, 1.0 Hz, 1H), 7.03 (dd, J = 8.5, 2.3 Hz, 1H), 6.95 (d, J = 7.4 Hz, 1H), 6.73 (dd, J 
= 7.5, 7.5 Hz, 1H), 6.64 (d, J = 7.9 Hz, 1H), 5.73 (s, 1H), 5.68 (br s, 1H), 4.47 (dd, J = 
8.3, 8.3 Hz, 1H), 4.10 – 4.03 (m, 1H), 3.09 (dd, J = 13.9, 7.9 Hz, 1H), 2.89 (dd, J = 13.9, 
8.9 Hz, 1H), 1.41 (d, J = 6.9 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 169.8, 168.4, 154.8 
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(q, JC-F = 38.0 Hz) 147.3, 144.0, 133.4, 132.8, 131.9, 129.0, 125.9, 124.0, 120.0, 119.7, 
115.4 (q, JC-F = 288.6 Hz) 113.0, 110.1, 85.1, 59.3, 58.7, 51.2, 38.2, 15.2; FTIR (NaCl, 
thin film): 3270, 1733, 1683, 1586, 1539, 1485, 1467, 1418, 1312, 1245, 1198, 1162 cm-
1; [α]D25 = +84 (c = 0.42, CHCl3); LRMS (EI+) calc’d for [M+H]+ 523.1, found 523.1. 
 
Preparation of Aniline 186b 
 
To a solution of pyrroloindoline 181b (140 mg, 0.268 mmol, 1.00 equiv) in EtOH (5.4 
mL) at 23 °C was added NaBH4 (76.3 mg, 2.00 mmol, 7.5 equiv). The solution was 
stirred vigorously for 1 h, then cooled to 0 °C and slowly quenched with saturated 
aqueous ammonium chloride (5 mL). The mixture was then diluted with H2O (50 mL) 
and extracted with EtOAc (3 x 45 mL). The combined organics were then dried over 
sodium sulfate, filtered, and concentrated in vacuo. Purification of the crude residue by 
flash silica gel chromatography (75% EtOAc, 20% Hexanes, 5% MeOH) afforded 
bromoaniline 186b as a white, amorphous solid (94.0 mg, 0.220 mmol, 82% yield). 1H 
NMR (500 MHz, CDCl3) δ 7.31 (d, J = 8.4 Hz, 1H), 7.04 (ddd, J = 7.6, 7.6, 1.3 Hz, 1H), 
6.91 - 6.85 (m, 1H), 6.85 (d, J = 2.3 Hz, 1H), 6.67 (ddd, J = 19.2, 7.7, 1.0 Hz, 2H), 6.56 
(dd, J = 8.4, 2.4 Hz, 1H), 5.72 (s, 1H), 4.56 (ddd, J = 10.0, 7.4, 1.6 Hz, 1H), 4.14 (qd, J = 
6.8, 1.5 Hz, 1H), 3.10 (ddd, J = 14.0, 7.5, 1.7 Hz, 1H), 2.52 (dd, J = 13.6, 9.9 Hz, 1H), 
1.37 (d, J = 6.9 Hz, 2H); FTIR (NaCl, thin film): 3345, 2919, 1668, 1605, 1483, 1418, 
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1300, 1209 cm-1; [α]D25 = +156 (c = 0.38, MeOH); LRMS (EI+) calc’d for [M+H]+ 
427.1, found 427.1. 
Preparation of (+)-Naseseazine A  
 
 In a glovebox, a 1-dram vial was charged with bromoaniline 186b (79.8 mg, 
0.187 mmol, 1.00 equiv), alkyne 185 (143 mg, 0.467 mmol, 2.50 equiv), Na2CO3 (49.5 
mg, 0.467 mmol, 2.50 equiv), and Pd[P(o-tol)3]2 (33.4 mg, 0.0467 mmol, 25 mol %). 
DMF (1.90 mL) was then added and the solution stirred vigorously for 3 minutes at 25 
°C. The solution was then heated to 100 °C for 1 h, cooled, and concentrated under 
reduced pressure and dried under high vacuum to ensure complete removal of residual 
DMF. The residue was then dissolved in CH2Cl2 (3 mL) and filtered through a plug of 
silica gel (50 g) to remove residual catalyst and base, then the filter cake rinsed (6% 
MeOH in CH2Cl2, 260 mL). The filtrate was then concentrated, and the crude residue 
dissolved in 1M methanolic HCl (12 mL), and stirred for 2 h at 23 °C. The solution was 
then concentrated and the residue was quenched by the addition of methanolic NH3 (1 N, 
12 mL) and reconcentrated. The residue was purified by flash chromatography on silica 
gel (2 to 10% MeOH in CH2Cl2) afforded Naseseazine A as a white, powdery solid (56.5 
mg, 0.105 mmol, 56% yield). Excess TES-alkyne 185 could be recovered during 
chromatography.  
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Spectroscopic and physical data, including 1H, 13C NMR in CD3OD, DMSO-d6, IR, MS, 
and [α]D25, obtained for Naseseazine A matched that as reported during isolation by Raju 
et. al15 and data obtained by Movassaghi and Kim.2 See below for 1H and 13C comparison 
table. The use of natural amino acids in this report to synthesize (+)-naseseazine A is in 
agreement with Movassaghi and Kim’s structural reassignment of the natural product.2 
During the course of this study, we determined that the exact chemical shifts (δ) of 
Naseseazine A observed in CD3OD had a slight concentration dependence. 
 
1H NMR (600 MHz, CD3OD) δ 7.55 (d, J = 8.4 Hz, 1H), 7.38 (s, 1H), 7.11 (s, 1H), 7.04 
(app t, J = 7.6 Hz, 1H), 7.00 (d, J = 8.4 Hz, 1H), 6.83 (d, J = 7.4 Hz, 1H), 6.70 – 6.62 (m, 
2H), 5.80 (s, 1H), 4.58 (app t, J = 8.6 Hz, 1H), 4.37 (dd, J = 4.7, 4.7 Hz, 1H), 4.10 (q, J = 
6.8 Hz, 1H), 3.95 (dd, J = 10.7, 6.5 Hz, 1H), 3.41 (dt, J = 11.8, 8.3 Hz, 1H), 3.29 – 3.25 
(m, 3H), 3.23 (dd, J = 13.2, 7.8 Hz, 2H), 2.58 (dd, J = 13.5, 10.0 Hz, 1H), 2.00 – 1.91 (m, 
1H), 1.71 – 1.60 (m, 1H), 1.48 – 1.40 (m, 1H), 1.36 (d, J = 6.8 Hz, 3H), 1.01 – 0.91 (m, 
1H); 13C NMR (126 MHz, CD3OD) δ 172.5, 170.8, 170.7, 167.3, 149.1, 137.9, 137.2, 
135.9, 129.4, 127.6, 126.4, 125.0, 120.5, 120.4, 119.6, 111.1, 110.3, 109.7, 87.1, 61.2, 
60.3, 60.0, 57.1, 52.2, 45.9, 39.7, 29.2, 29.0, 22.6, 15.3. 
 
 1H NMR (600 MHz, DMSO-d6) δ 10.80 (s, 1H), 8.18 (s, 1H), 7.68 (s, 1H), 7.57 (d, J = 
8.4 Hz, 1H), 7.29 (s, 1H), 7.19 (s, 1H), 7.01 – 6.96 (m, 2H), 6.83 (d, J = 7.3 Hz, 1H), 
6.73 (s, 1H), 6.65 – 6.54 (m, 2H), 5.66 (s, 1H), 4.61 (dd, J = 8.6, 8.6 Hz, 1H), 4.28 (dd, J 
= 4.6, 4.6 Hz, 1H), 4.14 (q, J = 6.7 Hz, 1H), 4.10 – 4.03 (m, 1H), 3.40 – 3.35 (m, 1H), 
3.28 – 3.18 (m, 2H), 3.07 (ddd, J = 26.8, 14.2, 6.7 Hz, 2H), 2.42 (dd, J = 13.1, 10.3 Hz, 
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1H), 2.02 – 1.93 (m, 1H), 1.70 (ddd, J = 27.0, 9.2, 9.2 Hz, 1H), 1.65 – 1.56 (m, 1H), 1.48 
– 1.37 (m, 1H), 1.23 (d, J = 6.8 Hz, 3H). 13C NMR (126 MHz, DMSO-d6) δ 170.0, 
169.1, 168.6, 165.5, 148.1, 135.9, 135.7, 134.4, 127.9, 126.1, 125.0, 123.6, 119.1, 117.9, 
117.8, 109.3, 109.2, 109.1, 85.0, 59.3, 58.4, 58.4, 55.2, 50.3, 44.6, 38.8, 27.7, 25.7, 21.9, 
14.8. FTIR: 3306, 2913, 2859, 1668, 1449, 1418, 1343, 1308 cm-1; [α]D25 = +121 (c = 
0.30, MeOH); LRMS (EI+) calc’d for [M+H]+ 539.2, found 539.2.  
Comparison of 1H NMR data for Natural vs. Synthetic (+)-Naseseazine A 
Raju et al. Report, 
(+)–Naseseazine A 
1H NMR, 600 MHz, CD3OD 
This Work 
(+)–Naseseazine A 
1H NMR, 600 MHz, CD3OD 
δ 7.57 (d, J = 8.4 Hz, 1H) δ 7.55 (d, J = 8.4 Hz, 1H) 
7.40 (s, 1H) 7.38 (s, 1H) 
7.11 (s, 1H) 7.11 (s, 1H) 
7.05 (t, 7.2 Hz, 1H) 7.04 (app t, J = 7.6 Hz, 1H) 
7.02 (d, J = 8.4 Hz, 1H) 7.00 (d, J = 8.4 Hz, 1H) 
6.85 (d, J = 7.4 Hz, 1H) 6.83 (d, J = 7.4 Hz, 1H) 
6.69 (d, J = 7.6 Hz, 1H) 6.70 – 6.62 (m, 2H) 
6.67 (t, J = 8.5 Hz, 1H) – 
5.83 (s, 1H) 5.80 (s, 1H) 
4.64 (dd, J = 8.4, 7.4 Hz, 1H) 4.58 (app t, J = 8.6 Hz, 1H) 
4.39 (br t, J = 4.5 Hz, 1H) 4.37 (dd, J = 4.7, 4.7 Hz, 1H) 
4.15 (q, J = 6.9 Hz, 1H) 4.10 (q, J = 6.8 Hz, 1H) 
3.97 (dd, J = 10.8, 6.6 Hz, 1H) 3.95 (dd, J = 10.7, 6.5 Hz, 1H 
3.42 (dt, J = 11.8, 8.1 Hz, 1H) 3.41 (dt, J = 11.8, 8.3 Hz, 1H) 
3.30 (m, 1H) 3.29 – 3.25 (m, 3H) 
3.29 (m, 1H) – 
3.26 (m, 1H) – 
3.24 (m, 1H) 3.23 (dd, J = 13.2, 7.8 Hz, 2H) 
2.59 (dd, J  = 13.7, 10.2 Hz, 1H) 2.58 (dd, J = 13.5, 10.0 Hz, 1H) 
1.97 (m, 1H) 2.00 – 1.91 (m, 1H) 
1.66 (m, 1H) 1.71 – 1.60 (m, 1H) 
1.43 (m, 1H) 1.48 – 1.40 (m, 1H) 
1.38 (d, J = 6.9 Hz, 1H) 1.36 (d, J = 6.8 Hz, 3H) 
0.93 (m, 1H) 1.01 – 0.91 (m, 1H) 
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Comparison of 13C NMR data for Natural vs. Synthetic (+)-Naseseazine A 
Raju et al. Report, 
(+)–Naseseazine A 
13C NMR, 151 MHz, CD3OD 
This Work 
(+)–Naseseazine A 
13C NMR, 126 MHz, CD3OD 
Chemical Shift Difference, Δδ 
172.6 172.5 0.1 
170.6 170.8 0.2 
170.6 170.7 0.1 
167.3 167.3 0.0 
149.1 149.1 0.0 
137.9 137.9 0.0 
137.2 137.2 0.0 
135.8 135.9 0.1 
129.2 129.4 0.2 
127.6 127.6 0.0 
126.2 126.4 0.2 
124.9 125.0 0.1 
120.3 120.5 0.2 
120.2 120.4 0.2 
119.5 119.6 0.1 
110.9 111.1 0.2 
110.1 110.3 0.2 
109.5 109.7 0.2 
87.1 87.1 0.0 
61.2 61.2 0.0 
60.2 60.3 0.1 
60.0 60.0 0.0 
57.2 57.1 0.1 
52.1 52.2 0.1 
45.8 45.9 0.1 
39.7 39.7 0.0 
29.0 29.2 0.2 
29.0 29.0 0.0 
22.5 22.6 0.1 
15.2 15.3 0.1 
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KVC15-025
 Sample Name:
   KVC15-025
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-025
 FidFile: PROTON01
Pulse Sequence: PROTON (s2pul)
Solvent: dmso
Data collected on: Jan 25 2013
Sample #10, Operator: mkieffer
 Relax. delay 5.000 sec
 Pulse 45.0 degrees
 Acq. time 3.000 sec
 Width 7995.2 Hz
 32 repetitions
OBSERVE   H1, 499.7072806 MHz
DATA PROCESSING
 Line broadening 0.2 Hz
FT size 65536
Total time 4 min 16 sec
  1.96
  1.97
  1.99
  1.99
  6.00
ppm
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KVC15-025
 Sample Name:
   KVC15-025
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-025
 FidFile: CARBON01
Pulse Sequence: CARBON (s2pul)
Solvent: dmso
Data collected on: Jan 25 2013
Sample #10, Operator: mkieffer
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.043 sec
 Width 31409.5 Hz
 256 repetitions
OBSERVE  C13, 125.6515531 MHz
DECOUPLE  H1, 499.7097867 MHz
 Power 39 dB
 continuously on
 WALTZ-16 modulated
DATA PROCESSING
 Line broadening 0.5 Hz
FT size 65536
Total time 8 min 45 sec
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355 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-071
 Sample Name:
   KVC15-071
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-071
 FidFile: PROTON01
Pulse Sequence: PROTON (s2pul)
Solvent: dmso
Data collected on: Jan 25 2013
Sample #12, Operator: mkieffer
 Relax. delay 5.000 sec
 Pulse 45.0 degrees
 Acq. time 3.000 sec
 Width 7995.2 Hz
 32 repetitions
OBSERVE   H1, 499.7072806 MHz
DATA PROCESSING
 Line broadening 0.2 Hz
FT size 65536
Total time 4 min 16 sec
  4.01
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356 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-071
 Sample Name:
   KVC15-071
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-071
 FidFile: CARBON01
Pulse Sequence: CARBON (s2pul)
Solvent: dmso
Data collected on: Jan 25 2013
Sample #12, Operator: mkieffer
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.043 sec
 Width 31409.5 Hz
 256 repetitions
OBSERVE  C13, 125.6515531 MHz
DECOUPLE  H1, 499.7097867 MHz
 Power 39 dB
 continuously on
 WALTZ-16 modulated
DATA PROCESSING
 Line broadening 0.5 Hz
FT size 65536
Total time 8 min 45 sec
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357 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-029
 Sample Name:
   KVC15-029
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-029
 FidFile: PROTON01
Pulse Sequence: PROTON (s2pul)
Solvent: dmso
Data collected on: Jan 25 2013
Sample #11, Operator: mkieffer
 Relax. delay 5.000 sec
 Pulse 45.0 degrees
 Acq. time 3.000 sec
 Width 7995.2 Hz
 32 repetitions
OBSERVE   H1, 499.7072806 MHz
DATA PROCESSING
 Line broadening 0.2 Hz
FT size 65536
Total time 4 min 16 sec
  0.99
  0.97
  1.00
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ppm
1
2
3
4
5
6
7
8
9
10
I OTf
M
e
M
e
358 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-029
 Sample Name:
   KVC15-029
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-029
 FidFile: CARBON01
Pulse Sequence: CARBON (s2pul)
Solvent: dmso
Data collected on: Jan 25 2013
Sample #11, Operator: mkieffer
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.043 sec
 Width 31409.5 Hz
 256 repetitions
OBSERVE  C13, 125.6515531 MHz
DECOUPLE  H1, 499.7097867 MHz
 Power 39 dB
 continuously on
 WALTZ-16 modulated
DATA PROCESSING
 Line broadening 0.5 Hz
FT size 65536
Total time 8 min 45 sec
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359 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-165
 Sample Name:
   KVC15-165
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-165
 FidFile: PROTON02
Pulse Sequence: PROTON (s2pul)
Solvent: dmso
Data collected on: Feb  3 2013
Sample #47, Operator: mkieffer
 Relax. delay 5.000 sec
 Pulse 45.0 degrees
 Acq. time 3.000 sec
 Width 7995.2 Hz
 32 repetitions
OBSERVE   H1, 499.7072806 MHz
DATA PROCESSING
 Line broadening 0.2 Hz
FT size 65536
Total time 4 min 16 sec
  0.93
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  1.04
  0.95
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360 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-165
 Sample Name:
   KVC15-165
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-165
 FidFile: CARBON02
Pulse Sequence: CARBON (s2pul)
Solvent: dmso
Data collected on: Feb  3 2013
Sample #47, Operator: mkieffer
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.043 sec
 Width 31409.5 Hz
 1000 repetitions
OBSERVE  C13, 125.6515531 MHz
DECOUPLE  H1, 499.7097867 MHz
 Power 39 dB
 continuously on
 WALTZ-16 modulated
DATA PROCESSING
 Line broadening 0.5 Hz
FT size 65536
Total time 34 min
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361 Appendix 2 – Spectra Relevant to Chapter 3 
MEK5047-1
 Sample Name:
   MEK5047-1
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/kangway/vnmrsys/data
 Sample directory:
   MEK5047-1
 FidFile: PROTON01
Pulse Sequence: PROTON (s2pul)
Solvent: cdcl3
Data collected on: Dec 10 2012
Sample #7, Operator: kangway
 Relax. delay 5.000 sec
 Pulse 45.0 degrees
 Acq. time 2.500 sec
 Width 8000.0 Hz
 32 repetitions
OBSERVE   H1, 499.7049153 MHz
DATA PROCESSING
 Line broadening 0.2 Hz
FT size 65536
Total time 4 min 0 sec
  5.97
  1.90
  2.07
  1.04
  0.98
  1.01
  0.97
  0.93
  0.98
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362 Appendix 2 – Spectra Relevant to Chapter 3 
MEK5047-1
 Sample Name:
   MEK5047-1
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/kangway/vnmrsys/data
 Sample directory:
   MEK5047-1
 FidFile: CARBON01
Pulse Sequence: CARBON (s2pul)
Solvent: cdcl3
Data collected on: Dec 10 2012
Sample #7, Operator: kangway
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.042 sec
 Width 31446.5 Hz
 1000 repetitions
OBSERVE  C13, 125.6509042 MHz
DECOUPLE  H1, 499.7074131 MHz
 Power 39 dB
 continuously on
 WALTZ-16 modulated
DATA PROCESSING
 Line broadening 0.5 Hz
FT size 65536
Total time 34 min
ppm
20
40
60
80
100
120
140
160
180
200
 
N
NH
NH O
O
H
H
Bn
363 Appendix 2 – Spectra Relevant to Chapter 3 
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364 Appendix 2 – Spectra Relevant to Chapter 3 
MEK5049-1
 Sample Name:
   MEK5049-1
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/kangway/vnmrsys/data
 Sample directory:
   MEK5049-1
 FidFile: PROTON01
Pulse Sequence: PROTON (s2pul)
Solvent: cdcl3
Data collected on: Dec 11 2012
Sample #9, Operator: kangway
 Relax. delay 5.000 sec
 Pulse 45.0 degrees
 Acq. time 2.500 sec
 Width 8000.0 Hz
 32 repetitions
OBSERVE   H1, 499.7049153 MHz
DATA PROCESSING
 Line broadening 0.2 Hz
FT size 65536
Total time 4 min 0 sec
  4.31
  1.20
  1.20
  0.94
  0.97
  0.91
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  0.87
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365 Appendix 2 – Spectra Relevant to Chapter 3 
MEK5049-1
 Sample Name:
   MEK5049-1
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/kangway/vnmrsys/data
 Sample directory:
   MEK5049-1
 FidFile: CARBON01
Pulse Sequence: CARBON (s2pul)
Solvent: cdcl3
Data collected on: Dec 11 2012
Sample #9, Operator: kangway
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.042 sec
 Width 31446.5 Hz
 2000 repetitions
OBSERVE  C13, 125.6509011 MHz
DECOUPLE  H1, 499.7074131 MHz
 Power 39 dB
 continuously on
 WALTZ-16 modulated
DATA PROCESSING
 Line broadening 0.5 Hz
FT size 65536
Total time 1 hr, 8 min
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366 Appendix 2 – Spectra Relevant to Chapter 3 
MEK5105
 Sample Name:
   MEK5105
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   MEK5105
 FidFile: PROTON01
Pulse Sequence: PROTON (s2pul)
Solvent: cdcl3
Data collected on: Jan 23 2013
Sample #37, Operator: mkieffer
 Relax. delay 5.000 sec
 Pulse 45.0 degrees
 Acq. time 3.000 sec
 Width 7995.2 Hz
 32 repetitions
OBSERVE   H1, 499.7049152 MHz
DATA PROCESSING
 Line broadening 0.2 Hz
FT size 65536
Total time 4 min 16 sec
  4.35
  1.09
  1.20
  1.00
  1.00
  1.06
  0.96
  1.00
  0.98
  1.00
  1.02
  1.03
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  2.97
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367 Appendix 2 – Spectra Relevant to Chapter 3 
MEK5105
 Sample Name:
   MEK5105
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   MEK5105
 FidFile: CARBON01
Pulse Sequence: CARBON (s2pul)
Solvent: cdcl3
Data collected on: Jan 23 2013
Sample #37, Operator: mkieffer
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.043 sec
 Width 31409.5 Hz
 1000 repetitions
OBSERVE  C13, 125.6509063 MHz
DECOUPLE  H1, 499.7074131 MHz
 Power 39 dB
 continuously on
 WALTZ-16 modulated
DATA PROCESSING
 Line broadening 0.5 Hz
FT size 65536
Total time 34 min
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368 Appendix 2 – Spectra Relevant to Chapter 3 
MEK5048-1
 Sample Name:
   MEK5048-1
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/kangway/vnmrsys/data
 Sample directory:
   MEK5048-1
 FidFile: PROTON01
Pulse Sequence: PROTON (s2pul)
Solvent: cdcl3
Data collected on: Dec 11 2012
Sample #8, Operator: kangway
 Relax. delay 5.000 sec
 Pulse 45.0 degrees
 Acq. time 2.500 sec
 Width 8000.0 Hz
 32 repetitions
OBSERVE   H1, 499.7049150 MHz
DATA PROCESSING
 Line broadening 0.2 Hz
FT size 65536
Total time 4 min 0 sec
  4.18
  0.86
  1.18
  1.05
  1.01
  1.04
  1.00
  1.00
  1.03
  1.06
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369 Appendix 2 – Spectra Relevant to Chapter 3 
MEK5048-1
 Sample Name:
   MEK5048-1
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/kangway/vnmrsys/data
 Sample directory:
   MEK5048-1
 FidFile: CARBON01
Pulse Sequence: CARBON (s2pul)
Solvent: cdcl3
Data collected on: Dec 11 2012
Sample #8, Operator: kangway
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.042 sec
 Width 31446.5 Hz
 1500 repetitions
OBSERVE  C13, 125.6509051 MHz
DECOUPLE  H1, 499.7074131 MHz
 Power 39 dB
 continuously on
 WALTZ-16 modulated
DATA PROCESSING
 Line broadening 0.5 Hz
FT size 65536
Total time 51 min
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370 Appendix 2 – Spectra Relevant to Chapter 3 
MEK5104
 Sample Name:
   MEK5104
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   MEK5104
 FidFile: PROTON02
Pulse Sequence: PROTON (s2pul)
Solvent: cdcl3
Data collected on: Jan 27 2013
Sample #11, Operator: mkieffer
 Relax. delay 5.000 sec
 Pulse 45.0 degrees
 Acq. time 3.000 sec
 Width 7995.2 Hz
 32 repetitions
OBSERVE   H1, 499.7049152 MHz
DATA PROCESSING
 Line broadening 0.2 Hz
FT size 65536
Total time 4 min 16 sec
  4.27
  0.72
  1.16
  1.01
  1.02
  1.01
  0.94
  1.04
  0.97
  0.99
  1.05
  1.00
  1.04
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  3.05
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371 Appendix 2 – Spectra Relevant to Chapter 3 
MEK5104
 Sample Name:
   MEK5104
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   MEK5104
 FidFile: CARBON02
Pulse Sequence: CARBON (s2pul)
Solvent: cdcl3
Data collected on: Jan 27 2013
Sample #11, Operator: mkieffer
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.043 sec
 Width 31409.5 Hz
 1000 repetitions
OBSERVE  C13, 125.6509024 MHz
DECOUPLE  H1, 499.7074131 MHz
 Power 39 dB
 continuously on
 WALTZ-16 modulated
DATA PROCESSING
 Line broadening 0.5 Hz
FT size 65536
Total time 34 min
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372 Appendix 2 – Spectra Relevant to Chapter 3 
MEK5108
 Sample Name:
   MEK5108
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   MEK5108
 FidFile: PROTON05
Pulse Sequence: PROTON (s2pul)
Solvent: cdcl3
Data collected on: Feb  3 2013
Sample #49, Operator: mkieffer
 Relax. delay 5.000 sec
 Pulse 45.0 degrees
 Acq. time 3.000 sec
 Width 7995.2 Hz
 32 repetitions
OBSERVE   H1, 499.7049152 MHz
DATA PROCESSING
 Line broadening 0.2 Hz
FT size 65536
Total time 4 min 16 sec
  4.14
  1.07
  1.09
  1.04
  1.04
  0.99
  0.99
  0.82
  1.08
  1.10
  2.10
  1.13
  1.08
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373 Appendix 2 – Spectra Relevant to Chapter 3 
MEK5108
 Sample Name:
   MEK5108
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   MEK5108
 FidFile: CARBON01
Pulse Sequence: CARBON (s2pul)
Solvent: cdcl3
Data collected on: Jan 27 2013
Sample #12, Operator: mkieffer
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.043 sec
 Width 31409.5 Hz
 1000 repetitions
OBSERVE  C13, 125.6509053 MHz
DECOUPLE  H1, 499.7074131 MHz
 Power 39 dB
 continuously on
 WALTZ-16 modulated
DATA PROCESSING
 Line broadening 0.5 Hz
FT size 65536
Total time 34 min
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374 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-057-A
 Sample Name:
   KVC15-057-A
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-057-A
 FidFile: PROTON02
Pulse Sequence: PROTON (s2pul)
Solvent: cdcl3
Data collected on: Jan  5 2013
Sample #41, Operator: mkieffer
 Relax. delay 5.000 sec
 Pulse 45.0 degrees
 Acq. time 3.000 sec
 Width 7995.2 Hz
 32 repetitions
OBSERVE   H1, 499.7049149 MHz
DATA PROCESSING
 Line broadening 0.2 Hz
FT size 65536
Total time 4 min 16 sec
  1.74
  0.74
  3.90
  2.16
  1.24
  1.03
  0.98
  1.02
  0.95
  0.96
  0.96
  1.00
  1.00
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375 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-057-A
 Sample Name:
   KVC15-057-A
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-057-A
 FidFile: CARBON01
Pulse Sequence: CARBON (s2pul)
Solvent: cdcl3
Data collected on: Jan  5 2013
Sample #41, Operator: mkieffer
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.043 sec
 Width 31409.5 Hz
 1000 repetitions
OBSERVE  C13, 125.6509044 MHz
DECOUPLE  H1, 499.7074131 MHz
 Power 39 dB
 continuously on
 WALTZ-16 modulated
DATA PROCESSING
 Line broadening 0.5 Hz
FT size 65536
Total time 34 min
ppm
20
40
60
80
100
120
140
160
180
200
 
N
NH
NH O
O
H
H
Bn
M
e
376 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-057-B
 Sample Name:
   KVC15-057-B
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-057-B
 FidFile: PROTON02
Pulse Sequence: PROTON (s2pul)
Solvent: cdcl3
Data collected on: Jan  6 2013
Sample #42, Operator: mkieffer
 Relax. delay 5.000 sec
 Pulse 45.0 degrees
 Acq. time 3.000 sec
 Width 7995.2 Hz
 32 repetitions
OBSERVE   H1, 499.7049152 MHz
DATA PROCESSING
 Line broadening 0.2 Hz
FT size 65536
Total time 4 min 16 sec
  2.18
  0.97
  0.91
  2.06
  2.30
  1.80
  0.96
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  0.93
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377 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-057-B
 Sample Name:
   KVC15-057-B
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-057-B
 FidFile: CARBON01
Pulse Sequence: CARBON (s2pul)
Solvent: cdcl3
Data collected on: Jan  6 2013
Sample #42, Operator: mkieffer
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.043 sec
 Width 31409.5 Hz
 1000 repetitions
OBSERVE  C13, 125.6509053 MHz
DECOUPLE  H1, 499.7074131 MHz
 Power 39 dB
 continuously on
 WALTZ-16 modulated
DATA PROCESSING
 Line broadening 0.5 Hz
FT size 65536
Total time 34 min
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378 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-187
 Sample Name:
   KVC15-187
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-187
 FidFile: PROTON02
Pulse Sequence: PROTON (s2pul)
Solvent: cdcl3
Data collected on: Jan 20 2013
Sample #20, Operator: mkieffer
 Relax. delay 5.000 sec
 Pulse 45.0 degrees
 Acq. time 3.000 sec
 Width 7995.2 Hz
 32 repetitions
OBSERVE   H1, 499.7049149 MHz
DATA PROCESSING
 Line broadening 0.2 Hz
FT size 65536
Total time 4 min 16 sec
  1.73
  0.79
  2.08
  1.05
  4.08
  0.99
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  0.99
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379 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-187
 Sample Name:
   KVC15-187
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-187
 FidFile: CARBON01
Pulse Sequence: CARBON (s2pul)
Solvent: cdcl3
Data collected on: Jan 20 2013
Sample #20, Operator: mkieffer
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.043 sec
 Width 31409.5 Hz
 512 repetitions
OBSERVE  C13, 125.6509053 MHz
DECOUPLE  H1, 499.7074131 MHz
 Power 39 dB
 continuously on
 WALTZ-16 modulated
DATA PROCESSING
 Line broadening 0.5 Hz
FT size 65536
Total time 17 min
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380 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-197
 Sample Name:
   KVC15-197
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-197
 FidFile: PROTON01
Pulse Sequence: PROTON (s2pul)
Solvent: cdcl3
Data collected on: Jan 27 2013
Sample #9, Operator: mkieffer
 Relax. delay 5.000 sec
 Pulse 45.0 degrees
 Acq. time 3.000 sec
 Width 7995.2 Hz
 32 repetitions
OBSERVE   H1, 499.7049047 MHz
DATA PROCESSING
 Line broadening 0.2 Hz
FT size 65536
Total time 4 min 16 sec
  2.21
  0.99
  1.70
  1.03
  2.24
  1.08
  3.14
  1.04
  0.99
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  1.02
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381 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-197
 Sample Name:
   KVC15-197
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-197
 FidFile: CARBON01
Pulse Sequence: CARBON (s2pul)
Solvent: cdcl3
Data collected on: Jan 27 2013
Sample #9, Operator: mkieffer
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.043 sec
 Width 31409.5 Hz
 1000 repetitions
OBSERVE  C13, 125.6509034 MHz
DECOUPLE  H1, 499.7074131 MHz
 Power 39 dB
 continuously on
 WALTZ-16 modulated
DATA PROCESSING
 Line broadening 0.5 Hz
FT size 65536
Total time 34 min
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382 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-057-G
 Sample Name:
   KVC15-057-G
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-057-G
 FidFile: PROTON02
Pulse Sequence: PROTON (s2pul)
Solvent: cdcl3
Data collected on: Jan  6 2013
Sample #43, Operator: mkieffer
 Relax. delay 5.000 sec
 Pulse 45.0 degrees
 Acq. time 3.000 sec
 Width 7995.2 Hz
 32 repetitions
OBSERVE   H1, 499.7049149 MHz
DATA PROCESSING
 Line broadening 0.2 Hz
FT size 65536
Total time 4 min 16 sec
  4.12
  2.11
  1.02
  2.12
  1.09
  2.09
  0.96
  0.96
  1.92
  0.92
  0.95
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383 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-057-G
 Sample Name:
   KVC15-057-G
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-057-G
 FidFile: CARBON01
Pulse Sequence: CARBON (s2pul)
Solvent: cdcl3
Data collected on: Jan  6 2013
Sample #43, Operator: mkieffer
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.043 sec
 Width 31409.5 Hz
 1000 repetitions
OBSERVE  C13, 125.6509044 MHz
DECOUPLE  H1, 499.7074131 MHz
 Power 39 dB
 continuously on
 WALTZ-16 modulated
DATA PROCESSING
 Line broadening 0.5 Hz
FT size 65536
Total time 34 min
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384 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-195
 Sample Name:
   KVC15-195
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-195
 FidFile: PROTON01
Pulse Sequence: PROTON (s2pul)
Solvent: cdcl3
Data collected on: Jan 27 2013
Sample #8, Operator: mkieffer
 Relax. delay 5.000 sec
 Pulse 45.0 degrees
 Acq. time 3.000 sec
 Width 7995.2 Hz
 32 repetitions
OBSERVE   H1, 499.7049152 MHz
DATA PROCESSING
 Line broadening 0.2 Hz
FT size 65536
Total time 4 min 16 sec
  0.97
  1.00
  2.36
  1.04
  4.35
  1.27
  1.05
  1.09
  1.06
  0.93
  0.97
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385 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-195
 Sample Name:
   KVC15-195
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-195
 FidFile: CARBON01
Pulse Sequence: CARBON (s2pul)
Solvent: cdcl3
Data collected on: Jan 27 2013
Sample #8, Operator: mkieffer
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.043 sec
 Width 31409.5 Hz
 1000 repetitions
OBSERVE  C13, 125.6509044 MHz
DECOUPLE  H1, 499.7074131 MHz
 Power 39 dB
 continuously on
 WALTZ-16 modulated
DATA PROCESSING
 Line broadening 0.5 Hz
FT size 65536
Total time 34 min
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386 Appendix 2 – Spectra Relevant to Chapter 3 
MEK5100
 Sample Name:
   MEK5100
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   MEK5100
 FidFile: PROTON02
Pulse Sequence: PROTON (s2pul)
Solvent: cdcl3
Data collected on: Jan 21 2013
Sample #22, Operator: mkieffer
 Relax. delay 5.000 sec
 Pulse 45.0 degrees
 Acq. time 3.000 sec
 Width 7995.2 Hz
 32 repetitions
OBSERVE   H1, 499.7049149 MHz
DATA PROCESSING
 Line broadening 0.2 Hz
FT size 65536
Total time 4 min 16 sec
  0.95
  2.00
  1.11
  1.30
  3.08
  1.01
  1.02
  1.00
  0.98
  1.00
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387 Appendix 2 – Spectra Relevant to Chapter 3 
MEK5100
 Sample Name:
   MEK5100
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   MEK5100
 FidFile: CARBON01
Pulse Sequence: CARBON (s2pul)
Solvent: cdcl3
Data collected on: Jan 21 2013
Sample #22, Operator: mkieffer
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.043 sec
 Width 31409.5 Hz
 1000 repetitions
OBSERVE  C13, 125.6509034 MHz
DECOUPLE  H1, 499.7074131 MHz
 Power 39 dB
 continuously on
 WALTZ-16 modulated
DATA PROCESSING
 Line broadening 0.5 Hz
FT size 65536
Total time 34 min
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388 Appendix 2 – Spectra Relevant to Chapter 3 
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389 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-023
 Sample Name:
   KVC15-023
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-023
 FidFile: PROTON02
Pulse Sequence: PROTON (s2pul)
Solvent: cdcl3
Data collected on: Jan 27 2013
Sample #13, Operator: mkieffer
 Relax. delay 5.000 sec
 Pulse 45.0 degrees
 Acq. time 3.000 sec
 Width 7995.2 Hz
 32 repetitions
OBSERVE   H1, 499.7049149 MHz
DATA PROCESSING
 Line broadening 0.2 Hz
FT size 65536
Total time 4 min 16 sec
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390 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-023
 Sample Name:
   KVC15-023
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-023
 FidFile: CARBON02
Pulse Sequence: CARBON (s2pul)
Solvent: cdcl3
Data collected on: Jan 27 2013
Sample #13, Operator: mkieffer
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.043 sec
 Width 31409.5 Hz
 1000 repetitions
OBSERVE  C13, 125.6509072 MHz
DECOUPLE  H1, 499.7074131 MHz
 Power 39 dB
 continuously on
 WALTZ-16 modulated
DATA PROCESSING
 Line broadening 0.5 Hz
FT size 65536
Total time 34 min
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391 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-213
 Sample Name:
   KVC15-213
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-213
 FidFile: PROTON01
Pulse Sequence: PROTON (s2pul)
Solvent: dmso
Data collected on: Jan 30 2013
Sample #42, Operator: mkieffer
 Relax. delay 5.000 sec
 Pulse 45.0 degrees
 Acq. time 3.000 sec
 Width 7995.2 Hz
 32 repetitions
OBSERVE   H1, 499.7072806 MHz
DATA PROCESSING
 Line broadening 0.2 Hz
FT size 65536
Total time 4 min 16 sec
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392 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-213
 Sample Name:
   KVC15-213
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-213
 FidFile: CARBON01
Pulse Sequence: CARBON (s2pul)
Solvent: dmso
Data collected on: Jan 30 2013
Sample #42, Operator: mkieffer
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.043 sec
 Width 31409.5 Hz
 1500 repetitions
OBSERVE  C13, 125.6515512 MHz
DECOUPLE  H1, 499.7097867 MHz
 Power 39 dB
 continuously on
 WALTZ-16 modulated
DATA PROCESSING
 Line broadening 0.5 Hz
FT size 65536
Total time 51 min
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393 Appendix 2 – Spectra Relevant to Chapter 3 
MEK5077-1
 Sample Name:
   MEK5077-1
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   MEK5077-1
 FidFile: PROTON01
Pulse Sequence: PROTON (s2pul)
Solvent: cdcl3
Data collected on: Jan 14 2013
Sample #48, Operator: mkieffer
 Relax. delay 5.000 sec
 Pulse 45.0 degrees
 Acq. time 3.000 sec
 Width 7995.2 Hz
 32 repetitions
OBSERVE   H1, 499.7049149 MHz
DATA PROCESSING
 Line broadening 0.2 Hz
FT size 65536
Total time 4 min 16 sec
  0.88
  2.00
  2.00
  0.98
  0.98
  0.99
  2.04
  1.02
  9.19
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394 Appendix 2 – Spectra Relevant to Chapter 3 
MEK5077-1
 Sample Name:
   MEK5077-1
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   MEK5077-1
 FidFile: CARBON01
Pulse Sequence: CARBON (s2pul)
Solvent: cdcl3
Data collected on: Jan 14 2013
Sample #48, Operator: mkieffer
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.043 sec
 Width 31409.5 Hz
 1000 repetitions
OBSERVE  C13, 125.6509044 MHz
DECOUPLE  H1, 499.7074131 MHz
 Power 39 dB
 continuously on
 WALTZ-16 modulated
DATA PROCESSING
 Line broadening 0.5 Hz
FT size 65536
Total time 34 min
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395 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-107
 Sample Name:
   KVC15-107
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-107
 FidFile: PROTON01
Pulse Sequence: PROTON (s2pul)
Solvent: cdcl3
Data collected on: Jan  6 2013
Sample #44, Operator: mkieffer
 Relax. delay 5.000 sec
 Pulse 45.0 degrees
 Acq. time 3.000 sec
 Width 7995.2 Hz
 32 repetitions
OBSERVE   H1, 499.7049149 MHz
DATA PROCESSING
 Line broadening 0.2 Hz
FT size 65536
Total time 4 min 16 sec
  0.99
  1.12
  1.03
  1.04
  0.96
  0.95
  0.98
  0.97
  1.02
  0.74
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396 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-107
 Sample Name:
   KVC15-107
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-107
 FidFile: CARBON01
Pulse Sequence: CARBON (s2pul)
Solvent: cdcl3
Data collected on: Jan  6 2013
Sample #44, Operator: mkieffer
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.043 sec
 Width 31409.5 Hz
 1000 repetitions
OBSERVE  C13, 125.6509044 MHz
DECOUPLE  H1, 499.7074131 MHz
 Power 39 dB
 continuously on
 WALTZ-16 modulated
DATA PROCESSING
 Line broadening 0.5 Hz
FT size 65536
Total time 34 min
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397 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-291
 Sample Name:
   KVC15-291
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/kangway/vnmrsys/data
 Sample directory:
   KVC15-291
 FidFile: PROTON02
Pulse Sequence: PROTON (s2pul)
Solvent: cdcl3
Data collected on: Feb 27 2013
Sample #4, Operator: kangway
 Relax. delay 5.000 sec
 Pulse 45.0 degrees
 Acq. time 3.000 sec
 Width 8000.0 Hz
 32 repetitions
OBSERVE   H1, 499.7049151 MHz
DATA PROCESSING
 Line broadening 0.2 Hz
FT size 65536
Total time 4 min 16 sec
  1.03
  1.13
  1.02
  2.07
  2.02
  1.00
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  3.08
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398 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-291
 Sample Name:
   KVC15-291
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/kangway/vnmrsys/data
 Sample directory:
   KVC15-291
 FidFile: CARBON01
Pulse Sequence: CARBON (s2pul)
Solvent: cdcl3
Data collected on: Feb 27 2013
Sample #4, Operator: kangway
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.042 sec
 Width 31446.5 Hz
 1000 repetitions
OBSERVE  C13, 125.6509033 MHz
DECOUPLE  H1, 499.7074131 MHz
 Power 39 dB
 continuously on
 WALTZ-16 modulated
DATA PROCESSING
 Line broadening 0.5 Hz
FT size 65536
Total time 34 min
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399 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-297
 Sample Name:
   KVC15-297
 Data Collected on:
   fid.caltech.edu-inova600
 Archive directory:
 Sample directory:
 FidFile: KVC15-297-Final
Pulse Sequence: PROTON (s2pul)
Solvent: cd3od
Data collected on: Mar  2 2013
 Temp. 25.0 C / 298.1 K
Operator: hwwang
 Relax. delay 5.000 sec
 Pulse 45.0 degrees
 Acq. time 1.705 sec
 Width 9611.9 Hz
 32 repetitions
OBSERVE   H1, 599.6380902 MHz
DATA PROCESSING
FT size 32768
Total time 3 min 35 sec
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  1.99
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400 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-297
 Sample Name:
   KVC15-297
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/kangway/vnmrsys/data
 Sample directory:
   KVC15-297
 FidFile: CARBON02
Pulse Sequence: CARBON (s2pul)
Solvent: cd3od
Data collected on: Mar  2 2013
Sample #46, Operator: kangway
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.042 sec
 Width 31446.5 Hz
 5000 repetitions
OBSERVE  C13, 125.6512180 MHz
DECOUPLE  H1, 499.7093819 MHz
 Power 39 dB
 continuously on
 WALTZ-16 modulated
DATA PROCESSING
 Line broadening 0.5 Hz
FT size 65536
Total time 2 hr, 50 min
ppm
20
40
60
80
100
120
140
160
180
200
 
N
NH
N O
O
H H
H
NH
N
NH
O
O
H
H
401 Appendix 2 – Spectra Relevant to Chapter 3 
KVC16-015
(+)-Naseseazine B
 Sample Name:
   KVC16-015
 Data Collected on:
   fid.caltech.edu-inova600
 Archive directory:
 Sample directory:
 FidFile: KVC16-015
Pulse Sequence: PROTON (s2pul)
Solvent: dmso
Data collected on: Mar  5 2013
 Temp. 25.0 C / 298.1 K
Operator: yeomanjo
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.708 sec
 Width 9594.6 Hz
 20 repetitions
OBSERVE   H1, 599.6385703 MHz
DATA PROCESSING
FT size 32768
Total time 5 min 47 sec
  0.94
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402 Appendix 2 – Spectra Relevant to Chapter 3 
KVC16-017
 Sample Name:
   KVC16-017
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/kangway/vnmrsys/data
 Sample directory:
   KVC16-017
 FidFile: CARBON01
Pulse Sequence: CARBON (s2pul)
Solvent: dmso
Data collected on: Mar  5 2013
Sample #33, Operator: kangway
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.042 sec
 Width 31446.5 Hz
 3000 repetitions
OBSERVE  C13, 125.6515529 MHz
DECOUPLE  H1, 499.7097867 MHz
 Power 39 dB
 continuously on
 WALTZ-16 modulated
DATA PROCESSING
 Line broadening 0.5 Hz
FT size 65536
Total time 1 hr, 42 min
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403 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-105
 Sample Name:
   KVC15-105
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-105
 FidFile: PROTON01
Pulse Sequence: PROTON (s2pul)
Solvent: cdcl3
Data collected on: Jan  5 2013
Sample #40, Operator: mkieffer
 Relax. delay 5.000 sec
 Pulse 45.0 degrees
 Acq. time 3.000 sec
 Width 7995.2 Hz
 32 repetitions
OBSERVE   H1, 499.7049149 MHz
DATA PROCESSING
 Line broadening 0.2 Hz
FT size 65536
Total time 4 min 16 sec
  0.97
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404 Appendix 2 – Spectra Relevant to Chapter 3 
KVC15-105
 Sample Name:
   KVC15-105
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-105
 FidFile: CARBON01
Pulse Sequence: CARBON (s2pul)
Solvent: cdcl3
Data collected on: Jan  5 2013
Sample #40, Operator: mkieffer
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.043 sec
 Width 31409.5 Hz
 256 repetitions
OBSERVE  C13, 125.6509120 MHz
DECOUPLE  H1, 499.7074131 MHz
 Power 39 dB
 continuously on
 WALTZ-16 modulated
DATA PROCESSING
 Line broadening 0.5 Hz
FT size 65536
Total time 8 min 45 sec
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405 Appendix 2 – Spectra Relevant to Chapter 3 
 Sample Name:
   KVC15-293
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-293
 FidFile: PROTON02
Pulse Sequence: PROTON (s2pul)
Solvent: cd3od
Data collected on: Mar  3 2013
Sample #7, Operator: mkieffer
 Relax. delay 5.000 sec
 Pulse 45.0 degrees
 Acq. time 3.000 sec
 Width 8000.0 Hz
 32 repetitions
OBSERVE   H1, 499.7068814 MHz
DATA PROCESSING
 Line broadening 0.2 Hz
FT size 65536
Total time 4 min 16 sec
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406 Appendix 2 – Spectra Relevant to Chapter 3 
 Sample Name:
   KVC15-293
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC15-293
 FidFile: CARBON01
Pulse Sequence: CARBON (s2pul)
Solvent: cd3od
Data collected on: Mar  3 2013
Sample #7, Operator: mkieffer
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.042 sec
 Width 31446.5 Hz
 1000 repetitions
OBSERVE  C13, 125.6512209 MHz
DECOUPLE  H1, 499.7093819 MHz
 Power 39 dB
 continuously on
 WALTZ-16 modulated
DATA PROCESSING
 Line broadening 0.5 Hz
FT size 65536
Total time 34 min
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407 Appendix 2 – Spectra Relevant to Chapter 3 
KVC16-019
(+)-Naseseazine A
 Sample Name:
   KVC16-019
 Data Collected on:
   fid.caltech.edu-inova600
 Archive directory:
   /home/antond/vnmrsys/data
 Sample directory:
   KVC16-019
 FidFile: PROTON02
Pulse Sequence: PROTON (s2pul)
Solvent: cd3od
Data collected on: Mar  5 2013
 Temp. 25.0 C / 298.1 K
Operator: antond
 Relax. delay 5.000 sec
 Pulse 45.0 degrees
 Acq. time 1.705 sec
 Width 9611.9 Hz
 32 repetitions
OBSERVE   H1, 599.6380891 MHz
DATA PROCESSING
FT size 32768
Total time 3 min 35 sec
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408 Appendix 2 – Spectra Relevant to Chapter 3 
KVC16-019
 Sample Name:
   KVC16-019
 Data Collected on:
   indy.caltech.edu-inova500
 Archive directory:
   /home/mkieffer/vnmrsys/data
 Sample directory:
   KVC16-019
 FidFile: CARBON01
Pulse Sequence: CARBON (s2pul)
Solvent: cd3od
Data collected on: Mar  5 2013
Sample #8, Operator: mkieffer
 Relax. delay 1.000 sec
 Pulse 45.0 degrees
 Acq. time 1.042 sec
 Width 31446.5 Hz
 1500 repetitions
OBSERVE  C13, 125.6512190 MHz
DECOUPLE  H1, 499.7093819 MHz
 Power 39 dB
 continuously on
 WALTZ-16 modulated
DATA PROCESSING
 Line broadening 0.5 Hz
FT size 65536
Total time 51 min
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409 Appendix 2 – Spectra Relevant to Chapter 3 
KVC16-019
(+)-Naseseazine A
 Sample Name:
   KVC16-019
 Data Collected on:
   fid.caltech.edu-inova600
 Archive directory:
   /home/antond/vnmrsys/data
 Sample directory:
   KVC16-019
 FidFile: PROTON01
Pulse Sequence: PROTON (s2pul)
Solvent: dmso
Data collected on: Mar  5 2013
 Temp. 25.0 C / 298.1 K
Operator: antond
 Relax. delay 5.000 sec
 Pulse 45.0 degrees
 Acq. time 1.705 sec
 Width 9611.9 Hz
 32 repetitions
OBSERVE   H1, 599.6385641 MHz
DATA PROCESSING
FT size 32768
Total time 3 min 35 sec
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410 Appendix 2 – Spectra Relevant to Chapter 3 
KVC16-019
(+)-Naseseazine A
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Chapter 4 
 
A Mild and General Larock Indolization Protocol for the Synthesis of 
Unnatural Tryptophan Derivatives: Total Synthesis of (–)-Aspergilazine 
A.† 
 
 
4.1 INTRODUCTION 
The Pd(0)-catalyzed heteroannulation of disubstituted alkynes and 2-haloanilines, 
widely known as the Larock indole synthesis, is a powerful method for the preparation of 
structurally complex 2,3-disubstituted indoles that has found tremendous utility in 
accessing indole building blocks, unnatural tryptophan derivatives, and indole-containing 
natural products.1,2,3,4 Mechanistically, it is expected to proceed through an active Pd(0) 
catalyst which can then undergo oxidative addition into 2-iodoaniline 188. Coordination 
of an internal alkyne to adduct 190, followed by migratory insertion and reductive 
elimination furnishes the indole product 189 and regenerates the Pd(0) catalyst. To date, 
Larock’s original conditions – which couple an o-iodoaniline to an internal alkyne in the 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
† Portions of this chapter have been reproduced from submitted studies (Chuang, K. V.; Kieffer, M. E.; 
Reisman, S. E. submitted) and the supporting information found therein. Work was conducted in 
collaboration with Kangway V. Chuang. 
Chapter 4 – A Mild and General Larock Indolization Protocol for the Synthesis of Unnatural 
Tryptophan Derivatives: Total Synthesis of (–)-Aspergilazine A 
412 
presence of a “ligandless” Pd-catalyst, an inorganic base, and a chloride additive – still 
remain the most widely employed.5  
Scheme 4.1. The Larock indole synthesis catalytic cycle 
 
 
Despite the broad utility of the Larock indole synthesis, a surprisingly small 
portion of the literature has been dedicated to improving reaction conditions and 
expanding the substrate scope. From the standpoint of transition-metal catalysis, 
significant challenges remain, as the application of this reaction in the presence of more 
complex functionality requires increased catalyst loadings and reaction times due to 
diminished catalytic activity and poor catalyst turnover. These challenges were 
highlighted in our synthesis of (+)-naseseazines A and B (Chapter 3).6 Specifically, low 
reactivity was observed with substoichiometric amounts of Pd catalyst, whereas use of 
higher Pd-loadings or more forcing conditions resulted in competitive 
hydrodehalogenation, problematic epimerization of the diketopiperazine, poor 
regioselectivity, and low mass recovery. This chapter describes our efforts to better 
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understand the intricacies of this transformation to aid in the development of a modified 
Larock indolization protocol. The mild procedure described herein enables the coupling 
of 2-bromoanilines with high functional group compatibility to provide structurally 
complex and synthetically useful indoles. 
 
4.1.1  The Larock Indole Synthesis in Natural Products 
 
 Following its initial disclosure in 1991, the Larock indole synthesis has been 
beautifully employed in a variety of total syntheses. Elegant examples from the Baran lab 
demonstrate the ability to quickly advance iodoaniline substrates 194 and 196 to highly 
functionalized intermediates en route to natural products such as psychotrimine and (+)-
kapakahine B.3 Despite the impressive and rapid generation of substrate complexity, 
these examples highlight the limitations of this catalyst system in tolerating 
functionalized substrates. For example, in their synthesis of kapakahine B, 20 mol % 
Pd(OAc)2 is necessary to effect two productive turnovers on a complex iodoaniline 
substrate (Scheme 4.2, b). Generally, increased substrate complexity, especially with 
respect to polar functionality and epimerizable centers, necessitates increased catalyst 
loadings and reaction times, and typically results in lower product yields.  
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Scheme 4.2. Iodoanilines in natural product synthesis 
 
 It was not until 2004 that modifications to Larock’s original conditions allowed 
for the successful implementation of bromo- and chloro-electrophiles. Employing 10 mol 
% of bidentate phosphine ligand 1,1’bis(di-tert-butylphosphino)ferrocene at elevated 
temperatures (110 – 130 °C), Senanayake and co-workers found that haloaniline 
substrates underwent smooth reaction to provide simple indoles in moderate to good 
yields (Scheme 4.3).7  
Scheme 4.3. Larock modfications to include bromo- and chloroelectrophiles. 
 
 
 Boger and co-workers have further explored the application of this phosphine 
ligand and bromoanilines in the context of total synthesis.4 Utilizing a strategic 
intramolecular Larock reaction to assemble the key macrocyclic framework (200), early 
efforts resulted in poor mass recovery, competitive hydrodechlorination, and undesired 
epimerization of several critical α-stereocenters. Only after extensive optimization and 
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use of superstoichiometric Pd-catalyst and ligand were high yields obtained (Scheme 4.4, 
a). In a follow-up report, a catalytic Larock macrocyclization reaction was reported using 
15 mol % Pd(OAc)2 and 30 mol % ligand at 130 °C, but only substrates without polar 
functionality and epimerizable centers are competent  in this transformation.4 
 Scheme 4.4. Bromoanilines as electrophiles for the Larock indole synthesis 
 
 
 
 
4.2 REACTION DESIGN 
Our synthesis of (+)-naseseazines A and B constitutes the first catalytic Larock 
indolization on a bromoaniline in the context of total synthesis. We wondered whether 
these conditions could be further improved to create a low temperature, mild, and general 
protocol for the indolization of 2-bromoaniline starting materials, which serve as more 
desirable substrates due to their increased ease of synthesis as well as commercial 
availability compared to 2-iodoanilines. Specifically, we aimed to develop conditions 
compatible with highly functionalized substrates in order to directly access tryptophan 
derivatives. We hoped to identify conditions that would 1) increase substrate scope by 
enabling less reactive 2-bromoaniline substrates; 2) proceed with synthetically useful 
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catalyst loadings; and 3) deliver products at lower temperatures in order to mitigate 
deleterious side reactivity. To accomplish this, we sought to understand why Pd[P(o-
tol)3]2, our optimal catalyst in the preparation of the (+)-naseseazines, appeared to be 
uniquely effective in catalyzing our desired transformation. 
In assessing the existing limitations of the Larock indolization, we rationalized 
that the poor reactivity of 2-bromoanilines under Larock’s ligandless conditions was 
likely due to slow rates of oxidative addition. Although this elementary step could be 
easily remedied by the addition of an electron-donating phosphine ligand, we recognized 
that the limited success of this approach might be due to diminished rates of alkyne 
insertion due to coordinative saturation of Pd.8 We hypothesized that the use of sterically 
demanding phosphines, such as P(o-tol)3 and P(tBu)3, which have been demonstrated to 
proceed via Pd-monophosphine rather than Pd-bisphosphine intermediates as the active 
catalyst, may serve to balance these opposing factors by providing a vacant coordination 
site to facilitate alkyne insertion (Scheme 4.5).9  
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Scheme 4.5. Improving the Larock indole synthesis 
 
 
4.3 REACTION OPTIMIZATION 
With the goal of identifying conditions tolerant of more complex functionality, we 
elected to study the coupling of 2-bromoaniline (203a) and alkyne 204a10 to afford 2-
triethylsilyl-Boc-Trp-OMe (205a). Treatment with 5 mol % Pd(OAc)2 with Na2CO3 at 
100 °C, Larock’s original conditions, surprisingly provided 27% yield of the desired 
coupling product. Turning our attention to the addition of phosphine ligands, the addition 
of 11 mol % PPh3, PCy3, DavePhos, or the dtbpf, the optimal ligand in Senanayake’s 
report, suppressed the desired reactivity (entries 2–5). Returning to the preformed 
complex Pd[P(o-tol)3]2, our most successful catalyst in the synthesis of the (+)-
naseseazines, we were gratified to obtain 70% yield of the desired product. Moreover, by 
increasing the steric demand through the use of Pd[P(tBu)3]2, a yield increase to 78% was 
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observed. We next investigated whether this reaction was competent at decreased 
temperatures. Lowering the temperature to 60 °C enabled a clean reaction and provided 
the product in an improved 85% yield (entry 8). To the best of our knowledge, this 
reaction represents the lowest temperature Larock indolization of any 2-haloaniline 
previously reported in the literature. Additionally, a soluble organic base (Cy2NMe), and 
non-polar solvent could also be employed without loss in reaction efficiency (entries 9 
and 10). Finally, in support of a highly active, Pd-monophosphine complex, use of a 1:1 
[Pd]/L ratio generated by the addition of Pd2(dba)3 and P(tBu)3 offered improved initial 
rates of the reaction (entry 11). However, application of this catalyst system did not 
significantly reduce the overall reaction time, and furnished in the product in nearly 
identical yield. Although these final variations did not significantly affect yield, these 
data illustrate the robust nature of the active catalyst, as well as flexibility in the reaction 
conditions that may prove useful in individual substrate optimization. For simplicity of 
reaction setup, we elected to conduct our scope studies using the air-stable and crystalline 
Pd[P(tBu)3]2. 
  
Chapter 4 – A Mild and General Larock Indolization Protocol for the Synthesis of Unnatural 
Tryptophan Derivatives: Total Synthesis of (–)-Aspergilazine A 
419 
Table 4.1. Optimization Studies 
 
entry [Pd cat.] ligand base temp (°C) yield (%)b 
1 Pd(OAc)2 – Na2CO3 100 27 
2 Pd(OAc)2 PPh3 Na2CO3 100 17 
3 Pd(OAc)2 DavePhos Na2CO3 100 8 
4 Pd(OAc)2 PCy3 Na2CO3 100 <5 
5 Pd(OAc)2 dtbpf Na2CO3 100 <5 
6 Pd[P(o-tol)3]2 – Na2CO3 100 70 
7 Pd[P(tBu)3]2 – Na2CO3 100 78 
8 Pd[P(tBu)3]2 – Na2CO3 60 85 
9 Pd[P(tBu)3]2 – Cy2NMe 60 85 
10e Pd[P(tBu)3]2 – Cy2NMe 60 84 (87)d 
11 e Pd2(dba)3 P(tBu)3 Cy2NMe 60 83 
a Reactions conducted on 0.1 mmol scale with 2.0 equiv alkyne 204a and 2.5 equiv base in DMF (0.5 mL). 
b Yield determined by 1H NMR analysis of the crude reaction mixture relative to an internal standard. c 1:1 
[Pd]/ligand used. d Isolated yield on 0.3 mmol scale. e Reaction performed in 1,4-dioxane. 
 
4.4 REACTION SCOPE 
4.4.1  Bromoaniline scope 
 
As shown in Table 4.2, the reaction exhibits excellent scope; both electron-rich 
(205a–205d) and electron-deficient (205e–205l) substrates react efficiently to provide a 
structurally diverse array of unnatural tryptophan derivatives. Substitution is readily 
tolerated at all positions of the indole, including the indole nitrogen, although the 
preparation of sterically demanding 4-substituted indoles requires slightly elevated 
temperatures to improve reaction rates (205c and 205l). Halogenated substrates perform 
with excellent chemoselectivity for the aryl bromide over potentially reactive aryl 
chloride functionality, and a variety of useful chlorinated (205f, 205g, 205l) and 
fluorinated (205e, 205j) tryptophans are readily accessed. Remarkably, even additional 
bromide functionality can be tolerated to provide bromotrytophan 205h.  Furthermore, 
we were pleased to find that Lewis-basic heterocycles also perform well under these 
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conditions (205n and 205o). It is noteworthy that tryptophan 205o, readily prepared here 
in two steps from commercially available materials, has recently been reported as a new 
fluorescent probe with interesting photophysical properties.11 Finally, these conditions are 
also readily extended to 2-bromophenol to provide direct access to a substituted 
benzofuran derivative (205t). Importantly, chiral SFC analysis verified that this reaction 
proceeds without deleterious racemization, providing all products in enantiopure form. 
The 2-triethylsilyl group is easily removed using aqueous acid or fluoride sources, or 
alternatively can serve as a useful functional handle for a variety of transformations.12 
Table 4.2. Bromoaniline scope 
 
a Reactions conditions: Substituted 2-bromoaniline, alkyne (2.0 equiv), Cy2NMe (2.5 equiv) in 1,4-dioxane 
(0.2 M) at 60 °C.  Isolated yields are reported. b Reaction performed at 80 °C. c To facilitate purification, 
desilylation with 1 M TBAF or 1 N HCl in MeOH was performed prior to chromatography. 
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To investigate the scope of the alkyne, several dipeptide-and diketopiperazine-
based substrates were prepared and subjected to the reaction conditions (Table 4.3). In all 
cases, the products are obtained in good yields and with no observed epimerization of the 
α-stereocenters. Excellent functional group tolerance is demonstrated by the preparation 
of 205y in 86% yield. Although the focus of this study was the coupling of peptide-based 
alkynes, simple alkynes such as TMS-phenyl acetylene can also be used (3z), reacting 
under considerably milder conditions than those previously reported.13  
Table 4.3. Alkyne scope 
 
a Reactions conditions: 203a (1.0 equiv), 204 (2.0 equiv), CyNMe (2.5 equiv), in 1,4-
dioxane (0.2 M) at 60 °C. Isolated yields are reported. b Reaction performed at 80 °C. 
 
4.4.3  Scale-up Reaction 
 
The synthetic studies described above utilized 5 mol % catalyst for operational 
simplicity; however, individual couplings can be reoptimized for preparatively useful 
scales with lower catalyst loadings. For example, the coupling between 3-bromo-2-
aminopyridine (203n) and alkyne 204a was carried out on 5 mmol scale using 2.5 mol % 
Pd[P(tBu)3]2 and 1.5 equiv alkyne, which upon quenching with 1M TBAF in THF to 
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effect protodesilylation, provided 1.28 g (80% yield) of N-Boc-7-aza-tryptophan methyl 
ester 206 (Scheme 4.6). 
Scheme 4.6. Reaction scale-up 
 
 
 
4.5 TOTAL SYNTHESIS OF (–)-ASPERGILAZINE A 
4.5.1  Previous Synthesis of (–)-Aspergilazine A 
 
With optimized conditions in hand, we set out to demonstrate the versatility and 
efficiency of this transformation through the total synthesis of (–)-aspergilazine A. (–)-
aspergilazine A is (bis)diketopiperazine-containing indole natural product with a 
distinctive C6–N1 linkage.14 First synthesized in 2014, Sperry and co-workers adopted a 
traditional approach utilizing a protecting group strategy.15 In six-steps, they are able to 
synthesize Boc-protected 6-bromo tryptophan 207 via enzymatic resolution, which upon 
subjection to 30 mol % [Pd] and 60 mol % Xphos, undergoes C–N bond formation. 
Trifluoroacetic acid mediated removal of the Boc-protecting group then affords the 
natural product. 
Scheme 4.6. Sperry’s synthesis of (–)-aspergilazine A 
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4.5.2  Our Synthesis of (–)-Aspergilazine A 
 
Retrosynthetically, we imagined a slightly more direct disconnection that could 
highlight our newly developed methodology. We proposed a disconnection through both 
tryptophan indoles via a sequential Larock indolization between known diketopiperazine 
209 and diarylamine 210. We hoped to synthesize diarylamine 210 using a selective 
Buchwald-Hartwig reaction of 1-bromo-2-iodobenzene (211) and commercially-available 
4-bromo-1,2-diaminobenzene (212). Importantly, the success of this strategy hinges 
largely on the ability of this new protocol to enable the coupling of 2-bromoanilines; the 
preparation of the diiodinated analog of diarylamine 210 via C–N bond formation is a 
considerably more challenging synthetic undertaking.  
Scheme 4.7. Retrosynthetic analysis of (–)-aspergilazine A 
 
 
To this end, the requisite bis-bromoaniline (210) was readily prepared via 
coupling of 1-bromo-2-iodobenzene with 4-bromo-m-phenylenediamine (212). 16 
Subjection of a mixture of dibromide 210 and alkyne 209 to 10 mol % Pd[P(tBu)3] and 
2.5 equiv of Cy2NMe in 1,4-dioxane at 80 °C furnished bis-triethylsilyl-(–)-aspergilazine 
A in 62% isolated yield, representing an average reaction efficiency of 79% per 
indolization. Subsequent HCl-mediated desilylation cleanly provided the natural product. 
This highly convergent synthesis underscores the utility of this methodology in the direct 
preparation of complex molecular scaffolds. 
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Scheme 4.8. Total synthesis of (–)-aspergilazine A 
 
4.6 CONCLUSION 
In summary, this chapter describes the development of a mild and general 
protocol for the Pd-catalyzed synthesis of functionalized tryptophan derivatives. The 
reaction proceeds with low catalyst loadings, displays excellent substrate scope, and is 
readily scalable to provide gram quantities of synthetically useful indoles and unnatural 
tryptophans. Furthermore, the synthetic utility of this transformation has been 
demonstrated in the concise synthesis of the natural product (–)-aspergilazine A. We 
anticipate that this versatile protocol will find broad applicability in the preparation of 
complex indole and tryptophan scaffolds, and provide efficient entry to a broad array of 
natural products.  
4.7 EXPERIMENTAL SECTION 
4.7.1  Materials and Methods 
 
Unless otherwise stated, reactions were performed under a nitrogen atmosphere 
using freshly dried solvents. Tetrahydrofuran (THF), methylene chloride (CH2Cl2), 
acetonitrile (MeCN), dimethylformamide (DMF), and toluene (PhMe) were dried by 
passing through activated alumina columns. 1,4-Dioxane was dried by passing through 
activated alumina columns or purchased from Sigma-Aldrich (>99.8%, anhydrous). 
HN
N
O
O
H
TES
H
I
NH2
NH2 NH2
Br
N
Br
H
N
HN N
HN
O
O
N
H
N
O
O
H
H
H
H
Br
Pd2(dba)3 (1 mol %)
rac-BINAP (2 mol %)
(+)-aspergilazine A (208)
Br
211
(1.0 equiv)
212
(1.2 equiv)
NaOtBu (2.0 equiv)
PhMe, 70 °C
(75% yield)
1. Pd[P(tBu)3]2 (10 mol %)
    Cy2NMe, 1,4-dioxane, 80 °C
    (62% yield)
2. 1N HCl/MeOH, 23 °C
    (74% yield)
+
210
209
(3 equiv)
Chapter 4 – A Mild and General Larock Indolization Protocol for the Synthesis of Unnatural 
Tryptophan Derivatives: Total Synthesis of (–)-Aspergilazine A 
425 
Triethylamine (Et3N), diisopropylamine (i-Pr2NH), diisopropylethylamine (i-Pr2NEt), 
and dicyclohexylmethylamine (Cy2NMe) were distilled over calcium hydride prior to 
use. Unless otherwise stated, chemicals and reagents were used as received. All reactions 
were monitored by thin-layer chromatography using EMD/Merck silica gel 60 F254 pre-
coated plates (0.25 mm) and were visualized by UV, p-anisaldehyde, or KMnO4 staining. 
Flash column chromatography was performed either as described by Still et al. using 
silica gel (particle size 0.032-0.063) purchased from Silicyle. Optical rotations were 
measured on a Jasco P-2000 polarimeter using a 100 mm path-length cell at 589 nm. 1H 
and 13C NMR spectra were recorded on a Varian 400 MR (at 400 MHz and 101 MHz, 
respectively), a Varian Inova 500 (at 500 MHz and 126 MHz, respectively), or a Varian 
Inova 600 (at 600 MHz and 150 MHz, respectively), and are reported relative to internal 
CHCl3 (1H, δ = 7.26), MeCN (1H, δ = 1.94), or DMSO (1H, δ = 2.50), and CDCl3 (13C, δ 
= 77.0), MeCN (13C, δ = 118.26), or DMSO (13C, δ = 40.0). Data for 1H NMR spectra are 
reported as follows: chemical shift (δ ppm) (multiplicity, coupling constant (Hz), 
integration). Multiplicity and qualifier abbreviations are as follows: s = singlet, d = 
doublet, t = triplet, q = quartet, m = multiplet, br = broad, app = apparent. IR spectra were 
recorded on a Perkin Elmer Paragon 1000 spectrometer and are reported in frequency of 
absorption (cm–1). Preparatory HPLC was performed with either an Agilent 1200 Series 
HPLC utilizing an Agilent XDB-C18 5µm column (30 x 250 mm). Analytical SFC was 
performed with a Mettler SFC supercritical CO2 analytical chromatography system with 
Chiralcel AD-H column (4.6 mm x 25 cm). HRMS were acquired using an Agilent 6200 
Series TOF with an Agilent G1978A Multimode source in electrospray ionization (ESI), 
atmospheric pressure chemical ionization (APCI), or mixed (MM) ionization mode. 
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4.7.2  Preparation of haloaniline substrates 
 
Bromoaniline 203o 
 
6-bromoquinoline was purchased from Combi-Blocks and nitrated using a known 
procedure.  5-nitro,6-bromo-quinloline (500 mg, 2.0 mmol, 1.0 equiv) was dissolved in 
MeOH (6 mL).  Fe powder (331 mg, 5.9 mmol, 3.0 equiv) and concentrated HCl (2 mL) 
were added and the reaction was heated to 50 °C for 1 h.  Upon cooling, the reaction was 
basified with NH4OH to pH 9, filtered through celite, and extracted with EtOAc (2X, 10 
mL).  The combined organic layers were washed with brine, dried over Na2SO4, filtered 
and concentrated in vacuo.  The crude material was purified by chromatography on silica 
gel (40% acetone, 60% hexanes) to provide a light yellow, amorphous solid (300 mg, 1.3 
mmol, 68% yield). 
1H NMR (500 MHz, CDCl3) δ 8.90 (dd, J = 4.2, 1.6 Hz, 1H), 8.16 (ddd, J = 
8.6, 1.5, 0.9 Hz, 1H), 7.72 (d, J = 9.0 Hz, 1H), 7.45 (dd, J = 9.0, 0.7 Hz, 1H), 
7.39 (dd, J = 8.6, 4.2 Hz, 1H) , 4.68 (s, 2H); 13C NMR (126 MHz, CDCl3) δ 150.31, 
148.1, 139.6, 133.3, 129.4, 120.7, 120.2, 118.7, 104.3; FTIR (NaCl, thin film): cm-1; 
3423, 3297, 3162, 1635, 1581, 1569, 1457, 1398, 1357, 1323; HRMS (MM) calc’d 
[M+H]+ 222.9865, found 222.9862. 
 
Bromoaniline 203m 
N
Br H2SO4, HNO3
NaNO2 (cat)
N
Br
NO2
Fe, conc. HCl
MeOH
50 °C N
Br
NH2
203o(83% yield) (68% yield)
N
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In a glovebox, a 2 dram vial was charged with 4-iodo,2-bromoaniline 
(500 mg, 1.7 mmol, 1.0 equiv), Pd(dppf)Cl2•CH2Cl2 (69 mg, 0.08 mmol, 
0.05 equiv), bis(pinacolato)diboron (448 mg, 1.8 mmol, 1.05 equiv), KOAc (557 mg, 5.9 
mmol (3.5 equiv), and DMSO (5 mL).  The vial was sealed, removed from the glove box 
and heated to 80 °C.  After 24 h, the reaction was cooled, filtered through celite and 
flushed with ethyl acetate.  This mixture was then washed with water (3 X), dried 
Na2SO4, filtered and concentrated.  The crude reaction mixture was purified by 
chromatography on silica gel (10% ethyl acetate, 90% hexanes) to give white, amorphous 
solid 203m (315 mg, 1.1 mmol, 63% yield). 
1H NMR (500 MHz, CDCl3) δ 7.86 (d, J = 1.3 Hz, 1H), 7.52 (dd, J = 7.9, 1.4 Hz, 1H), 
6.72 (d, J = 7.9 Hz, 1H), 1.32 (s, 12H); 13C NMR (126 MHz, CDCl3) δ146.6, 139.2, 
135.0, 114.8, 108.8, 83.58, 24.8 (carbon adjacent to Boron was not observed); FTIR 
(NaCl, thin film): cm-1; 3477, 3368, 2977, 2930, 1616, 1594, 1385, 1372, 1319, 1143, 
1098; HRMS (MM) calc’d [M+H]+ 297.0645, found 297.0637. 
4.7.3  Preparation of alkyne substrates 
 
Alkyne 204a 
Alkyne 204a was prepared on decagram scale according to the procedure 
reported by Baran and co-workers.  
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 Methyl ester 204a (1.02 g, 3.0 mmol, 1.00 equiv) was dissolved in a 5:1 mixture 
of CH2Cl2:TFA (20 mL) .  After one hour, the reaction was concentrated and dissolved in 
34 mL CH2Cl2.  The solution was cooled to 0 °C under a positive pressure of N2 and  
EDC•HCl (0.862 g, 4.5 mmol, 1.50 equiv), HOBt•H2O (0.680 g, 4.5 mmol, 1.50 equiv) 
and Et3N (1.88 mL, 13.5 mmol, 4.5 equiv) were added sequentially. The mixture was 
then stirred for 5 minutes, and Boc–D–phenylalanine (1.59 g, 6.0 mmol, 2.0 equiv) was 
added. The reaction was slowly warmed to 23 °C over 2 hours and stirring continued for 
20 hours. The reaction was then quenched with 1 N HCl (500 mL) and extracted with 
EtOAc (3 x 250 mL), then the combined organics washed with saturated aqueous 
NaHCO3 (500 mL), and aqueous layer back extracted with EtOAc (200 mL). The 
combined organic layers were then dried over anhydrous Na2SO4, filtered, and 
concentrated in vacuo to afford crude dipeptide as a viscous oil. 
 The residue was then dissolved in CH2Cl2 (50 mL), and trifluoroacetic acid (15 
mL) was added dropwise by addition funnel at room temperature over 10 minutes. 
Stirring was continued for 20 minutes, then the solution diluted with toluene (100 mL) 
and the mixture concentrated in vacuo to afford a thick oil. The residue was then 
redissolved in MeOH (35 mL) and the mixture cooled to 0 °C. Et3N (27 mL) was then 
added dropwise the stirring solution over 10 minutes by addition funnel. Upon 
completion of the addition, the cooling bath was removed and the reaction was heated to 
50 °C over 16 h. The mixture was cooled to 0 °C to yield a milky solution, which was 
filtered and washed with cold methanol to provide alkyne 204v as a colorless solid (771 
mg, 72% yield) 
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1H NMR (500 MHz, DMSO) δ 8.35 (d, J = 1.6 Hz, 1H), 8.02 (d, J = 1.0 
Hz, 1H), 7.29 – 7.19 (m, 3H), 7.18 – 7.12 (m, 2H), 4.15 (s, 1H), 3.19 – 
3.11 (m, 2H), 2.88 (dd, J = 13.5, 4.9 Hz, 1H), 2.63 (dd, J = 16.9, 3.2 Hz, 1H), 2.40 (dd, J 
= 17.0, 4.7 Hz, 1H), 0.91 (t, J = 7.9 Hz, 9H), 0.50 (q, J = 7.9 Hz, 6H); 13C NMR (126 
MHz, DMSO) δ 166.6, 166.0, 135.8, 130.1, 128.0, 126.7, 104.0, 83.9, 55.4, 52.6, 38.4, 
24.8, 7.3, 3.9; FTIR (NaCl, thin film): cm-1; 2916, 2350, 1732, 1651, 1557, 1455; [α]D25 
= –19.4 (c = 0.28, CHCl3);  HRMS (MM) calc’d [M+H]+ 357.1993, found 357.1992. 
 
Alkyne 204w 
 
 To a solution of methyl ester 204a (550 mg, 1.5 mmol, 1.00 equiv) in THF/H2O 
(4 mL/2 mL) at 0 °C under a positive pressure of N2 was added aqueous LiOH (1 M, 1.9 
mL, 1.2 equiv).  After 1 hour, the reaction was quenched by slow addition of 1 M HCl (3 
mL) and Et2O (6 mL).  The layers were separated and the aqueous was extracted with 
Et2O (3X, 10 mL).  The organics were combined, washed with brine, dried over MgSO4, 
filtered and concentrated in vacuo to afford a colorless oil.  The oil was dissolved in 24 
mL THF and cooled to 0 °C under a positive pressure of N2.  EDC (337 mg, 1.8 mmol, 
1.2 equiv), anhydrous HOBt (277 mg, 2.0 mmol, 1.4 equiv) and Et3N (610 µL, 4.4 mmol, 
3.0 equiv) were added sequentially.  After 5 minutes of stirring, a solution of (l)-Phe-
OMe•HCl  (347 mg, 1.6 mmol, 1.1 equiv) in THF (10 mL) was added via cannula.  The 
reaction was warmed to room temperature and stirred for 12 h.  The heterogeneous 
solution was concentrated and purified by chromatography on silica gel (20% ethyl 
acetate, 80% hexanes) to give white, amorphous solid 204w (500 mg, 1.02 mmol, 70% 
yield) 
N
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O
HNSET
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1H NMR (500 MHz, CDCl3, Major Rotamer) δ 7.30 – 7.19 (m, 3H), 
7.13 – 7.04 (m, 2H), 6.84 (d, J = 4.9 Hz, 1H), 5.25 (s, 1H), 4.81 
(ddd, J = 7.5, 6.0, 6.0 Hz, 1H), 4.22 (d, J = 4.9 Hz, 1H), 3.67 (s, 3H), 3.18 – 3.01 (m, 
2H), 2.74 (dd, J = 17.1, 6.1 Hz, 1H), 2.65 (dd, J = 17.1, 6.5 Hz, 1H), 1.42 (s, 9H), 0.95 (t, 
J = 7.9 Hz, 9H), 0.55 (q, J = 7.9 Hz, 6H); 13C NMR (126 MHz, CDCl3) δ 171.3, 169.9, 
155.3, 135.7, 129.1, 128.4, 127.0, 102.5, 85.5, 80.2, 53.4, 53.0, 52.2, 38.0, 28.1, 23.3, 7.7, 
4.2; FTIR (NaCl, thin film): cm-1; 3319, 2954, 2935, 2874, 2177, 1746, 1689, 1660, 
1527, 1498, 1456, 1367, 1274, 1251, 1172, 1048, 1017; [α]D25 = +39.2 (c = 4.29, CHCl3);  
HRMS (MM) calc’d [M–C4H9]+ 433.2153, found 433.2138. 
 
Alkyne 204u 
 
  To a solution of Boc-alkyne 204a (500 mg, 1.5 mmol, 1.00 equiv) in CH2Cl2 (15 
mL) at 0 °C was added TFA (2.0 mL).  The mixture was warmed to room temperature 
and stirred for 3 hours, after which PhMe (30 mL) was added and the reaction 
concentrated.  The resultant oil was dissolved in THF (10 mL) and cooled to 0 °C under a 
positive pressure of N2.  In a separate flask, (l)-Boc-Phe-OH (466 mgs, 1.8 mmol, 1.2 
equiv) was dissolved in THF (24 mL) and cooled to 0 °C. EDC (337 mg, 1.8 mmol, 1.2 
equiv), anhydrous HOBt (277 mg, 2.0 mmol, 1.4 equiv) and Et3N (610 µL, 4.4 mmol, 3.0 
equiv) were added sequentially.  After stirring for 5 minutes, the alkyne was transferred 
via cannula.  The reaction was warmed to room temperature and stirred for 12 h.  The 
heterogeneous reaction was concentrated and purified by chromatography on silica gel 
O
HNSET
Boc
OMe
1) TFA/CH2Cl2
2) EDC, HOBt, Et3N, Boc–L–Phe
(77% yield)
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(20% ethyl acetate, 80% hexanes) to provide the product as a colorless oil (552 mg, 1.13 
mmol, 77% yield). 
1H NMR (500 MHz, CDCl3, Major Rotamer) δ 7.28 – 7.22 (m, 2H), 
7.19 (dd, J = 7.1, 7.1 Hz, 3H), 6.77 (d, J = 6.3 Hz, 1H), 5.16 (d, J = 
5.9 Hz, 1H), 4.67 (d, J = 6.5 Hz, 1H), 4.44 (d, J = 6.1 Hz, 1H), 3.70 (s, 3H), 3.11 (dd, J = 
13.9, 6.3 Hz, 1H), 2.98 (dd, J = 12.8, 6.6 Hz, 1H), 2.73 (dd, J = 17.0, 4.0 Hz, 1H), 2.57 
(dd, J = 17.1, 5.3 Hz, 1H), 1.35 (s, 9H), 0.98 – 0.87 (m, 9H), 0.57 – 0.46 (m, 6H); 13C 
NMR (126 MHz, CDCl3) δ170.8, 170.4, 155.2, 136.4, 129.2, 128.4, 126.7, 101.3, 85.5, 
79.8, 55.3, 52.4, 50.8, 38.4, 28.1, 23.5, 7.3, 4.1; FTIR (NaCl, thin film): cm-1; 3419, 
3335, 2963, 2868, 2179, 1743, 1661, 1518, 1451, 1365; [α]D25 = +52.7 (c = 5.4, CHCl3);  
HRMS (MM) calc’d [M+H]+ 489.2779, found 489.2793. 
 
Alkyne 204y 
 
 To a solution of Boc-alkyne 204a (1.00 g, 2.9 mmol, 1.00 equiv) in CH2Cl2 (30 
mL) at 0 °C was added TFA (4 mL).  The mixture was warmed to room temperature and 
stirred for 3 hours, after which PhMe (100 mL) was added and the reaction concentrated.  
The resultant oil was dissolved in THF (10 mL) and cooled to 0 °C under a positive 
pressure of N2.  In a separate flask, (R)-2-hydroxy-3-methylbutanoic acid (346 mgs, 2.9 
mmol, 1.0 equiv) was dissolved in THF (100 mL) and cooled to 0 °C. EDC (674 mg, 3.5 
mmol, 1.2 equiv), anhydrous HOBt (554 mg, 4.1 mmol, 1.4 equiv) and hünigs base (1.5 
mL, 8.6 mmol, 3.0 equiv) were added sequentially.  After stirring for 5 minutes, the 
alkyne was transferred via cannula.  The reaction was warmed to room temperature and 
stirred for 12 h.  The heterogeneous reaction was concentrated and purified by 
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chromatography on silica gel (100% ethyl acetate) to provide the product as a colorless 
oil (995 mg, 2.9 mmol, 99% yield). 
1H NMR (500 MHz, CD3CN, Major Rotamer) δ 7.43 (d, J = 7.6 
Hz, 1H), 4.59 (dt, J = 8.2, 5.3 Hz, 1H), 3.89 (dd, J = 5.5, 3.1 Hz, 
1H), 3.71 (d, J = 5.6 Hz, 1H), 3.69 (s, 3H), 2.80 (dd, J = 17.2, 
5.5 Hz, 1H), 2.73 (dd, J = 17.2, 5.2 Hz, 1H), 2.07 (heptd, J = 6.9, 3.1 Hz, 1H), 1.01 – 
0.93 (m, 12H), 0.82 (d, J = 6.9 Hz, 3H), 0.61 – 0.52 (m, 6H); 13C NMR (126 MHz, 
CD3CN) δ 174.2, 171.7, 118.3, 103.6, 85.8, 76.4, 53.0, 51.4, 32.7, 23.9, 19.5, 15.9, 7.8, 
5.0; FTIR (NaCl, thin film): cm-1; 3385, 2952, 2863, 2176, 1744, 1653, 1507; [α]D25 = -
+89.4 (c = 3.40, CHCl3);  HRMS (MM) calc’d [M+H]+ 342.2095, found 342.2087. 
 
4.7.4  Optimization of reaction parameters 
 
Optimization Procedure – In a glovebox, an oven-dried 1 dram vial was charged 
with 2-bromoaniline (17.2 mg, 0.1 mmol, 1.0 equiv), alkyne 204a (68.3 mg, 0.2 mmol, 
2.0 equiv), base (2.5 equiv), Pd-catalyst (0.05 equiv), and appropriate solvent (0.5 mL).   
The vial was sealed and heated to the required temperature for 2 – 36 h.  Upon cooling, 
the crude reaction mixture was filtered through a silica plug, thoroughly washed with 
ethyl acetate and concentrated in vacuo to provide a crude oil.    
The crude residue was dissolved in a standard solution of 2,3,5,6-tetrachloronitrobenzene 
in DMSO-d6, and the yield of 205 was determined by 1H NMR by integration relative to 
the internal standard. 
** In entry 9 of Table 1, Pd2(dba)3 and PtBu3 were prestired for 1 h before being added to 
a vial containing the other reagents. 
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4.7.5  Substrate scope – characterization data 
 
General Procedure I:  In a glovebox, a 2 dram vial was charged with bromoaniline (0.3 
mmol, 1.0 equiv), alkyne 204a (0.6 mmol, 2.0 equiv), Cy2NMe (0.75 mmol, 2.5 equiv), 
Pd[P(PtBu)3]2 (0.015 mmol, 0.05 mmol) and anhydrous 1,4-dioxane (1.5 mL, 0.2 M).  
The vial was sealed and heated to 60 °C until there was complete consumption of starting 
material (12 – 72 h).  In most cases the solution became cloudy as the reaction 
progressed.  Upon cooling, the crude mixture was filtered through a plug of silica, which 
was subsequently flushed with ethyl acetate.  The organics were concentrated and the 
crude residue was purified by chromatography on silica gel to provide tryptophan 
derivatives. 
 
General Procedure II:  In a glovebox, a 2 dram vial was charged with bromoaniline (0.3 
mmol, 1.0 equiv), alkyne 204a (0.6 mmol, 2.0 equiv), Cy2NMe (0.75 mmol, 2.5 equiv), 
Pd[P(PtBu)3]2 (0.015 mmol, 0.05 mmol) and anhydrous 1,4-dioxane (1.5 mL, 0.2 M).  
The vial was sealed and heated to 80 °C until there was complete consumption of starting 
material (12 – 72 h).  In most cases the solution became cloudy as the reaction 
progressed.  Upon cooling, the crude mixture was filtered through a plug of silica, which 
was subsequently flushed with ethyl acetate.  The organics were concentrated and the 
crude residue was purified by chromatography on silica gel to provide tryptophan 
derivatives. 
 
General Procedure III:  In a glovebox, a 2 dram vial was charged with bromoaniline 
(0.3 mmol, 1.0 equiv), alkyne 204a (0.6 mmol, 2.0 equiv), Cy2NMe (0.75 mmol, 2.5 
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equiv), Pd[P(PtBu)3]2 (0.015 mmol, 0.05 mmol) and anhydrous 1,4-dioxane (1.5 mL, 0.2 
M).  The vial was sealed and heated to 80 °C until there was complete consumption of 
starting material (12 – 72 h).  In most cases the solution became cloudy as the reaction 
progressed.  Upon cooling, the crude mixture was filtered through a plug of silica, which 
was subsequently flushed with ethyl acetate.  The organics were concentrated and the 
crude residue was dissolved in 1M TBAF in THF. After 20 minutes, aqueous NH4Cl was 
added and the reaction mixture was partitioned in a separatory funnel.  The aqueous layer 
was back extracted with ethyl acetate (3 X 15 mL).   The organics were then recombined, 
washed with brine, dried over Na2SO4, filtered and concentrated.  The crude residue was 
purified using silica gel chromatography. 
 
Tryptophan 205a 
Prepared following General Procedure I (36 h).  The crude residue was 
purified by silica gel chromatography (88% hexanes, 12% ethyl acetate) 
to afford 3a as a colorless oil (113.6 mg, 0.26 mmol, 88% yield).  1H NMR (500 MHz, 
CDCl3, Major Rotamer) δ 8.04 (s, 1H), 7.57 (d, J = 7.9 Hz, 1H), 7.36 (d, J = 8.1 Hz, 1H), 
7.21 – 7.15 (m, 1H), 7.09 (dd, J = 7.4, 7.4 Hz, 1H), 4.93 (d, J = 7.7 Hz, 1H), 4.57 (dd, J = 
14.4, 7.1 Hz, 1H), 3.63 (s, 3H), 3.36 – 3.18 (m, 2H), 1.36 (s, 9H), 1.05 – 0.98 (m, 9H), 
0.97 – 0.89 (m, 6H); 13C NMR (126 MHz, CDCl3) δ 173.7, 155.1, 138.5, 132.8, 128.6, 
122.4, 119.5, 119.3, 118.9, 110.8, 79.6, 54.2, 52.2, 29.3, 28.2, 7.4, 3.7; FTIR (NaCl, thin 
film): cm-1; 3383, 2954, 2911, 2875, 1739, 1700, 1501, 1456, 1367, 1284, 1164; [α]D25 = 
+1.4 (c = 1.4, CHCl3);  HRMS (MM) calc’d [M+H]+ 433.2517, found 433.2519. 
 
N
H
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Tryptophan 205b 
Prepared following General Procedure I (36 h).  The crude residue was 
purified by silica gel chromatography (88% hexanes, 12% ethyl acetate) 
to afford 205b as a colorless oil (102.9 mg, 0.230 mmol, 77% yield).   1H NMR (500 
MHz, CD3CN, Major Rotamer) δ 8.68 (s, 1H), 7.37 (dd, J = 7.0, 1.3 Hz, 1H), 6.99 – 6.91 
(m, 2H), 5.41 (d, J = 7.8 Hz, 1H), 4.37 (dd, J = 14.9, 7.6 Hz, 1H), 3.57 (s, 3H), 3.29 (dd, 
J = 14.5, 6.7 Hz, 1H), 3.13 (dd, J = 14.5, 7.8 Hz, 1H), 2.51 (s, 3H), 1.32 (s, 9H), 1.01 – 
0.95 (m, 15H); 13C NMR (126 MHz, CD3CN) δ 173.9, 156.1, 139.4, 133.2, 129.3, 123.6, 
121.7, 121.5, 120.2, 117.2, 79.9, 56.1, 52.6, 29.6, 28.4, 17.4, 7.8, 4.3; FTIR (NaCl, thin 
film): cm-1; 3396, 2954, 2912, 2874, 1704, 1498, 1366, 1279, 1217, 1163, 1018; [α]D25 = 
–5.8 (c = 0.40, CHCl3);  HRMS (MM) calc’d [M–C4H9]+ 391.2048, found 391.2038. 
 
Tryptophan 205c 
Prepared following General Procedure II (12 h).  The crude residue was 
purified by silica gel chromatography (80% hexanes, 20% acetone) to 
afford 205c as a white, amorphous solid (114.3 mg, 0.234 mmol, 78% 
yield).   1H NMR (500 MHz, CD3CN, Major Rotamer) δ 9.22 (s, 1H), 8.33 (s, 1H), 7.31 
(d, J = 8.1 Hz, 1H), 7.08 (t, J = 7.7 Hz, 1H), 6.94 (d, J = 7.4 Hz, 1H), 5.54 (s, 1H), 4.34 
(dd, J = 15.7, 7.6 Hz, 1H), 3.60 (s, 3H), 3.37 (dd, J = 14.7, 6.1 Hz, 1H), 3.14 – 2.95 (m, 
1H), 2.13 (s, 3H), 1.34 – 1.18 (m, 9H), 1.03 – 0.89 (m, 15H); 13C NMR (126 MHz, 
CD3CN) δ 174.3, 171.1, 156.2, 141.6, 134.4, 130.5, 124.7, 122.8, 119.8, 118.5, 110.7, 
79.9, 57.0, 52.6, 29.3, 28.4, 23.8, 7.7, 4.3; FTIR (NaCl, thin film): cm-1; 3313, 2953, 
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1700, 1672, 1506, 1367, 1168; [α]D25 = –18.3 (c = 1.10, CHCl3);  HRMS (MM) calc’d 
[M+H]+ 490.2732, found 490.2719. 
 
Tryptophan 205d 
Prepared following General Procedure I (36 h).  The crude residue was 
purified by silica gel chromatography (85% hexanes, 15% ethyl 
acetate) to afford 205d as a colorless oil (102.2 mg, 0.220 mmol, 74% yield).  1H NMR 
(500 MHz, CD3CN, Major Rotamer) δ 8.95 (s, 1H), 7.28 (d, J = 8.8 Hz, 1H), 7.03 (d, J = 
1.5 Hz, 1H), 6.77 (dd, J = 8.8, 2.4 Hz, 1H), 5.53 (d, J = 8.2 Hz, 1H), 4.36 (dd, J = 14.6, 
8.2 Hz, 1H), 3.82 (s, 3H), 3.60 (s, 3H), 3.26 (dd, J = 14.5, 6.1 Hz, 1H), 3.08 (dd, J = 14.5, 
8.2 Hz, 1H), 1.28 (s, 9H), 1.01 – 0.95 (m, 9H), 0.95 – 0.91 (m, 6H); 13C NMR (126 MHz, 
CD3CN) δ 174.0, 156.1, 154.7, 135.2, 134.1, 130.0, 120.5, 113.3, 112.6, 101.1, 79.8, 
56.3, 56.2, 52.6, 29.8, 28.4, 7.7, 4.2; FTIR (NaCl, thin film): cm-1; 3379, 2953, 2874, 
1700, 1620, 1506, 1437, 1391, 1366, 1218, 1164; [α]D25 = +6.3 (c = 3.75, CHCl3);  
HRMS (MM) calc’d [M–C4H9]+ 407.1997, found 407.1994. 
Tryptophan 205e 
Prepared following General Procedure I (36 h).  The crude residue was 
purified by silica gel chromatography (88% hexanes, 12% ethyl acetate) 
to afford 205e as a colorless oil (97.2 mg, 0.216 mmol, 72% yield).	    1H NMR (500 MHz, 
CDCl3, Major Rotamer) δ 8.01 (s, 1H), 7.26 – 7.22 (m, 1H), 7.21 – 7.14 (m, 1H), 6.91 
(ddd, J = 8.9, 8.9, 2.2 Hz, 1H), 4.93 (d, J = 8.2 Hz, 1H), 4.53 (dd, J = 14.7, 7.0 Hz, 1H), 
3.65 (s, 3H), 3.30 – 3.14 (m, 2H), 1.35 (s, 9H), 1.05 – 0.97 (m, 9H), 0.96 – 0.88 (m, 6H); 
13C NMR (126 MHz, CDCl3) δ 173.17, 157.69 (d, JC-F = 234.9 Hz), 155.00, 135.12 (d, 
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JC-F = 13.4 Hz), 129.00 (d, JC-F = 9.2 Hz), 119.56 (d, JC-F = 4.7 Hz), 111.30 (d, JC-F = 9.8 
Hz), 110.83 (d, JC-F = 26.5 Hz), 103.61 (d, JC-F = 23.6 Hz), 79.75, 54.15, 52.26, 29.48, 
28.17, 7.38, 3.62; FTIR (NaCl, thin film): cm-1; 3372, 2956, 2875, 1734, 1718, 1700, 
1502, 1437, 1367, 1166, 1073, 1010; [α]D25 = +3.6 (c = 2.0, CHCl3);  HRMS (MM) 
calc’d [M+H]+ 395.1797, found 395.1804. 
 
Trytophan 205f 
Prepared following General Procedure I (36 h).  The crude residue was 
purified by silica gel chromatography (80% hexanes, 20% acetone) to 
afford 205f as a colorless oil (114.3 mg, 0.245 mmol, 82% yield).   1H NMR (500 MHz, 
CD3CN, Major Rotamer) δ 8.87 (s, 1H), 7.50 (d, J = 8.0 Hz, 1H), 7.17 (dd, J = 7.5, 0.8 
Hz, 1H), 7.08 – 6.97 (m, 1H), 5.50 (d, J = 8.1 Hz, 1H), 4.37 (dd, J = 15.1, 7.9 Hz, 1H), 
3.56 (s, 3H), 3.29 (dd, J = 14.5, 6.5 Hz, 1H), 3.12 (dd, J = 14.5, 8.0 Hz, 1H), 1.29 (s, 9H), 
1.02 – 0.96 (m, 15H); 13C NMR (126 MHz, CD3CN) δ 173.7, 156.1, 136.6, 135.3, 131.5, 
122.6, 122.4, 120.8, 118.6, 116.9, 79.9, 56.2, 52.6, 29.7, 28.4, 7.7, 4.2; FTIR (NaCl, thin 
film): cm-1; 3380, 2954, 2875, 1734, 1718, 1507, 1499, 1366, 1164; [α]D25 = +6.9 (c = 
0.87, CHCl3);  HRMS (MM) calc’d [M+H]+ 411.1501, found 411.1504. 
 
Tryptophan 205g 
Prepared following General Procedure I (36 h).  The crude residue 
was purified by silica gel chromatography (88% hexanes, 12% ethyl 
acetate) to afford 205g as a colorless oil (103.9 mg, 0.222 mmol, 74% yield).  1H NMR 
(500 MHz, CDCl3, Major Rotamer) δ 7.98 (s, 1H), 7.46 (d, J = 8.5 Hz, 1H), 7.33 (s, 1H), 
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7.04 (d, J = 8.5 Hz, 1H), 4.92 (d, J = 8.1 Hz, 1H), 4.55 (dd, J = 14.7, 7.1 Hz, 1H), 3.61 (s, 
3H), 3.22 (d, J = 6.6 Hz, 2H), 1.35 (s, 9H), 1.04 – 0.97 (m, 9H), 0.94 – 0.88 (m, 6H); 13C 
NMR (126 MHz, CDCl3) δ 173.2, 155.0, 138.8, 133.9, 128.4, 127.3, 120.1, 119.7, 110.7, 
79.8, 54.2, 52.3, 29.5, 28.2, 7.4, 3.6; FTIR (NaCl, thin film): cm-1; 3369, 2954, 2875, 
1738, 1699, 1505, 1439, 1392, 1367, 1338, 1163, 1062; [α]D25 = +7.1 (c = 1.63, CHCl3);  
HRMS (MM) calc’d [M+H]+ 467.2127, found 467.2129. 
 
Tryptophan 205h 
Prepared following General Procedure III (36 h).  The crude residue was 
purified by silica gel chromatography (80% hexanes, 20% acetone) to 
afford 205h as a colorless oil (61.2 mg, 0.245 mmol, 52% yield).   1H NMR (500 MHz, 
CD3CN, Major Rotamer) δ 9.33 (s, 1H), 7.54 (d, J = 7.9 Hz, 1H), 7.34 (d, J = 7.2 Hz, 
1H), 7.17 (d, J = 1.7 Hz, 1H), 7.00 (dd, J = 7.8, 7.8 Hz, 1H), 5.51 (d, J = 7.4 Hz, 1H), 
4.43 (dd, J = 13.5, 7.6 Hz, 1H), 3.64 (s, 3H), 3.23 (dd, J = 14.7, 5.4 Hz, 1H), 3.10 (dd, J = 
14.7, 7.7 Hz, 1H), 1.35 (s, 89H); 13C NMR (126 MHz, CD3CN) δ 173.5, 156.2, 135.6, 
130.0, 125.5, 125.0, 121.3, 119.0, 112.5, 105.2, 79.9, 55.3, 52.7, 28.4, 28.3; FTIR (NaCl, 
thin film): cm-1; 3365, 2968, 1738, 1696, 1501, 1434, 1365, 1335; [α]D25 = +44.0 (c = 
0.385, CHCl3);  HRMS (MM) calc’d [M–C5H10O2]+ 297.0233, found 297.0229. 
 
Tryptophan 205i 
Prepared following General Procedure II (12 h, 80 °C).  The crude 
residue was purified by silica gel chromatography (88% hexanes, 12% 
ethyl acetate) to afford 205i as a white, amorphous solid (113.7 mg, 0.243 mmol, 82% 
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yield).   1H NMR (500 MHz, CD3CN, Major Rotamer) δ 9.29 (s, 1H), 7.38 (dd, J = 7.8, 
0.9 Hz, 1H), 7.06 (dd, J = 7.7, 7.7 Hz, 1H), 7.02 (dd, J = 7.5, 1.2 Hz, 1H), 5.41 (d, J = 7.7 
Hz, 1H), 4.53 (dd, J = 15.2, 8.8 Hz, 1H), 3.61 (s, 3H), 3.55 (dd, J = 14.3, 5.7 Hz, 1H), 
3.28 – 3.17 (m, 1H), 1.23 (s, 9H), 1.02 – 0.89 (m, 15H); 13C NMR (126 MHz, CD3CN) δ 
173.8, 156.1, 141.7, 136.0, 125.8, 125.7, 123.5, 121.1, 120.5, 111.4, 79.8, 57.2, 52.5, 
29.8, 28.3, 7.7, 4.2; FTIR (NaCl, thin film): cm-1; 3369, 2954, 2934, 2875, 1721, 1700, 
1499, 1456, 1436, 1366, 1167; [α]D25 = –9.0 (c = 4.1, CHCl3);  HRMS (MM) calc’d [M–
C4H9]+ 411.1501, found 411.1505. 
 
Tryptophan 205j 
Prepared following General Procedure I (36 h).  The crude residue was 
purified by silica gel chromatography (88% hexanes, 12% ethyl acetate) 
to afford 205j as a colorless oil (109.1 mg, 0.188 mmol, 72% yield).  1H NMR (500 
MHz, CD3CN, Major Rotamer) δ 9.36 (s, 1H), 7.25 (dd, J = 10.0, 7.1 Hz, 1H), 5.58 (d, J 
= 8.4 Hz, 1H), 4.32 (dd, J = 14.7, 8.5 Hz, 1H), 3.59 (s, 3H), 3.24 (dd, J = 14.7, 6.0 Hz, 
1H), 3.04 (dd, J = 14.6, 8.7 Hz, 1H), 1.27 (s, 9H), 1.03 – 0.90 (m, 15H); 13C NMR (126 
MHz, CD3CN) δ 173.5, 156.0, 147.0 (dd, JC-F = 236.4, 11.9 Hz), 139.5 – 137.1 (m), 
137.4 (d, JC-F = 3.6 Hz), 137.2 (ddd, JC-F = 239.4, 18.9, 12.5 Hz), 125.8 (dd, JC-F = 9.1, 
5.4 Hz), 124.3 (dd, JC-F = 10.4, 2.1 Hz), 122.5 – 122.1 (m), 101.08 (d, JC-F = 19.1 Hz), 
79.87, 56.24, 52.70, 29.44, 28.32, 7.62, 4.04; FTIR (NaCl, thin film): cm-1; 3351, 2956, 
2876, 1700, 1514, 1467, 1436, 1367, 1350, 1165; [α]D25 = +4.2 (c = 0.65, CHCl3);  
LRMS (ESI) calc’d [M–C4H9]+ 431.5, found 431.2. 
 
N
H
TES
NHBoc
CO2MeF
F
F
Chapter 4 – A Mild and General Larock Indolization Protocol for the Synthesis of Unnatural 
Tryptophan Derivatives: Total Synthesis of (–)-Aspergilazine A 
440 
Tryptophan 205k 
Prepared following General Procedure I (36 h).  The crude residue was 
purified by silica gel chromatography (85% hexanes, 15% ethyl 
acetate) to afford 205k as a yellow oil (105.0 mg, 0.219 mmol, 73% yield).  1H NMR 
(500 MHz, CD3CN, Major Rotamer) δ 9.66 (s, 1H), 8.30 (d, J = 2.0 Hz, 1H), 7.91 (dd, J 
= 8.9, 2.1 Hz, 1H), 7.66 (d, J = 8.9 Hz, 1H), 5.59 (d, J = 8.4 Hz, 1H), 4.37 (dd, J = 15.0, 
8.3 Hz, 1H), 3.57 (s, 3H), 3.32 (dd, J = 14.6, 6.3 Hz, 1H), 3.15 (dd, J = 14.6, 8.4 Hz, 1H), 
1.26 (s, 9H), 1.05 – 0.92 (m, 15H); 13C NMR (126 MHz, CD3CN) δ 173.5, 156.1, 144.0, 
142.1, 138.1, 134.1, 121.9, 119.8, 114.9, 108.6, 79.9, 56.3, 52.7, 29.6, 28.3, 7.6, 4.0; 
FTIR (NaCl, thin film): cm-1; 3380, 2968, 2873, 1736, 1716, 1696, 1508, 1330, 1162, 
1065, 1004; [α]D25 = +7.9 (c = 0.75, CHCl3);  LRMS (ESI) calc’d [M+H]+ 478.3, found 
478.3. 
 
Tryptophan 205l 
Prepared following General Procedure I (36 h).  The crude residue was 
purified by silica gel chromatography (80% hexanes, 20% ethyl acetate) 
to afford 205l as a white, amorphous solid (109.0 mg, 0.238 mmol, 79% yield).  1H NMR 
(500 MHz, CD3CN, Major Rotamer) δ 9.48 (s, 1H), 8.03 (s, 1H), 7.51 (d, J = 8.5 Hz, 
1H), 7.38 (dd, J = 8.5, 1.5 Hz, 1H), 5.66 (d, J = 8.8 Hz, 1H), 4.35 (ddd, J = 9.0, 9.0, 5.5 
Hz, 1H), 3.62 (s, 3H), 3.31 (dd, J = 14.6, 5.4 Hz, 1H), 3.10 (dd, J = 14.6, 9.2 Hz, 1H), 
1.23 (s, 9H), 1.00 – 0.93 (m, 15H); 13C NMR (126 MHz, CD3CN) δ 173.5, 155.9, 141.4, 
136.9, 129.6, 126.0, 125.3, 122.3, 121.8, 113.0, 102.4, 79.8, 56.5, 52.7, 29.6, 28.3, 7.6, 
4.0; FTIR (NaCl, thin film): cm-1; 3350, 2953, 2878, 2218, 1728, 1696, 1508, 1370, 
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1167; [α]D25 = –2.3 (c = 2.2, CHCl3);  HRMS (MM) calc’d [M+H]+ 458.2470, found 
458.2454. 
 
Tryptophan 205 
Prepared following General Procedure I (36 h).  The crude residue 
was purified by silica gel chromatography (85% hexanes, 15% 
ethyl acetate – 80% hexanes, 20% ethyl acetate) to afford 205m as 
a white, amorphous solid (127.0 mg, 0.227 mmol, 76% yield).  1H NMR (500 MHz, 
CDCl3, Major Rotamer) δ 8.10 – 7.98 (m, 2H), 7.61 (d, J = 8.2 Hz, 1H), 7.33 (d, J = 8.2 
Hz, 1H), 4.90 (d, J = 8.1 Hz, 1H), 4.56 (dd, J = 14.4, 6.7 Hz, 1H), 3.75 (s, 3H), 3.39 – 
3.24 (m, 2H), 1.36 (d, J = 2.8 Hz, 12H), 1.32 (s, 9H), 1.03 – 0.97 (m, 9H), 0.96 – 0.90 
(m, 6H); 13C NMR (126 MHz, CDCl3) δ173.1, 155.2, 140.5, 133.1, 128.6, 128.4, 126.7, 
120.1, 110.2, 83.4, 79.5, 54.0, 52.3, 28.8, 28.2, 24.9, 7.4, 3.7 (carbon adjacent to Boron 
was not observed); FTIR (NaCl, thin film): cm-1; 3379, 2976, 2874, 1741, 1700, 1499, 
1351, 1146; [α]D25 = +15.0 (c = 1.0, CHCl3);  HRMS (MM) calc’d [M+H]+ 558.3406, 
found 558.3388. 
 
Tryptophan 205n 
Prepared following General Procedure I (12 h).  The crude residue was 
purified by silica gel chromatography (98% dichloromethane, 2% 
methanol) to afford 205n as a light yellow oil (111.2 mg, 0.256 mmol, 85% yield).   1H 
NMR (500 MHz, CDCl3, Major Rotamer) δ 9.78 (d, J = 14.4 Hz, 1H), 8.28 (d, J = 3.8 
Hz, 1H), 7.90 (d, J = 7.7 Hz, 1H), 7.03 (dd, J = 7.7, 4.8 Hz, 1H), 5.14 (d, J = 8.4 Hz, 1H), 
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4.59 (dd, J = 15.0, 7.1 Hz, 1H), 3.59 (s, 3H), 3.25 (d, J = 6.8 Hz, 2H), 1.33 (s, 9H), 1.02 – 
0.88 (m, 15H); 13C NMR (126 MHz, CDCl3) δ173.3, 155.0, 150.8, 143.3, 134.0, 127.3, 
120.9, 118.1, 115.2, 79.7, 54.2, 52.2, 29.8, 28.1, 7.3, 3.6; FTIR (NaCl, thin film): cm-1; 
3380, 3226, 2953, 1743, 1691, 1582, 1496, 1439, 1367, 1283, 1172; [α]D25 = +8.7  (c = 
2.5, CHCl3);  HRMS (MM) calc’d [M+H]+ 434.2470, found 434.2490. 
 
Tryptopahn 205o 
Prepared following General Procedure I (36 h).  The crude residue was 
purified by silica gel chromatography (98% dichloromethane, 2% 
methanol) to afford 205o as a light yellow oil (119.5 mg, 0.249 mmol, 83% yield).   1H 
NMR (500 MHz, CD3CN, Major Rotamer) δ 9.79 (s, 1H), 8.78 (dd, J = 4.3, 1.7 Hz, 1H), 
8.76 (ddd, J = 8.3, 1.5, 0.7 Hz, 1H), 7.86 (d, J = 8.9 Hz, 1H), 7.66 – 7.59 (m, 1H), 7.47 
(dd, J = 8.3, 4.3 Hz, 1H), 5.60 (d, J = 8.3 Hz, 1H), 4.40 (dd, J = 15.0, 7.8 Hz, 1H), 3.57 
(s, 3H), 3.37 (dd, J = 14.5, 6.6 Hz, 1H), 3.22 (dd, J = 14.5, 8.0 Hz, 1H), 1.26 (s, 9H), 1.01 
(s, 15H); 13C NMR (126 MHz, CD3CN) δ 173.8, 156.1, 148.6, 147.4, 133.9, 133.3, 130.0, 
125.6, 123.3, 123.1, 122.0, 121.2, 117.8, 80.0, 56.6, 52.7, 29.5, 28.4, 7.8, 4.4; FTIR 
(NaCl, thin film): cm-1; 3350, 2953, 2873, 1734, 1717, 1700, 1696, 1570, 1496, 1377, 
1164; [α]D25 = +8.7 (c = 1.2, CHCl3);  HRMS (MM) calc’d [M+H]+484.2626, found 
484.2621. 
 
Tryptophan 205p 
Prepared following General Procedure I (36 h).  The crude residue was 
purified by silica gel chromatography (88% hexanes, 12% ethyl 
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acetate) to afford 205p as a colorless foam (103.2 mg, 0.213 mmol, 71% yield). 1H NMR 
(500 MHz, CDCl3, Major Rotamer) δ 8.67 (s, 1H), 8.05 (d, J = 8.1 Hz, 1H), 7.92 (d, J = 
8.0 Hz, 1H), 7.64 (d, J = 8.7 Hz, 1H), 7.56 – 7.51 (m, 1H), 7.49 (d, J = 8.7 Hz, 1H), 7.44 
(ddd, J = 8.1, 7.0, 1.1 Hz, 1H), 4.97 (d, J = 7.9 Hz, 1H), 4.61 (app q, J = 7.1 Hz, 1H), 
3.62 (s, 3H), 3.34 (d, J = 6.8 Hz, 2H), 1.35 (s, 9H), 1.08 – 1.02 (m, 9H), 1.02 – 0.97 (m, 
6H); 13C NMR (126 MHz, CDCl3) δ173.3, 155.1, 133.6, 130.7, 130.6, 128.8, 125.4, 
124.6, 124.2, 121.4, 121.3, 120.4, 119.4, 118.9, 79.7, 54.4, 52.3, 28.2, 24.7, 7.5, 3.8; 
FTIR (NaCl, thin film): cm-1; 3409, 3350, 2953, 2868, 1743, 1694, 1501, 1392, 1362, 
1165; [α]D25 = +54.8 (c = 0.97, CHCl3);  HRMS (MM) calc’d [M–C4H9]+ 427.2048, 
found 427.2066. 
 
Tryptophan 205q 
Prepared following General Procedure I (36 h).  The crude residue was 
purified by silica gel chromatography (88% hexanes, 12% ethyl acetate) 
to afford 205q as a colorless oil (70.1 mg, 0.156 mmol, 52% yield).   1H NMR (500 MHz, 
CD3CN, Major Rotamer) δ 7.51 (d, J = 8.0 Hz, 1H), 7.35 (d, J = 8.3 Hz, 1H), 7.20 (ddd, J 
= 8.2, 6.9, 1.1 Hz, 1H), 7.04 (ddd, J = 7.9, 7.0, 0.9 Hz, 1H), 5.41 (d, J = 7.3 Hz, 1H), 4.33 
(dd, J = 15.1, 7.5 Hz, 1H), 3.83 (s, 3H), 3.52 (s, 3H), 3.33 (dd, J = 14.6, 7.1 Hz, 1H), 3.18 
(dd, J = 14.5, 7.4 Hz, 1H), 1.37 – 1.23 (m, 9H), 1.03 – 0.95 (m, 15H); 13C NMR (126 
MHz, CD3CN) δ 173.9, 156.1, 141.0, 135.5, 129.6, 123.2, 121.8, 119.6, 119.5, 110.2, 
80.0, 56.4, 52.5, 33.8, 28.9, 28.4, 7.9, 5.2; FTIR (NaCl, thin film): cm-1; 3350, 2956, 
2876, 1700, 1516, 1465, 1367, 1165; [α]D25 = +4.9 (c = 0.34, CHCl3);  HRMS (MM) 
calc’d [M–C4H9]+ 391.20480, found 391.2034. 
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Tryptophan 205r 
Prepared following General Procedure III (12 h).  The crude residue was 
purified by silica gel chromatography (20% acetone, 80% hexanes) to 
afford 205r as a colorless oil (80.2 mg, 0.203 mmol, 68% yield).   1H 
NMR (500 MHz, CD3CN, Major Rotamer) δ7.63 (d, J = 7.8 Hz, 1H), 7.58 – 7.50 (m, 
5H), 7.41 – 7.35 (m, 1H), 7.31 (s, 1H), 7.25 – 7.19 (m, 1H), 7.19 – 7.14 (m, 1H), 5.58 (d, 
J = 7.8 Hz, 1H), 4.51 (dd, J = 13.5, 7.7 Hz, 1H), 3.67 (s, 3H), 3.31 (dd, J = 14.7, 5.4 Hz, 
1H), 3.18 (dd, J = 14.7, 7.6 Hz, 1H), 1.35 (s, 9H); 13C NMR (126 MHz, CD3CN) δ 173.6, 
156.3, 140.4, 136.7, 130.7, 130.0, 127.9, 127.3, 124.8, 123.5, 121.1, 120.0, 118.3, 113.0, 
111.4, 79.9, 55.2, 52.7, 28.5; FTIR (NaCl, thin film): cm-1; 3380, 2966, 2930, 1741, 
1714, 1501, 1455, 1367; [α]D25 = +32.1 (c = 1.86, CHCl3);  HRMS (MM) calc’d [M–
C4H9]+ 339.1339, found 339.1326. 
 
Tryptophan 205s 
Prepared following General Procedure I (36 h).  The crude residue was 
purified by silica gel chromatography (86% hexanes, 14% ethyl acetate) 
to afford 205s as a colorless oil (107.0 mg, 0.226 mmol, 75% yield).   1H NMR (500 
MHz, CD3CN, Major Rotamer) δ 7.75 (d, J = 8.4 Hz, 1H), 7.61 (d, J = 7.8 Hz, 1H), 7.35 
(ddd, J = 8.5, 7.2, 1.3 Hz, 1H), 7.27 (ddd, J = 7.6, 7.6, 0.8 Hz, 1H), 5.57 (d, J = 8.3 Hz, 
1H), 4.40 (dd, J = 15.2, 8.0 Hz, 1H), 3.54 (s, 3H), 3.37 (dd, J = 14.4, 6.7 Hz, 1H), 3.20 
(dd, J = 14.3, 8.2 Hz, 1H), 2.78 (s, 3H), 1.30 (s, 9H), 1.00 – 0.89 (m, 15H); 13C NMR 
(126 MHz, CD3CN) δ 173.4, 171.0, 156.1, 138.0, 137.1, 133.7, 131.2, 125.9, 123.4, 
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120.4, 115.2, 80.0, 55.9, 52.7, 28.8, 28.4, 27.0, 8.6, 6.9; FTIR (NaCl, thin film): cm-1; 
3373, 2953, 2874, 1746, 1700, 1499, 1435, 1369, 1321, 1223, 1167, 1109; [α]D25 = +5.0 
(c = 0.69, CHCl3);  HRMS (MM) calc’d [M–C4H9]+ 419.1997, found 419.1986. 
 
Tryptophan 205t 
Prepared following General Procedure III (24 h).  The crude residue was 
purified by silica gel chromatography (25% acetone, 75% hexanes) to 
afford 205t as a colorless oil (68.9 mg, 0.216 mmol, 72% yield).   1H NMR (500 MHz, 
CD3CN, Major Rotamer) δ 7.60 (d, J = 7.2 Hz, 1H), 7.58 (s, 1H), 7.49 (d, J = 8.1 Hz, 
1H), 7.36 – 7.30 (m, 1H), 7.27 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 5.63 (d, J = 6.5 Hz, 1H), 
4.48 (dd, J = 13.5, 7.9 Hz, 1H), 3.67 (s, 3H), 3.20 (dd, J = 14.8, 5.3 Hz, 1H), 3.07 (dd, J = 
14.8, 8.0 Hz, 1H), 1.35 (s, 9H); 13C NMR (126 MHz, CD3CN) δ 173.2, 156.0, 144.1, 
128.8, 125.4, 123.6, 120.7, 118.3, 116.8, 112.2, 80.0, 54.5, 52.8, 28.4, 26.6; FTIR (NaCl, 
thin film): cm-1; 3375, 2977, 2925, 1744, 1716, 1690, 1505, 1455, 1367, 1165; [α]D25 = 
+16.8 (c = 0.64, CHCl3);  LRMS (MM) calc’d [M–C4H9]+ 263.2, found 263.2. 
 
Tryptophan 205u 
Prepared following General Procedure I (36 h).  The crude residue 
was purified by silica gel chromatography (80% hexanes, 20% 
acetone) to afford 205u as a colorless oil (109.1 mg, 0.188 mmol, 63% yield).   1H NMR 
(500 MHz, CD3CN, Major Rotamer) δ 9.10 (s, 1H), 7.59 (dd, J = 7.9, 0.8 Hz, 1H), 7.40 
(d, J = 8.1 Hz, 1H), 7.29 – 7.19 (m, 3H), 7.16 – 7.05 (m, 3H), 7.05 – 7.01 (m, 1H), 6.69 
(d, J = 6.1 Hz, 1H), 5.24 (d, J = 6.4 Hz, 1H), 4.62 (dd, J = 13.1, 6.8 Hz, 1H), 4.23 (ddd, J 
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= 8.4, 8.4, 5.7 Hz, 1H), 3.60 (s, 3H), 3.24 (ddd, J = 14.4, 6.5, 4.7 Hz, 1H), 3.08 – 2.91 (m, 
3H), 1.25 (s, 9H), 1.03 – 0.88 (m, 15H); 13C NMR (126 MHz, CD3CN) δ173.2, 172.1, 
156.2, 139.8, 138.3, 133.3, 130.2, 129.7, 129.1, 127.4, 122.8, 120.4, 119.8, 119.4, 112.1, 
79.9, 56.2, 55.4, 52.6, 38.4, 29.7, 28.4, 7.7, 4.2; FTIR (NaCl, thin film): cm-1; 3380, 
2948, 2878, 1736, 1666, 1506, 1367, 1244, 1165; [α]D25 = –4.2 (c = 1.6, CHCl3);  HRMS 
(MM) calc’d [M+H]+ 580.3201, found 580.3206. 
 
Tryptophan 205v 
Prepared following General Procedure I (72 h).  The crude residue was 
purified by silica gel chromatography (55% hexanes, 40% ethyl acetate, 
5% methanol) to afford 205v as a colorless oil (95.2 mg, 0.213 mmol, 71% yield).   1H 
NMR (500 MHz, CDCl3) δ 8.15 (s, 1H), 7.39 (d, J = 8.2 Hz, 1H), 7.36 – 7.32 (m, 2H), 
7.29 (ddd, J = 6.3, 5.1, 2.1 Hz, 2H), 7.22 (ddd, J = 8.1, 7.0, 1.1 Hz, 1H), 7.18 (dd, J = 8.0, 
1.2 Hz, 2H), 7.10 (ddd, J = 7.9, 7.0, 0.9 Hz, 1H), 6.94 (d, J = 2.2 Hz, 1H), 5.64 (s, 1H), 
4.24 (ddd, J = 5.2, 5.2, 2.5 Hz, 1H), 3.59 (dd, J = 14.5, 3.8 Hz, 1H), 3.45 (dd, J = 11.5, 
3.8 Hz, 1H), 3.14 (d, J = 5.1 Hz, 2H), 2.87 (dd, J = 14.5, 11.5 Hz, 1H), 1.02 – 0.94 (m, 
9H), 0.90 – 0.82 (m, 6H); 13C NMR (126 MHz, CDCl3) δ 168.8, 167.0, 138.7, 134.8, 
133.9, 129.9, 128.9, 127.6, 127.6, 122.8, 119.7, 118.7, 118.0, 111.1, 56.6, 53.3, 40.2, 
30.0, 7.4, 7.4, 3.7; FTIR (NaCl, thin film): cm-1; 3356, 3226, 2958, 2864, 1676, 1451, 
1437, 1316; [α]D25 = +5.6 (c = 0.47, CHCl3);  HRMS (MM) calc’d [M+H]+ 448.2415, 
found 448.2426. 
 
Tryptophan 205w 
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Prepared following General Procedure I (36 h).  The crude residue 
was purified by silica gel chromatography (80% hexanes, 20% 
acetone) to afford 205w as a colorless oil (108.0 mg, 0.186 mmol, 
62% yield).1H NMR (500 MHz, CD3CN, Major Rotamer) δ 9.10 (s, 1H), 7.59 (dd, J = 
7.9, 0.8 Hz, 1H), 7.40 (d, J = 8.1 Hz, 1H), 7.29 – 7.19 (m, 3H), 7.16 – 7.05 (m, 3H), 7.05 
– 7.01 (m, 1H), 6.69 (d, J = 6.1 Hz, 1H), 5.24 (d, J = 6.4 Hz, 1H), 4.62 (dd, J = 13.1, 6.8 
Hz, 1H), 4.23 (ddd, J = 8.4, 8.4, 5.7 Hz, 1H), 3.60 (s, 3H), 3.24 (ddd, J = 14.4, 6.5, 4.7 
Hz, 1H), 3.08 – 2.91 (m, 3H), 1.25 (s, 9H), 1.03 – 0.88 (m, 15H); 13C NMR (126 MHz, 
CD3CN) δ 172.6, 172.3, 156.0, 140.1, 137.6, 133.4, 130.3, 129.6, 129.3, 127.7, 122.9, 
121.0, 119.8, 119.7, 112.0, 80.0, 57.1, 54.3, 52.7, 38.2, 29.6, 28.3, 7.8, 4.3, 4.2; FTIR 
(NaCl, thin film): cm-1; 3370, 2953, 2878, 1745, 1666, 1508, 1449, 1370, 1241, 1170; 
[α]D25 = +10.0 (c = 1.06, CHCl3);  HRMS (MM) calc’d [M+H]+ 580.3201, found 
580.3206. 
 
Tryptophan 205x 
Prepared following General Procedure I (72 h).  The crude residue was 
purified by silica gel chromatography (55% hexanes, 40% ethyl acetate, 
5% methanol) to afford 3x as an amorphous, white solid (98.6 mg, 0.249 mmol, 83% 
yield).   1H NMR (500 MHz, CDCl3) δ 8.12 (s, 1H), 7.56 (dd, J = 7.9, 0.7 Hz, 1H), 7.40 
(ddd, J = 8.2, 0.8, 0.8 Hz, 1H), 7.22 (ddd, J = 8.2, 7.0, 1.1 Hz, 1H), 7.11 (ddd, J = 8.0, 
7.0, 0.9 Hz, 1H), 5.59 (s, 1H), 4.42 (dd, J = 11.8, 2.4 Hz, 1H), 4.07 (dd, J = 11.6, 4.5 Hz, 
1H), 3.84 (dd, J = 15.0, 3.9 Hz, 1H), 3.75 – 3.66 (m, 1H), 3.65 – 3.54 (m, 1H), 3.00 (dd, J 
= 15.0, 11.8 Hz, 1H), 2.39 – 2.29 (m, 1H), 2.13 – 2.00 (m, 2H), 1.99 – 1.87 (m, 1H), 1.04 
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– 0.98 (m, 9H), 0.94 – 0.85 (m, 6H); 13C NMR (126 MHz, CDCl3) δ 169.0, 165.7, 138.9, 
133.6, 127.9, 123.0, 119.9, 118.8, 118.3, 111.3, 59.2, 54.8, 45.4, 28.4, 27.5, 22.6, 7.4, 
3.8; FTIR (NaCl, thin film): cm-1; 3365, 2953, 2873, 1671, 1456, 1412, 1303, 1239; [α]D-
25 = –34.4 (c = 0.82, CHCl3);  HRMS (MM) calc’d [M+H]+ 398.2258, found 398.2272. 
 
Tryptophan 205y 
Prepared following General Procedure II (0.87 mmol scale, 12 h).  
The crude residue was purified by silica gel chromatography (100% 
ethyl acetate) to afford 205y as a light yellow oil (370.2 mg, 0.756 
mmol, 86% yield).   1H NMR (500 MHz, CD3CN, Major Rotamer) δ 9.28 (s, 1H), 8.44 
(s, 1H), 7.35 (d, J = 8.1 Hz, 1H), 7.17 (d, J = 5.6 Hz, 1H), 7.11 (t, J = 7.8 Hz, 1H), 6.96 
(d, J = 7.4 Hz, 1H), 4.53 (dt, J = 10.3, 6.3 Hz, 1H), 3.65 (s, 3H), 3.64 – 3.62 (m, 1H), 
3.59 (d, J = 5.9 Hz, 1H), 3.45 (dd, J = 14.7, 6.2 Hz, 1H), 3.17 (dd, J = 14.7, 10.3 Hz, 1H), 
2.19 (s, 3H), 1.91 – 1.79 (m, 1H), 1.07 – 0.94 (m, 15H), 0.87 (dd, J = 15.7, 4.0 Hz, 3H), 
0.70 (d, J = 6.8 Hz, 3H); 13C NMR (126 MHz, CD3CN) δ 174.4, 173.6, 171.5, 141.7, 
134.9, 130.2, 124.9, 122.9, 119.4, 118.9, 110.9, 76.3, 52.6, 32.6, 29.5, 29.3, 23.8, 19.4, 
15.6, 7.7, 4.3; FTIR (NaCl, thin film): cm-1; 3324, 2956, 2875, 1742, 1657, 1516, 1435, 
1369; [α]D25 = –1.8 (c = 1.3, CHCl3);  HRMS (MM) calc’d [M+H]+ 490.2732, found 
490.2772. 
4.7.6  Stability of tryptophan center 
 
In order to confirm that the tryptophan products were not undergoing deleterious 
racemization under the reaction conditions, tryptophan 205a was desilylated with 1 N 
HCl/MeOH and compared to racemic N-Boc-tryptophan methyl ester  through chiral SFC 
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analysis (AD-H, 2.5 mL/min, 10% IPA in CO2, λ = 254 nm):  tR(minor) = 19.6 min, 
tR(major) = 21.2 min.  We observed no racemization of the tryptophan stereocenter under 
the reaction conditions.  Additionally, Larock indole syntheses using dipeptide-derived 
alkynes to provide tryptohans 205u – 205y show the formation of a single diastereomer 
of product by crude 1H NMR and LCMS, further supporting the stability of the 
tryptophan stereocenter under Larock conditions.  The low optical rotations exhibited by 
tryptophans 205a – 205z are consistent with literature values of related compounds. 
 
 
 
 
 
4.7.7  Scale-up and desilylation of tryptophan 205o 
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In a glovebox, pyridyl aniline 203o (865 mg, 5.0 mmol, 1.0 equiv), alkyne 204a 
(2.56 g, 7.5 mmol, 1.5 equiv), Pd[P(tBu)3]2 (64 mg, 0.125 mmol, 0.025 equiv), and 
Cy2NMe (2.7 mL, 12.5 mmol, 2.5 equiv) were combined in a 50 mL flask.  The solids 
were dissolved in 15 mL 1,4-dioxane and the solution was heated to 60 °C for 30 h.  
Upon cooling, the milky yellow solution was filtered through a silica plug, which was 
washed thoroughly with ethyl acetate.  The solution was concentrated and then 
redissolved in 50 mL ethyl acetate and 1 M TBAF in THF (5 mL).  After 20 minutes, 
aqueous NH4Cl was added and the reaction mixture was partitioned in a separatory 
funnel.  The aqueous layer was back extracted with ethyl acetate (3 X 150 mL).   The 
organics were then recombined, washed with brine, dried over Na2SO4, filtered and 
concentrated.  The crude residue was purified using silica gel chromatography (60% 
hexanes, 35% ethyl acetate, 5% methanol) to afford tryptophan as a light yellow solid 
(1.28 g, 80% yield). 
 
1H NMR (500 MHz, CD3CN, Major Rotamer) δ 10.06 (s, 1H), 8.30 – 8.18 (m, 1H), 7.94 
– 7.85 (m, 1H), 7.20 (s, 1H), 7.06 (dd, J = 7.9, 4.7 Hz, 1H), 5.64 (d, J = 7.7 Hz, 1H), 4.45 
(dd, J = 13.4, 7.6 Hz, 1H), 3.64 (s, 3H), 3.23 (dd, J = 14.7, 5.4 Hz, 1H), 3.11 (dd, J = 
14.7, 7.5 Hz, 1H), 1.34 (s, 9H); 13C NMR (126 MHz, CD3CN) δ 173.6, 156.2, 149.6, 
143.8, 127.8, 125.0, 120.7, 116.3, 110.0, 79.9, 55.3, 52.7, 28.4, 28.4; FTIR (NaCl, thin 
N
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film): cm-1; 3365, 2978, 1743, 1698, 1511, 1434, 1362; [α]D25 = 49.1 (c = 1.25, CHCl3);  
HRMS (MM) calc’d [M+H]+ 320.1605, found 320.1594. 
4.7.8  Total synthesis of (–)-aspergilazine A 
 
 
 In a glove box, a flame-dried 250 mL flask was charged with iodobromobenzene 
(771 µL, 6.0 mmol, 1.0 equiv), dianiline 212 (1.34 g, 7.2 mmol, 1.2 equiv), Pd2(dba)3 (54 
mg, 0.06 mmol, 0.01 equiv), rac-BINAP (75 mg, 0.12 mmol, 0.02 equiv), and NaOtBu 
(865 mg, 9.0 mmol, 1.5 equiv).  60 mL of PhMe was added and the reaction flask was 
sealed and heated to 70 °C for 3.5 hours.  Upon cooling, the reaction mixture was filtered 
through a plug of silica gel, which was flushed with ethyl acetate.  The organics were 
concentrated and purified by silica gel chromatography (20% acetone, 80% hexanes) to 
provide the diarylamine 7 as a light yellow oil (1.54 g, 75% yield). 
1H NMR (500 MHz, CDCl3) δ 7.59 (dd, J = 8.0, 1.4 Hz, 1H), 7.36 (d, J = 8.5 Hz, 1H), 
7.31 (dd, J = 8.2, 1.6 Hz, 1H), 7.27 – 7.20 (m, 1H), 6.83 (ddd, J = 8.0, 7.2, 1.6 Hz, 1H), 
6.56 (d, J = 2.5 Hz, 1H), 6.49 (dd, J = 8.5, 2.6 Hz, 1H), 6.03 (s, 1H), 4.11 (s, 2H); 13C 
NMR (126 MHz, CDCl3) δ144.6, 141.9, 140.7, 132.9, 132.8, 128.0, 121.2, 116.6, 112.5, 
111.2, 106.3, 101.9; FTIR (NaCl, thin film): cm-1; 3464, 3380, 1612, 1582, 1511, 1459, 
1407, 1330, 1303, 1276; HRMS (MM) calc’d [M+H]+ 340.9284, found 340.9264. 
 
Synthesis of bis-triethylsilyl-(–)-aspergilazine A 
 
I NH2H2N
NaOt-Bu (2.0 equiv)
 PhMe, 70 °C
(75% yield)
NH2
N
Br
HBr Br
Br
Pd2(dba)3 (1 mol%)
rac-BINAP (2 mol%)
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In a glovebox, a one dram vial was charged with diarylamine (35 mg, 0.1 mmol, 
1.0 equiv), alkyne 209 (94 mg, 0.3 mmol, 3.0 equiv), Cy2NMe (55 µL, 0.25 mmol, 2.5 
equiv), Pd[P(tBu)3]2 (5.2 mg, 0.01 mmol, 0.1 equiv) and 1,4-dioxane (500 µL).  The vial 
was sealed and heated to 80 °C for 4 hours.  Upon cooling, the reaction mixture was 
filtered through celite, which was washed with ethyl acetate (15 mL).  The organics were 
concentrated and the crude reaction mixture was purified by preparative reverse phase 
HPLC (65–85% acetonitrile in H2O, 30 mL/min, 20 min) to give the product as a 
colorless solid (49.5 mg, 62% yield). 
1H NMR (500 MHz, CD2Cl2, Major Rotamer) δ 8.47 (d, J = 11.0 Hz, 1H), 7.72 (dd, J = 
8.3, 2.5 Hz, 1H), 7.69 – 7.64 (m, 1H), 7.47 (dd, J = 7.6, 1.6 Hz, 1H), 7.21 – 7.11 (m, 3H), 
7.03 – 6.94 (m, 1H), 5.71 (s, 1H), 5.56 (s, 1H), 4.60 – 4.52 (m, 1H), 4.52 – 4.47 (m, 1H), 
4.25 – 4.08 (m, 2H), 3.98 – 3.84 (m, 2H), 3.78 – 3.68 (m, 2H), 3.67 – 3.57 (m, 2H), 3.22 
(ddd, J = 14.7, 11.7, 2.9 Hz, 1H), 3.11 (ddd, J = 14.9, 11.7, 1.4 Hz, 1H), 2.46 – 2.30 (m, 
2H), 2.18 – 2.03 (m, 4H), 2.05 – 1.89 (m, 2H), 1.19 – 1.08 (m, 9H), 1.08 – 0.98 (m, 6H), 
0.98 – 0.84 (m, 9H), 0.75 – 0.52 (m, 6H); FTIR (NaCl, thin film): cm-1; 3375, 2963, 
2859, 1671, 1446, 1414; [α]D25 = –79.5 (c = 0.055, 1:1 DCM:MeOH);  HRMS (MM) 
calc’d [M–SiC6H15]+ 679.3423, found 679.3426. 
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The 1H NMR was found to coalesce in deuterated acetonitrile at 60 °C. The 13C NMR 
was still rotameric, even at elevated temperature. 
1H NMR (400 MHz, CD3CN) δ 9.42 (s, 1H), 7.74 (d, J = 8.3 Hz, 1H), 7.72 – 7.65 (m, 
1H), 7.51 (s, 1H), 7.22 – 7.04 (m, 3H), 6.94 (s, 1H), 5.60 (s, 1H), 5.49 (s, 1H), 4.47 (dd, J 
= 11.4, 11.4 Hz, 2H), 4.15 (t, J = 7.7 Hz, 2H), 3.85 (d, J = 14.7 Hz, 1H), 3.79 (dd, J = 
15.0, 4.2 Hz, 1H), 3.72 – 3.58 (m, 2H), 3.50 (ddd, J = 11.6, 8.1, 3.8 Hz, 2H), 3.28 – 3.16 
(m, 1H), 3.12 (dd, J = 14.9, 10.8 Hz, 1H), 2.33 – 2.15 (m, 2H), 2.06 – 1.70 (m, 6H), 1.23 
– 0.94 (m, 11H), 0.88 (t, J = 7.7 Hz, 6H), 0.74 – 0.51 (m, 5H). 
 
Synthesis of (–)-aspergilazine A 
 
The silylated compound (49.5 mg, 0.06 mmol, 1.0 equiv) was dissolved in 1 N 
HCl in MeOH (10 mL) and allowed to stir for 15 minutes.  The reaction was quenched by 
addition of aqueous NaHCO3 and diluted with ethyl acetate.  The organics were removed 
in vacuo and the aqueous extracted with ethyl acetate (3 X 20 mL).  The organics were 
combined, dried over Na2SO4, filtered, and concentrated.  The crude residue was purified 
by silica gel chromatography (5% MeOH, 95% CH2Cl2) to provide (–)-aspergilazine A as 
a colorless solid (26.0 mg, 74% yield). 
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Spectroscopic and physical data, including 1H, 13C NMR in DMSO-d6, IR, and MS 
obtained for (–)-aspergilazine A matched that as reported during isolation by Gu et. Al 
and data obtained by Sperry and co-workers. See below for 1H and 13C comparison table.  
 
 1H NMR (500 MHz, DMSO) δ 11.05 (s, 1H), 7.98 (s, 1H), 7.87 (s, 1H), 7.73 (d, J = 8.4 
Hz, 1H), 7.67 (d, J = 7.9 Hz, 1H), 7.47 (d, J = 8.3 Hz, 1H), 7.45 (s, 1H), 7.43 (d, J = 1.7 
Hz, 1H), 7.28 (d, J = 2.0 Hz, 1H), 7.18 – 7.14 (m, 1H), 7.14 – 7.11 (m, 1H), 7.09 (t, J = 
7.4 Hz, 1H), 4.39 (t, J = 4.8 Hz, 1H), 4.35 (t, J = 4.7 Hz, 1H), 4.12 – 4.05 (m, 2H), 3.45 – 
3.35 (m, 3H), 3.33 – 3.20 (m, 3H), 3.19 – 3.10 (m, 2H), 2.05 – 1.89 (m, 2H), 1.79 – 1.49 
(m, 4H), 1.47 – 1.31 (m, 2H);  13C NMR (126 MHz, DMSO) δ 169.6, 169.5, 165.9, 
165.9, 136.5, 136.0, 133.5, 129.0, 128.8, 126.5, 126.2, 122.5, 120.2, 119.9, 115.7, 111.4, 
110.5, 110.2, 107.1, 58.9, 55.7, 55.6, 45.1, 28.2, 26.3, 26.2, 22.3, 22.3; FTIR (NaCl, thin 
film): cm-1; 3365, 3246, 2933, 1666, 1459, 1414; [α]D25 = –90.6 (c = 0.625, 1:1 
CH2Cl2:MeOH);  HRMS (MM) calc’d [M+H]+ 565.2558, found 565.2555. 
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Comparison of 1H NMR data for Natural vs. Synthetic (-)-Aspergilazine A 
Isolation 
(–)-Aspergilazine A 
1H NMR, 600 MHz, DMSO 
This Work 
(–)-Aspergilazine A 
1H NMR, 500 MHz, DMSO 
δ 11.09 (s, 1H) 11.05 (s, 1H) 
8.00 (s, 1H) 7.98 (s, 1H) 
7.89 (s, 1H) 7.87 (s, 1H) 
7.75 (br d, J = 8.4 Hz, 1H) 7.73 (d, J = 8.4 Hz, 1H) 
7.68 (br d, J = 7.8 Hz, 1H) 7.67 (d, J = 7.9 Hz, 1H) 
7.48 (d, J = 8.2 Hz, 1H) 7.47 (d, J = 8.3 Hz, 1H) 
7.47 (s, 1H) 7.45 (s, 1H) 
7.45 (d, J = 1.9 Hz, 1H) 7.43 (d, J = 1.7 Hz, 1H) 
7.29 (d, J = 1.7 Hz, 1H) 7.28 (d, J = 2.0 Hz, 1H) 
7.16 (ddd, J = 7.7, 7.4, 1.0 1H) 7.18 – 7.14 (m, 1H) 
7.14 (dd, J = 8.3, 1.9, 1H) 7.14 – 7.11 (m, 1H) 
7.09 (ddd, J = 7.4, 7.4, 0.8 1H) 7.09 (t, J = 7.4 Hz, 1H) 
4.41 (dd, J = 4.9, 5.0 Hz, 1H) 4.39 (dd, J = 4.8, 4.8 Hz, 1H) 
4.37 (dd, J = 5.0, 5.0 Hz, 1H) 4.35 (t, J = 4.7 Hz, 1H) 
4.07 (dd, J = 8.3, 8.3 Hz, 2H) 4.12 – 4.05 (m, 2H) 
3.38 (m, 3H) 3.45 – 3.35 (m, 3H) 
3.26 (m, 3H) 3.33 – 3.20 (m, 3H) 
3.16 (m, 2H) 3.19 – 3.10 (m, 2H) 
1.98 (m, 2H) 2.05 – 1.89 (m, 2H) 
1.65 (m, 4H) 1.79 – 1.49 (m, 4H) 
1.37 (m, 2H) 1.47 – 1.31 (m, 2H) 
 
Comparison of 13C NMR data for Natural vs. Synthetic (–)-Aspergilazine A 
Isolation 
(–)-Aspergilazine A 
13C NMR, 150 MHz, DMSO 
This Work 
(–)-Aspergilazine A 
13C NMR, 126 MHz, DMSO 
Chemical Shift Difference, Δδ 
169.7 169.6 0.1 
169.6 169.5 0.1 
166.0 165.9 0.1 
165.9 165.9 0.0 
136.7 136.5 0.2 
136.2 136.0 0.2 
133.6 133.5 0.1 
129.1 129.0 0.1 
128.9 128.8 0.1 
126.6 126.5 0.1 
126.3 126.2 0.1 
122.6 122.5 0.1 
120.3 120.2 0.1 
119.9 119.9 0.0 
115.8 115.7 0.1 
111.5 111.4 0.1 
110.6 110.5 0.1 
110.3 110.2 0.1 
107.2 107.1 0.1 
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59.0 58.9 0.1 
59.0 58.9 0.1 
55.8 55.7 0.1 
55.7 55.6 0.1 
45.2 45.1 0.1 
45.2 45.1 0.1 
28.3 28.2 0.1 
28.3 28.2 0.1 
26.4 26.3 0.1 
26.3 26.2 0.1 
22.4 22.3 0.1 
22.4 22.3 0.1 
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